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Preface 
 
 
 
 
 
 
 
 
 
 
 
 
In this thesis several synthetic aspects of carbohydrate chemistry are explored with a 
particular emphasis on the development and implementation of mild glycosylation 
procedures. 
 
The use of Yb(OTf)3 and acid washed molecular sieves as alternative feasible promoters 
for trihaloacetimidate method is proposed. Their effectiveness is confirmed by the 
assembly of biologically relevant oligosaccharide structures in stepwise as well as in one-
pot fashion. 
 
The extreme mildness of the above mentioned promoting systems is demonstrated by the 
syntheses of novel glycoconjugates with pharmacological activity. 17β-Estradiol and 
derivatives thereof are regioselectively glycosylated in order to improve their 
pharmacokinetic and pharmacodinamic properties. Whereas, a peculiar β-lactam structure 
is variously conjugated to saccharidic structures with the aim of generating a novel class of 
antibiotics. 
 
Novel procedures are developed for the synthesis of synthetically useful glycosyl iodides 
and glycosyl phosphates, rendering the access to these classes of molecules more 
straightforward and experimentally convenient. 
 
Portions of this work have been adapted form the following articles that were co-written 
by the author: 
 
A. Ravidà, X. Liu, L. Kovacs, P. H. Seeberger “Synthesis of Glycosyl Phosphates from 
1,2-Orthoesters and Application to in Situ Glycosylation Reactions” Organic Letters 
2006, 9, 1815-1818. 
 
M. Adinolfi, A. Iadonisi, A. Ravidà “Tunable Activation of Glycosyl Trichloro- and 
(N-phenyl)Trifluoroacetimidates with Ytterbium(III) Triflate: One-pot Synthesis of 
Trisaccharides under Catalytic Conditions” Synlett  2006, 583-586. 
 
  ii
M. Adinolfi, P. Galletti, D. Giacomini, A. Iadonisi, A. Quintavalla, A. Ravidà “Toward 
Novel Glycoconjugates: Efficient Synthesis of Glycosylated 4-Alkylidene-β-lactams” 
European Journal of Organic Chemistry 2005, 69-73.  
 
M. Adinolfi, A. Iadonisi, A. Pezzella, A. Ravidà “Regioselective Phenol or Carbinol 
Glycosidation of 17β-Estradiol and Derivatives Thereof” Synlett  2005, 1848-1852.  
 
M. Adinolfi, A. Iadonisi, A. Ravidà, M. Schiattarella “Versatile Use of Ytterbium(III) 
Triflate and Acid Washed Molecular Sieves in the Activation of Glycosyl 
Trifluoroacetimidate Donors. Assemblage of a Biologically Relevant Tetrasaccharide 
Sequence of Globo H” Journal of Organic Chemistry 2005, 13, 5316-5319. 
 
M. Adinolfi, A. Iadonisi, A. Ravidà, M. Schiattarella “Effect of 1,2-Dimethoxyethane in 
Yb(OTf)3 Promoted Glycosidations” Tetrahedron Letters 2004, 23, 4485-4488.  
 
M. Adinolfi, A. Iadonisi, A. Ravidà, M. Schiattarella “Moisture Stable Promoters for 
Selective α-Fucosylation Reactions: Synthesis of Antigen Fragments” Synlett  2004, 
275-278.  
 
M. Adinolfi, A. Iadonisi, A. Ravidà, M. Schiattarella “Efficient and Direct Synthesis of 
Saccaridic 1,2-Ethylidenes, Orthoesters, and Glycals from Peracetylated Sugars via the 
in Situ Generation of Glycosyl Iodides with I2/Et3SiH” Tetrahedron Letters 2003, 44, 
7863-7866.  
Preface
 iii
List of Abbreviations 
 
 
 
 
)))  
13CNMR 
 
1HNMR 
 
Ac 
Ala 
All 
Alloc 
AW 300 MS 
 
AW 500 MS 
 
AW MS 
Bn 
BSA 
BSP 
Bz 
Bzd 
Cbz 
CIP 
Cp 
CSA 
CyHex 
DAST 
 
DBTO 
DBU 
DCC 
DCE 
DCM 
DIPEA 
DMAP 
DMDO 
DME 
DMF 
DMT 
 
DMTST 
 
DNA 
DPC 
DTBP 
Fmoc 
Gal 
GalNAc 
Gly 
GSLs 
HPLC 
 
Sonication 
Carbon nuclear magnetic 
resonance 
Proton nuclear magnetic 
resonance 
Acetyl 
Alanine 
Allyl 
Allyloxycarbonyl 
Acid washed molecular sieves 
4Å 
Acid washed molecular sieves 
5Å 
Acid washed molecular sieves 
Benzyl 
Bovine serum albumin 
1-Benzenesulfinyl piperidine 
Benzoyl 
Benzylidene 
Benzyloxycarbonyl 
Contact ion pair 
Cyclopentenyl 
(±)-Camphor-10-sulfonic acid 
Cyclohexane 
(Diethylamino)sulphur 
trifluoride 
Dibenzothiophene-5-oxide 
Diazabicyclo[5.4.0]undec-7-ene 
N,N’-Dicyclohexylcarbodiimide 
1,2-Dichloroethane 
Dichloromethane 
N-Ethyldiisopropylamine 
4-Dimethylaminopyridine 
Dimethyldioxyrane 
1,2-Dimethoxyethane 
N,N-Dimethylformamide 
4,4’-Dimethoxytrityl (=4,4’-
Dimethoxytriphenylmethyl) 
Dimethyl(methylthio)sulfonium 
triflate 
2’-Deoxyribonucleic acid 
N,N’-Diisopropylcarbodiimide 
2,6-Di-tert-butylpyridine 
9-Fluorenylmethyl-carbonate 
Galactose 
N-Acetyl galactosamine 
Glycine 
Glycosphingolipids 
High performance liquid 
chromatography 
HRMS 
 
IAD  
 
IDCP 
 
IDCT 
 
ImH 
KLH 
 
Lev 
Lex/y/a/b 
mAb 
MALDI 
 
MBz 
mDAP 
MIC 
 
mRNA 
Mur 
NAG 
NAM 
NBS 
NDPs 
 
NIS 
NISac 
PBP 
PCR 
PE 
PEG 
Pent 
PEP 
Ph 
PhH 
Phth 
Piv 
pMBn 
ppm 
Py 
RRVs 
RT 
Box 
SN1 
 
SN2 
 
SSIP 
High resolution mass 
spettrometry 
Intramolecular aglycon 
delivery 
Iodonium dicollidine 
perchlorate 
Iodonium dicollidine 
triflate 
Imidazole 
Keyhole limphet 
hemocyanin 
Levulinoyl 
Lewisx/y/a/b antigen 
Monoclonal antibody 
Matrix assisted laser 
desorption ionization 
4-Methoxybenzoyl 
meso-Diaminopimelic acid 
Minimum inhibition 
concentration 
Messenger ribonucleic acid 
Muraminic acid 
N-Acetyl glucosamine 
N-Acetyl muraminic acid 
N-bromo succinimide 
Nucleotide 5’-diphospho 
sugars 
N-iodo succinimide 
N-Iodosaccharin 
Penicillin binding protein 
Polymerase chain reaction 
Phytoalexin elicitor 
Poly(ethylene glycol) 
Pentenyl 
Phosphoenolpyruvate 
Phenyl 
Benzene 
Phtaloyl 
Pivaloyl 
para-Methoxybenzyl 
Parts per million 
Pyridine 
Relative reactivity values 
Room tempreature 
Benzoxazoyl 
Unimolecular nucleophilic 
substitution 
Bimolecular nucleophilic 
substitution 
Solvent separed ion pair 
  iv
TBAB 
TBAC 
TBAI 
TBDMS 
TBDPS 
TBS 
TCA 
TCL 
TES 
Tf 
 
TFA 
THF 
TIPS 
TMEDA 
 
TMS 
TMSOTf 
TOF 
Tr 
Troc 
Ts 
TTBP 
UDP 
WHO  
 
Tetrabutylammonium bromide 
Tetrabutylammonium chloride 
Tetrabutylammonium iodide 
tert-Butyldimethylsilyl 
tert-Butyldiphenylsilyl 
Tributylsilyl 
Trichloroacetyl 
Thin layer chromatography 
Triethylsilyl 
Trifluoromethansulfonyl (= 
Triflyl) 
Trifluoroacetic acid 
Tetrahydrofuran 
Triisopropylsilyl 
N,N,N’-
Trimethylethylenediamine 
Trimethylsilyl 
Trimethylsilyl triflate 
Time of flight 
Triphenylmethyl (= Trityl) 
Trichloroethoxycarbonyl 
Toluensulfonyl (=Tosyl) 
2,4,6-Tri-tert-butylpyridine 
Uridine 5’-diphosphate 
World Health Organisation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
List of Abbreviations
Chapter 1 
 
Introduction 
 
 
 
 
 
 
 
 
 
General Introduction 
Carbohydrates do represent a third class of bio-informative macromolecules, together with 
nucleic acids and proteins. This concept has strongly emerged only recently, although 
sugars have already been considered for very long time as one of the most important class 
of bio-molecules, because of their essential role in metabolism and as important structural 
components of biological systems.1 
The idea of carbohydrates, one of the most abundant macromolecules in nature, “just“ as 
energy source or building block for cell walls, is pretty limiting. Furthermore it’s very 
improbable that nature didn’t use the huge bio-informative potential of carbohydrates, far 
greater than that of nucleic acids or proteins. Abundant and diverse glycans cover all the 
cells of all living organisms. Carbohydrate chains are prominent components at the 
surfaces of mammalian cells, occurring as N- and O-glycans on glycoproteins, 
glycosaminoglycan chains on proteoglycans, and oligosaccharides of glycolipids. 
Carbohydrate chains also occur on many secreted and extra cellular glycoproteins. Some 
carbohydrate sequences are widely distributed in different cell types, while others, such as 
the blood group antigens,2 are genetically determined. Still others have a regulated 
expression at different stages of embryonic development and cellular differentiation.3  
A very different portrait of sugars has been emerging due to new rising fields of research 
gathered under the very general name of glycoscience.   
The study of the structure-function relation of carbohydrates and, especially, of 
oligosaccharide chains of carbohydrate-decorated molecules (also known as 
glycoconjugates) evidenced that the saccharidic moieties are very often involved in cell 
communication, signaling and trafficking processes, playing key roles in immune 
response, viral replication, cell-cell adhesion, fertilisation, parasitic infection, cell growth 
                                                 
1 Taylor M. E., Drickamer K. in Introduction to Glycobiology, Oxford University Press: New York, 2006. 
2 Lowe, J. B., in The molecular basis of blood diseases, Eds.: Stamatoyannopolous, G., Nienhuis, a. W., Majerus, P. 
W., Varmus, H., Saunders, Philadelphia, 1987, chap 8.   
3 Lehmann J. in Carbohydrates-Structure and Biology-, Thieme, Stuttgart·New York: 1998. 
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and differentiation, and inflammation.4 Cancer is another area where carbohydrates turn 
out to play a big role, helping to transmit the signals that trigger unchecked cell growth.5 
Obviously the involvement of carbohydrates in so many crucial biological processes 
suggested their use in medicinal chemistry. Several carbohydrate-based drugs have been 
developed in several different fields.6  
The multiplicity of signal trasduction processes involving specific oligosaccharide 
sequences put strongly in evidence the bio-informative nature of carbohydrates. But, in 
contrast to the two major classes of bio-informative macromolecules, in the case of sugars, 
scientists haven’t cracked the code yet. The pivotal, but still not well understood, role of 
sugars in so many and different cellular processes has been driving the scientific 
community to investigate the glycome -all the glycan molecules synthesized by an 
organism- in the same systematic way than for DNA and proteins. A new field of research 
has been opened named glycomics, in analogy with genomics and proteomics, with the 
aim of creating a cell-by-cell catalogue of glycan structures and glycosyltransferases 
involved in their bio-synthesis.  
 In 1958 F. Crick referred to the “central dogma” as a universally accepted rule for the 
direction of genetic information (DNA to mRNA, and mRNA to protein). Almost fifty 
years ago the central dogma ended with proteins, nowadays we should reconsider it, 
including the post-translational modifications of the proteins, terminating the cascade of 
the genetic information with glycans. 
Post-translational glycosylation of proteins is a non-template-driven synthesis, a glycan 
structure does not mimic the sequences of the proteins that produced it,  this means that at 
the sugars point  nature gives a new challenge to scientists: a code-break. The task of the 
glycoscientists is to decipher the “sweet-code”.  
From this point of view, glycomics is far behind genomics and proteomics, not only 
because the youngest subject, but also for the great structural complexity carbohydrates 
exhibit. While DNA and proteins have essentially linear sequences, sugars branch; DNA 
has just four basic building blocks and proteins have 20, but sugars have more than 30. 
The number of all linear and branched isomers of an hexasaccharide is calculated to be 
over 1x1012. Even a simple disaccharide composed of two glucose units can be represented 
by 19 different structures. 
Because of this great structural diversity between carbohydrates and the others bio-
informative molecules glyco-scientists have to face a completely different scenario, “the 
languages of both nucleic acids and proteins can be compared to the Western phonogram 
(alphabet); and that of glycans, to the Eastern ideogram (kanji)”.7 
 
                                                 
4 a) Rudd, P. M.; Elliot, T.; Cresswell, P.; Wilson, I. A.; Dwek, R. A. Science 2001, 291, 2370; b) Dwek, R. A. 
Chem. Rev. 1996, 96, 683; c) Feizi, T. Curr. Opin. Struct. Biol. 1993, 3, 701; d) Rosen, S. D.; Bertozzi, C. R. Curr. 
Biol. 1996, 6, 261; e) Varki, A. Glycobiology 1993, 3, 97; f) Philips, M. L.; Nudelman, E.; Gaeta, F. C. A.; Perez, 
M.; Singal, A. K.; Hakomori, S.; Paulson, J. C. Science 1990, 250, 1130; g) Lasky, L. A. Science 1992, 258, 964; 
Miller, D. J.; Macek, M. B.; Schur, B. D. Nature 1992, 357, 589; h)  Feizi, T. Nature 1985, 314, 53.  
5 a) Treves, A. J.; Carnaud, C.; Tranin, N.; Feldman, M.; Cohen, I. R. Eur. J. Immunol. 1974, 4, 722; b) Fujimoto, 
S.; Greene, M. I.; Sehon, A. H. J. Immunol. 1976, 116, 791; c) Naor, D. Adv. Cancer. Res. 1979, 29, 45; d) Dye, E. 
S.; North, R. J. J. Exp. Med. 1981, 154, 1033; e) Kirchner, H.; Chused, T. M.; Herberman, R. B.; Holden, H. T.; 
Lavrin, D. H. J. Exp. Med. 1974, 139, 1473. 
6 Carbohydrate-based Drug Discovery, Wong C. –H., Ed., Wiley-VCH: Weinheim, 2003. 
7 Hirabayashi, J.; Kasai, K.-I. Trends in Glycoscience and Glycotechnology, 2000,  63, 1. 
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Clearly, for unravelling the mysteries of sugars, elucidating their biological functions, pure 
oligosaccharides of defined structure are required in sufficient amounts for biophysical 
and biochemical studies. But these biomolecules are often found in nature in low 
concentrations and in microheterogeneous forms. Most glycoproteins are not uniform, but 
consist of various “glycoforms” differing in type, length, branching and terminal 
decoration of oligosaccharides, and number or site of glycosylation. The isolation of 
oligosaccharides in a pure form from natural sources is therefore extremely challenging, 
when at all possible. 
Access to pure carbohydrates for biological studies relies on chemical or enzymatic 
synthesis. No amplification methods analogous to the polymerase chain reaction (PCR) for 
DNA are available for carbohydrates, nor a fully developed automated synthesis 
technology as in the case of oligopeptides and oligonucleotides. Recently automated8 and 
computer-assisted9 synthetic approaches have been developed to boost the raising field of 
glycomics. To date these technologies are not yet diffused and in the glycolabs the 
synthesis of target molecules is still mainly practised by chemical synthesis. 
Enzymatic or chemoenzymatic approaches are certainly promising, but of the vast array of 
glycosyltranferases involved in biosynthetic pathways of carbohydrates, only a small 
fraction has been overexpressed and few of these are commercially available.10 
Additionally, glycosyltranferases have narrow substrate specificities, being able to catalyse 
the formation of single types of glycosidic linkages.  The extreme specificity exhibited by 
enzymes is the dream of every synthetic chemist, guaranteeing the desired glycosylation 
outcomes in terms of regio- and stereo-selectivity, without any previous chemical 
modification of the substrates. But, since every type of linkage requires a specific enzyme, 
the synthesis of target oligosaccharides via enzymatic catalysis is still expensive, every lab 
needing a wide library of glycosyltransferases.  
In conclusion, although lots of promising approaches for the synthesis of oligosaccharide 
have been emerging as the future, unfortunately we are still in the present and the 
chemical approach is still more reliable and cheap. 
Glycosylation Reaction 
The key step in oligosaccharide synthesis is surely the glycosylation reaction. The majority 
of glycosylations are performed by nucleophilic substitution reaction at the anomeric 
carbon (Scheme 1.1). 
 
O
X + ROH
O
OR
 
 
SCHEME 1.1 Glycoside Synthesis by Nucleophilic Substitution at the Anomeric Carbon. 
 
The glycosylating agent, in the vocabulary of carbohydrate chemists, is called glycosyl 
donor. Generally it carries a leaving group at the anomeric position, that can be activated 
by an appropriate promoter. Several different glycosylation methods exist whose 
classification relies on the nature of the leaving groups. Every class of leaving groups 
                                                 
8 Plante, O. J.; Palmacci, E. R.; Seeberger, P. H. Science 2001, 291, 1523. 
9 Zhang, Z.; Ollmann, I. R.; Ye, X. –S.; Wishnat, R.; Baasov, T.; Wong, C. –H. J. Am. Chem. Soc. 1999, 121, 734. 
10 Carbohydrates in Chemistry and Biology, Part II Vol.2, Ernst B., Hart G. W., Sinaÿ P., Eds, Wiley-VCH: 
Weinheim, 2000.  
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requires specific promoting systems. Since a universal glycosylation method - generally 
applicable - hasn’t been developed yet, several different methods are used in the 
glycolabs, and the choice depends on the specific reaction to be performed and on the 
planned synthetic strategy. 
The nucleophile species is generally called glycosyl acceptor (Scheme 1.2).  
 
OPO
PO
XOP
OP
+
OHO
PO
OPPO
OP OPO
PO
OP
OP
OO
PO
OPPO
OP
donor acceptor
promoter
P: Protecting group
 
SCHEME 1.2 Glycosylation Reaction. 
 
An ideal glycosylation reaction should be fast, high yielding, experimentally simple and 
completely regio- and stereo-selective. 
The regioselectivity of glycosidation is generally controlled by the use of  protection 
strategies. Both glycosyl donor and acceptor have several nuclephilic functionalities 
(mostly hydroxyl and amino groups) that are able to compete each other in the reaction 
with the glycosylating agent. The regioselective protection of all the potentially reactive 
moieties, but the one desired, allows the regiochemical outcome to be perfectly controlled. 
Stereoselectivity is one of the major challenge in glycosylation reactions. The anomeric 
carbon on the glycosyl donor is a chiral centre, thus the nucleophilic attack on it generates 
two diasteroisomers. If the newly formed glycosidic bond is axially oriented (on the 
saccharidic backbone of the former glycosyl donor), the resulting sugar is called α anomer; 
β anomer is formed when equatorial orientation is obtained (Figure 1.1). 
 
OHO
HO
OH
HO
OH
OHO
HO OH
HO
OH
α-anomer β-anomer  
 
FIGURE 1.1 Anomeric Configurations of D-Glucopyranose. 
 
Several approaches are used to achieve the desired stereoselectivity. The most effective 
method involves the use of neighboring group participation. Installation of an acyl 
protecting group at the donor O-2 generally results in excellent stereoselectivities for 1,2-
trans-glycoside syntheses. When formation of 1,2-cis-glycosides is required, different 
strategies have to be used. Very common is the use of solvent effect: coordinating solvents 
such as ethers or nitriles influence the stereochemical outcome of the reaction via the 
formation of intermediate carbocation-solvent adducts. 
Further aspects have to be considered when approaching to the synthesis of structures 
longer than a disaccharide. The synthesis of oligosaccharides requires a careful planning 
of the protection strategy and differentiation between permanent and temporary 
protecting groups is crucial. Thus, the building blocks synthesis becomes more complicate 
and time consuming. Also the synthetic strategy is a matter of choice, often driven by the 
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intrinsic nature of the target molecules. The oligosaccharide chain can be elongated 
following stepwise or convergent approaches, or more straightforwardly in one-pot 
fashion.  
Insights in all these aspects of the glycosylation reactions are the object of next paragraphs 
and represent the topic of several excellent work.11 
 
Glycosylation Methods 
As anticipated in the previous paragraph, glycosylations are mostly carried out by 
nucleophilic substitution at the anomeric carbon of the glycosyl donor. Other approaches 
are used such as the nucleophilic substitution at the aglycone carbon or addition reactions 
to 1,2-unsaturated sugars. 
Most of the methods belong to the first class, they are classified on the nature of the 
leaving group on the glycosyl donor and can be grouped according to the heteroatom  
attached to the anomeric center (Figure 1.2). 
 
O
XPO
O
SRPO
O
ORPO
Glycosyl halides Thio derivatives O-derivatives
Bromides and Chlorides
Fluorides
Iodides
Thioglycosides
Sulfoxides, Sulfones
Others
Imidates
1,2-Anhydro derivatives
Phosphates, Phosphites
Others  
 
FIGURE 1.2 Types of Glycosyl Donors. 
 
The departure of the leaving group is generally activated by the use of specific promoters. 
The choice of the glycosylation method implies the use of its specific promoter, this means 
that also the synthetic strategy has to be planned considering the compatibility of all 
protecting groups in the glycosylation conditions. 
Glycosyl halogenides (especially bromides and chlorides) were the first type of glycosyl 
donors used for the synthesis of complex oligosaccharides. 
Glycosylations with glycosyl bromides and chlorides in the presence of stoichiometric 
amounts of silver salts (Ag2O, Ag2CO3), known as the Koenigs-Knorr reaction,12 is one of 
the oldest glycosylation methods.  Over the years a wide variety of promoters to activate 
glycosyl halides in glycosylation reactions have been developed. The heavy metal salts 
frequently used as promoters include silver salts of hydroxyl carboxylic acids, such as 
silver salicilate,12b silver imidazolate,13 Hg(CN)2 and HgBr2,14 HgO and HgBr2,15 HgI216 and 
                                                 
11 a) Carbohydrates in Chemistry and Biology, Part II Vol.2, Ernst B., Hart G. W., Sinaÿ P., Eds, Wiley-VCH: 
Weinheim, 2000; b) The Organic Chemistry of Sugars, Levy D. E., Fügedi, P., Eds., Taylor & Francis: Boca 
Raton, 2006. 
12 a) Koenigs, W.; Knorr, E. Ber. Dtsch. Chem. Ges. 1901, 34, 957; b) Wulff, G.; Röhle, G. Angew. Chem. Int. Ed. 
Engl. 1974, 13, 157; c) Igarashi, K. Adv. Carbohydr. Chem. Biochem. 1977, 34, 243. 
13 Garegg, P. J.; Johansson, R.; Samuelsson, B. Acta Chem. Scand. B 1982, 36, 249. 
14 a) Helferich, B.; Wedemeyer, K. -F. Liebigs Ann. Chem. 1949, 563, 139; b) Helferich, B.; Jung, K. -H. Liebigs 
Ann. Chem. 1954, 589, 77; c) Helferich, B.; Berger, A. Chem. Ber. 1957, 90, 2492. 
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CdCO3.17 AgClO418 and AgOTf19 are the most efficient among the heavy metal promoters, 
and the latter is the most frequently used. Heterogeneous catalysts such as silver silicate,20 
silver zeolite21 and silver silica-alumina22 were developed particularly for the synthesis of 
otherwise hard to synthesize β-mannosidic and β-rhamnosidic linkages. 
Besides heavy metal salts, Lewis acids such as SnCl4, BF3·Et2O, 23 or ZnCl224 have also been 
introduced as promoters. 
The use of acid scavengers and drying agents in the reaction mixture in combination with 
the promoters is advantageous, and often necessary. Metal carbonates and oxides (Ag2O, 
Ag2CO3, HgO, CdCO3) not only serves as promoters, but they also neutralize the acid 
released in the reaction. 
It should be noted that glycosylation reactions of glycosyl halides with participating 
groups at O-2 in the presence of excess base lead to 1,2-orthoesters instead of glycosides. 
Therefore the amount of base in the reaction mixture should be limited. 
A different type of activation was introduced by Lemieux: converting α-glycosyl bromides 
into glycosides via their highly reactive β-anomers.25 In these cases, promoters such as 
Bu4NBr or Et4NBr in combination with DIPEA (Hünig’s base) are used. These halide ion-
catalyzed glycosylations give 1,2-cis-glycosides in excellent stereoselectivity. 
Unfortunately, the scope of the method is limited to reactive glycosyl halides and 
acceptors. 
Glycosyl halides, for a long time pratically the only type of glycosyl donors, have now lost 
their predominant role in glycosylations. This is due to attempts to avoid the use of 
stoichiometric amounts of toxic, expensive and often light- and moisture-sensitive heavy 
metal salts for their activation. Additionally, glycosyl halides are moderately stable. In the 
synthesis of glycosyl halogenides with non trivial protecting group patterns, the 
introduction of the halide is usually the last step of the synthetic pathway. The chemical 
elaboration of the non-anomeric regions can be hardly performed without damaging the 
highly reactive halide at the anomeric position. Furthermore, purification of the halides 
from these reactions is often problematic. 
Installation of the halide at the anomeric centers is generally performed by treatment of 1-
O-Ac-sugars with the desired hydrogen halide in acetic acid.  
Of course, this procedure is not compatible with acid-labile protecting groups, several 
different approaches have been developed, but for the synthesis of peracetylated glycosyl 
halogenides this represents still one of the easiest and most reliable procedures. 
Glycosyl fluorides are more stable than glycosyl bromides and chlorides, but this has an 
effect also on their reactivity. Infact they are too unreactive to be activated under standard 
                                                                                                                                                                  
15 Schroeder, L. R.; Green, J. W. J. Chem. Soc. C 1966, 530.  
16 Bock, K.; Medal, M. Acta Chem. Scand. B 1983, 37, 775. 
17 Conrow, R. B.; Bernstein, S. J. Org. Chem. 1971, 36, 863. 
18 a) Bredereck, H.; Wagner, A.; Faber, G.; Ott, H. Chem. Ber. 1959, 92, 1135; b) Bredereck, H.; Wagner, A.; 
Kuhn, H.; Ott, H. Chem. Ber. 1960, 93, 1201; c) Bredereck, H.; Wagner, A.; Geissel, D.; Gross, P.; Hutten, U.; 
Ott, H. Chem. Ber. 1962, 95, 3056; d) Bredereck, H.; Wagner, A.; Geissel, D.; Ott, H. Chem. Ber. 1962, 95, 3064. 
19 a) Lemieux, R. U.; Takeda, T.; Chung, B. Y. ACS. Symp. Ser. 1976, 39, 90; b) Hanessian, S.; Banoub, J. 
Carbohydr. Res. 1977, 53, C13.  
20 Paulsen, H.; Lockhoff, O. Chem. Ber. 1981, 114, 3102. 
21 Garegg, P. J.; Ossowski, P. Acta Chem. Scand. B 1983, 37, 249. 
22 van Boeckel, C. A. A.; Beetz, T. Recl. Trav. Chim. Pays-Bas 1987, 106, 596. 
23 Ogawa, T.; Matsui, M. Carbohydr. Res. 1976, 51, C13. 
24 Higashi, K.; Nakayama, K.; Soga, T.; Shioya, E.; Uoto, K.; Kusama, T. Chem. Pharm. Bull. 1990, 38, 3280. 
25 Leimieux, R. U.; Hendriks, K. B.; Stick, R. V.; James, K. J. Am. Chem. Soc. 1975, 97, 4056.  
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Koenigs-Knorr conditions, and, for this reason, their use as glycosyl donors was explored 
relatively late. Their use was introduced in 1981 by Mukaiyama and coworkers,26 and 
glycosyl fluorides are currently among the most frequently used glycosyl donors. 
Several methods for the preparation of glycosyl fluorides are known.27 They are 
commonly prepared by the reaction of a protected sugar with a free anomeric hydroxyl 
group with diethylaminosulfur trifluoride (DAST) (Scheme 1.3).28 
 
OBnO
BnO
OHBnO
OBn
OBnO
BnO
FBnO
OBn
DAST
THF
-30°C-> RT
99%
α/β = 1: 7.7  
 
SCHEME 1.3 Synthesis of Glycosyl Fluorides. 
 
Most importantly, glycosyl fluorides can be activated under specific conditions that most 
protecting groups survive. The first useful activation of glycosyl fluorides for 
glycosylation was introduced by Mukaiyama27 using a combination of SnCl2 with AgClO4 
(often replaced by AgOTf).29 Noyori and coworkers introduced the use of SiF4 and 
TMSOTf,30 whereas BF3·Et2O was introduced independently by Nicolau and Kunz.31 
Additionally, Wessel et al. introduced Tf2O as a powerful glycosylaton promoter for 
glycosyl fluoride donors.32 The sequence TMSOTf < SnCl2-AgOTf <Tf2O was suggested for 
the relative reactivity of different promoters, all used in stoichiometric amounts. Catalytic 
amounts of the protic acid TfOH were recently used by Mukaiyama and coworkers.33 
Glycosyl fluorides have found use in the synthesis of a wide range of complex natural 
products. In Scheme 1.4 is reported the Nicolaou’s synthesis of avermectin B1a, where 
glycosyl fluorides are prepared from thioglycosides by reaction with NBS and DAST.34 
Although emphasis is placed on the donor properties of glycosyl fluorides, it should be 
mentioned that, in contrast to glycosyl bromides, partially unprotected glycosyl fluorides 
could also serve as glycosyl acceptors in oligosaccharides synthesis, acting as latent 
                                                 
26 Mukaiyama, T.; Murai, Y.; Shoda, S. -Y. Chem. Lett. 1981, 431. 
27 a) Shimizu, M.; Togo, H.; Yokoyama, M. Synthesis 1998, 799; b) Toshima, K. In Glycoscience – Chemistry and 
Chemical Biology, Fraser-Reid, B., Tatsuta, K., Thiem, J., Eds., Springer Verlag, Berlin, Heidelberg, 2001, pp. 
584-625. 
28 Posner, G. H.; Haines, S. R. Tetrahedron Lett. 1985, 26, 5. 
29 a) Ogawa, T.; Takahashi, Y. Carbohydr. Res. 1985, 138, C5; b) Takahashi, Y.; Ogawa, T. Carbohydr. Res. 1987, 
164, 277. 
30 Hashimoto, S.; Hayashi, M.; Noyori, R. Tetrahedron Lett. 1984, 25, 1379. 
31 a) Nicolaou, K. C.; Chucholowski, A.; Dolle, R. E.; Randall, J. L. J. Chem. Soc. Chem. Commun. 1984, 1155; b) 
Kunz, H.; Sager, W. Helv. Chim. Acta 1985, 68, 283; c) Kunz, H.; Waldmann, H. J. Chem. Soc. Chem. Commun. 
1985, 638.  
32 a) Dobarro-Rodriguez, A.; Trumtel, M.; Wessel, H. P. J. Carbohydr. Chem. 1992, 11, 255; b) Wessel, H. P. 
Tetrahedron Lett. 1990, 31, 6863; c) Wessel, H. P.; Ruiz, N. J. Carbohydr. Chem. 1991, 10, 901. 
33 a) Jona, H.; Mandai, H.; Chavasiri, W.; Takeuchi, K.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 2002, 75, 291; b) 
Mukaiyama, T.; Jona, H.; Takeuki, K. Chem. Lett. 2000, 696; c) Jona, H.; Takeuki, K.; Mukaiyama, T. Chem. 
Lett. 2000, 1278. 
34 Nicolaou, K.C.; Dolle, R.E.; Papahatjis, D. P. J. Am. Chem. Soc. 1984, 106, 4189. 
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glycosylating agents. They can be glycosylated by a variety of methods including 
thioglycoside and trichloroacetimidate donors.35 
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SCHEME 1.4 Synthesis of Avermectin B1a. 
 
Glycosyl iodides have been known for a long time.36 However, because of their instability, 
they have been used only occasionally as glycosyl donors. Since the introduction of the 
halide ion-catalysed glycosylation method,25 a number of glycosylations actually 
proceeded through in situ generated glycosyl iodides intermediates by activating glycosyl 
bromides with tetraalkylammonium iodides. Recently improved methods for the 
preparation of glycosyl iodides have been developed, and several glycosyl iodides were 
prepared and isolated. Although benzylated glycosyl iodides are very unstable and should 
be used directly, acyl protected derivatives are considerably less labile, and stable 
crystalline glycosyl iodides can be prepared. 37 
                                                 
35 Barena, M. I.; Echarri, R.; Castillon, S. Synlett 1996, 675. 
36 Fischer, E.; Fischer, H. Ber. Dtsch. Chem. Ges. 1910, 43, 2521. 
37 Glycosyl iodides are object of Chapter 2, for more insights in their preparation and use in glycosylation 
reactions see pp 51-63.  
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Thioglycosides are the most used type of donors in oligosaccharide synthesis. The first 
thioglycoside was synthesized in 1909,38 but it is only recently that their excellent glycosyl 
donor qualities have been recognized. The strength of thioglycosides as glycosylating 
agents is their easy synthesis combined with their stability, and, at the same time, their 
effective activation using chemoselective thiophilic promoters. 
Thioglycosides show remarkable stability: not only they do have long shelf lives, but they 
also tolerate very diverse chemical manipulations leaving the thioglycoside function 
intact. Importantly, most of the common carbohydrate protecting group manipulations 
can be performed on thioglycosides, a feature making the preparation of highly 
functionalized thioglycoside donors possible. Moreover, they are inert under several 
glycosylation conditions, so thioglycosides can serve as glycosyl acceptor in the assembly 
of oligosaccharide blocks. In addition, thioglycosides can also directly be converted into 
other types of donors, making them a very versatile class of compounds (Figure 1.3). 
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FIGURE 1.3 Conversion of Thioglycosides into Other Types of Donors. 
 
The synthesis of the most used types of thioglycoside donors, mainly simple alkyl and aryl 
glycosides, is straightforward and can be performed on a large scale using cheap 
chemicals. Often the product is crystalline and can be purified without chromatography. 
Numerous ways to prepare thioglycosides have been described,39 but for the easy 
production of thioglycosides mainly two synthetic methods are commonly employed, 
namely the raction of peracetylated glycosides with a thiol in the presence of a Lewis 
acid40 and the reaction of an acylated glycosyl halide with a thiolate (Scheme 1.5).38 
 
                                                 
38 Fisher, E.; Delbrück, K. Ber. 1909, 42, 1476. 
39 a) Horton, D.; Hutson, D. H. Adv. Carbohydr. Chem. 1963, 18, 123; b) Norberg, T. in Modern methods in 
Carbohydrate Synthesis, Khan, S. H., O’Neill, R. A., Eds., Harwood Academic Publishers, 1995, pp 82-106; c) 
Garegg, P. J. Adv. Carbohydr. Chem. Biochem. 1997,  52, 179. 
40 a) Ferrier, R. J.; Furneaux, R. H. Carbohydr. Res. 1976, 52, 63; b) Dasgupta, F.; Garegg, P. J. Acta Chem. Scand. 
1989, 43, 471. 
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SCHEME 1.5 Synthesis of Thioglycosides. 
 
Indirect formation of thioglycosides can also be performed from glycosyl halides. Reaction 
with thiourea yields a pseudothiouronium salt, which can be hydrolyzed under mild, 
selective conditions to give the anomeric thiol, which then can be alkylated in an efficient, 
non-smelling procedure to produce thioglycosides (Scheme 1.6).41 
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SCHEME 1.6  Alternative non-Smelling Procedure for Thioglycosides Generation. 
 
All common protecting groups such as esters, ethers, acetals and orthoesters can 
effectively be introduced, manipulated and removed. Problems encountered are the 
removal of benzyl groups using catalytic hydrogenolysis, since the sulfur generally 
contaminates the catalyst.  
Despite their stability, thioglycosides can be easily activated with thiophilic reagents, 
typically soft electrophilic reagents, under mild conditions (Scheme 1.7). Treatment of a 
thioglycoside with a thiophilic electrophile leads to the formation of a sulfonium ion 
species, that, with the assistance of the ring oxygen or a neighbouring group, evolves to 
the common intermediate of glycosylation reactions, the oxycarbenium ion depicted in the 
scheme, which then reacts with the nucleophile to afford the desired glycoside. 
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SCHEME 1.7  Activation of Thioglycosides for Glycosylations by Electrophilic Reagents. 
 
The first efforts to use thioglycosides directly as donors were performed mainly with 
mercury (II) salts as promoters. It was early recognised that mercury had high affinity for 
the sulfur functionality. In the first successful attempt HgSO4 was employed.42 Other 
                                                 
41 Horton, D. Methods Carbohydr. Chem. 1963, 2, 433.  
42 Ferrier, R. J.; Hay, R. W.; Vethaviyasar, N. A. Carbohydr. Res. 1973, 27, 55. 
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mercury salts, such as Hg(OAc)2, HgCl2, Hg(OBz)2, and PhHgOTf, were later tried.43 These 
activations gave moderate yields, and were not powerful enough to be of general use. 
Starting from the mid-1980s, however, a series of highly powerful activation methods of 
thioglicosides was developed. Starting with NBS,44 and especially with MeOTf45 and 
dimethyl(methylthio)sulfonium triflate (DMTST)46 a seemingly never ending spectrum of 
new promoters has been reported, but also electrochemical and radical activation have 
been described.47  
Iodine-containig compounds are also used as promoters. Iodonium dicollidine perchlorate 
(IDCP) was introduced first as iodonium source,48 later on the corresponding triflate 
(IDCT) started to be effectively used.49 A very efficient promoter system, N-
iodosuccinimide in the presence of a catalytic amount of triflic acid, was introduced 
independently by van Boom50 and Fraser-Reid.51 Glycosylations promoted by NIS-TfOH 
are frequently used as they proceed at low temperatures within a short time, and are 
capable of activating a wide variety of glycosyl donors with various acceptors. Triflic acid 
is frequently replaced by different Lewis acids such as TMSOTf, TESOTf, AgOTf or 
BF3·Et2O.  
N-iodosaccharin (NISac) (Figure 1.4) was recently proposed as a replacement of NIS to 
reduce occasional by-products caused by the nucleophilicity of succinimide generally 
obtained as by-product in NIS promoted reactions.52 
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FIGURE 1.4 N-iodosaccharin. 
 
                                                 
43 a)Tsai, T. Y. R.; Jin, H.; Wiesner, K. A. Can. J. Chem. 1984, 62, 1403; b) van Cleve, J. W. Carbohydr. Res. 1979, 
70, 161; c) Garegg, P. J.; Henrichson, C.; Norberg, T. Carbohydr. Res. 1983, 116, 162. 
44 a) Hanessian, S.; Bacquet, C.; Lehong, N. Carbohydr. Res. 1980, 80, C17; b) Nicolaou, K. C.; Seitz, S. P.; 
Papahatjis, D. P. J. Am. Chem. Soc. 1983, 105, 2430. 
45 a) Lönn, H. Carbohydr. Res. 1985, 139, 105; b) Lönn, H. Carbohydr. Res. 1985, 139, 115; c) Lönn, H. J. 
Carbohydr. Chem. 1987, 6, 301. 
46 a) Andersson, F.; Fügedi, P.; Garegg, P. J.; Nashed, M. Tetrahedron Lett. 1986, 27, 3919; b) Fügedi, P. in e-
EROS, Electronic Encyclopedia of Reagents for Organic Synthesis, Paquette, L. A., Ed., Wiley Interscience, New 
York, 2002, http://www.mrw.interscience.wiley.com/eros/eros_articles_fs.html.   
47 a) Griffin, G. W.; Bandara, N. C.; Clarke, M. A.; Tsang, W. –S.; Garegg, P. J.; Oscarson, S.; Silwanis, B. A. 
Heterocycles 1990, 30, 939; b) amatore, C.; Jutand, A.; Mallet, J. –M.; Meyer, G.; Sinaÿ, P. J. Chem. Soc. Chem. 
Commun. 1990, 718; c) Balavoine, G. Greg, A.; Fischer, J. –C.; Lubineau, A. Tetrahedron Lett. 1990, 31, 5761; d) 
Marra, A.; Amatore, J. –M.; Amatore, C.; Sinaÿ, P. Synlett 1990, 572. 
48 a) Veeneman, G. H.; van Boom, J. H. Tetrahedron Lett. 1990, 31, 275; b) Zuurmond, H. M.; van der Laan, S. 
C.; van der Marel, G. A.; van Boom, J. H. Carbohydr. Res. 1991, 215, C1; c) Smid, P.; de Ruiter, G. A.; van der 
Marel, G. A.; Rombouts, F. M.; van Boom, J. H. J. Carbohydr. Chem. 1991, 10, 833. 
49 Veeneman, G. H.; van Leeuwen, S. H.; Zuurmond, H.; van Boom, J. H. J. Carbohydr. Chem. 1990, 9, 783. 
50 Veeneman, G. H.; van Leeuwen, S. H.; van Boom, J. H. Tetrahedron Lett.. 1990, 31, 1331. 
51 a) Konradsson, P.; Mootoo, D. R.; McDevitt, R. E.; Fraser-Reid, B. J. Chem. Soc. Chem. Commun. 1990, 270; b)  
Konradsson, P.; Udodong, U. E.; Fraser-Reid, B. Tetrahedron Lett. 1990, 31, 4313. 
52 Aloui, M.; Fairbanks, A. J. Synlett 2001, 797. 
Introduction
  12
Numerous highly complex structures have been synthesized using the here cited 
promoting systems, verifying the impressive utility of the method. 
These promoters also complement each other nicely regarding reactivity, from the least 
reactive IDCP and MeOTf through the intermediate DMTST up to the most reactive 
NIS/TfOH. This promoter reactivity difference, in combination with the different 
reactivity of donors and acceptors, allows many practical orthogonal couplings between 
thioglycosides. Furthermore, the thioglycosides reactivity can also be tuned by the choice 
of the aglycone.53 Bulky or electron withdrawing groups on the sulphur decrease the 
reactivity of thioglycoside donors. Furthermore, several heterocyclic aglycones, such as 
benzothiazol-2-yl,54 pyridine-2-yl,44a pyrimidin-2-yl44a and, most recently, benzoxazol-2-
yl55 derivatives, have been installed on the sulfur atom.  
These heterocyclic thioglycosides can be activated by the remote activation concept by 
reagents, which do not necessarily activate common alkyl- and aryl-thioglycosides. Thus, 
pyrimidinyl thioglycosides, for example, were activated by TMSOTf, which does not 
activate alkyl-/aryl-thioglycosides, to give glycosides in good yields.56 AgOTf or ZrCl4-
Ag2CO3 proved to be effective promoters for the recently introduced benzoxazolyl 
thioglycosides (SBox glycosides).55b  
As shown in Scheme 1.8, the thioglycoside acceptor 2 could be glycosylated by SBox 
glycoside 1 in excellent yield as the promoter does not activate the ethylthio-function of 
the acceptor 2.55b 
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SCHEME 1.8 Glycosylation with SBox Thioglycoside. 
 
Notwithstanding the efficiency of thioglycosides as donors, problems can, of course, be 
encountered in various applications. The problems are connected both to the type of 
thioglycoside used as well as to the promoter employed. Regarding the promoter,  MeOTf 
can, if the acceptor is unreactive, give methylation instead of glycosylation of the acceptor 
hydroxyl group.57 As previously reported, N-succinimide glycosides can be formed as 
major product in NIS-promoted glycosylations with unreactive acceptors.58 Soft 
nucleophilic centers, such as double bonds, could compete with the sulfur in its reaction 
with the electrophilic promoter, but allyl and pentenyl groups proved to be compatible 
                                                 
53 The effect of protecting groups on the reactivity of both glycosyl donors and acceptors is discussed in the 
following paragraphs. 
54 a) Mukaiyama, T.; Nakatsuka, T.; Shoda, S. Chem. Lett. 1979, 487; b) Gama, Y.; Yasumoto, A. Chem. Lett. 
1993, 319. 
55 a) Demchenko, A. V.; Kamat, M. N.; De Meo, C. Synlett 2003, 1287; b) Demchenko, A. V.; Malysheva, N. N.; 
De Meo, C. Org. Lett. 2003, 5, 455.   
56 Chen, Q.; Kong, F. Carbohydr. Res. 1995, 272, 149. 
57 Garegg, P. J.; Oscarson, S.; Szönyi, M. Carbohydr. Res. 1990, 205, 125. 
58 a) Oscarson, S.; Tedebarck, D.; Turek, D. Carbohydr. Res. 1997, 159, 159; b) Wang, L. –X.; Sakiri, N.; 
Kezukura, H. J. Chem. Soc. Perkin I 1990, 1677; c) Krog-Jensen, C.; Oscarson, S. J. Org. Chem. 1996, 61, 1234. 
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with thioglycoside method performing glycosidation under controlled conditions.59 
Problems have been encountered when the acceptor hydroxyl group is adjacent to an allyl 
protecting group, which have resulted in internal addition to an activated double bond 
being the major reaction (Scheme 1.9).48a 
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SCHEME 1.9 Side-product of Thioglycosides Activation. 
 
The use of thioglycosides in glycosylations has been reviewed.60 
 
Thioglycoside method is surely the most exploited in oligosaccharide syntheses, another 
very versatile and widely used approach is represented by glycosyl trichloroacetimidate 
method. Although the first paper on this method was published as recently as 1980,61 it 
has already become a classical approach. This is essentially because only catalytic amounts 
of promoter are required to provide very high glycosyl donor properties whereas the here 
so far described methods generally require at least equimolar amounts of promoting 
system, which is obviously often associated with disadvantages of various kind. 
Glycosyl trichloroacetimidates are synthesized by reacting the free hydroxyl of lactols 
with trichloroacetonitrile under basic conditions. This reaction is generally high-yielding 
and, because of its reversibility, high anomeric control can often be achieved. In the 
presence of a weak base, such as potassium carbonate, the β-imidate can be isolated as the 
kinetic product, whereas the use of strong bases, such as sodium hydride or 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU), results in the formation of the thermodynamically 
more stable α-trichloroacetimidates (Scheme 1.10).62  
Controlling the anomeric configuration of glycosyl trichloroacetimidates isn’t only of 
academic interest. The two diasteromers exhibit different reactivity, α anomers are 
generally more stable, thus less reactive, and require slightly harsher conditions to be 
activated. Furthermore, the use of diasteroisomerically pure glycosyl donors is of utmost 
importance when a SN2 mechanism in the glycosylation medium is invoked. 
Recently, Yu and coworkers introduced a class of fluorinated analogues of the Schmidt’s 
donors: glycosyl N-phenyl trifluoroacetimidates.63 Schmidt and co-workers also 
pioneered the preparation of glycosyl trifluoroacetimidates, whereupon the toxic CF3CN 
with low boiling point (-63.9 °C) was used.64 
                                                 
59 a) Das, S. K.; Ghosh, R.; Roy, N. J. Carbohydr. Chem. 1993, 12, 693; b) Zuurmond, H. M.; van der Laan, S. C.; 
van der Marel, G. A.; van Boom, J. H. Carbohydr. Res. 1991, 215, c1. 
60 a) Fügedi, P.; Garegg, P. J.; Lönn, H.; Norberg, T. Glycoconjugate J. 1987, 4, 97; b) Garegg, P. J. Adv. 
Carbohydr. Chem. Biochem. 1997, 52, 179.  
61 Schmidt, R. R.; Michel, J. Angew. Chem. Int. Ed. Engl. 1980, 19, 731. 
62 Schmidt, R. R.; Michel, J. Tetrahedron Lett. 1984, 25, 821. 
63 a) Yu, B.; Tao, H. Tetrahedron Lett. 2001, 42, 2405; b) Yu, B.; Tao, H. J. Org. Chem. 2002, 67, 9099. 
64 Schimdt, R. R.; Michel, J.; Roos, M. Liebigs Ann. Chem. 1984, 1343. 
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SCHEME 1.10 Anomeric Control in Trichloroacetimidate Synthesis. 
 
Glycosyl N-phenyl trifluoroacetimidates are synthesized in high yield by treatment of the 
corresponding 1-hydroxyl sugar with N-phenyl trifluoroacetimidoyl chloride in the 
presence of K2CO3 in lab grade non-anhydrous CH2Cl2 or acetone at room temperature 
(Scheme 1.11).  
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SCHEME 1.11 Synthesis of N-Phenyl Trifluoroacetimidates. 
 
It should be mentioned that moisture in the solvent was found to be important, it might 
increase the solubility of K2CO3 and/or result in the presence of HO- to facilitate the 
deprotonation of 1-OH sugars, otherwise the reaction was found sluggish.65 Furthermore, 
termodinamically favoured α anomers were produced predominantly due to the anomeric 
effect of the corresponding 1-O-potassium sugars. When DIPEA is used as base in 
anhydrous dichloromethane almost exclusively β anomers were obtained.66  
Unlike trichloroacetonitrile, N-phenyl trifluoroacetimidoyl chloride is not commercially 
available and it has to be synthesized by reacting trifluoroacetic acid with aniline in a 
PPh3-Et3N-CCl4 system (Scheme 1.12).67 
 
                                                 
65 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Synlett 2002, 269.  
66 Adinolfi, M.; Iadonisi, A.; Ravidà, A.; Schiattarella, M. J. Org. Chem. 2005, 70, 5316. 
67 Tamura, K.; Mizukami, H.; Maeda, K.; Watanabe, H.; Uneyama, K. J. Org. Chem. 1993, 58, 32. 
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SCHEME 1.12 Synthesis of N-phenyl Trifluoroacetimidoyl Chloride. 
 
Aniline can easily be replaced by other nucleophiles, thus variously N-substituted 
trifluoroacetimidate donors might be prepared, providing an additional element for 
tuning the reactivity of the glycosyl trifluoroacetimidate donors.68 
The presence of electron-withdrawing fluorine atoms on the leaving group greatly 
influences both reactivity and stability of N-phenyl trifluoroacetimidate donors. As a 
matter of fact, if compared with the chlorinated analogues, they are less prone to 
undesired degradation reactions during glycosylations and exhibit better storability 
properties. Like glycosyl halides, trichloro- and trifluoro-acetimidate moieties are too 
labile to survive protecting group manipulations. The installation of the imidate leaving 
group at the anomeric centre is the last step of multistep glycosyl donor syntheses. 
Generally in the early steps, a temporary protecting group is installed at the anomeric 
centre, in order to safely manipulate the other hydroxyl groups on the saccharide 
backbone. Both glycosyl trichloro- and N-phenyl trifluoro-acetimidates are relatively 
stable under basic or neutral conditions, but react readily in presence of catalytic amounts 
of Brønsted or Lewis acids. Originally, pTsOH and BF3·Et2O were used,61 while the latter 
together with TMSOTf69 are currently the most frequently employed promoters. 
Glycosylations with these promoters take place at low temperatures and in high yields. 
Besides the activators mentioned thus far, several additional promoters have been 
introduced, these include strong protic and Lewis acids.  
One of the aim of our lab is the development of new mild, moisture-stable, non-corrosive 
glycosylation promoting systems for the trihaloacetimidate methods. Several mild 
promoters have been proposed during the last years, such as the system I2/Et3SiH, as 
source of in situ generated HI,70 and lanthanide salts such as Sm(OTf)371 or Yb(OTf)3.72 
More recently, commercially available acid washed molecular sieves (AW 300 MS) proved 
                                                 
68 Cai, S.; Yu, B. Org. Lett. 2003, 5, 3827. 
69 Schmidt, R. R.; Grundler, G. Angew. Chem. Int. Ed. Engl. 1982, 21, 781. 
70 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Synlett 2002, 269. 
71 Adinolfi, M.; Barone, G.; Guariniello, L.; Iadonisi, A. Tetrahedron Lett. 2000, 41, 9005. 
72 a) Adinolfi, M.; Barone, G.; Iadonisi, A.; Mangoni, L.; Schiattarella, M. Tetrahedron Lett. 2001, 42, 5967; b) 
Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Tetrahedron Lett. 2002, 43, 5573. 
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to effectively activate trihaloacetimidates without any further promoter.73 The last and 
very powerful promoting system developed in our lab concerns the use of catalytic 
amounts of Bi(OTf)3.74 Especially in the cases of Yb(OTf)3, AW 300 MS and Bi(OTf)3 the 
glycosylation conditions proved to be extremely mild and compatible with a number of 
acid sensitive protecting groups. In the case of Yb(OTf)3-catalyzed glycosylations, it has 
been proved the stability of the extremely labile dimethoxytrityl group (DMT), never used 
before in glycosylation media.75 
The higher stability of N-phenyl trifluoro- compared with that of trichloro-acetimidates 
has also an effect on the reactivity. Generally, Schmidt’s donors are activated at lower 
temperatures and by smaller amounts of promoter than those required by the fluorinated-
analogues. These observations allowed the development of an effective one-pot procedure 
in which trichloro-acetimidates first, and then N-phenyl trifluoro-acetimidates are 
sequentially activated by catalytic amounts of Yb(OTf)3, adjusting reaction temperature 
and promoter amounts in due course.76 
It should be observed that the presence of three fluorine atoms is responsible by itself of 
the higher amount of promoter required for effectively activate glycosyl trifluoro-
acetimidates, instead the presence of a bulky group on the nitrogen might entail the better 
yields often registered with N-phenyl trifluoroacetimidates, if compared with trichloro-
acetimidate donors. 
In Table 1.1 is shown a comparative study on BF3·Et2O-catalyzed glycosylations with 
glycosyl trichloro- vs trifluoro-acetimidate donors.77 As evident from the table, best results 
are achieved with 0.25 equivalents of promoter for trichloroacetimidate donor and with 0.5 
equivalents in the case of the fluorinate-analogue, in both cases the desired product was 
isolated in 73% yield. 
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X BF3·Et2O (equiv.) Yield (%) 
CCl3 0.25 73 
CCl3 0.5 67 
CF3 0.25 65 
CF3 0.5 73 
 
TABLE 1.1 BF3·Et2O-catalyzed Glycosylation: Glycosyl Trichloroacetimidates vs Trifluoroacetimidates. 
                                                 
73 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Org. Lett. 2003, 5, 987. 
74 Adinolfi, M.; Iadonisi, A.; Ravidà, A.; Valerio, S. Tetrahedron Lett. 2006, 47, 2595. 
75 Adinolfi, M.; Iadonisi, A.; Schiattarella, M. Tetrahedron Lett. 2003, 44, 6479. 
76 Adinolfi, M.; Iadonisi, A.; Ravidà, A. Synlett  2006, 583. The results of this work are described with more 
details in Chapter 7. 
77 Nakajima, N.; Saito, M.; Kudo, M.; Ubukata, M. Tetrahedron 2002, 58, 3579. 
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The effect of the phenyl group in N-phenyl trifluoroacetimidate donors is generally related 
to the prevention of undesired side-reactions, that often take place with Schmidt’s donors, 
such as β-elimination78 or rearrangement to unreactive glycosyl trichloroacetamides.79 
N-phenyl trifluoroacetimidate donors proved to be very effective glycosylating agents in 
several different syntheses sometimes furnishing better results than the Schimidt’s donors, 
but are not yet as diffused as the tricholoro-analgues.  
Besides the introduction of new promoters, another technical development related to 
glycosyl trichloroacetimidates as glycosyl donors was the introduction of the inverse 
procedure.80  In the original procedure, the promoter is added to a mixture of glycosyl 
donor and acceptor. It was assumed that highly reactive glycosyl trichloroacetimidates 
might partially decompose prior to being exposed to the glycosyl acceptor. In support of 
this hypothesis, adding the glycosyl donor to a mixture of the acceptor and promoter 
resulted in increased yields (Scheme 1.13). 
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SCHEME 1.13 The Normal and the Inverse Procedure. 
 
Glycosylation of the disaccharide acceptor 5 with the reactive fucosyl imidate 4 gave the 
trisaccharide 6 in a 43% yield by the normal procedure, whereas 6 was obtained in a 78% 
yield by the inverse procedure.  
A completely different glycosyl donor’s family is represented by 1,2-anhydro sugars. 
Glycals recently came into the limelight because of the work of Danishefsky and co-
workers, who developed a highly efficient procedure for their oxidation to 1,2-anhydro 
sugars with dimethyldioxirane (DMDO).81 Reaction of the epoxides  8 and 12, promoted 
by ZnCl2 in tetrahydrofuran or dichloromethane, produced 1,2-trans-glycosides (Scheme 
1.14). Glycosylation of glycals by this method gives a reiterative glycosylation strategy for 
the synthesis of oligosaccharides. Unfortunately, it was established that the glycosylation 
reaction is not always stereospecific.82 A potentially useful feature of the glycosides 
formed in glycosylations with 1,2-anhydro sugars is that they possess a free 2-OH ready 
for further transformations, for example, into 2-deoxy glycosides,83 or for configurational 
inversion as in the synthesis of β-mannosides from β-glucosides.84 1,2- anhydro sugars are 
very versatile because they can also be readily converted into other types of glycosyl 
donors, such as thioglycosides, glycosyl fluorides and phosphates. 
                                                 
78 Schmidt, R. R.; Kinzy, W. Adv. Carbohydr. Chem. Biochem. 1994, 50, 21. 
79 a) Cramer, F.; Hennrich, N. Chem. Ber. 1961, 94, 976; b) Zhu, T.; Boons, G. –J. Carbohydr. Res. 2000, 329, 709. 
80 Schmidt, R. R.; Toepfer, A. Tetrahedron Lett. 1991, 32, 3353. 
81 Halcomb, R. L.; Danishefsky, S. J.; J. Am. Chem. Soc. 1989, 111, 6661. 
82 Danishefsky, S. J.; Bilodeau, M. T.  Angew. Chem. Int. Ed. Engl.  1996, 35, 1380. 
83 Gervay, J.; Danishefsky, S. J. J. Org. Chem. 1991, 56, 5448. 
84 Liu, K. K. C.; Danishefsky, S. J. J. Org. Chem. 1994, 59, 1892. 
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SCHEME 1.14 Iterative Glycosylation with Glycals. 
 
Glycosyl phosphate triesters can be considered the nature’s glycosyl donors. Nucleotide 
5’-diphospho sugars (NDPs) (Figure 1.5) are the natural substrates of glycosyl trasferases, 
that are the enzymes responsible for the biosynthesis of oligosaccharides in living 
systems.85 
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FIGURE 1.5 Nucleotide 5’-Diphospho Sugar. 
 
Despite this strong suggestion from nature, glycosyl phosphate triesters  were introduced 
as glycosyl donors in the scenario of saccharides synthesis only relatively recently by 
Ikegami and co-workers.86 Stoichiometric amounts of TMSOTf proved to efficiently 
activate glycosyl phosphates at low temperatures. A variety of other Lewis acids, such as 
SnCl2, ZnI2, Zn(OTf)2 and BF3·Et2O, was screened achieving in all cases moderate results.87 
                                                 
85 a) Bayer, T. A.; Sadler, J. E.; Rearick, J. I.; Paulson, J. C.; Hill, R. L. Adv. Enzymol. Relat. Areas Mol. Biol. 1981, 
52, 23; b) Heidlas, J. E.; Williams, K. W.; Whitesides, G. M. Acc. Chem. Res. 1992, 25, 307. 
86 Hashimoto, S.; Honda, T.; Ikegami, S. J. Chem. Soc. Chem. Commun. 1989, 685. 
87 Plante, O. J.; Palmacci, E. R.; Andrade, R. B.; Seeberger, P. H. J. Am. Chem. Soc. 2001, 123, 9545. 
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Most frequently, diphenyl and di-n-butyl phosphates are used. Recently, Singh and co-
workers introduced the cyclic propane-1,3-diyl phosphates (Figure 1.6).88  
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FIGURE 1.6 Most Commonly Used Glycosyl Phosphates. 
 
Synthesis of glycosyl phosphates is the subject of Chapter 8, there the variety of approaches 
proposed for their preparation is described. 
Glycosyl phosphates proved to be very effective glycosylating agents in the syntheses of 
various biologically relevant oligosaccharides both in solution and on solid-support.89 
Furthermore, their versatility was demonstrated in orthogonal and regioselective 
glycosylation strategies.87 
Glycosyl phosphate 13  could be activated in the presence of thioglycoside-acceptor 14 at 
very low temperature to furnish the desired disaccharide 15 in good yield (Scheme 1.15). 
The disaccharide donor thus obtained was further activated by the use of MeOTf/DTBP 
system for the coupling with the glycal 16, affording the trisaccharide 17 in 68% yield. 
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SCHEME 1.15 Orthogonal Glycosylation with Glycosyl Phosphates and Thioglycosides. 
 
Orthogonal glycosylation strategies, similar to that described above, had previously been 
established for glycosyl donors other than glycosyl phosphates. Control of donor 
                                                 
88 a) Hariprasad, V.; Singh, G.; Tranoy, I Chem. Commun. 1998, 2129; b) Singh, G.; Vankayalapati, H. 
Tetrahedron: Asymmetry 2000, 11, 125; c) Vankayalapati, H.; Singh, G. J. Chem. Soc. Perkin. Trans.1  2000, 2187; 
d) Vankayalapati, H.; Singh, G.; Tranoy, I. Tetrahedron: Asymmetry 2001, 12, 1373. 
89 a) Love, K. R.; Andrade, R. B.; Seeberger, P. H. J. Org. Chem. 2001, 66, 8165; b) Bosse, F.; Marcaurelle, L. A.; 
Seeberger, P. H.  J. Org. Chem. 2002, 67, 6659; c) Swanson, E. R.; Seeberger, P. H. Org. Lett. 2003, 24, 4717; d) 
Love, K. R.; Seeberger, P. H. Angew. Chem. Int. Ed. 2004, 43, 602. 
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reactivity via anomeric configuration was, instead, never explored previously. The latter 
strategy is based on the reactivity differences of α- and β-glycosyl phosphates (Scheme 
1.16).  
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SCHEME 1.16 Orthogonal Glycosylation Based on Anomeric Configuration. 
 
Glycosylation of α-galactosyl phosphate 19 with β-glucosyl phosphate 18 at -78°C resulted 
exclusively in β-phosphate activation and afforded β-(1→6)-linked disaccharide α-
phosphate 20. Disaccharide 20 was coupled with 21 at -40 °C to afford trisaccharide 22 in 
two steps and good overall yield (64%). 
One of the reason of the growing interest toward glycosyl phosphates is their 
compatibility with the automated solid-phase approach. Recently, Seeberger and co-
workers developed the first  automated solid-phase oligosaccharide synthesizer.8  
A peptide synthesizer was adapted to carbohydrate synthesis. Specific coupling cycles 
were designed for glycosyl  trichloroacetimidate and phosphate methods. The success of 
the approach was demonstrated by the assembly of the phytoalexin elicitor (PE) 
dodecasaccharide in automated fashion (Scheme 1.17). 
Two different glycosyl phosphate donors, 22 and 23, were synthesized. Levulinoyl esters 
were employed as 6-O temporary protecting groups and the 2-O-pivaloyl group was used 
to control the stereochemical outcome of the glycosylation reaction via neighbouring 
participation effect. Each cycle incorporated double glycosylations (at -15 °C) and double 
deprotections to ensure high yielding steps (Table 1.2). A branched hexasaccharide was 
constructed in ten hours in over 80% yield, whereas dodecasaccharide 24 was prepared in 
17 hours and in 50% yield using the same cycle. 
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SCHEME 1.17 Automated Solid Phase Synthesis of Protected Phytoalexin Elicitor β-Glucan. 
 
Step Function Reagent Time  (min) 
1 Couple 5 equiv. building block and 5 equiv. TMSOTf 30 
2 Wash Dichloromethane 6 
3 Couple 5 equiv. building block and 5 equiv. TMSOTf 30 
4 Wash 1:9 Methanol:Dichloromethane 4 
5 Wash Tetrahydrofuran 4 
6 Wash 3:2 Pyridine:Acetic Acid 3 
7 Deprotection 2 x 20 equiv. Hydrazine (3:2 Pyridine:Acetic Acid) 30 
8 Wash 3:2 Pyridine:Acetic Acid 3 
9 Wash 1:9 Methanol:Dichloromethane 4 
10 Wash 0.2 M Acetic Acid in Tetrahydrofuran 4 
11 Wash Tetrahydrofuran 4 
12 Wash Dichloromethane 6 
 
TABLE 1.2 General Cycle Used with Glycosyl Phosphate Donors. 
 
Despite the efficiency and versatility of glycosyl phosphate donors, their use isn’t widely 
spread. This can be attributed to different reasons. First of all, their synthesis often 
requires the use of moisture-sensitive, expensive, or non-commercially available 
reagents.90 Furthermore glycosyl phosphates are unstable toward prolonged time 
purifications on silica gel. Synthetic procedures requiring only fast filtration of the reaction 
crude are generally preferable. Once in pure form, α- and β-glycosyl phosphates were 
found to be completely stable to storage for several months at 0 °C.  
The use of stoichiometric amounts of promoter implies strong acidic condition in the 
glycosylation medium. This limits the number of protecting group compatible with the 
method. Acid-labile protecting groups have to be avoided, but an efficient protection 
strategy has been developed, using base-labile and UV-detectable 9-fluorenylmethyl-
carbonate (Fmoc) as temporary group.91 
                                                 
90 See Chapter 8. 
91 Love, K. R.; Seeberger, P. H. Angew. Chem. Int. Ed. 2004, 43, 602.  
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Besides glycosyl phosphates, a variety of other phosphorus containing leaving groups 
have been designed and proposed. Glycosyl phosphites were introduced by Schmidt,92 
Wong93 and Watanabe.94 They react with alcohols at low temperatures in the presence of 
catalytic amounts of Lewis acid promoters such as TMSOTf, BF3·Et2O and Sn(OTf)2, thus 
creating glycosides. The typical activators are ZnCl2, ZnCl2-AgClO4 and BiCl3.87, 95 
Glycosyl thio compounds with phosphorus in the leaving group, such as 
dithiophosphates96,87  or phosphorodiamidimidothioates,97 have also been studied (Figure 
1.7). 
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FIGURE 1.7 Glycosyl Dithiophosphate and Phosphorodiamidimidothioate Donors. 
 
Despite their efficiency, none of the glycosylation methods described so far is generally 
applicable. The choice of the suitable glycosylation method for a given glycosidation 
depends on several parameters, among the others the specific linkage to be formed and 
the nature of the coupling partners. Generally the best results cannot be predicted in 
advance and come after several experimental attempts. Often a complementarity is found 
among the methods. For this reason many new glycosylation methods have been being 
developed, in order to achieve the universal one. Although we are still far to it, very 
efficient methodologies have been described and, besides the ones already illustrated, 
some others are worth mentioning. n-Pentenyl glycosides, introduced by Fraser-Reid,98 
provide excellent stability under a variety of protecting group manipulations. These 
glycosyl donors are activated by halogenation of the double bond, which results in 
cyclization and the release of the aglycone, thus providing active glycosylating carbocation 
(Scheme 1.18). 
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SCHEME 1.18 Glycosylation with n-Pentenyl Glycosides. 
                                                 
92 a) Martin, T. J.; Schmidt, R. R. Tetrahedron Lett. 1992, 33, 6123; b) Müller, T.; Schneider, R.; Schmidt, R. R. 
Tetrahedron Lett. 1994, 35, 4763. 
93 a) Kondo, H.; Ichikawa, Y.; Wong, C. –H. J. Am. Chem. Soc. 1992, 114, 8748; b) Sim, M. M.; Kondo, H.; 
Wong, C –H.; J. Am. Chem. Soc. 1993, 115, 2260; c) Kondo, H.; Aoki, S.; Ichikawa, Y.; Halcomb, R. L.; Ritzen, 
H.; Wong, C. –H. J. Org. Chem. Soc. 1994, 59, 864. 
94 a) Watanabe, Y.; Nakamoto, C.; Ozaki, S. Synlett 1993, 115; b) Watanabe, Y.; Nakamoto, C.; Yamamoto, T.; 
Ozaki, S. Tetrahedron 1994, 50, 6523.   
95 Corey, E. J.; Wu, Y. –J. J. Am. Chem. Soc. 1993, 115, 8871. 
96 a) Lauplicher, L.; Sajus, H.; Thiem, J. Synthesis 1992, 1133; b) Bielawska, H.; Michalska, M.  Tetrahedron Lett. 
1998, 39, 9761. 
97 a) Hashimoto, S.; Honda, T.; Ikegami, S. Tetrahedron Lett. 1990, 31, 4769; b) Hashimoto, S.; Sakamoto, H.; 
Honda, T.; Ikegami, S. Tetrahedron Lett. 1997, 38, 5181.  
98 Fraser-Reid, B.; Konradsson, P.; Mootoo, D. R.; Udodung, U. J. Chem. Soc. Chem. Commun. 1988, 823. 
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These glycosylation reactions are promoted by NBS, iodonium dicollidine perchlorate 
(IDCP) or the corresponding triflate (IDCT). NIS in combination with catalytic amounts of 
protic or Lewis acids such as TfOH99 or TESOTf,100 was introduced as a more active 
catalyst. 
The n-pentenyl glycosylation was used in the synthesis of biologically important 
molecules.101 
Glycosyl sulfoxides as glycosyl donors were introduced by Kahne.102 When activated by 
triflic anhydride or catalytic amounts of triflic acid, glycosyl sulfoxides react with 
unreactive substrates giving glycosides in good yields. The reaction is reported to proceed 
through the glycosyl α-triflate, which forms the basis of a very useful method for the 
synthesis of β-mannopyranosides.103 Compared with glycosyl sulfoxides, glycosyl 
sulfones are far less reactive. Neverthless, activation of sulfones of some 2-deoxy sugars 
has been successfully used in glycosylations using MgBr2·Et2O.104 
Stereoselectivity of Glycosidation Reactions 
The effectiveness of a glycosylation doesn’t relies only on the coupling yield. The 
stereoselectivity is a crucial issue in glycosylation reactions. Problems of stereocontrol 
arise as result of difficulties in accomplishing clean SN2 reactions at the anomeric center. 
The ready assistance of the endocyclic oxygen in the glycosyl donor’s leaving group 
diparture and subsequent  stabilisation of the carbocation gives a considerable SN1 
component to these reactions rendering stereocontrol difficult. 
Depending on the spatial orientation of the substituent on the anomeric center, the newly 
formed glycosidic linkage can either be α or β, but it can also be referred as 1,2-trans or 1,2-
cis, highlighting the relation with the substituent at the neighbouring carbon (Figure 1.8). 
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FIGURE 1.8 Anomeric Configurations of D-Glucose and D-Mannose. 
 
The latter description is rather diffused, because it furnishes an easy way to understand 
the difficulty of making a determinate glycosidic bond. 1,2-trans-Glycosides can be easily 
synthesized exploiting neighbouring group participation. When a glycosyl donor is 
equipped at O-2 position with an acyl group, the departure of the leaving group on the 
                                                 
99 Konradsson, P.; Mootoo, D. R.; McDevitt, R. E.; Fraser-Reid, B. J. Chem. Soc. Chem. Commun. 1990, 270. 
100 Fraser-Reid, B.; Udodung, U.; Wu, Z.; Ottosson, H.; Merritt, J. R.; Rao, C. S.; Roberts, C.; Madsen, R. 
Synlett 1992, 927.  
101 Mootoo, D. R.; Konradsson, P.; Fraser-Reid, B. J. Am. Chem. Soc. 1989, 111, 8540. 
102 Kahne, D.; Walzer, S.; Cheng, Y.; van Engen, D. J. Am. Chem. Soc. 1989, 111, 6881. 
103 Crich, D.; Sun, S. Tetrahedron 1998, 54, 8321. 
104 Brown, D. S.; Ley, S. V.; Tetrahedron Lett. 1988, 29, 4873. 
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anomeric position is anchimerically assisted by the carbonyl moiety and the acyloxonium 
ion 25 is readily formed (Scheme 1.19). 
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SCHEME 1.19 Neighbouring Group Participation. 
 
Reaction of the nucleophile with the acyloxonium ion 25 takes place from the upper face of 
the ring and therefore results in the formation of 1,2-trans-glicoside 26 with regeneration of 
the acyloxy group. 
The nucleophile might also react with the other electrophile carbon, thus forming the 
undesired orthoester 27 (Scheme 1.20). 
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SCHEME 1.20 1,2-Orthoester Formation. 
 
In the most commonly used glycosylation methods, strong Lewis and Brønsted acids are 
used as promoters and the orthoester formation is a reversible process. When mild 
promoters are used, such as lanthanide salts for the trihaloacetimidate methods,71,72 
glycosyl orthoesters become non-reactive side-products that negatively affect the 
glycosylation yield. Electrophilicity of the carbonyl carbon can be decreased in order to 
avoid this side-reaction. Sterically hindered pivaloyl groups are often used, but  their 
cleavage require harsher conditions than those used for the common acetyl and benzoyl 
groups. Recently, methoxycarbonyl group was introduced as neighbouring participating 
group.105 The use of this protecting group guarantees complete 1,2-trans-stereoselectivities, 
orthocarbonate side-products being not detected even in glycosylations assisted by very 
mild promoters. Furthermore, cleavage of methoxycarbonyl moieties requires the same 
conditions as for acetyl and benzoyl groups. 
Neighbouring group participation represents the most reliable tool to control the 
stereoselectivity of glycosylation reactions, providing excellent stereo-selectivities with 
various types of glycosyl donors. However the neighbouring group participation is 
limited to the synthesis of 1,2-trans-glycosides, but, since its effectiveness, it is sometimes 
used for the indirect synthesis of 1,2-cis-mannosides (Scheme 1.21). In this approach, 
advantage is taken of the ready formation of 1,2-trans-glucoside 29 by neighbouring group 
                                                 
105 a) Adinolfi, M.; Barone, G.; Guariniello, L.; Iadonisi, A. Tetrahedron Lett. 2000, 41, 9005; b) Adinolfi, M.; 
Barone, G.; Iadonisi, A.; Mangoni, L.; Schiattarella, M. Tetrahedron Lett. 2001, 42, 5967.  
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participation from glucosyl donor 28, which possesses orthogonally removable acetyl at O-
2. After selective removal of this protecting group, the C-2 configuration of the resulting 30 
is inverted by nucleophilic displacement or oxidation-reduction type reactions, thus 
creating the 1,2-cis-mannoside 31. 
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SCHEME 1.21 Synthesis of β-D-Mannopyranosides by Configurational Inversion at C-2. 
 
Other approaches to achieve stereoselective glycosylations have been developed. 
Obviously, the major challenge is represented by the formation of 1,2-cis-glycosides, but 
it’s useful when not necessary to rely on alternative methods for the control of the 
stereochemistry of glycosylations also for 1,2-trans-linkage formation. Participating groups 
are generally acyl or carbonyl moieties. These groups don’t influence only the 
stereochemical outcome of the reactions but also the reactivity of glycosyl donors. Their 
electron-withdrawing nature has a destabilizing effect on the carbocation intermediate 
that is formed after the departure of the glycosyl donor leaving group. Glycosyl donors 
equipped with electron-withdrawing protecting groups are called disarmed and exhibit 
decreased reactivity.106  Depending on specific synthetic demands, this effect might be 
undesired and also 1,2-trans-selectivity has to be achieved in a different fashion. 
The solvent effect is widely used for controlling the stereoselectivity of glycosylation 
reactions. A prerequisite for the use of the solvent effect is the avoidance of participating 
groups on C-2 heteroatom of glycosyl donors. Ether-type protecting groups have a low 
tendency to participate and therefore are commonly used for this purpose. In these cases, 
benzyl ethers are the most frequently used derivatives for hydroxyl groups, whereas for 
amino sugars, the azido function serves as an excellent non-participating masked form of 
the amino group.  
In non-coordinating solvents, such as toluene and CH2Cl2, glycosylation reactions proceed 
through a tight ion pair, favouring an SN2-like mechanism with inversion of configuration 
at the anomeric carbon (Scheme 22).107 
The accomplishment of a pure SN2 reaction is very difficult. The ready participation of the 
endocyclic oxygen in leaving group displacement gives a considerable SN1 component 
and, generally, anomeric mixtures, enriched in the inversion product, are obtained. 
When glycosylation reactions are conducted in coordinating solvents, the stereoselectivity 
is altered by the direct involvement of the solvent in the reaction mechanism. 
Experimental evidence has shown that ether-type solvents favour the formation of α-
glycosides, alternatively, the use of nitrile-type solvents shifts the selectivity toward the 
preferential formation of β-anomers. 
 
                                                 
106 Mootoo, D. R.; Konradsson, P.; Udodung, U.; Fraser-Reid, B. J. Am. Chem. Soc. 1988, 110, 5583. 
107 Lemieux, R. U.; Hendriks, K. B.; Stick, R. V.; James, K. J. Am. Chem. Soc. 1975, 97, 4056. 
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SCHEME 1.22 Halide Ion-Catalized Glycosylation. 
 
This effect on the stereoselectivity was rationalized invoking an SN1-type reaction 
mechanism in which a sugar-solvent adduct is formed as intermediate.108 After the 
departure of the leaving group from the glycosyl donor, the oxocarbenium ion 32 is 
solvated by the coordinating solvent (Scheme 1.23). 
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SCHEME 1.23 Solvent Participation in Glycosylations. 
 
In the case of ether-type solvents, the kinetic formation of the α-adduct 33 is rapidly 
followed by its conversion into the termodinamically favoured β-oxonium intermediate 
34. The β-adduct 34 is more stable than the axial oxonium 33 because of reverse anomeric 
                                                 
108 a) Wulff, G.; Röhle, G. Angew. Chem. In. Ed. Eng. 1974, 3, 157; b) Schmidt, R. R.; Rüker, E. Tetrahedron Lett. 
1980, 21, 1421; c) Schmidt, R. R.; Behrendt, M.; Toepfer, A. Synlett 1990, 694; d) Demchenko, A.; Stauch, T.; 
Boons, G. –J. Synlett 1997, 818.    
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effect. The presence of a positive charge on the exocyclic heteroatom, favours the 
equatorial displacement of the aglycone because of dipolar effects (Figure 1.9).  
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FIGURE 1.9 Dipole-Dipole Interaction in Direct and Reverse Anomeric Effects. 
 
Intermediate 34 then reacts with the nucleophile to form the axial glycoside 35, thus 
achieving the desired α-stereoselectivity. When nitrile-type solvents are used, the same 
model can be applied. In this case, the conversion of the α-adduct 36 into the 
termodinamically more stable β-nitrilium ion 37 is slower than in the case of ether-type 
solvents. This is due to the formation of nitrilium-nitrile-conjugate species that, stabilized 
by polydispersion of the positive charge, evolves to the corresponding β-adduct very 
slowly. The nucleophile, in this case, attaks the α-adduct with an equatorial approach 
leading to the formation of the desired β-glycoside 38. This model is well established and 
the solvent effect is widely recognized. It had been supported by several experimental 
evidences, collected in the course of the years. Reaction at different temperatures and rates 
were conducted and the nitrilium ion was also trapped.109 
Although the solvent and the neighbouring participation effect are the most used 
methods, other approaches have been developed in order to control the sereoselectivity of 
glycosylation reactions. Protecting groups on position other than O-2 can influence the 
stereochemistry of glycosylations exploiting long range participation or sterical and 
torsional effects.  
The use of an acyl protection on O-4 of galactose and fucose donors proved to improve the 
α-selectivity of glycosylation reactions via long range participation effect (Scheme 1.24).87  
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SCHEME 1.24 Long-Range Participation Effect. 
                                                 
109 a) Pougny, J. –R.; Sinaÿ, P. Tetrahedron Lett. 1976, 45, 4073; b) Ratcliffe, A. J.; Fraser-Reid, B. J. Chem. Soc. 
Perkin Trans. I 1990, 747. 
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Furthermore, α-selectivity can also be enhanced by the use of bulky protecting groups on 
the primary hydroxyl of glycosyl donors. As shown in Scheme 1.25, the presence of the 
bulky dimethoxytrityl group on the O-6 of glucosyl N-phenyl trifluoroacetimidate 39 
guaranteed the exclusive formation of the desired α-glycoside 40 in high yield (Scheme 
1.25).75 
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SCHEME 1.25 Effect of the donor 6-O-substituents on α-selectivity of glycosylations. 
 
The use of 4,6-O-benzylidene protection on mannosyl donors is one of the keys to the 
efficient 1,2-cis-selectivity reported by Crich and coworkers in their work.110 4,6-O-
Benzylidene-protected mannosyl sulfoxides are first activated with triflic anhydride to 
give a covalent triflate, that is then displaced by the acceptor to give the β-mannoside with 
excellent yield and selectivity. In a more recent version, the α-mannosyl triflate is 
generated from a mannosyl thioglycoside by the combination of triflic anhydride and 1-
benzenesulfinyl piperidine (BSP) before addition of the acceptor (Scheme 1.26).111 
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SCHEME 1.26 Synthesis of β-Mannosides via α-Triflate Formation. 
 
The mechanism proposed and verified by  Kinetic Isotope Effect invokes the formation of 
a transient contact ion pair (CIP) or a functionally equivalent “exploded” transition state 
(Scheme 1.27).112 In the CIP mechanism the triflate anion is necessarily closely associated 
with the face of the oxacarbenium ion from which it has just departed and shields that face 
against attack by the incoming alcohol. In the alternative mechanism there is a loose 
association of the nucleophile with the anomeric center as the leaving group departs. The 
minor amount of α-mannosides formed in these reactions most likely arise through the 
                                                 
110 Crich, D.; Sun, S. J. Am. Chem. Soc. 1997, 119, 11217. 
111 Crich, D.; Smith, M. J. Am. Chem. Soc. 2001, 123, 9015. 
112 Crich, D.; Chandrasekera, N. S. Angew. Chem. Int. Ed.. 2004, 43, 5386. 
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intermediacy of a looser, perhaps solvent-separated, ion pair (SSIP), which is in 
equilibrium with an initial CIP. The benzylidene group plays an important role in this 
equilibrium. It opposes to rehybridisation at anomeric carbon because of torsional effect 
and, so, shifts the complete set of equilibria toward the covalent triflate and away from the 
SSIP, thereby minimizing α-glycoside formation. 
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SCHEME 1.27  Proposed Glycosylation Mechanism for Crich Method. 
 
In most of the approaches described so far, the steric and electronical nature of the 
glycosyl donor is tuned to direct the stereochemistry of glycosylation reactions. 
Manipulation of the protection pattern of the glycosyl acceptor to control the 
stereochemical outcome of coupling ractions has received less attention. Two features of 
the acceptor are known to influence the streochemical course of the reaction: the intrinsic 
reactivity of the hydoxy groups that function as nucleophile (axial hydroxyl groups are 
generally less reactive than equatorial hydroxyl groups)113 and steric factors, which result 
in matched/mismatched pairs of glycosyl dononors and acceptors.114 Recently, a new 
concept for stereochemical control of glycosylation reaction has been developed by 
locking the conformation of the monosaccharide acceptor.115 
In the synthesis of key disaccharide building blocks for the assembly of the heparin 
backbone, the reaction of C-2-azido glucose trichloroacetimidate 41 with glucuronic acid 
acceptor 42 yielded anomeric mixture of disaccharide 43 (Scheme 1.28).  
 
                                                 
113 Haines, A. H. Adv. Carbohydr. Chem. Biochem. 1976, 33, 11. 
114 Spijker, N. M.; van Boeckel, C. A. A. Angew. Chem. Int. Ed. 1991, 30, 180. 
115 Orgueira, H. A.; Bartolozzi, A.; Schell, P. Seeberger, P. H. Angew. Chem. Int. Ed. 2002, 41, 2128. 
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SCHEME 1.28  Improvement of α-Selectivity by Conformational Locking of Glycosyl Acceptor. 
 
Glucuronic acid 42 adopts a 4C1 conformation with the C-4 hydroxyl group equatorially 
oriented. Locking the conformation of the glycosyl acceptor in a 1C4 conformation allowed 
the completely selective preparation of the desired cis-glycoside. Coupling glycosyl 
tricholoroacetimidate 41 with acceptor 44 resulted exclusively in formation of the α-linked 
disaccharide 45 in very good yield.  
The intramolecular aglycone delivery (IAD) method is a new and effective strategy 
developed to improve stereocontrol and yields in difficult glycosylations. It was 
introduced by Hindsgaul and coworkers for the preparation of β-D-mannopyranosides.116 
The strategy involves the initial covalent attachment of the glycosyl acceptor to a group on 
O-2 of the glycosyl donor (Scheme 1.29). Activation of the anomeric leaving group in the 
tethered derivative 47 by an electrophile is then expected to proceed intramolecularly via a 
concerted mechanism. Thus, the derivative 47 results in formation of 49 via 48. On 
quenching with water, 49 releases O-2 and yields the glycoside 50. 
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SCHEME 1.29  Intramolecular Aglycone Delivery. 
 
This concept was implemented using isopropylidene ketal type tethering. As shown in 
Scheme 1.30, the 2-O-acetyl thioglycoside 51 was transformed into the isoprenyl ether 52 
using Tebbe’s reagent. Acid-catalyzed addition of the glycosyl acceptor 53 afforded the 
tethered derivative 54. Glycosylation by activation of the thioglycoside with NIS afforded 
the β-mannopyranoside 55 with excellent stereoselectivity. 
                                                 
116 Barresi, F.; Hindsgaul, O. J. Am. Chem. Soc. 1991, 113, 9376. 
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SCHEME 1.30  Intramolecular Aglycone Delivery Using Isopropylidene Ketal Tethering. 
 
The method worked well on simple molecules; however its exstension to higher 
oligosaccharides and complex structures had limited success.117 Numerous variations of 
the above intramolecular glycosylation were studied, including changes in the position of 
linkers and variations in the length, the type and the rigidity of the linker.118 
Regioselectivity of Glycosidation Reactions 
Glycosylation reactions have to fulfil the essential requirement of regioselectivity. This 
issue is generally settled by the use of protection strategies. Protecting group 
manipulations represent an essential aspect of all total syntheses of organic molecules. 
This is particularly true in oligosaccharide synthesis, because of the multifunctional nature 
of carbohydrates. Most of the functional groups present on these molecules are of the same 
sort - hydroxyl groups – and necessitate regioselective protection strategies. As anticipated 
previously, all the functional groups that could potentially compete with the desired 
nucleophile in the attack on glycosyl donor are, generally, suitably protected.119 When a 
simple disaccharide has to be synthesized, theoretically, only one kind of protecting group 
can be used for both reaction partners. Even in this simple case, however, regioselective 
protecting group manipulations have to be exerted on both molecules, in order to 
differentiate the anomeric center from the other hydroxyl groups of glycosyl donor and 
regioselectively protect all the nucleophilic groups on the acceptor but the one desired. All 
the protecting groups used in carbohydrate chemistry have to be stable in glycosylation 
conditions and must be installed and removed without compromising the stability of both 
saccharide ring and the sensitive glycosidic bond. 
 
                                                 
117 Barresi, F.; Hindsgaul, O. Can. J. Chem. 1994, 72, 1447. 
118 a) Ito, Y.; Ogawa, T. Angew. Chem. Int. Ed. 1994, 33, 1765; b) Steward, C. M. P.; Cumpstey, I.; Aloui, M.; 
Ennis, S. C.; Redgrave, A. J.; Fairbanks, A. J. Chem. Commun. 2000, 1409; c) Jung, K. –H.; Müller, M.; Schmidt, 
R. R. Chem. Rev. 2000, 100, 4423.  
119 See Scheme 1.2, page 5. 
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TABLE 1.3 Protecting Groups Most Commonly 
Employed in Carbohydrate Chemistry. 
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These requirements limit the number of protecting groups that are used in carbohydrate 
chemistry, if compared with those used in other fields of organic chemistry. On the other 
hand, like in any other area of organic synthesis, in oligosaccharide syntheses it’s 
extremely crucial to rely on a wide range of protecting groups, in order to  project efficient 
synthetic strategies.  
By far, the most important protecting groups in carbohydrate chemistry are those used for 
the protection of hydroxyl groups, including the anomeric hemiacetal. Amino-protecting 
groups (for amino-deoxy sugars) and carboxyl protection (for uronic acids) are also of 
interst. In Table 1.3 the protecting groups most frequently used in carbohydrate chemistry 
are illustrated. Several procedures can be followed for their installation and cleavage also 
in regioselective fashion.120 
 In oligosaccharide synthesis beyond the level of disaccharides, temporary and permanent 
protecting groups must frequently be distinguished. Permanent protecting groups will 
remain through all synthetic steps until the liberation of final target oligosaccharide. The 
removal of temporary protecting groups during the synthetic sequence will reveal a free 
hydroxyl group, most often to produce a glycosyl acceptor ready for glycosylation (Scheme 
1.31). 
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SCHEME 1.31  Schematic Synthesis of a Trisaccharide. 
 
The two different types of protecting groups require different qualities. It must be possible 
to introduce and remove permanent groups in bulk with regiocontrol and high efficiency. 
                                                 
120 a) Green, T.; Wuts, P. G. M., Protective Groups in Organic Synthesis, 3rd ed., Wiley, New York, 1999; b) 
Kocienski, P. Protecting Groups, Georg Thieme Verlag, Stuttgart, 2000. 
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Obviously, they should be stable to conditions used for the removal (and introduction) of 
temporary groups. In the synthesis of branched structures or structures with substituents 
(phosphates, sulfates, acetates, etc.), it might be required the preparation of building 
blocks whose hydroxyl groups have to be differentiated from each other by orthogonal 
sets of temporary protecting groups. The idea of orthogonal protection was defined by 
Baranay and Mettifield as “a set of completely independent classes of protection groups, 
such that each class can be removed in any order and in the presence of all other 
classes”.121 As summarized in Figure 1.10, when individual hydroxyl groups are protected 
with A, B, C, and D, respectively, and individual protecting groups can be removed in any 
order under certain conditions, the protecting groups can be said to be in an orthogonal 
relationship. A representative set of orthogonal hydroxyl protecting groups successfully 
used in carbohydrate chemistry is A: chloroacetyl (a: NaHCO3/MeOH/H2O), B: 
methoxybenzyl (b: TFA/CH2Cl2), C: levulinoyl (c: NH2NH2/AcOH/THF/MeOH), and D: 
TBDPS (d: HF/Py/AcOH/THF).122 
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FIGURE 1.10 Orthogonal Protecting Group Manipulations. 
 
Preferably only one type of permanent protecting group should be used, to allow only one 
final deprotection step, an aspiration seldom possible to realize. Very few of the large 
numbers of protecting groups available fulfil the criteria for permanent protecting groups. 
More or less only acetates, benzoates, benzyl ethers, benzylidene and isopropylidene 
acetals have the stability and, at the same time, the efficient introduction/deprotection 
properties needed to make them suitable for this purpose. 
When planning the protection strategy, several issues have to be considered, first of all it 
has to be taken into account that protecting groups can modify the reactivity of the 
                                                 
121 Barany, G.; Merrifield, R. B.; J. Am. Chem. Soc. 1977, 116, 7363. 
122 Wong, C. –H.; Ye, X. –S.; Zhang, Z. J. Am. Chem. Soc. 1998, 120, 7137. 
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molecules they are installed on. As examined in details in the previous paragraph, some 
protecting groups can direct the stereochemical outcome of glycosylations via 
neighbouring or long range participation effects or because of torsional constraints. 
Furthermore, the intrinsic reactivity of glycosyl donors during glycosylations is strictly 
dependent by the nature of the protecting groups used for their protection. A major 
difference in reactivity between perbenzylated and peracylated derivatives was first 
observed in the case of n-pentenyl glycosides. Specifically, the acylated glycosyl donors 
react at much slower rates. This observation resulted in the development of the armed-
disarmed concept, now widely extended also to other glycosyl donor classes.106 A 
disarmed (acylated) n-pentenyl glycoside with a free hydroxyl group could be 
glycosylated by an armed (benzylated) n-pentenyl glycoside without self-condensation of 
the previous one (Scheme 1.32).123 
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SCHEME 1.32  Oligosaccharide Synthesis by Armed-Disarmed Glycosylations. 
 
A rationalization of this effect can be advanced considering the effects that ether- and acyl-
type protecting groups have on the carbocationic intermediates 56 and 57, that are formed 
in the glycosylation medium after the departure of the leaving group from the glycosyl 
donor (Figure 1.11). 
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FIGURE 1.10  Carboxonium Ion Intermediates. 
                                                 
123 Fraser-Reid, B.; Wu, Z.; Udodong, U. E.; Ottoson, H. J. Org. Chem. 1990, 55, 6068. 
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The electron-withdrawing acyl groups destabilize the cationic intermediate 57. The parent 
glycosyl donor is, thus, less prone to be activated and converted into 57 with the overall 
effect of deactivation of the glycosylating capability. In the case of ether-type protecting 
groups, the destabilizing effect is less strong and the corresponding glycosyl donors are 
more reactive (armed). 
The arming-disarming effect of protecting groups is also used for tuning the reactivity of 
glycosyl donors. Deoxy sugars, such as fucose or rhamnose, when equipped with a 
suitable leaving group on the anomeric center, are extremely reactive glycosyl donors. 
Glycosylations involving these kind of donors generally lead to formation of considerably 
amounts of lactols as products of hydrolysis side-reaction. In order to decrease their 
reactivity and, thus, the amount of degradation by-products, acyl protecting groups can be 
used. 
So far, it has been described the crucial role played by protecting groups in the synthesis 
of saccharides and the accurate study required for planning a protection strategy. It’s clear 
that for effectively synthesize complex oligosaccharidic targets differently protected 
precursors have to be prepared. For this scope, it’s essential to dispose of synthetic 
methodologies for distinguishing between the several hydroxyl groups present on the 
saccharidic backbone in order to regioselectively install a given protection on a 
determinate position.124  
General considerations on the reactivity of the various hydroxyl groups present on the 
sugar ring  have to be discussed. In aldo-hexo-pyranoses three different kind of hydroxyl 
groups can be distinguished: the hemiacetalic at C-1, the primary at C-6, and three 
secondary hydroxyl groups at C-2, C-3 and C-4. The reactivity of the hemiacetalic OH is 
clearly different from the others. Unlike the other positions, the anomeric center in acidic 
conditions undergoes nucleophilc attack and, because of this, can be easily differentiated. 
Installation of a temporary protecting group at the anomeric position in Fischer conditions 
is generally the first operation of a multi-step building block synthesis. 
Most of the procedures for protecting groups installation exploit the nucleophilicity of the 
hydroxyl functions of the sugars. In these cases the primary position is appreciably more 
reactive than the other non-anomeric positions. The primary alchool can be effectively 
chemoselectively functionalized with a bulky protecting group (such as DMT, TBDMS, 
TIPS, etc.) in the presence of free secondary hydroxyl groups.  
The ability of distinguishing between the three secondary position is strongly dependent 
by their configuration. Consistent with well-known generalizations from cyclohexane 
chemistry, equatorial secondary hydroxyl groups of pyranoid compounds tend to react 
more readily than axial groups as illustrated in Scheme 1.33, which involves two D-
mannopyranosyl compounds in the 4C1 and 1C 4 conformations, whose hydroxyl groups at 
C-2, C-3 thus are axial, equatorial and equatorial, axial, respectively.125 
Further generalizations are difficult to make, although it is frequently noted that the 
hydroxyl group at C-2 of glucopyranosides is the most reactive of the secondaries while 
that at C-4 is least so. 
 
 
                                                 
124 For a wide treatment of selective manipulations on saccharide backbone: Collins, P., Ferrier, R. In 
Monosaccharides -Their Chemistry and Their Role in Natural Products-, John Wiley & Sons: Chichester, 1995. 
125  Aspinall, G. O.; Zweifel, G. J. Chem. Soc. 1957, 2271. 
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SCHEME 1.33  Regioselective Protection of Equatorial Hydroxyl Groups. 
 
Formation of trialkylstannyl ethers or cyclic stannylidene derivarives enhances the 
nucleophilicity of the oxygen atoms involved and thus activates the hydroxyl groups 
towards electrophilic reagents.126 Selective stannylation or stanniylidene formation can 
consequently alter relative reactivities within polyhydroxyl compounds, and practical use 
can be made of this finding. Cyclic stannylidene acetals are generally formed by reaction 
of dibutyltin oxide with a cis vicinal diol. The stannylidene generation is generally 
followed by the in situ addition of an electrophile that preferentially reacts with only one 
of the two oxygen atoms involved in the acetal cycle. The tin chemistry is effectively used 
for the regioselective protection of the C-3 equatorial hydroxyl groups that are in a cis 
relationship with the axial C-4 and C-2 hydroxyl groups of galacto- and manno-pyranoses, 
respectively (Scheme 1.34). 
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SCHEME 1.34 Generic Regioselective 3-O-Allylation via Stannilidene Acetal Intermediate Formation. 
 
A very useful approach for the differentiation of the several alcohol moieties of 
monosaccharides is the use of cyclic protecting groups for diols, such as benzylidene and 
isopropilidene acetals, orthoesters and orthocarbonates. These strategies rely on strict 
spatial relationships that have to be fulfilled by the hydroxyl groups to be protected. 
Benzylidene acetals are generally regioselectively installed on C-4 and C-6 position, thus 
forming a stable six-memberd pyranose ring; isopropylidene acetals as well as carbonates 
require a 1,2-cis relationship between the two hydroxyl groups; orthoesters are often 
formed involving C-1 and C-2 positions (Figure 1.11). 
As evident from Figure 1.11, blocking at least two out of five hydroxyl groups enormously 
simplifies the further manipulations required for the completion of the synthetic pathway. 
It has also to be considered that the use of benzylidene acetals and orthoesters allows 
further differentiation of the two oxygen atoms involved in the protection. 
                                                 
126 David, S.; Hanessian, S.Tetrahedron 1985, 41, 643. 
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FIGURE 1.11 4,6-O-Benzylidene-D-Glucopyranose, 1,2:3,4-Di-O-Isopropylidene-D-Galactopyranoside  and D-
Mannopyranose 1,2-Orthoacetate. 
 
In the case of 4,6-O-benzylidene acetals, efficient methods have been developed for the 
regioselective reductive opening of the acetal to yield benzyl ethers and a free hydroxyl 
group.  The control of the regioselectivity of the reaction is exerted by the choice of the 
suitable reducing system (Scheme 1.35).127 
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SCHEME 1.35 Reductive Cleavage of Benzylidene Acetals. 
 
Orthoesters undergo ring opening by mild acidic hydrolysis to yield the corresponding 
ester derivative exposing a hydroxyl for further reactions.128 Interestingly, the selectivity is 
opposite to many other methods, since opening of an orthoester protecting a vicinal cis-
diol gives the ester on the axial hydroxyl group (Scheme 1.36). 
Care has to be taken to avoid acyl migration to the uncovered equatorial hydroxyl group, 
using, for example, orthobenzoates instead of orthoacetates, since benzoates migrate more 
slowly than acetates. 
                                                 
127 a) Gelas, J. Adv. Carbohydr. Chem. Biochem. 1981, 39, 71; b) Garegg, P. J. in Preparative Carbohydrate 
Chemistry, Hanessian, S., Ed., Marcel Dekker, New York, 1997, pp.53-68. 
128 Lemieux, R. U.; Driguez, H. J. Am. Chem. Soc. 1975, 15, 4069. 
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SCHEME 1.36 Orthoester Formation and Opening. 
 
The methods to achieve regioselectively protected derivatives by selective deprotection are 
less common, however, a few standard procedures utilize this approach.129 The rate 
difference in acetolysis of primary (as compared with secondary) benzyl ethers is high 
enough to allow selective removal. The obtained 6-O-acetate can then be removed to 
expose the 6-hydroxyl group (Scheme 1.37).130 
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SCHEME 1.37 Regioselective Removal of Primary Benzyl Group. 
 
Furthermore, anomeric esters are more labile than other esters and can be removed 
selectively by mild base treatment (Scheme 1.38).  
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SCHEME 1.38 Regioselective Removal of Anomeric Acetate. 
 
All the so far described protection strategies are applied in the syntheses of the variously 
functionalized building blocks that are then used in the oligosaccharide assembly. Often 
several consecutive protection-deprotection steps are required to obtain the desired 
monosaccharidic targets. Generally, the preparation of the monomeric precursors 
represents the most time-consuming and, at the same time, challenging issue in 
oligosaccharide syntheses. The excellence of a synthetic plan is strongly dependent by the 
                                                 
129 Haines, A. Adv. Carbohydr. Chem. Biochem. 1981, 39, 13. 
130 Yang, G.; Ding, X.; Kong, F. Tetrahedron Lett. 1997, 38, 6725. 
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protection strategies adopted. Of course, the fewer protecting group manipulations, the 
better the synthesis is valued.  
An elegant approach in this sense is represented by regioselective glycosylation strategies, 
where the intrinsic differences in nucleophilicity of different hydroxyl groups are used to 
drive the regiochemistry of glycosylation reactions. Very often a primary hydroxyl group 
is glycosylated in the presence of a less reactive secondary position, thus building a 
disaccharide with an unprotected secondary hydroxyl that can be further glycosylated. In 
Scheme 1.39 the regioselective glycosylation of acceptor 21 using C4-OH glucosyl 
phosphate 58 as glycosylating agent is reported.87 
Fundamental to this approach was the use of the central building block 58 capable of 
displaying both donor and acceptor properties. Activation of donor 58 at -78 °C in the 
presence of the primary alcohol 21 afforded β-(1→6)-linked disaccharide 59 bearing a C-4 
hydroxyl group in excellent yield (94%) as the only coupled product. Subsequent 
glycosylation of disaccharide 59 containing a unique C-4 hydroxyl with glucosyl 
phosphate 18 provided trisaccharide 60 in 72% yield in a one-pot fashion. 
This strategy rely on the huge difference in reactivity between the primary position and 
the C-4 hydroxyl (the less reactive on the glucosidic backbone).  
However the usual regioselectivity can be increased or even reversed manipulating the 
protection pattern of the positions that surround the hydroxyl group directly involved in 
the glycosylation reaction. The absence of a protecting group in a neighbour position 
generally induces an improvement in the coupling yields. 
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SCHEME 1.39  Regioselective Glycosylation with C4-OH Glucosyl Phosphate 58. 
 
On the contrary, the use of a bulky protecting group next to a nucleophilic center reduces 
its reactivity favouring the involvement of positions otherwise less prone to be 
glycosylated. A renowned example is given by the synthesis of Lewisx trisaccharide 
(Figure 1.12).  
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FIGURE 1.12 Lewisx Trisaccharide. 
 
Several straightforward strategies have been developed making use of regioselective 
glycosylation process at crucial steps.131 Most of them rely on the possibility to reverse the 
usual reactivity of a 3,4-diol in a glucosamine acceptor by the use of phtalimido function at 
C-2.132 
In Scheme 1.40 the synthesis of the protected form of Lewisx trisaccharide proposed Verez-
Bencomo and coworkers is reported.133 Complete regiospecific galactosylation of diol 
acceptor 62 bearing a phtalimido protecting groups was attained. The presence of a cis-
decalin bicyclic system on galactosyl donor 61 had already shown to have a profound 
effect on the donor properties.134 
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SCHEME 1.40  Regioselective Lewisx Trisaccharide Synthesis. 
                                                 
131 a) Nunomura, S.; Iida, M.; Numata, M.; Sugimoto, M.; Ogawa, T. Carbohydr. Res. 1994, 263, C1-C6; b) Jain, 
R. K.; Vig, R.; Locke, R. D.; Mohammad, A.; Matta, K. L. Chem. Commun. 1996, 65; c) Xia, J.; Alderfer, J. L.; 
Piskorz, C. F.; Matta, K. L. Chem. Eur. J. 2000, 18, 3442. 
132 a) Ehara, T.; Kameyama, A.; Yamada, Y.; Ishida, H.; Kiso, M.; Hasegawa, A. Carbohydr. Res. 1996, 281, 237; 
b) Zou, W.; Jennings, H.  Biorg. Med. Chem. Lett. 1997, 7, 647; c) Huang, B. G.; Locke, R. D.; Jain, R. K.; Matta, 
K. L. Biorg. Med. Chem. Lett. 1997, 1157. 
133 Figueroa-Pérez, S.; Verez-Bencomo, V. Tetrahedron Lett. 1998, 39, 9143. 
134 Qui, D.; Ganghi, S. S.; Koganty, R. R. Tetrahedron Lett. 1997, 37, 595. 
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The β-(1→4) disaccharide 63 was obtained in a 81% yield with complete regio- and stereo-
selectivity. Bromide ion catalyzed fucosylation of disaccharide 63 proceeded with 
complete stereoselectivity to provide the trisaccharide 65 in 82% yield. 
 
Oligosaccharide Synthesis 
For the successful synthesis of oligosaccharides, both chemical reactions and tactics are 
important concerns. All the methodologies developed for effectively promote, stereo- and 
regio-chemically direct glycosylation reactions have to be skilfully combined in order to 
achieve the desired oligosaccharide targets  in high yields and reasonable time. 
For the efficient synthesis of oligosaccharides, stepwise or convergent methods can be 
employed (Figure 1.13).  
 
 
 
FIGURE 1.13 Stepwise and Convergent Methods in the Synthesis of Oligosaccharides. 
 
In the stepwise format the synthesis might start either from the reducing or the non-
reducing end. The first approach is generally more convenient. Because of their reactivity, 
during glycosylations most glycosyl donors often undergo side-reactions (hydrolysis, 
rearrangement, etc.). Thus, in order to maximize coupling yields, they are used in slight 
excess compared with glycosyl acceptors. Starting from the non-reducing end implies the 
use of oligosaccharide donors and, therefore, the waste of precious oligosaccharide 
structures in case of decomposition. The use of monosaccharide donors and 
oligosaccharide acceptors is preferable instead. Unreacted glycosyl acceptors can be easily 
recovered from the glycosylation medium and directly reused. Hydrolysis or 
decomposition products require more synthetic steps to be converted into the parent 
glycosyl donors. The recent development of new anomeric protecting groups and some 
substituent groups that can be easily converted into leaving groups, however, has enabled 
the alternative format (starting from the non-reducing end) to be used. 
The concept of stepwise synthesis is especially important for the construction of relatively 
small oligomers, but the convergent format is preferably employed for the synthesis of 
larger saccharides, especially in the syntheses of oligosaccharides possessing repeating 
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units in their structures. Furthermore, block syntheses reduce the overall number of steps 
and the convergent nature of this strategy makes it more efficient. Also, block syntheses 
afford greater flexibility in synthetic design. Specifically critical steps can be performed at 
early stages on smaller molecules, thereby facilitating chromatographic separations. 
In block syntheses, the reducing end unit of a block has to fulfil opposite requirements. It 
should be stable enough to serve as a glycosyl acceptor in the synthesis of the block and, at 
the same time, it should be reactive enough to serve as glycosyl donor in the assembly of 
the oligosaccharide from the blocks. Several strategies have been adopted to settle this 
issue.  
One solution to this problem is to exchange the anomeric substituent after the synthesis 
of the block. During the synthesis of the block, the reducing end is protected by a 
temporary protecting group (T), that is then removed converting the block into a glycosyl 
donor with a leaving group (X) at the reducing end (Scheme 1.41). 
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SCHEME 1.41 Block Synthesis by Reactivation via Exchange of the Anomeric Substituent. 
 
A drawback of this strategy is that the conversion of the block into a glycosyl donor 
requires several steps, which are especially undesirable in the case of larger fragments. 
An alternative approach uses different types of glycosyl donors in sequential 
glycosylation steps. As Scheme 1.42 shows, the key intermediate 67 carries an unprotected 
hydroxyl and has an anomeric substituent (Y) that withstand glycosylation with donor 66. 
After glycosylation, the newly generated block 68 can be used directly as a donor, without 
any replacement of the anomeric substituent, to provide the oligosaccharide 70. An 
example of this strategy is reported in Scheme 1.15.135 
 
                                                 
135 See page 19. 
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SCHEME 1.42 Block Synthesis by Sequential Glycosylations with Different Types of Glycosyl Donors. 
 
Nicolaou and coworkers proposed the two-stage activation strategy,34 where two types of 
anomeric substituents are used. One type, having Y at the anomeric center, serves as 
glycosyl acceptor (67), the other one, possessing X, is used as glycosyl donor 66 (Scheme 
1.43). 
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SCHEME 1.43 Block Two-Stage Activation. 
 
After glycosylating 67 with 66, the anomeric substituent Y in the coupling product 68 is 
converted back into X (71), so the resulting block can be used as a donor in further 
glycosylations. Using acceptor 72 of the same type as before makes the process suitable for 
further reiteration. Nicolaou used glycosyl fluorides as glycosyl donors and thioglycosides 
as acceptors and the procedure took advantage of the ready conversion of thioglycoside 
into glycosyl fluorides with NBS and DAST, as also shown in Scheme 1.4.136  
                                                 
136 See page 8. 
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In active-latent glycosylation strategy, the glycosyl donor capability of an acceptor is 
turned on by a slight chemical modification in its aglycone. Glycosylation of the latent 
compound 74 by the active donor 73 affords the latent disaccharide 75 (Scheme 1.44).  
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SCHEME 1.44 Active-Latent Glycosylation. 
 
Conversion of disaccharide aglycone (R2) into an active form (R1), transforms 75 into active 
glycosyl donor 76 that can be used in further chain elongations. 
This approach has been used by Danishefsky in iterative glycosylations using glycals as 
latent compounds and 1,2-anhydro sugars as active glycosyl donors, as depicted in Scheme 
1.14.137 
The armed-disarmed concept138 can also be counted among the several glycosylation 
strategies used in block syntheses. As shown in Scheme 1.45 , the armed glycosyl donor 66 
can be coupled with the disarmed 77 without self condensation of the latter. The resulting 
disarmed compound 78 can be used as a glycosyl donor in further coupling, either by 
arming it, by exchanging the protecting groups, or by using a more powerful promoter 
capable of activating the disarmed compound. 
Besides general synthetic strategies, some new methods and techniques are also worthy of 
discussion. 
In the traditional approaches of oligosaccharide synthesis, the product of a glycosylation 
reaction had to be isolated and it required some chemical transformations to make it 
suitable for the next glycosylation reaction. 
                                                 
137 See page 18. 
138 See page 35. 
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SCHEME 1.45 Block Armed-Disarmed Glycosylation. 
 
In some of the synthetic strategies herein described, such as in the sequential and in the 
armed-disarmed glycosylations, the product of one glycosylation reaction is used directly 
in the next coupling reaction. This opened the way for omitting the isolation step and 
performing multiple glycosylations in a one-pot fashion (Figure 1.14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1.14 General Scheme of One-Pot Glycosylation.  
 
Several glycosylation strategies can be performed in a one-pot manner. Often different 
types of glycosyl donors are employed in one-pot sequential glycosylations. Generally, the  
orthogonality between the different classes of the used donors is not required. 
Glycosylation are performed starting from the non reducing end, sequentially activating 
glycosyl donors with increasing stability. The first one-pot glycosylation sequence using 
this approach performed the progressive glycosylation of thioglycoside acceptor 81 by 
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glycosyl bromide 80, and then of O-glycoside 83 by the newly formed thioglicoside donor 
82 (glycosyl bromide → thioglycoside → O-glycoside) (Scheme 1.46).139 
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SCHEME 1.46 One-pot Sequential Glycosylation Using Different Types of Glycosyl Donors. 
 
Similar one-pot glycosylation sequences were performed using glycosyl 
trichloroacetimidate → thioglycoside → O-glycoside; glycosyl fluoride → thioglycoside → 
O-glycoside  or glycosyl phosphate → thioglycoside → glycal.140 
Armed-disarmed type glycosylations can also be readily performed in a one-pot fashion. 
In this case the leaving group on the glycosyl donors is always the same. The control of the 
chemoselectivity is exerted by tuning the glycosyl donor reactivities through suitable 
protection strategies. The ability to control glycosyl donor reactivity by careful selection of 
hydroxyl protecting groups is one of the underlying principles of programmable one-pot 
oligosaccharide syntheses. Wong and coworkers set up a procedure for determining 
glycosyl donor reactivity by a competitive HPLC experiment.9  Donors and acceptors with 
donor capability (thioglycosides with one hydroxyl group exposed) with various 
protecting group patterns provided a set of building blocks with diverse reactivities. The 
relative reactivity values (RRVs), as observed by HPLC, were tabulated in a database, from 
which the computer program ‘Optimer’ was created. After the user has selected an 
oligosaccharide structure, the program lists the best combination of building blocks for its 
preparation (Figure 1.15). 
With this strategy, oligosaccharides containing three to six monosaccharides are rapidly 
assembled in minutes or hours by mixing the selected building blocks in sequence, with 
the most reactive first. ‘Optimer’ has been successfully applied to the synthesis of linear 
and branched oligosaccharide structures, as well as to the construction of a 33-membered 
oligosaccharide library.141  
 
                                                 
139 Yamada, H.; Harada, T.; Miyazaki, H.; Takahashi, T. Tetrahedron Lett. 1994, 35, 3979. 
140 The latter case is depicted in Scheme 1.15, page 19. 
141 Ye, X. –S.; Wong, C. –H. J. Org. Chem. 2000, 65, 2410. 
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FIGURE 1.15 Programmable One-Pot Oligosaccharide Synthesis with the Aid of ‘Optimer’ Computer 
Program.  
 
Solid-phase synthesis proved to be a very effective technique in several fields of the 
organic chemistry. The advantage of solid-phase reactions is the simple and quick workup 
process. Because only the growing molecule is attached on the support, a simple filtration 
is enough to wash away all the other reagents used in the reaction. Higher reaction yields 
can generally be achieved by use of excess amounts of reagents. 
Solid-phase oligosaccharide synthesis has been extensively studied, especially since the 
advent of effective glycosylation methods in the 1980s.142 As support matrices, Merrifield’s 
resin (polystyrene cross-linked with 1% divinylbenzene), controlled pore glass or PEG 
grafted on polystyrene (TentaGel, ArgoGel) are commonly employed. Various linkers 
have been applied to attach the carbohydrate to the solid support, including silyl ethers 
and acid- or base-labile linkers. The recently introduced octanediol linker is very versatile 
as it provides n-pentenyl glycosides after cleavage by olefin metathesis.143 
A great variety of glycosyl donors and glycosylation methods have been tried in solid-
phase synthesis, including glycals,144 glycosyl sulfoxides,145 thioglycosides,146 glycosyl 
                                                 
142 a) Osborn, H. M. I.; Khan, T. H. Tetrahedron 1999, 55, 1807; b) Seeberger, P. H.; Haase, W. C. Chem. Rev. 
2000, 100, 4349; c) Seeberger, P. H. J. Carbohydr. Chem. 2002, 21, 613. 
143 Andrade, R. B.; Plante, O. J.; Melean, L. G.; Seebereger, P. H. Org. Lett. 1999, 1, 1811. 
144 Danishefsky, S. J.; McClure, K. F.; Randolph, J. T.; Ruggeri, R. B. Science  1993, 260, 1307. 
145 Liang, R.; Yan, L.; Loebach, J.; Ge, M.; Uozumi, Y.; Sekanina, K.; Horan, N.; gildersleeve, J.; Thompson, C.; 
Smith, A.; Biswas, K.; Still, W. C.; Kahne, D. Science 1996, 274, 1520. 
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trichloroacetimidates,147 n-pentenyl glycosides148 and glycosyl phosphates.149 
Oligosaccharides up to the size of a dodecamer have been synthesized.146b,8 
Recently solid-phase oligosaccharide synthesis has been automated by the use of a 
modified peptide synthesizer (Figure 1.16).8   
The effectiveness of the automated approach has been confirmed by the successful 
assembly of a host of biologically relevant oligosaccharides using glycosyl 
trichloroacetimidate and glycosyl phosphate methods. As an example of automated 
oligosaccharide synthesis, in Scheme 1.17150 is reported the synthesis of dodecamer 
phytoalexin elicitor β-glucan. Automated solid-phase oligosaccharide synthesis shows 
great promise as a future technology to fuel the growing need for defined oligosaccharide 
structures as glycomics efforts gather momentum. 
 
 
 
FIGURE 1.16 The First Oligosaccharide Automated Synthesizer. 
 
Aim and Outline of the Thesis 
 
In this work several synthetic aspects of carbohydrate chemistry have been explored with 
a particular emphasis on the development and implementation of mild glycosylation 
procedures. As described above, the most versatile glycosylation methods, thioglicosydes, 
glycosyl trihaloacetimidates and phosphate triesters, although very efficient, suffer from 
the use of strong Lewis and Brønsted acids as promoters (such as BF3·Et2O, TMSOTf, NIS 
                                                                                                                                                                  
146 a) Nicolaou, K. C.; Wissinger, N.; Pastor, J.; DeRoose, F. J. Am. Chem. Soc. 1997, 119, 449; b) Nicolaou, K. C.; 
Watanabe, N.; Li, J.; Pastor, J.; Wissinger, N. Angew. Chem. Int. Ed. 1998, 37, 1559. 
147 Wu, X.; Grathwohl, M.; Schmidt, R. R. Angew. Chem. Int. Ed. 2002, 4489. 
148 Rodebaugh, R.; Joshi, S.; Fraser-Reid, B.; Geysen, H. M. J. Org. Chem. 1997, 62, 5660. 
149 Palmacci, E. R.; Plante, O. J.; Seeberger, P. H. Eur. J. Org. Chem. 2002, 595. 
150 See page 21. 
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and TfOH). These reagents not only complicate the experimental procedures because of 
their corrosiveness, moisture sensitiveness and difficulty to be handled, but, because of 
their strong acidity, they also limit the pattern of protecting groups to be used. In the last 
years in our laboratory a great effort has been addressed to the development of novel mild 
protocols for the activation of glycosyl trichloroacetimidates and N-phenyl 
trifluoroacetimidates, of more recent introduction. In this thesis a particular interest is 
addressed to the use of Yb(OTf)3 and AW MS in performing glycosylation reactions. The 
experimental advantages connected with the use of these cheap and easy to handle 
reagents had been evidenced by previous work.  
 
In Chapter 2 a novel approach for the synthesis of glycosyl iodides is reported. The 
effective protocol, that takes advantage of the in situ generation of HI with the I2/Et3SiH 
combined system, is applied to directly access to glycosyl 1,2-orthoesters, 1,2-ethylidenes 
and 1,2-glycals. 
 
In Chapter 3 the effective use of Yb(OTf)3 and AW MS was exerted in the synthesis of 
complex oligosaccharide antigen portions, testing their effectiveness and, at the same time, 
furnishing an alternative feasible synthetic strategy for the obtainment of pharmacological 
active molecules. 
 
In Chapter 4 the use of dimethoxyethane (DME) as a novel α-stereodirecting cosolvent is 
proposed. The beneficial effect of DME in α-selectivity improvement was demonstrated in 
both Yb(OTf)3 and TMSOTf promoted glycosylations. 
 
The mildness of these promoting systems was also effectively exerted in the preparation of 
novel glycoconjugates. In Chapter 5 17β-estradiol and derivatives thereof were regio-
selectively glycosylated in order to improve the pharmacokinetic and pharmacodinamic 
properties of the studied drugs. While in Chapter 6, two different classes of glycosyl β-
lactams are synthesized with the aim of producing novel carbohydrate-containing 
antibiotics active against resistant bacteria.  
 
In Chapter 7 a novel one-pot approach for the synthesis of oligosaccharides is reported. 
Glycosyl trichloro- and N-phenyl trifluoro-acetimidates are sequentially activated in the 
glycosylation medium by tuning the Yb(OTf)3 activation conditions. 
 
In the last project a highly effective protocol to convert 1,2-glycosyl orthoesters, 1,2-
oxazolines and 1,2,6 mannosyl orthoester to C2-acyl glycosyl phosphates is illustrated 
(Chapter 8). Furthermore, the protocol is conveniently applied to the synthesis of  a 
biologically relevant trisaccharide antigen exerting the in situ generation of the anomeric 
phosphates. 
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Chapter 2 
 
Synthesis of Glycosyl Iodides with I2/Et3SiH Combined System.  
Some Applications 
 
 
 
 
 
 
 
 
 
Introduction 
Glycosyl iodides have been known for a long time, but, due to their instability, they have 
been considered unpractical reagents in carbohydrate chemistry. Their application was 
mostly restricted to halide ion-catalysed glycosylations, where reactive β-glycosyl iodides 
were in situ generated by treatment of more stable α-glycosyl bromides with 
tetraalkykammonium iodides.1 Procedures for directly synthesizing these derivatives were 
known since 1929 (reaction of glycosyl bromides with sodium iodide in acetone2  or 
treatment of anomeric acetates with hydroiodic acid in glacial acetic acid3), but difficulties 
in isolation and purification limited their use. α-D-Glycosyl iodides have served as 
glycosyl donors in only a few cases,4 and the general consensus has been that these 
compounds are too reactive to be synthetically useful.5 
However, in the last years glycosyl iodides have attracted some interest and a variety of 
approaches have been published for their synthesis. For example, glycosyl iodides have 
been prepared by treatment of the corresponding hemiacetals with iodoenamines6 or with 
a complex of polystyryl phosphane and iodine7 (Scheme 2.1).  
In addition, these compounds can also be prepared from glycosyl acetates with catalytic 
BiI3 with an excess of alkyl silyl iodides.8  
 
                                                 
1 Leimieux, R. U.; Hendriks, K. B.; Stick, R. V.; James, K. J. Am. Chem. Soc. 1975, 97, 4056. 
2 Helferich, B.; Gootz, R. Chem. Ber. 1929, 62, 2788.  
3 Ness, R. K.; Fletcher, H. G.; Hudrson, C. S. J. Am. Chem. Soc.  1950, 72, 2200. 
4 a) Kronzer, F. J.; Schuerch, C. Carbohydr. Res. 1974, 34, 71; b) Araki, Y.; Endo, T.; Tanji, M.; Nagasama, J.; 
Ispido, Y. Tetrahedron Lett. 1987, 28, 5853. 
5 Schmidt, R. R. Angew. Chem. Int. Ed. Eng. 1986, 25, 212. 
6 Ernst, B.; Winkler, T. Tetrahedron Lett. 1989, 30, 3081. 
7 Caputo, R.; Kunz, H.; Mastroianni, D.; Palumbo, G.; Pedatella, S.; Solla, F. Eur. J. Org. Chem. 1999, 3147. 
8 Montero, J.-L.; Winum, J.-Y; Leydet, A.; Kamal, M.; Pavia, A. A.; Roque, J.-P. Carbohydr. Res. 1997, 297, 175. 
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SCHEME 2.1 Glycosyl Iodides Synthesis from Hemiacetals. 
 
Quite recently, a practical access to glycosyl iodides from the corresponding 1-O-
acetylated derivatives has been described by Gervay and coworkers.9 This procedure is 
based on the use of TMSI and takes advantage of the easy removal of volatile by-products.  
The same research group has shown the feasible utilization of the obtained donors in the 
synthesis of O-, C-, and N-glycosides exploiting either a mechanism of direct 
displacement10 or an α-selective glycosidation based on the in situ anomerization 
promoted by tetrabutylammonium iodide. As depicted in Scheme 2.2, this procedure found 
straightforward application in iterative iodination/glycosylation steps leading to the fast 
assembly of exasaccharide structures.11  
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SCHEME 2.2 Iterative Oligosaccharide Synthesis Using Glycosyl Iodides. 
 
In order to find an alternative to the unstable and expensive TMSI, Koreeda has reported a 
protocol for converting glycosyl acetates into iodides by in situ generation of anhydrous 
                                                 
9 Gervay, J.; Nguyen, T. N.; Hadd, M. J. Carbohydr. Res. 1997, 300, 119. 
10 a) Gervay, J.; Hadd, M. J. J. Org. Chem. 1997, 62, 6961; b) Bhat, A. S.; Gervay-Hague, J. Org. Lett. 2001, 3, 
2081; c) Ying, L.; Gervay-Hague, J. Carbohydr. Res. 2003, 338, 835. 
11 a) Hadd, M. J.; Gervay, J. Carbohydr. Res. 1999, 320, 61; b) Lam, S. N.; Gervay-Hague, J. Org. Lett. 2002, 4, 
2039; c) Lam, S. N.; Gervay-Hague, J. Carbohydr. Res. 2002, 337, 1953. 
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HI through the combination of cheap and stable co-reagents such as iodine and thiolacetic 
acid (or 1,3-propanedithiol) (Scheme 2.3).12  
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SCHEME 2.3 Synthesis of Glycosyl Iodides with in Situ Generated HI. 
 
Investigation into this reagent mixture indicated that the source of the HI was likely the 
result of the oxidation of the thiol in the presence of iodine. In the general scheme depicted 
below, a thiol molecule reacts with molecular iodine to form an intermediate sulfenyl iodo 
species and one molecule of HI (Scheme 2.4). The sulfenyl iodide reacts with the second 
thiol molecule to yield the corresponding disulfide and a second molecule of HI. 
 
RSH I2 RSI H I
RSHRSI H IRS SR  
 
SCHEME 2.4 HI Generation via Thiol Oxidation by Iodine. 
 
More recently, the use of the I2/Et3SiH reagent as glycosidation promoter13 highlighted as 
an ancillary result that this combined system could be a feasible alternative to the latter 
approach avoiding the use of malodorous thiols, whose nucleophilic character proved to 
give undesired interferences. As a matter of fact, in the Koreeda method the use of 1,3-
propanedithiol in combination with iodine, although proved to be an effective source of 
HI in addition reactions to alkenes, in the case of glycosyl iodides led to the production of 
β-thioglycosides as side-products (Scheme 2.5). 
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SCHEME 2.5 Thioglycoside Side-Product Formation Using I2/HS(CH2)3SH System. 
 
This thioglycoside may result from the nucleophilic capture of the oxonium ion 
intermediate or direct displacement of the α-glycosyl iodide product.  
                                                 
12 Chervin, S. M.; Abada, P.; Koreeda, M. Org. Lett. 2000, 2, 369. 
13 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Synlett, 2002, 269. 
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Results and Discussion 
On the basis of our experience with I2/Et3SiH system as a source of HI, we set up a new 
protocol for the convenient conversion of peracetylated sugars into the corresponding 
glycosyl iodides. Treatment of peracetylated sugar 85 in dry dichloromethane with a slight 
stoichiometric excess of iodine and triethylsylane led to the quantitative formation of the 
desired glycosyl iodide 86 within 10-20 minutes under reflux (Scheme 2.6).  
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SCHEME 2.6 Effective Preparation of Glycosyl Iodide 86 Using I2/Et3SiH system. 
 
This procedure was effectively applied to the preparation of several derivatives (Table 2.1). 
 
Entry Reagent Product 
1 
O
OAc
AcO
AcO
OAc
OAc
 
87 
O
OAc
AcO
AcO
I
OAc
 
88 
2 
O
AcO
AcO
OAc
OAc
AcO
 
89 
O
AcO
AcO
OAc
I
AcO
 
90 
3 
O
OAc
AcO
AcO
CH3
OAc  
91 (β:α = 1.3) 
O
OAc
AcO
AcO
CH3
I  
92 
4 
O
O
AcO
AcO OAc
OAcO
OAc
AcO
AcO
OAc
 
93(α:β = 5) 
O
O
AcO
AcO
I
OAcO
OAc
AcO
AcO
OAc
 
94 
Procedure: I2 (1.4 eq.), Et3SiH (1.4 eq.), CH2Cl2, reflux, 10-20 mins, yields > 90% (1HNMR) 
 
TABLE 2.1 Quantitative Conversion of Peracetylated Sugars into Corresponding Glycosyl Iodides. 
 
In all cases extractive work-up was sufficient to furnish in excellent yields the desired 
products contaminated only by traces of non-reactive silyl ether side-products. 
Noteworthy, the stability of the glycosidic linkage of lactose 93 was not compromised by 
the stoichiometric amounts of HI in situ generated. Of particular interest is also the 
generation in high yield of fucosyl iodide 92, since the well-known deoxy-sugars aptitude 
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for easily undergoing hydrolysis reaction. Furthermore, it has to be observed that the 
effectiveness of the procedure isn’t affected by the anomeric configuration of starting 
materials. Pure β anomers were used in the case of glucose and galactose 85 and 87, 
respectively, whereas in the cases of mannose, fucose and lactose, pure α or variously 
enriched anomeric mixtures furnished the corresponding iodides in high yields. These 
observations are in contrast with the results obtained with glucosamine derivatives. 
Iodination of 2-deoxy aminosugars was reported to be a challenging issue. Peracetylated 
N-acetyl glucosamine proved to react scarcely with the effective TMSI procedure. From 
Lay and co-workers work emerged that the nitrogen protecting groups play a crucial role 
in the iodination reaction.14 In fact N-dimethyl-maleimido or N-phtalimido protection 
were required for the effective conversion of glucosamine derivatives into the 
corresponding iodides by treatment with TMSI. We intended to test the effectiveness of 
the I2/Et3SiH system in this difficult task, setting as starting material the previously 
unexplored 1-O-Acetyl glucosamine 96 (Scheme 2.7). 
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HO
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20%
 
 
SCHEME  3.7 Synthesis of Glucosamine Iodides 97. 
 
Trichloroethoxycarbonyl protection for amino groups is very common in carbohydrate 
chemistry, therefore the development of an effective procedure for the synthesis of a thus 
functionalized iodide is very useful and of practical interest. Glucosamine hydrochloride 
95 was transformed into Troc-protected derivative 96 using a standard procedure that calls 
for Troc installation followed by peracetylation. Derivative 96 was then treated with 
I2/Et3SiH system, but only a partial conversion (ca. 20%) into the desired iodide 97 was 
observed. By accurate NMR analysis of the crude, it turned out that the sole β-anomer of 
the anomeric mixture 96 was consumed during the iodination step. As a matter of fact 
1,3,4,6-tetra-O-acetyl N-Troc glucosamine 96 was obtained as an α/β 4:1 mixture after 
py/Ac2O treatment. Consequently, a stereocontrolled route to the sole β-anomer of 96 was 
pursued following a versatile strategy that may also be easily extended to nitrogen 
protections other than Troc (Scheme 2.8). Amino group of glucosamine hydrochloride 95 
was first protected as imine by treatment with anisaldehyde and subsequently acetylated 
to furnish derivative 98 in a β/α ratio of 9.15 After acidic hydrolysis of derivative 98 any 
protecting group can be installed on the amine. In our case, Troc-protection was 
performed and glucosamine 96 was then exposed to I2/Et3SiH system eventually 
                                                 
14 Miquel, N.; Vignando, J.; Russo, G.; Lay, L. Synlett 2004, 275. 
15 Domingos, J. S.; Wang, H.; Allanson, N. M.; Jain, R. K.; Sofia, M. J. J. Org. Chem. 1999, 64, 5926. 
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furnishing the corresponding iodide 97 slightly contaminated by a small amount (less than 
10%) of unreacted 1α-acetyl glucosamine. 
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SCHEME  3.8 Improved Synthesis of Glucosamine Iodide 97. 
 
Set up this effective procedure for glycosyl iodides preparation, we exploited it for the 
one-pot conversion of easily prepared and commercially available peracetylated sugars 
into broadly used saccharidic building blocks such as 1,2-orthoesters, 1,2-ethylidenes and 
1,2-glycals. 
All these intermediates are typically prepared from the corresponding glycosyl bromides, 
whose synthesis from the corresponding 1-O-acetylated precursors requires quite tedious 
experimental conditions, especially in large scale preparations, either for the necessity to 
neutralize strongly acidic solutions (HBr in acetic acid) or for the adoption of moisture 
sensitive reagents (for example TiBr4).16 
The whole investigation on glycosyl iodides synthesis and application was inspired by a 
practical problem we met in the preparation of intermediate 102 (Scheme 2.9), useful for 
preparation of galactosyl donors equipped with a selectively removable group at C-2 
position.17 The preparation of 102 had first been accomplished exploiting the standard 
procedure with glycosyl bromides. Acetobromo galactose 100 was initially converted into 
the acetylated orthoester 101 under standard conditions for the halide promoted 
anomerization (lutidine, ethanol and tetrabutylammonium bromide),18 the concentrated 
crude mixture containing the orthoester 101 was then treated with KOH in toluene and 
subsequent addition of benzyl bromide afforded compound 102 in good overall yield (56% 
                                                 
16 For a discussion on the problems associated to synthesis of glycosyl bromides and related references: 
Franz, A. H.; Wei, Y. Q.; Samoshin, V. V.; Gross, P. H. J. Org. Chem. 2002, 67, 7662. 
17 An example is represented by galactosyl donor 129, page 77. 
18 Lemieux, R. U.; Morgan, A. R. Can. J. Chem. 1965, 43, 2199. 
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for three synthetic operations). Although efficient, the procedure suffered from the use of 
the relatively expensive acetobromo galactose 100 as a precursor, and therefore we 
searched for a more practical alternative approach. 
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SCHEME 2.9  Synthesis of Orthoester 102 Starting from Acetobromo Galactose 100. 
 
Therefore, a novel synthesis of 102 has been attempted starting from the cheaper 
pentaacetyl galactose 87 (Scheme 2.10). Treatment of derivative 87 with 1.4 equivalents of I2 
and Et3SiH in refluxing dichloromethane produced the fast formation of the 
corresponding α-iodide 88 (TLC and NMR analysis of an aliquot of the crude reaction 
mixture). Lutidine, ethanol, and tetrabutylammonium bromide were then simply added 
and the mixture was left under stirring overnight. NMR analysis of the crude material 
evidenced the high yielding formation of the desired orthoester derivative 101. Without 
purification, the crude mixture was subjected to the one-pot deacetylation-benzylation 
sequence to afford compound 102 in a 50% overall yield over four synthetic operations 
and a single chromatographic purification. 
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SCHEME 2.10 One-Pot Synthesis of Orthoester 102 Starting from Peracetylated Galactose 87. 
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Encouraged by these results, the synthesis of a variety of useful saccharidic building-
blocks commonly prepared from peracetylated glycosyl bromides was investigated. For 
example, the same synthetic sequence of Scheme 2.10 was also applied on the gluco 
precursor 85 with a good overall yield (Table 2.2, entry 1). 
 
Entry Reagent Procedure Product Overall  Yield (%) 
1 
O
AcO
AcO
AcO
OAc
AcO
 
85 
A 
OBnO
BnO
O
O
BnO
OEt  
103 
58 
2 
O
AcO
AcO
OAc
OAc
AcO
 
89 
B O
AcO
AcO
O
O
AcO
OEt
 
104 
71 
Procedure A: See Scheme 2.10. 
Procedure B: I2 (1.4 eq), Et3SiH (1.4 eq.), CH2Cl2, reflux, 30 mins; lutidine (4 eq), EtOH (6 eq.), 
TBAB (0.4 eq.), overnight, RT. 
 
TABLE 2.2 One-Pot Conversion of Peracetylated Sugars into 1,2-Glycosyl Othoesters. 
 
It should be noted that the orthoesterification reaction was accomplished through a one 
pot procedure without any work-up of the iodination mixture, differently from the case of 
the corresponding synthesis via glycosyl bromides. In addition, the efficacy of the whole 
synthetic sequence was not compromised by the use of unpurified intermediates. The 
acetylated orthoester 104 was prepared from the corresponding peracetylated D-mannose 
derivative 89 with an analogous one-pot sequence of anomeric iodination and 
orthoesterification (entry 2). The sequence afforded the product as a single 
diastereoisomer in a 71 % overall yield after the final chromatographic purification. 
 
Further interesting application of the protocol is represented by the synthesis of 1,2-
ethylidenes, another class of very useful precursors in carbohydrate chemistry. These 
derivatives are routinely prepared by treating glycosyl bromides with excess of NaBH4, 
and (for gluco- and galacto- derivatives) catalytic tetrabutylammonium bromide in 
acetonitrile.19 The feasible synthesis of these compounds directly from peracetylated 
precursors has been demonstrated starting from mannose and fucose derivatives (Scheme 
2.11).  
After glycosyl iodide generation the initial solvent (dichloromethane) was removed to be 
replaced by acetonitrile, sodium borohydride and (only for the fucose) 
tetrabutylammoniun bromide were then added. Also in these cases the one-pot sequence 
gave the useful advantage of experimental operations minimization. In addition the 
generation of 1,2-ethylidenes from glycosyl iodide intermediates turned out to be a faster 
process than in the case of brominated analogues. 
                                                 
19 Betaneli, V. I.; Ovchinnicov, M. V.; Backinowsky, L. L.; Kochetkov, N. K. Carbohydr. Res. 1982, 107, 285. 
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Procedure C: : I2 (1.4 eq), Et3SiH (1.4 eq.), CH2Cl2, reflux, 30 mins; 
then removal of the solvent and addition of NaBH4, CH3CN, RT, 
2-4 h. 
 
SCHEME 2.11  One-Pot Conversion of Peracetylated Sugars into 1,2-Ethylidenes. 
 
A further application has been evaluated in the synthesis of 1,2-glycals (Table 2.3).  
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Entry Reagent Procedure Product 
Overall  
Yield 
(%) 
1 
O
AcO
AcO
AcO
OAc
AcO
 
85 
D 
O
AcO
AcO
AcO
 
107 
81 
2 
O
AcO
AcO
AcO
CH3
OAc  
91 (β:α = 1.3) 
D 
O
AcO
AcO
CH3
 
108 
47 
3 
O
O
AcO
AcO OAc
OAcO
OAc
AcO
AcO
OAc
 
93 (α:β = 5) 
D OO
AcO
OAcO
OAc
AcO
AcO
OAc
 
109 
71 
Procedure D: I2 (1.4 eq), Et3SiH (1.4 eq.), CH2Cl2, reflux, 30 mins; then extractive work-up and addition of 
Cp2TiCl2 (2.5 eq.), Mn (5 eq.), THF, RT, 2-5 h. 
 
TABLE 2.3 One-Pot Conversion of Peracetylated Sugars into 1,2-Glycals. 
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In this case the iodination mixture was worked up by a simple extraction and the crude 
product was directly subjected to the elimination conditions described by Skrydstrup and 
coworkers (Cp2TiCl2 and manganese in THF).20 The original procedure was developed for 
anomeric bromides reduction. In the proposed mechanism the reactive species is Ti(III) 
that is in situ generated (as Cp2TiCl) by reaction of Cp2TiCl2 with a metal reductant (Mn). 
Ti(III) promotes a fast electron transfer  to the bromide to give an anomeric radical species 
111 which is subsequently reduced by another Cp2TiCl to the corresponding anion 112 
that evolves eliminating the C-2-acetate to give the corresponding glycal 107 (Scheme 2.12). 
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SCHEME 2.11  One-Pot Conversion of Peracetylated Sugars into 1,2-Ethylidenes. 
 
Also in this case the elimination step required typically much shorter times than with the 
corresponding glycosyl bromides (2-4 hours instead of more than 10 hours).19 A relevant 
applications of this approach was performed in the synthesis of the expensive lactal 
derivative 109 (entry 3). 
Conclusion 
In conclusion, an efficient approach for the synthesis of glycosyl iodides based on the use 
of cheap and easily handled reagents has been described. These intermediates can be 
efficiently converted into 1,2-orthoesters and 1,2–ethylidenes with a one-pot approach, 
while 1,2-glycals can be readily obtained after a simple extractive work-up of the 
iodination mixture. The protocol was efficiently applied also to the difficult case of 2-
deoxy glucosamine obtaining the desired iodide in high yield. 
 
 
 
 
                                                 
20 Hansen, T.; Krintel, S. L.; Daasbjerg, K.; Skrydstrup, N. Tetrahedron Lett. 1999, 40, 6087 
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Experimental Section 
 
General methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were 
recorded on Varian spectrometers at 200 or 300 MHz and 50 or 75 MHz, respectively; or on 
a Bruker Avance 500 spectrometer at 500 MHz. The chemical shifts are given in parts per 
million (ppm) on the delta (δ) scale. Analytical thin layer chromatography (TLC) was 
performed on E. Merck pre-coated (25 nm) silica gel 60F-254 plates. Column 
chromatography was performed using Carlo Erba 0.06-0.20 silica gel. When specified, 
anhydrous solvents stored over molecular sieves (purchased from Aldrich) were used.  
 
General procedure for the synthesis of glycosyl iodides: the peracetylated sugar (2 
mmol) is coevaporated with dry toluene, and then dissolved in anhydrous 
dichloromethane (6 mL). To the solution are added I2 (711 mg, 2.8 mmol) and 
triethylsilane (450 µL, 2.8 mmol). The mixture is refluxed until TLC analysis displays the 
complete consumption of the peracetylated sugar (the glycosyl iodides are partially 
unstable on TLC, especially in the case of the fucose derivative), and then submitted to 
further reactions. 
 
97. 1H NMR (200 MHz, CDCl3) δ 6.91 (1H, d, J1,2 = 3.8 Hz, H-1), 5.53 (1H, 
d, J2,NH = 8.6 Hz, NH), 5.30-5.20 (2H, m, H-3 e H-4), 4.76 e 4.64 (2H, AB, 
Jgem = 12.0 Hz, -OCH2CCl3), 4.31 (1H, dd, J5,6a = 4.2 Hz, J6a,6b = 12.6 Hz, 
H-6a), 4.07 (1H, bd, H-6b), 3.99 (1H, m, H-5), 3.42 (1H, m, H-2), 2.06, 2.02, 
2.00 (9H, 3xs, 3x CH3 acetyls).13C NMR and DEPT (50 MHz, CDCl3) δ 
171.0, 170.4, e 169.2 (3 x -COCH3), 153.8 (-NHCO2CH2CCl3), 95.0 (-NHCO2CH2CCl3), 79.0 
(C-1), 75.2 , 72.1, 66.4 (C-3, C-4, C-5), 74.6 (-NHCO2CH2CCl3), 60.7 (C-6), 55.3 (C-2), 20.4 (-
COCH3) .  
 
General procedure for preparation of 1,2-orthoesters. To the iodination mixture are 
sequentially added lutidine (930 µL, 8 mmol), ethanol (680 µL, 12 mmol) and 
tetrabutylammonium bromide (258 mg, 0.8 mmol). The mixture is left under stirring 
overnight at rt (in the case of galacto- and manno derivatives) or refluxed for 4 hours (gluco 
derivative). When the reaction is complete (TLC analysis), the mixture is concentrated and 
chromatographed on silica gel (Table 2.2, entry 2) or directly submitted to the 
deacetylation-benzylation one pot procedure (Scheme 2.10 and Table 2.2, entry 1). 
 
102. (ca 4:1 mixture of diastereoisomers): 1H NMR major diastereoisomer 
(300 MHz, CDCl3) δ 7.40-7.15 (aromatic protons), 5.74 (1H, d, J1,2 = 4.8 Hz, 
H-1), 4.96-4.40 (7H, m, 3x benzyl CH2 and H-2), 4.15-4.05 (3H, m, H-3, H-
4 and H-5), 3.74-3.55 (4H, m, 6-CH2 and –OCH2CH3), 1.64 (3H, s, 
orthoester CH3), 1.24 (3H, t, Jvic = 6.9 Hz, -OCH2CH3). 
13C NMR major diastereoisomer (50 MHz, CDCl3) δ 138.1, 137.9, and 137.7 (aromatic C), 128.3-
127.5 (aromatic CH), 121.6 (quaternary C orthoester), 97.6 (C-1), 80.2, 79.4, 74.4, 73.4, 73.0, 72.8, 
71.3, 67.9, 57.7 (C-2, C-3, C-4, C-5, C-6, 3x -CH2Ph, and OCH2CH3), 24.7 (orthoester CH3), 15.1 
(-OCH2CH3). 
 
O
BnO
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 103. (ca 12:1 mixture of diastereoisomers): 1H NMR major 
diastereoisomer (200 MHz, CDCl3) δ 7.40-7.10 (aromatic protons), 5.76 
(1H, d, J1,2 = 5.2 Hz, H-1), 4.74-4.36 (7H, m, 3x benzyl CH2 and H-2), 
3.87 (1H, t, J2,3 = J3,4 = 4.0 Hz, H-3), 3.80-3.62 (4H, m, H-4, H-5, and 6-
CH2), 3.60-3.49 (2H, m, –OCH2CH3), 1.56 (3H, s, orthoester CH3), 1.19 
(3H, t, Jvis= 7.2 Hz, -OCH2CH3). 13C NMR major diastereoisomer (50 
MHz, CDCl3) δ 138.0, 137.8, and 137.6 (aromatic C), 128.2-126.7 (aromatic CH), 120.8 
(quaternary C orthoester), 97.6 (C-1), 78.6, 75.6, 74.8, 73.2, 72.7, 71.8, 70.4, 69.1, 58.5 (C-2, C-
3, C-4, C-5, C-6, 3x -CH2Ph, and OCH2CH3), 21.7 (orthoester CH3), 15.2 (-OCH2CH3).  
 
104. 1H NMR (200 MHz, CDCl3) δ 5.43 (1H, d, J1,2 = 2.6 Hz, H-1), 5.24 
(1H, t, J3,4 = J4,5 = 9.8 Hz, H-4), 5.10 (1H, dd, J2,3 = 4.0 Hz, H-3), 4.54 
(1H, dd, H-2), 4.24-4.02 (2H, m, 6-CH2), 3.64 (1H, m, H-5), 3.58-3.42 
(2H, m, –OCH2CH3), 2.06, 2.01, and 1.99 (9H, 3xs, 3x acetyl CH3), 1.69 
(3H, s, orthoester CH3), 1.12 (3H, t, Jvis= 7.2 Hz, -OCH2CH3).13C NMR (50 MHz, CDCl3) δ 
170.5, 170.2, and 169.3 (3x -COCH3), 124.0 (quaternary C orthoester), 97.2 (C-1), 76.3, 71.1, 
70.5, 65.4, 62.2, and 58.0 (C-2, C-3, C-4, C-5, C-6, and OCH2CH3), 24.6 (orthoester CH3), 20.6 
(3x -COCH3), 14.9 (-OCH2CH3).  
 
General procedure for preparation of 1,2-ethylidenes. After the above described 
synthesis of the glycosyl iodide intermediate, dichloromethane is removed under reduced 
pressure. The residue is dissolved in acetonitrile, and then sodium borohydride (378 mg, 
10 mmol) and tetrabutylammonium bromide (258 mg, 0.8 mmol) (only for fucose) are 
sequentially added (exothermic reaction). After reaction completion (TLC analysis), the 
mixture is diluted with dichloromethane and washed with water. Concentration of the 
organic phase affords a residue that is purified by silica gel chromatography. 
 
105. (ca 1.2:1 mixture of diastereoisomers) 1H NMR (200 MHz, CDCl3) δ 
5.57 (1H, t, J1,2 = 4.8 Hz, H-1 minor), 5.50 (1H, t, J1,2 = 4.8 Hz, H-1 major), 
5.44 (1H, q, Jvic = 4.8 Hz, –CHCH3 minor), 5.30-5.04 (m, H-4 major and 
minor, –CHCH3 major), 5.04 (1H, dd, J2,3 = 7.6 Hz, J3,4 = 3.4 Hz, H-3 minor),  
4.97 (1H, dd, J2,3 = 7.6 Hz, J3,4 = 3.4 Hz, H-3 major), 4.35-4.10 (m, H-5 major 
and minor, H-2 minor), 3.99 (1H, dd, H-2 major), 2.13, 2.11, 2.04, and 2.04 
(4x acetyl CH3), 1.43 (3H, d, Jvic = 4.8 Hz, –CHCH3 major), 1.36 (3H, d, Jvic = 4.8 Hz, –
CHCH3 minor), 1.17 (3H, d, J5,6 = 6.6 Hz, 6-CH3 major), 1.15 (3H, d, J5,6 = 6.6 Hz, 6-CH3 
minor). 13C NMR (50 MHz, CDCl3) δ 170.3 (4x -COCH3), 100.4, 99.2, 98.6, 97.5 (–CHCH3 
major and minor, C-1 major and minor), 73.2, 72.7, 70.6, 69.3, 69.3, 68.8, 67.2, 66.8 (C-2, C-3, 
C-4, C-5 major and minor), 21.1 and 21.0 (–CHCH3 mjor and minor), 20.8 and 20.6 (4x -
COCH3), 16.1 (6-CH3 major and minor). 
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106. (ca 5:1 mixture of diatereoisomers) 1H NMR (200 MHz, CDCl3) δ 
5.32-5.10 (4H, m, H-1, H-3, H-4, and –CHCH3), 4.19 (1H, t, J2,3 = J2,3 = 
3.0 Hz, H-2), 4.15-4.00 (2H, m, 6-CH2), 3.63 (1H, m, H-5), 2.03, 1.99, 
and 1.97 (9H, 3xs, 3x acetyl CH3), 1.45 (3H, d, Jvic = 5.0 Hz, –CHCH3). 
13C NMR (50 MHz, CDCl3) δ 170.5, 170.1, and 169.3 (3x -COCH3), 104.5 (–CHCH3), 96.3 (C-
1), 77.2, 71.4, 70.4, 65.9, 62.3 (C-2, C-3, C-4, C-5, C-6), 21.4 (–CHCH3), 20.6 (3x -COCH3), 
14.9 (-OCH2CH3).  
 
General procedure for preparation of 1,2-glycals. After the above described synthesis of 
the glycosyl iodide intermediate, the mixture is diluted with dichloromethane and washed 
with a solution of sodium bicarbonate containing sodium thiosulfate. The organic phase is 
dried and concentrated. The residue is dissolved in THF (5 mL), Cp2Cl2Ti (1.25 g, 5 mmol) 
and manganese (50 mesh, 550 mg, 10 mmol) are added at room temperature under argon. 
After completion of the reaction (TLC) the mixture is concentrated and the residue 
chromatographed on silica gel. 
 
107. 1H NMR (200 MHz, CDCl3) δ 6.44 (1H, dd, J1,2 = 6.2 Hz, J1,3 = 1.4 Hz, 
H-1), 5.31 (1H, ddd, J2,3 = 3.2 Hz, J3,4 = 5.8 Hz, H-3), 5.21 (1H, dd, J4,5 = 7.4 
Hz, H-4), 4.81 (1H, dd, H-2), 4.44-4.13 (3H, m, H-5 and 6-CH2), 2.06, 2.05, 
and 2.02 (9H, 3xs, 3x acetyl CH3). 13C NMR (50 MHz, CDCl3) δ 170.5, 170.4, 169.6 (3x -
COCH3), 145.6 (C-1), 98.9 (C-2), 73.9, 67.4, 67.1, 61.3 (C-3, C-4, C-5, and C-6), 20.9, 20.8, and 
20.7 (3x -COCH3). 
 
108. 1H NMR (200 MHz, CDCl3) δ 6.40 (1H, dd, J1,2 = 6.4 Hz, J1,3 = 1.8 Hz, 
H-1), 5.52 (1H, m, H-3), 5.23 (1H, bd, J3,4 = 4.6 Hz, H-4), 4.58 (1H, dt, J2,4 = 
J2,3 = 1.8 Hz, H-2), 4.16 (1H, bq, J5,6 = 6.8 Hz, H-5), 2.10 and 1.96 (6H, 2xs, 2x 
acetyl CH3), 1.22 (3H, d, 6-CH3). 13C NMR (50 MHz, CDCl3) δ 170.5, 170.2 
(2x -COCH3), 146.0 (C-1), 98.1 (C-2), 71.4, 66.1, 64.9 (C-3, C-4, C-5), 20.7 and 20.5 (2x -
COCH3), 16.4 (6-CH3). 
 
109. 1H NMR (200 MHz, CDCl3) δ 6.39 (1H, bd, J1,2 = 6.2 Hz, 
H-1), 5.41-5.34 (2H, m, H-3 Glc and H-4 Gal), 5.18 (1H, dd, 
J1,2 = 7.6 Hz, J2,3 = 10.4 Hz, H-2 Gal), 4.98 (1H, dd, J3,4 = 3.4 
Hz, H-3 Gal), 4.83 (1H, dd, J2,3 = 3.4 Hz, H-2 Glc), 4.65 (1H, d, 
H-1 Gal), 4.45-3.99 (6H, 6-CH2 Gal and Glc, H-5 Glc, and H-4 Glc), 3.89 (1H, bt, J5,6 = 6.8 
Hz, H-5 Gal), 2.14, 2.10, 2.07, 2.05, 2.04, 1.97 (18H, 6xs, 6x acetyl CH3). 13C NMR (50 MHz, 
CDCl3) δ 170.2, 170.2, 170.0, 169.9, 169.7, 169.1 (6x -COCH3), 145.3 (C-1 Glc), 100.8 (C-1 
Gal),  98.8 (C-2 Glc), 74.4, 74.0, 70.6, 70.5, 68.7, 68.7, 66.6, 61.6, an 60.8 (C-2 Gal, C-3, C-4, C-
5, C-6 Gal and Glc), 20.8, 20.6, and 20.4 (6x -COCH3). 
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Chapter 3 
 
Synthesis of Oligosaccharide Antigen Fragments 
 
 
 
 
 
 
 
 
 
Introduction 
Carbohydrates mediate a variety of biological functions including inflammation, control of 
growth and differentiation, cell-cell adhesion, as well as are involved in cell 
communication, signalling and trafficking processes.1 These tasks are generally 
accomplished by specific oligosaccharide structures exposed on the cell surface. Very often 
these saccharidic moieties play their biological roles in conjugated form with bio-
molecules such as proteins, lipids or sphingolipids. The latter class of glycoconjugates, 
glycosphingolipids (GSLs), is essential for cellular adhesion and recognition.2 
An interesting paradigm is offered by the human blood group antigens. Erythrocyte 
membranes are  characterized by the presence of genetically determined oligosaccharide 
structures (occurring conjugated either via N- or O-linkages to proteins or via a ceramide 
linkage to lipids).3 Antigen specificity is inherited and three specific alleles are involved at 
the ABO locus. The ABO related antigens are the terminal carbohydrate portions of glycan 
chains located on the erythrocyte surface. The core pentasaccharide, called H antigen, is 
expressed on the surface of red blood cells of O blood-type individuals. In individuals of 
type A blood group, an N-acetyl galactosamine  (GalNAc) is also added to the terminal 
galctose residue, whereas in B-type individuals a Gal residue is appended (Figure 3.1).  
Closely related to the ABO(H) blood groups are the Lewis blood group antigens (Le), 
which refer to the family name of individuals suffering from a red blood cell 
incompatibility problem that led to the discovery of this group of antigens. Lewis 
oligosaccharides are, actually, secretory substances adsorbed onto erythrocytes and are 
complexly related to blood-group type. 
                                                 
1 a) Rudd, P. M.; Elliot, T.; Cresswell, P.; Wilson, I. A.; Dwek, R. A. Science 2001, 291, 2370; b) Dwek, R. A. 
Chem. Rev. 1996, 96, 683; c) Feizi, T. Curr. Opin. Struct. Biol. 1993, 3, 701; d) Rosen, S. D.; Bertozzi, C. R. Curr. 
Biol. 1996, 6, 261; e) Varki, A. Glycobiology 1993, 3, 97; f) Philips, M. L.; Nudelman, E.; Gaeta, F. C. A.; Perez, 
M.; Singal, A. K.; Hakomori, S.; Paulson, J. C. Science 1990, 250, 1130; g) Lasky, L. A. Science 1992, 258, 964; 
Miller, D. J.; Macek, M. B.; Schur, B. D. Nature 1992, 357, 589; h)  Feizi, T. Nature 1985, 314, 53.  
2 Vankar, Y. D.; Schmidt, R. R. Chem. Soc. Rev. 2000, 29, 201. 
3 a) Lowe, J. B., in The molecular basis of blood diseases, Eds.: Stamatoyannopolous, G., Nienhuis, a. W., Majerus, 
P. W., Varmus, H., Saunders, Philadelphia, 1987, chap 8; b) Greenwell, P. Glycoconj. J. 1997, 14, 159. 
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FIGURE 3.1 Structure of Type ABO(H) Carbohydrate Determinats. 
 
The Lewis blood group oligosaccharides (fucosylated, ceramide-containing GSLs) are 
composed of a reducing end lactose β-(1→3) linked to a central N-acetyl glucosamine unit. 
The structures differ in the arrangement of galactose and fucose residues about this core 
glucosamine (Figure 3.2). 
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FIGURE 3.2 Structure of Lewis Blood Group Antigens. 
 
These ABO(H) and Lewis structures are not restricted to the surface of erythrocytes. They 
are also present in secretions and ectodermally derived tissues (digestive and respiratory 
mucosa, salivary glands).4 The Lewis antigens have widespread implications in both 
                                                 
4 a) Hakomori, S. Semin. Hemat. 1981, 18, 39; b) Oriol, L. in Blood Cell Biochemistry, vol. 6; Plenum Press: New 
York, 1995, 37-73. 
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normal cellular adhesion processes like inflammatory response,5 as well as adhesion 
associated with disease states, including microbial infections6 and metastatic cancers.7 
The role played by Lewis oligosaccharides in inflammatory response is of utmost 
importance, being the principal responsible for white blood cells adhesion to endothelial 
tissues. In order to repair and defend damaged tissues against possible microbial infection, 
circulating leucocytes (white blood cells) must interact with endothelial cells lining blood 
vessel to reach the underlying site of injury (Figure 3.3).  
 
 
 
FIGURE 3.3 Leucocyte Interactions with Endothelial Cells. 
                                                 
5 Simanek, E. E.; McGarvey, G. J.; Jablonowski, J. A.; Wong, C. H. Chem. Rev. 1998, 98, 833. 
6 a) Karlsson, K. A. Curr. Opin. Struct. Biol. 1995, 5, 622.; b) Ilver, D.; Arnqvist, A.; Ögren, J.; Frick, I. –M.; 
Kersulyte, D.; Incecik, E. T.; Berg, D. E.; Covacci, A.; Engstrand, L.; Borén, T. Science 1998, 279, 373. 
7 Hakomori, S.; Zhang, Y. Chem. Biol. 1997, 4, 97. 
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This complex process takes place in several steps.  First damaged tissue releases cytokines 
that trigger the expression of two proteins on the endothelium surface, E- and P-selectin. 
These selectins recognize Lex and Lea sequences (including sialylated and sulphated 
congeners) exposed on leukocyte surfaces, mediating the initial rolling phase. The rolling 
process is then followed by integrin-mediated extravasation into tissue where the white 
blood cells eventually perform their protective response.8  
The key role played by this class of antigens in adhesion events explains their frequent 
involvement in diseases such as microbial infections or cancer metastatic processes where 
adhesion is a crucial issue. In a manner analogous to migration of leukocytes through the 
endothelium adjacent to a site of injury, Helicobacter pylori infects host organisms by 
recognition of Leb antigen exposed on the gastric epithelium. Furthermore, Helicobacter is 
also able to bind sialyl-Lewisx with a different protein. Expression of sialyl-Lewisx is not 
common in normal stomach tissue, but it’s greatly increased during inflammation, 
including inflammation caused by H. pilori infection. It is thought that adherence of 
Helicobacter to sialyl-Lewisx contributes to virulence and persistence of infection  leading to 
a variety of diseases including gastric ulcers and gastric adenocarcinoma.6b,9  
Lewis antigens, like other glycosphingolipids, were also found on the surface of different 
cancerous cells.10 Although GSLs are present in both normal and cancerous cellular 
tissues, the latter are characterized by aberrant glycosylation, thus making these 
oligosaccharide structures markers for various human cancers. Carcinomas, including 
colon, breast, and lung tumours, derive from epithelial cells and are particularly prone to 
metastasis. The ability of cells released from a primary tumour to travel through the blood 
and enter and colonize distant organs is reminiscent of the way leukocytes enter tissues at 
sites of inflammation using selectins to adhere to the endothelium before extravasation 
into the tissue. There is a good correlation between the degree of expression of sialyl-
Lewisx and sialyl-Lewisa antigens on carcinomas and their metastatic potential. 
Furthermore, Ley determinant has also recently been implicated as a marker in metastatic 
prostate cancer and was found to be overexpressed in ovarian tumors.11 
Overexpression of Lewis antigens isn’t the only cancer-associated change in glycosylation 
patterns of tumour cells. Among the others, changes in glycosaminoglycans structures 
were also detected. Since glycosamino-glycans attached to cell-surface proteoglycans play 
an important part in the action of growth factors at the surface of cells, it’s reasonable that 
changes in the structures of the glycosaminoglycans would affect the response of cells to 
growth factors and thus their capacity for replication.   
Moreover, it was found that specific type of cancer cells expose on their surface peculiar 
oligosaccharide motifs in the form of glycoproteins or glycolipids, such as the MBr1 
antigen Globo-H  or the KH-1 antigen  (Figure 3.4).  
 
                                                 
8 Taylor, M. E., Drickamer, K. In Introduction to Glycobiology, Second Ed., Oxford University Press: New York, 
2006, 131-136. 
9 a) Boren, T.; Falk, P.; Roth, K. A.; Larson, G.; Normark, S. Science 1993, 262, 1892; b) Appelmelk, B. J.; 
Monteiro, M. A.; Martin, S. L.; Moran, A. P.; Vandenbroucke-Grauls, C. M. J. E. Trends in Microbiology 2000, 8, 
565; c) Wang, G.; Ge, Z. M.; Rasko, A.; taylor, D. E. Mol. Microbiol. 2000, 36, 1187. 
10 a) Hakomori, S. I. Adv. Cancer. Res. 1989, 52, 257; b) Brockhausen, I. Biochimica et Biophys Acta 1999, 1473, 67; 
c) Kim, Y.J.; Varki, A. Glycoconj. J. 1997, 14, 569. 
11 Yin, B. W.; Finstad, C. L.; Kitamura, K.; Federici, M. G.; Welshiner, M.; Kudryashov, V.; Hoskins, W. J.; 
Welt, S.; Lloyd, K. O. Int. J. Cancer 1996, 65, 406. 
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FIGURE 3.4 Globo-H and KH-1 Antigens. 
 
Globo-H is a hexasaccharide isolated in submilligram quantities as a ceramide-liked 
glycolipid from the human breast cancer cell line MCF-7 by Hakomori et al.12 Subsequent 
immunohistological analysis with monoclonal antibody (mAb) MBr113 found that the 
antigen is also expressed in other type of carcinomas including colon, lung, ovary, and 
small cell lung cancers.14 Globo-H has also been detected in the majority of the carcinomas 
of the pancreas, stomach, uterine endometrium, and, in particular, was found to be 
espressed in both primary and metastatic prostate cancer specimens.  
The glycolipid KH-1 is perhaps the most complex carbohydrate-based tumour antigen 
thus far characterized.15 The antigen was isolated from human colonic adenocarcinoma 
cells by using antibodies generated against the classical Ley determinant (Figure 3.2). KH-1 
has been present on the cell surface of all adenocarcinoma cells thus far studied.  
Monoclonal antibodies were raised against this antigen and found to bind specifically to 
KH-1 antigen. Based on these studies, Hakomori et al. postulated that the KH-1 antigen is a 
highly specific marker for malignancy and premalignancy involving colonic 
adenocarcinoma.16 
 
                                                 
12 a) Kannagi, R.; Levery, S. B.; Ishijamik, F.; Hakomori, S.; Schevinsky, L. H. J. Biol. Chem. 1983, 258, 8934; b) 
Bremer, E. G.; Levery, S. B.; Sonnino, S.; Ghidoni, R.; Canevari, S.; Kannagi, R.; Hakomori, S. J. Biol. Chem. 
1984, 259, 14773. 
13 The antibody had been obtained from mice immunized with intact MCF-7 cell lines. 
14 a) Livingston, P. O. Cancer. Biol. 1995, 6, 357; b) Zhang, S.; Cordon-Cardo, C.; Zhang, H. S.; Reuter, V. E.; 
Adluri, S.; Hamilton, W. B.; Lloyd, K. O.; Livingston, P. O. Int. J. Cancer 1997, 3, 42. 
15 Nudelman, E.; Levery, S. B.; Kaizu, T.; Hakomori, S. J. Biol. Chem. 1986, 261, 11247. 
16 a) Kaizu, T.; Levery, S. B.; Nudelman, E.; Stenkamp, R. E.; Hakomori, S. J. Biol. Chem. 1986, 261, 11254; b) 
Kim, S. Y.; Yuan, M.; Itzkowitz, S. H.; Sun, Q., Kaizu, T.; Palekar, A.; Trump, B. F.; Hakomori, S. Cancer Res. 
1986, 46, 5985.  
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Even in the absence of a complete understanding of how changes in glycosylation relate to 
tumour progression, these changes provide important avenues to cancer detection and 
treatment. As a matter of fact high levels of expression of specific types of glycolipids or 
glycoproteins on tumour cells cause an antibody response, consequently rendering the 
cell-surface glycoconjugate recognizable as a tumour-associated antigen. The idea of such 
glycoconjugates as tumour-associated antigens is the basis of Danishefsky group intuition 
of using carbohydrates in the development of anticancer vaccines.17 The underlying 
strategy is the targeted killing of cancer cells by stimulating an immune response directed 
towards antigen specific to tumour cells. Thus immunogens based on tumour-specific 
glycans can be used to stimulate a cytotoxic response by the host immune system. The 
carbohydrate-based vaccines are meant not to prevent tumour occurrence but to provide 
enhanced protection against tumour relapse and metastasis when the tumour burden has 
been rendered minimal through surgery, radiation, or chemotherapeutic treatment.  
Tumour immunotherapy is based on the theory that tumours possess specific antigens 
that can be recognized when presented to or processed by a properly trained immune 
system. A conceptual drawback of this strategy raises observing that these antigens in 
vaccines should trigger the immune machinery, while in their natural form on tumour 
cells they don’t induce any effective immune response. The goal in the development of 
anticancer vaccine is to break the tolerance the immune system has developed for antigens 
expressed mainly or exclusively by the tumour. This aim can be pursued suitably 
conjugating synthetically derived, cell-free antigens with immunogenic molecules, such as 
keyhole limphet hemocyanin, KLH, bovine serum albumin, BSA, or ceramides. Obviously, 
one of the most critical issues to settle is the obtainment of discrete amounts of antigens in 
pure and homogeneous form. The immense difficulties associated with isolation and 
purification of these molecules from natural source make the synthesis the only feasible 
way to follow. Moreover, chemistry plays a major role also in the conjugation phase, 
which is decisive in upgrading a synthetic antigen to a vaccine.  
In Figure 3.5 it is depicted the general approach to synthetic carbohydrate vaccines 
performed by Danishefsky and co-workers. In their elegant work the several 
oligosaccharide antigens were  synthesized exploiting the glycal assembly method, 
developed over many years in the same laboratory.18,19 The conjugation was performed 
reductively aminating the oligosaccharide, terminating in a glycoaldehyde, with a lysine 
residue of the appropriate carrier protein.20 
Preclinical and clinical studies with synthetic conjugates carbohydrate vaccines 
(containing the MBr-1 antigen Globo-H, the adenocarcinoma antigen KH-1, the blood 
group determinant and ovarian cancer antigen Ley) show induction of IgM and IgG 
antibody responses. Noteworthy, The Globo-H-KLH conjugate is poised to enter phase II 
and phase III human clinical trials for the treatment of progressive and reoccurring 
prostate cancer, and it has also been administrated to breast cancer patients in a phase I 
clinical trial. These first results raise hopes of effectively using carbohydrate-based 
vaccines to enable a more favourable survival and “quality of life” prognosis.  
                                                 
17 For a review on the subject: Danishefsky, S. J.; Allen, J. R. Angew. Chem. Int. Ed. 2000, 39, 836. 
18 Danishefsky, S. J.; Bilodeau, M. T. Angew. Chem. Int. Ed. Engl. 1996, 35, 1380.  
19 See Chapter 1. 
20 Bernstein, M. A.; Hall, L. D. Carbohydr. Res.1980, 78, C1. 
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FIGURE 3.5 General Approach to Synthetic Carbohydrate Vaccines. 
 
The only limit in this new field of research is represented by the synthetic ability to 
assemble such and even more complex glycoconjugate structures in sufficient amounts for 
immunological studies.  
Several research groups have been addressing their efforts to the development of effective 
alternative synthetic strategies for the obtainment of these and other oligosaccharide 
antigen structures.  
One of the main interest of our research group is the development of alternative 
glycosylation procedures relying on the use of mild and moisture stable promoters, 
featuring undoubted experimental advantages if compared with the acidic agents 
employed in the standard procedures. Recently, the feasible use of catalytic Yb(OTf)3 for 
the activation of both armed and disarmed glycosyl trichloro-21 and N-
                                                 
21 Schmidt, R. R.; Kinzy, W. Adv. Carbohydr. Chem. Biochem.  1994, 50, 21. 
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phenyltrifluoroacetimidates22 was reported.23 The extremely mildness of Yb(OTf)3–
promoted glycosylation conditions was confirmed by the use of the very acid-labile 
dimethoxytrityl as protecting group, never  reported before to withstand the strong acidic 
conditions imposed on the glycosylation medium by other promoters.24  
 
More recently, 4Å acid washed molecular sieves (commercially known as AW 300 MS) 
were also found to efficiently activate glycosyl trihaloacetimidates, although in this case 
glycosidations did not exhibit a satisfying stereocontrol with donors devoid of 
participating groups.25 The experimental advantages of using these promoters are a matter 
of fact, as they are cheap, very ordinary reagents (always present on the shelf of every 
synthesis lab), insoluble (thus, easily removable from the reaction medium by simple 
filtration), non toxic and very mild. 
In order to expand the scope of these approaches to the synthesis of complex 
oligosaccharide sequences and contextually test their effectiveness, we investigate the 
feasible application of such promoters in the difficult task of Lex trisaccharide and Globo-
H tetrasaccharide fragment synthesis. 
Results and Discussion 
 
α-L-Fucosylation: a common synthetic challenge 
As it can be observed in Figures 3.2 and 3.4 all the depicted antigen structures (with a 
particular interest in Lex and Globo-H) are characterized by the presence of one or more L-
fucose units with α-anomeric configuration. The stereoselective construction of α-fucosidic 
linkages is a very challenging issue to perform.26 In fact, fucosyl donors are quite reactive 
and amenable to decomposition, so that excess amounts are often required to achieve high 
glycosidation yields, especially with poorly reactive glycosyl acceptors.27,28a Additionally, 
α-fucosylation reactions lead to 1,2-cis glycosides whose stereoselective construction can 
not be guaranteed by an approach as efficient as the neighbouring participation effect 
exerted by acyl protecting groups on C-2 position in the stereo-controlled synthesis of 1,2-
trans glycosides.29  
To face these problems several tactics were described over the last years. For example, 
Schmidt has reported the use of the inverse procedure (slow addition of a fucosyl 
trichloroacetimidate to a mixture containing the promoter and the acceptor) to minimize 
                                                 
22 Yu, B.; Tao, H. Tetrahedron Lett. 2001, 42, 2405. 
23 a) Adinolfi, M.; Barone, G.; Iadonisi, A.; Mangoni, L.; Schiattarella, M. Tetrahedron Lett. 2001, 42, 5967; b) 
Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Tetrahedron Lett. 2002, 43, 5573. 
24 Adinolfi, M.; Iadonisi, A.; Schiattarella, M. Tetrahedron Lett. 2003, 44, 6479. 
25 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Org. Lett. 2003, 5, 987. 
26 For a discussion on the problems related to α-fucosylations and pertinent references see: (a) Plante, O. J.; 
Palmacci, E. R.; Andrade, R. B.; Seeberger, P. H. J. Am. Chem. Soc. 2001, 123, 9545; (b) Love, K. R.; Andrade, R. 
B.; Seeberger, P. H. J. Org. Chem. 2001, 66, 8165. 
27 For other recent examples: (a) Manzoni, L.; Lay, L.; Schmidt, R. R. J. Carbohydr. Chem. 1998, 17, 739; (b) Xia, 
J.; Alderfer, J. L.; Piskorz, C. F., Matta, K. L. Chem. Eur. J. 2000, 6, 3442; (c) Söderman, P.; Larsson, E. A.; 
Wilman, G. Eur. J. Org. Chem. 2002, 1614; (d) Ando, T.; Ishida, H.; Kiso, M. Carbohydr. Res. 2003, 338, 503; (e) 
Xia, J.; Alderfer, J. L.; Locke, R. D.; Piskorz, C. F.; Matta, K. L. J. Org. Chem. 2003, 68, 2752. 
28 a) Schmid, U.; Waldmann, H. Chem. Eur. J. 1998, 4, 494; b) Böhm, G.; Waldmann, H. Tetrahedron Lett. 1995, 
36, 3843. 
29 For a discussion on 1,2-cis-glycosides synthesis see pp. 23-31. 
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the fall in yields due to donor degradation.30 An alternative and effective approach, used 
also with other galactose-type donors, relies on the long range participation effect 
performed by acyl protection on C-4 position of fucosyl donors.26, 31 In order to avoid 1,2-
trans-fucosides formation, C-2 hydroxyl group has to be functionalized with a non-
participating protecting group, most commonly a benzyl group. Obviously, this entails an 
increased number of steps in the building block preparation, since a fine differentiation in 
the protection pattern of secondary hydroxyls is required, but glycosidation yields are 
generally improved as the partially acylated donors appear relatively less prone to 
degradation than their perbenzylated counterparts.32  
With our target molecules in mind, we first investigated the feasible synthesis of α-
fucosides by adopting the readily prepared perbenzylated donor 113 (Table 3.1). N-
phenyltrifluoroacetimidate donors were chosen for their lower propensity to give 
undesired side products in the course of glycosidations,33 and their higher stability in 
storage than the corresponding trichloroacetimidate analogues.22 Furthermore, in order to 
reconcile this methodological investigation with the possibility to prepare useful 
disaccharide building blocks to be elaborated into the antigenic structures of our interest 
(preparing also useful precursors for Lewisa,b and Ley sequences), secondary model 
acceptors 114-116 were chosen.  
 
Entry Donor (equiv.) Acceptor Product 
Yielda 
(α:β) 
1 O
O
OBn
OBn
OBn
PhN CF3
 
113 (1.4) 
O
OAc
AcO
HO
OAc
OAc  
114 
O
OBn
OBn
OBn
O
OAc
AcO
O
OAc
OAc
 
117 
66%b 
(9:1) 
2 113 (1.4) 114 117 79% (8:1) 
3 113 (3.0) 
OO
HO
TrocHN
OTBDMS
OPh
115 
OO
O
TrocHN
OTBDMS
OPh
O
OBn
OBn
OBn
 
118 
83% 
(>10:1) 
4 113 (2.5) 
OHO
AllocO
TrocHN
OTBDMS
BnO
 
116 
OBn
OO
AllocO
TrocHN
OTBDMS
OBn
OH3C
BnO
OBn
 
119 
75% 
(>10:1) 
a Procedure: Yb(OTf)3 (0.1 equiv.), AW 300 MS, CH2Cl2/Et2O/dioxane 4:1:1, -30 °C, 1-3 h; b Toluene/ Et2O/dioxane 4:1:1 
was used as solvent mixture. 
 
TABLE 3.1 α-Selective Fucosylation of Acceptors 114-116 under the Agency of Yb(OTf)3. 
                                                 
30 Schmidt, R. R.; Toepfer, A. Tetrahedron Lett. 1991, 32, 3353. A paradigm is also depicted in Scheme 1.13 
(page 17). 
31 See Scheme 1.24 (page 27). 
32 Flowers, H. M. Carbohydr. Res. 1983, 119, 75. 
33 Tanaka, H.; Iwata, Y.; Takahashi, D.; Adachi, M.; Takahashi, T. J. Am. Chem. Soc. 2005, 127, 1630-1631. 
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Noteworthy donor 113 is devoid of acyl protecting group on C-4 position, therefore the 
stereoselectivity of the reaction had to be controlled exploiting the α-directing effect of 
ether-type solvents. Since the AW 300 MS protocol proved to be incompatible with the 
solvent effect, for these couplings, only activation of Yb(OTf)3 was examined. Thus, several 
conditions were tested for the coupling of 113 with acceptor 114, starting from those 
previously reported for a perbenzylated glucosyl donor (-10 °C to r.t, 0.1 eq of Yb(OTf)3, 
toluene/Et2O/dioxane 4:1:1 as the solvent).23b As shown in Table 3.1 (entries 1 and 2) 
fucosyl donor 113 proved to be reactive even at -30 °C in the presence of 0.1 eq of  
Yb(OTf)3, while the ternary mixture dichloromethane/Et2O/dioxane 4:1:1 represented the 
solvent of choice due to the best solubility of the acceptor at the low reaction temperature. 
Under these conditions a good yield was achieved for disaccharide 117 together with a 
good control of stereoselectivity. The established conditions of activation were then tested 
in the α-fucosylation of the glucosamine acceptors 115 and 116, and also in these cases 
synthetically useful results in terms of both yield and selectivity were smoothly obtained  
(entries 3 and 4). Encouraged by these results, some effort was dedicated to ascertain 
whether α-selective fucosylations might be achieved with the simple activation of acid 
washed molecular sieves taking advantage of a long range participation effect.  
For this purpose fucosyl N-penyl trifluoroacetimidate 120 was prepared following the 
synthetic pathway illustrated in Scheme 3.1.  
 
O
OH
OH
OH
OH
AllOH, H2SO4 conc
reflux, 5 mins, 65%
O
OAll
OH
OH
OH
1) CH3C(OMe)3, CSA
DMF, 40°C, 12 h O
OAll
OO
OBn2) NaH, BnBr, RT, 12 h
H3C
OCH3
O
OAll
OAc
OAc
OBn
1) AcOH (80% sol)
    from 0 °C to RT, 2h 
2) Ac2O, Py, RT, 12 h
121 122 123
124
60% 
overall yield from 122
O
OH
OAc
OAc
OBn
125
ClC(=NPh)CF3, NaH
CH2Cl2, 0°C, 3 h, 55%
O
O
OAc
OAc
OBn
120
F3C NPh
PdCl2
MeOH, RT, 2.5 h, 70%
 
 
SCHEME 3.1 Synthesis of Fucosyl Donor 120. 
 
The synthetic strategy used for the obtainment of donor 120 proved to be very 
straightforward. In fact, after allylation of fucose 121 in strongly acidic conditions, 
derivative 124 was obtained in four steps without any chromatographical purification of 
the intermediates. Allyl-fucoside 122 was one-pot converted into derivative 123, exploiting 
an in situ benzylation after the regioselective installation of orthoacetate moiety on C-3 and 
C-4 positions. The orthoester ring was then opened in acidic condition, leaving the 
hydroxyl on C-3 position unprotected. Standard acetylation in pyridine furnished 
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derivative 124 in 60% yield over four steps. Fucosyl donor 120 was obtained by Pd(II)-
catalyzed deallylation followed by treatment of the thus obtained lactol 125 with N-phenyl 
trifluoroaceimidoyl chloride in presence of a base.    
The activation of 120 was initially tested in the attempted fucosylation of acceptor 115 
(Table 3.2). The reaction proceeded at room temperature in 24-36 hours to afford the 
desired disaccharide 126 in good yield and high α-selectivity. Both toluene and 
dichloroethane proved to be suitable solvents for this reaction, comparable results being 
obtained (entries 1 and 2). The procedure was then tested on acceptors 114 and 116 to 
produce the corresponding disaccharides in good yield and complete α-selectivity (entries 
4 and 5).  
Having demonstrated the applicability of these alternative fucosylation protocols to the 
synthesis of several disaccharides, their extension to Lex and Globo-H structures was 
attempted. 
 
Entry Donor (equiv.) Acceptor Product 
Yielda 
(α:β) 
1 O
O
OAc
OAc
OBn
PhN CF3
 
120 (2.0) 
OO
HO
TrocHN
OTBDMS
OPh
 
115 
OO
O
TrocHN
OTBDMS
OPh
O
OAc
OAc
OBn
 
126 
61% 
(10:1) 
2 120 (2.0) 115 126 66%
b 
(10:1) 
3 120 (2.0) 
O
OAc
AcO
HO
OAc
OAc  
114 
O
OAc
OAc
OBn
O
OAc
AcO
O
OAc
OAc
 
127 
78%b 
(only α) 
4 120 (2.0) 
OHO
AllocO
TrocHN
OTBDMS
BnO
 
116 
OAc
OO
AllocO
TrocHN
OTBDMS
OBn
OH3C
AcO
OBn
 
128 
58% 
(only α) 
a Procedure: AW 300 MS, toluene, from 0 °C to RT, 24-36 h; b Dichloroethane was used as solvent. 
 
TABLE 3.2 α-Selective Fucosylation of Acceptors 114-116 under the Agency of AW 300 MS. 
 
Lewisx trisaccharide assembly 
Due to the central role played by Lex motif in several biological processes and to its 
structural complexity, several strategies have been developed for its synthesis.34 Although 
                                                 
34 For some examples of syntheses of Lewis X derivatives: a) Jacquinet, J.-C.; Sinaÿ, P. J. Chem. Soc., Perkin 
Trans. 1 1979, 314; b) Hindsgaul, O.; Norberg, T.; Pendu, J. L.; Lemieux, R. U. Carbohydr. Res. 1982, 109, 109; c) 
Lonn, H. Carbohydr. Res. 1985, 139, 115; d) Nillsson, M.; Norberg, T. Carbohydr. Res. 1988, 183, 71; e) Sato, 
S.; Ito, Y.; Ogawa, T. Tetrahedron Lett. 1988, 29, 5267; f) Classon, B.; Garegg, P. J.; Helland, A.-C. J. Carbohydr. 
Chem. 1989, 8, 543; g) Nillsson, M.; Norberg, T. J. Carbohydr. Chem. 1989, 8, 613; h) Nicolaou, K. C.; Hummel, 
C. W.; Bockovich, N. J.; Wong, C.H. Chem. Commun. 1991, 870; i) Toepfer, A.; Schmidt, R. R. Tetrahedron Lett. 
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it’s just a trisaccharide, Lex offers several synthetic challenges. The central glucosamine 
unit has to be sequentially glycosylated on vicinal secondary hydroxyls (C-3 and C-4). This 
implies a fine differentiation in secondary hydroxyls protection has to be performed. 
Furthermore, the C-4 hydroxyl group is notoriously the less nucleophile on the saccharidic 
backbone. Thus, in order to maximize coupling yields and minimize the steric hindrance 
in the vicinity of the OH-4, galactosylation of glucosamine has to be attained in the first 
step. This reasonable choice affects, on the other hand, the following α-fucosylation step, 
making this already difficult task even more complicate. 
Our synthetic strategy relies on the use of glucosamine acceptor 116 as key intermediate 
(Scheme 3.3). Derivative 116 posses on the C-4 a free OH, ready for the first galactosylation 
step, and carries on the C-3 position the selectively removable allyloxycarbonyl group. 
Since in the first glycosylation the formation of a β- linkage is required, derivative 129 was 
the donor of choice. The stereoselectivity of the reaction could be controlled by the 
neighbouring participating effect  exerted by methoxycarbonyl group at C-2 hydroxyl of 
the donor. The choice of this unusual protecting group was supported by our previous 
observations that 2-O-methoxycarbonylated donors display less propensity to yield 
orthoester-like coupling products than the more canonical acetylated or benzoylated 
counterparts, especially when glycosidations are conducted under very mild activation 
conditions.23a  Furthermore, chemical conditions for the removal of this group are 
comparable to those required by usual O-deacylations (see below).  
The need to effectively synthesizing a such functionalized galactosyl donor (C-1 and C-2 
hydroxyls are differentiated from the other positions and from each other) stimulated the 
development of a convenient alternative route to the one-pot preparation of glycosyl 1,2-
orthoesters via glycosyl iodides.35 As a matter of fact, galactosyl orthoester 122 (Scheme 3.2) 
represents an ideal precursor for galactosyl donor 129, since C-1 and C-2 positions are 
already differentiated from the others, and the further differentiation from each other can 
be easily performed in acidic conditions. Therefore an effective strategy for the synthesis 
of galactosyl donor 129 was pursued. Orthoester intermediate 122 (diastereoisomeric 
mixture) was accessed starting from peracetylated galactopyranose 107 through a one pot 
sequence of anomeric iodination, halide promoted orthoesterification, deacetylation, and 
benzylation followed by a chromatographical purification (50-56 % overall yield).36 122 
was then exposed to allyl alcohol at 70 °C in the presence of in situ generated HCl to 
achieve introduction of the anomeric allyl group and simultaneous deprotection of the 2-
OH. Intermediate 130 (anomeric mixture) was readily purified by chromatography and 
then protected with a methoxycarbonyl group. The product of the TMEDA based 
methoxycarbonylation procedure37 131 was recovered pure in quantitative yield after a 
very short reaction time by simple extractive work-up. Compound 131 was subjected to 
                                                                                                                                                                  
1992, 33, 5161; j) Nicolaou, K. C.; Bockovich, N. J.; Carcanague, D. R. J. Am. Chem. Soc. 1993, 115, 8843; k) 
Numomura, S.; Iida, M.; Numata, M.; Sugimoto, M.; Ogawa, T. Carbohydr. Res. 1994, 263, C1; l) vom de 
Brook, K.; Kunz, H. Angew. Chem. Int. Ed. Eng. 1994, 33, 101; m) Jain, R. K.; Vig, R.; Locke, R. D.; Mohammad, 
A.; Matta, K. L. Chem. Commun. 1996, 65; n) Yan, L.; Kahne, D. J. Am. Chem. Soc. 1996, 118, 9239; o) Hummel, 
G.; Schmidt, R. R. Tetrahedron Lett. 1997, 38, 1173; p) Figueroa-Perez, S.; Verez-Bencomo, V. Tetrahedron Lett. 
1998, 39, 9143; q) Ellervik, U.; Magnusson, G. J. Org. Chem. 1998, 63, 9314; r) Gege, C.; Vogel, J.; Bendas, G.; 
Rothe, U.; Schmidt, R. R. Chem. Eur. J. 2000, 6, 111; s) Gege, C.; Oscarson, S.; Schmidt, R. R. Tetrahedron Lett. 
2001, 42, 377.;t) Majumdar, D.; Zhu, T.; Boons, G.-J. Org. Lett. 2003, 5, 3591. 
35 See Chapter 2. 
36 Adinolfi, M.; Iadonisi, A.; Ravidà, A.; Schiattarella, M. Tetrahedron Lett. 2003, 44, 7863-7866. 
37 Adinolfi, M.; Barone, G.; Guariniello, L.; Iadonisi, A. Tetrahedron Lett. 2000, 41, 9305-9309. 
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anomeric deallylation with catalytic PdCl2. Crude compound 132, isolated by a simple 
filtration, was directly converted into the corresponding trifluoroacetimidate 129. It should 
be noted that the whole synthetic sequence to donor 129 requires eight chemical 
transformations but only three chromatographical purifications. 
 
O
BnO
BnO
O
O
OBn
102 OEt
73% 
overall yield from 130
MeOH, RT, 5 h
O
AcO
AcO
AcO
OAc
OAc
87
1) I2/Et3SiH, CH2Cl2, reflux
2) Lutidine, TBAB, EtOH
3) BnBr, KOH, toluene, reflux
50%
AllOH, AcCl
70°C, 2 h, 88%
O
BnO
BnO
HO
OAll
OBn
130
O
BnO
BnO
CH3O2CO OAll
OBn
131
TMEDA, CH3O2CCl
CH2Cl2, 0°C, 30 mins
quant.
PdCl2O
BnO
BnO
CH3O2CO OH
OBn
132
CH2Cl2, RT, 36 h
ClC(=NPh)CF3, DIPEAO
BnO
BnO
CH3O2CO O
OBn
129
CF3
NPh
 
 
SCHEME 3.2 Synthesis of Galactosyl donor 129. 
 
With galactosyl donor 129 in the hands, glycosylation of glucosamine acceptor 116 was 
performed under the activation of acid washed molecular sieves (Scheme 3.3).  
The choice of the promoter is strongly dependent by the nature of the linkage to be 
formed. Acid washed molecular sieves are generally preferable, because of the extreme 
simplification of the experimental procedure, but, as anticipated previously, their use is 
limited to 1,2-trans-glycosides formation with donors bearing participating groups at the 
C-2 position or alternatively to α-fucosides formation via C-4 acyl long range participation. 
In the absence of such a group, either 1,2-cis or 1,2-trans selectivity can be attained by the 
use of Yb(OTf)3 and the suitable choice of the reaction solvent. Since, in this case, the 
formation of a β-linkage was required, exclusively acid washed molecular sieves were 
used as promoters in the coupling, furnishing disaccharide 133 in good yield (65-76%). 
Disaccharide 133 was smoothly deprotected at C-338 position of the glucosamine to 
provide acceptor 134 that was submitted to the fucosylation procedures previously 
established. The coupling with excess of 113 in the presence of catalytic Yb(OTf)3 afforded 
trisaccharide 135 in high yield and complete α-selectivity (81%). Notably, the synthesis of 
the Lewisx trisaccharide 136 based on the exclusive activation with AW MS in all the 
glycosidation steps turned out to be feasible although the final fucosylation proceeded in 
average yield (42%) but with complete selectivity.  
The reported results demonstered the enforceability of our approaches to complex 
structures synthesis, thus encouraging to extend our methodologies to the synthesis of a 
tetrasaccharide fragment of Globo-H.  
                                                 
38 Tanaka, H.; Amaya, T.; Takahashi, T. Tetrahedron Lett. 2003, 44, 3053. 
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SCHEME 3.3 Synthesis of Lewisx Trisaccharides 135 and 136. 
 
Globo-H tetrasaccharide fragment assembly 
The very promising results registered using Globo-H-KLH coniugate as anticancer vaccin 
stimulated the implementation of  effective and high yielding synthetic strategies for the 
obtainment of this molecule.39 Several truncated versions of Globo-H have been prepared 
and biologically evaluated in order to define synthetically simpler candidates as anticancer 
vaccines.40 These investigations led to the disclosure of a relevant immunogenic activity 
associated to the tetrasaccharidic non reducing end of Globo-H (Figure 3.6).41 
 
                                                 
39 For other syntheses of the complete sequence: a) Park, T. K.; Kim, I. J.; Hu, S.; Bilodeau, M. T.; Randolph, J. 
T.; Kwon, O.; Danishefsky, S. J. J. Am. Chem. Soc. 1996, 118, 11488-11500. b) Lassaletta, J. M.; Schmidt, R. R. 
Liebigs Ann. 1996, 1417-1423. c) Zhu, T.; Boons, G.-J. Angew. Chem. Int. Ed. Eng. 1999, 38, 3495-3497. d) 
Burkhart, F.; Zhang, Z.; Wacowich-Sgarbi, S.; Wong, C.-H. Angew. Chem. Int. Ed. Eng. 2001, 40, 1274-1277. 
40 a) Lay, L.; Nicotra, F.; Panza, L.; Russo, G.; Adobati, E. Helv. Chim. Acta 1994, 77, 509-514. b) Lay, L.; Panza, 
L.; Russo, G.; Colombo, D.; Ronchetti, F.; Adobati, E.; Canevari, S. Helv. Chim. Acta 1995, 78, 533-538. c) Toma, 
L.; Colombo, D.; Ronchetti, F.; Panza, L.; Russo, G. Helv. Chim. Acta 1995, 78, 636-646. d) Kim, I. J.; Park, T. K.; 
Hu, S.; Abrampah, K.; Zhang, S.; Livingston, P. O.; Danishefsky, S. J. J. Org. Chem. 1995, 60, 7716-7717. e) 
Adobati, E.; Panza, L.; Russo, G.; Colnaghi, I.; Canevari, S. Glycobiology 1997, 7, 173-178. 
41 a) Panza, L.; Poletti, L.; Prosperi, D.; Canevari S.; Perico, M. E. Eur. J. Org. Chem. 2001, 4331-4336. b) Perico, 
M. E.; Mezzanzanica, D.; Luison, E.; Alberti, P.; Panza, L.; Russo, G.; Canevari S. Cancer Immunol. 
Immunother. 2000, 49, 296-304. 
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FIGURE 3.6 Biologically Active Tetrasaccharidic non-Reducing End of Globo-H Antigen. 
 
Tetrasaccharide 137 was our target molecule and monosaccharide building blocks 138, 139, 
129 and 113 were used as precursors of residues A-D, respectively (Figure 3.7).  
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FIGURE  4.7 Target Compound and Building Blocks. 
 
A linear approach was followed, because preliminary studies revealed the unfeasibility of 
a convergent approach (AB+CD). In fact, extreme poor reactivity was exhibited by CD 
residue precursors 140 and 141 in model couplings with monosaccharide acceptor 142 
even under the stronger promoting action of TMSOTf (Scheme 3.4).42  
 
O
OR
RO
O
OR
OH3C
OBn
OBn
OBn
O CF3
NPh
O
O
HO
N3
O
Ph
SePh
MeCN/EtCN 4:1
Yb(OTf)3 or TMSOTf NO REACTION
140: R = Ac
141: R = Bn 142  
 
SCHEME 3.4 Preliminary Studies for the Convergent Approach. 
                                                 
42 Unpublished results. 
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The whole synthetic sequence proposed relies on the complemetary use of acid washed 
molecular sieves and Yb(OTf)3 in stereocontrolled construction of three strategically 
different typologies of glycosidic linkages. 
The linear construction of the tetrasaccharide started with the coupling (Scheme 3.6) of the 
known acceptor 13843 with donor 139 (anomeric mixture), equipped with a 2-azido 
functionality, whose synthesis was conducted following the synthetic pathway depicted in 
Scheme 3.5. 
 
O
AcO
AcO
OAc
Ac2IPh, NaN3, (PhSe)2
DCM, RT, 48 h
72%
O
AcO
AcO
SePh
N3
OAc
O
AcO
AcO
OH
N3
OAc
I2, H2O
CH3CN, RT, 12h
42%
O
AcO
AcO
ON3
OAc
ClC(=NPh)CF3, NaH
DCM, RT, 5 h
81%CF3
NPh
143 144
145139
 
SCHEME 3.5 Synthesis of Galactosyl Donor 139.  
 
In the first step, the relatively cheap tri-O-acetyl-D-galactal 143 was effectively converted 
into galactosazide derivative 144. Azido-phenylselenylation was reported to occur with 
exclusive regio-selectivity providing the installation of the azido-moiety on the C-2 and 
the phenylselenide on the anomeric center.44 Furthermore, in the case of galacto-series the 
reaction exhibits also a regarding stereoselectivity: the azido function attacks the C-2 
position with an equatorial orientation, providing thus only the galacto-derivative 144. In 
the case of gluco-series a lower stereoeselctivity is observed and the azidoselenylation 
yield is decreased by the formation of undesired mannose-type derivative. 
Selenoglycoside 144 was hydrolized via iodine-mediated activation of the selenide 
moiety45 and then efficiently converted into galactosyl donor 139 by treatment with N-
phenyl trfluoroacetimidoyl chloride and sodium hydride.  
Despite the lack of participating ability of the azide group, the reaction gave excellent 
results thanks to the activation of catalytic ytterbium(III) triflate (0.1 eq) and the β-
directing effect exerted by the acetonitrile solvent.23b,46 As a matter of fact, the β-linked 
disaccharide 146 was obtained in high yield (70-77%) and traces of the α-linked 
disaccharide could be monitored only by a careful inspection of the NMR spectrum of the 
crude reaction mixture. Interestingly, this result was achieved without resorting to the low 
                                                 
43 Bazin, H. G.; Du, Y. ; Polat, T.; Linhardt, R. J. J. Org. Chem. 1999, 64, 7254-7259. 
44 Czerniecki, S.; Randriamandimby, D. Tetrahedron Lett. 1993, 34, 7915. 
45 Kartha, K. P. R.; Karkkainen, T. S.; Marsh, S. J.; Field, R. A. Synlett 2001, 260. 
46 Schmidt, R. R.; Behrendt, M.; Toepfer, A. Synlett 1990, 694-696. 
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temperatures required for the corresponding TMSOTf promoted reactions of 2-azido 
trichloroacetimidates.47 Moreover, 2-azido-3,4,6-O-acetylated trichloroacetimidates were 
recently reported to provide disappointing results in TMSOTf promoted glycosidatons in 
nitrile solvents.47 
Disaccharide 146 was submitted to a deacetylation-benzylidenation sequence that readily 
provided the disaccharide acceptor 147 (80% yield over two steps) that was then coupled 
with the galactose donor 129. In initial attempts the use of commercially available 4Å acid 
washed molecular sieves in the double role of activators and drying agents led to 
satisfying yields (61-64 %).25 Replacement of the 4Å with the 5Å AW MS afforded slightly 
higher yields (65-70%) within a sensibly shorter reaction time (ca. 24 h vs 48 h). A further 
improvement (75% yield) was registered with a modified procedure that entails the slow 
addition of donor 129 to a solution of acceptor 147 in a dichloroethane/cyclohexane 
mixture containing the 5Å sieves.  
The resulting trisaccharide 148 was easily deprotected with K2CO3 in methanol at 40°C to 
yield acceptor 149 (89%). The final sterecontrolled α-L-fucosylation of the sterically 
encumbered 2-OH was achieved by means of the previously described procedure which 
combines the efficient activation of catalytic ytterbium(III) triflate with the α-directing 
solvent mixture 4:1:1 dichloromethane/dioxane/diethyl ether. Due to the high reactivity 
of the perbenzylated fucosyl donor 113, the reaction was conducted at low temperature (- 
30°C) to give the desired α-anomer 137 (66% yield).  
Derivative 137 is expected to be a useful building-block for the planned synthesis of novel 
N-derivatized analogues, the 2-azido group functionality representing a useful handle to 
this purpose. However, in order to verify the feasibility of block deprotection, 
hydrogenolysis of 137 led to the removal of benzyl and benzylidene groups and the 
concomitant reduction of the azide functionality furnishing 150 tetrasaccharide in good 
yield. 
 
 
                                                 
47 Tsuda, T.; Nakamura, S.; Hashimoto, S. Tetrahedron 2004, 60, 10711-10737. 
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Conclusion 
In conclusion, we have reported the use of two alternative moisture stable and mild 
activating systems of N-phenyltrifluoroacetimidate donors for the stereocontrolled 
synthesis of α-fucosides. In a first approach catalytic Yb(OTf)3 was found to provide good 
yields and α-selectivity in short reaction times when used in combination with solvent 
mixtures containing  diethyl ether and dioxane. In an alternative approach, synthetically 
useful results were achieved by activating a partially acylated fucosyl donor with AW 300 
MS. In this case a high stereocontrol could be obtained exploiting a long-range 
participation effect of the acyl groups installed on the fucose residues. Both these 
approaches were used in the synthesis of several fragments contained in biologically 
interesting sequences, including the Lewisx trisaccharide and the tetrasaccharide extremity 
of Globo-H. In the latter case, complementary use of both promoting system was achieved. 
In the absence of 2-O-participating groups on the donor, ytterbium(III) triflate proved 
efficient in promoting the synthesis of either 1,2-cis or 1,2-trans glycosides, depending on 
the nature of the adopted solvents. With the donor equipped with appropriate 
participating group even the sole acid washed molecular sieves could be used to 
conveniently perform the required 1,2-trans glycosidation. This work demonstrates that 
Yb(OTf)3 and acid washed molecular sieves represent a practical alternative to the harsh 
and sensitive agents adopted in standard glycosylation protocols even for the assemblage 
of non trivial oligosaccharide sequences. 
 
Experimental Section 
 
General Methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were 
recorded on Varian spectrometers at 200 or 300 MHz and 50 or 75 MHz, respectively; or on 
a Bruker Avance 500 spectrometer at 500 MHz. The chemical shifts are given in parts per 
million (ppm) on the delta (δ) scale. Analytical thin layer chromatography (TLC) was 
performed on E. Merck pre-coated (25 nm) silica gel 60F-254 plates. Column 
chromatography was preformed using Carlo Erba 0.06-0.20 silica gel. Anhydrous solvents 
stored over molecular sieves (purchased from Aldrich) were used for performing the 
reactions.  
 
α-L-Fucosylations 
 
General procedure for the synthesis of  N-phenyl trifluoroacetimidate armed donors.  
0.192 mmol of lactol are fluxed under argon and then dissolved at room temperature in 3 
mL of dry CH2Cl2. The system is cooled down to 0°C and 32 µL (0.250 mmol)  of N-
phenyl trifluoroacetimidoyl chloride and 6 mg (0.250 mmol) of NaH (60%) are added. 
After 2 hours stirring the mixture is concentrated and the crude is purified by alumina 
column chromatography (petrol ether/ethyl acetate 9:1). 
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113. Donor 113 was prepared from the commercially available 
hemiacetal (purchased from CMS Chemicals) following the 
above described procedure. In this case the 
chromatographical purification was conducted on neutral 
alumina (eluent petroleum ether/ethyl acetate 95:5 with a few drops of TEA) to yield 113 
(99%) as a white solid. [α]D -92.4 (c 0.7 in CH2Cl2). 1H NMR (500 MHz, CDCl3)  δ 7.40-6.75 
(aromatic protons), 5.58 (1H, bs, H-1), 5.04-4.64 (6H, 3xAB, 3x- benzyl CH2), 4.04 (1H, bq, 
J5,6 = 6.8 Hz, H-5), 3.70-3.50 (3H, H-2, H-3, and H-5), 1.17 (3H, d, 6-CH3). 13C NMR (50 
MHz, CDCl3) δ 143.5, 138.1, 138.1, and 138.0 (aromatic C), 128.5-127.5, 124.0, and 119.2 
(aromatic CH), 97.4 (C-1), 16.5 (C-6). Other signals at 82.3, 77.9, 75.8, 75.4, 74.7, 73.0 and 
71.5. C35H34F3NO5: calcd C 69.41, H 5.66; found C 69.29, H 5.38. 
 
122. 40 mL of allyl alchool were added at room temperature to 2.105 g 
(12.8 mmol) of L-fucose 121. The system was refluxed until the 
complete solubilization of the sugar. 320 µL of conc. H2SO4 were added 
dropwise. After 5 minutes, the mixture was neutralized with K2CO3 aq. 
After filtration, the crude was purified by silica gel column chromatography 
(CH2Cl2/MeOH 94:6) furnishing 1.693 g of 122 (65% yield). 
 
124. 1.693 g (8.289 mmol) of 122  were coevaporated with dry toluene, 
fluxed under argon and dissolved into 15 mL of dry DMF at room 
temperature, then 16.1 mL (124.335 mmol) of methylorthoacetate and 
192 mg (0.829 mmol) of canphorsulforic acid were added. The mixture 
was stirred for 12 h at 40 °C. Then 3.9 mL (0.0331 mmol) of benzyl bromide and 2.487 g of 
NaH (60%) were admixed. After 5 hours stirring, 2mL of MeOH were added to quench 
the unreacted traces of benzyl bromide. The mixture was then diluted with  CH2Cl2 and 
the solvent removed under reduced pressure. The thus obtained crude 123 was dissolved 
in 20 mL of acetic acid (80% solution) at 0 °C. After 1.5 hours stirring the mixture was 
diluted with CH2Cl2 and washed with Na2CO3 aq. to neutrality. The organic phase was 
then concentrated. In order to achieve the final acetylation, the crude was dissolved in 
pyridine (10 mL)  and 5 mL of Ac2O were added. After reaction completion (12 hours at 
room temperature) MeOH was added to quench the unreacted anhydride, the mixture 
was diluted with CH2Cl2 and washed with water. The organic phase was concentrated 
and purified by silica gel column chromatography (petrol ether/ethyl acetate 8:2) 
obtaining 124 (1.867 g) in 60% yield. 1HNMR (CDCl3, 300 MHz) significative signals at δ : 
7.40-7.20 (aromatic), 5.90 (1H, m, CH=CH2), 5.40-5.10 (5H, m, H-3 α, H-4 α and β, 2H 
CH=CH2), 5.00 (1H, dd, J3,2= 9.37 Hz, J3,4= 3.5 Hz, H-3 β), 4.88 (1H, d, J1,2= 3.0 Hz, H-1 α), 
4.72 (4H, 2xAB, CH2 benzyl), 4.50 (1H, d, J1,2= 7.5 Hz, H-1 α), 4.20-4.10 (3H, m, H-5 α and 
2H CH2-CH=CH2), 3.86 (1H, dd, J1,2= 3.5 Hz, J2,3= 10.54 Hz, H-2 α), 3.76 (1H, m, H-5 β), 
3.64 (1H, dd, J1,2= 7.0 Hz, J2,3= 10.54 Hz, H-2 β), 2.14 (6H, 2xs, CH3 acetyl α and β), 1.997 
(3H, s, CH3 acetyl α), 1.966 (3H, s, CH3 acetyl β), 1.217 (3H, d, 3J= 7.3 Hz, 3H-6 β), 1.112 
(3H, d, 3J= 7.3 Hz, 3H-6 α) 
 
OH3C
OBn
OBn
OBn
F3C
O NPh
O
OAll
OH
OH
OH
O
OAll
OAc
OAc
OBn
Chapter 3
  85
125. To a solution of 124 (1.073 g, 2.840 mmol) in of MeOH (20 mL) 0.284 
mmol of PdCl2 were added. After 3 hours stirring, the mixture was 
diluted with CH2Cl2 and filtered through a small pad of silica gel 
(CH2Cl2/MeOH 9:1). The concentrated residue was purified by silica gel 
column chromatography furnishing 125 (649 mg, 70% yield). 1HNMR (CDCl3, 200 MHz) 
significative signals at δ : 7.50-7.20 (aromatic), 5.40-5.22 (3H, m, H-3 α, 2H-4 α and β), 5.15 
(1H, d, 3J= 3.8 Hz, H-1 α), 5.00-4.59 (6H, m, H-3 β, 2xCH2 benzyls α and β and H-1 β), 4.31 
(1H, q, 3J= 7.7 Hz, H-5 α), 3.90-3.70 (2H, m, H-2 α and H-5 β),  3.55 (1H, t, 3J= 9.6 Hz, H-2 
β), 2.20-1.80 (12H, 4xs, 4xCH3 acetyls α and β), 1.20-1.00 (6H, m, 2x 3H-6 α and β). 
 
120. (α/β 1:1.6): 1HNMR (CDCl3, 200 MHz) significative signals at δ: 
7.40-7.20 (aromatic), 6.90 (2H, d, 3J= 7.7 Hz, H-orto Ph, β), 6.75 (2H, d, 
3J= 7.2 Hz, H-orto Ph, α), 6.60 (1H, bs, H-1 α), 5.46-5.36 (2H, M, H-3 
and H-4), 5.26 (1H, bs, H-1 β), 4.90-4.65 (4H, 2x AB, CH2 benzyls α 
and β), 4.35 (1H, m, H-5 α), 4.10-3.80 (3H, m, H-2 α and β and H-5 β), 
2.22 (3H, s, CH3 acetyl β), 1.23-1.21 (6H, m, 3xH-6 α and β). 
 
Procedure with Yb(OTf)3: A mixture of acceptor (0.2 mmol) and donor 113 (see Table 3.1 
for relative amounts) were coevaporated three times in anhydrous toluene and the residue 
was kept under vacuum for 1 hour. Acid washed molecular sieves (4 Å AW 300 MS, 
pellets, 200 mg) were then added and the mixture dissolved at 0°C with dichloromethane 
(2.8 mL), and diethyl ether (700 µL). After cooling at -30 °C, a solution of Yb(OTf)3 (12.5 
mg, 0.02 mmol) in dioxane (700 µL) was added drop-wise. The mixture was kept under 
stirring at this temperature until complete consumption of the fucosyl donor (1-3 h, TLC) 
and then few drops of triethylamine were added. The mixture was filtered on a short pad 
of silica gel, concentrated, and the residue purified by silica gel chromatography (eluent: 
hexane/ethyl acetate mixtures).  
 
Procedure with AW 300 MS: A mixture of acceptor (0.2 mmol) and donor 120 (see Table 
3.2 for relative amounts) were coevaporated three times in anhydrous toluene and the 
residue was kept under vacuum for 1 hour. Acid washed molecular sieves (4 Å AW 300 
MS, pellets, 1.5-2 g) were then added and the solvent (dichloroethane or toluene, 2-4 mL) 
was added at 0 °C. The mixture was kept at 0 °C under stirring for 30 minutes and then 
temperature was left to raise spontaneously. After complete consumption of the donor 
(24-36 hours), the mixture was filtered through a cotton pad and concentrated. The 
residue was purified by silica gel chromatography (eluent: hexane/ethyl acetate 
mixtures). 
 
In the following list of selected NMR data, the saccharidic residue derived from the donor 
is indicated as A, while the residue derived from acceptor is indicated as B.    
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117. 1H NMR (200 MHz, CDCl3) δ 7.40-7.20 (aromatic protons), 6.28 
(1H, d, J1,2 = 3.8 Hz, H-1 B), 5.48 (1H, bd, J3,4 = 3.2 Hz, H-4 B), 5.35 (1H, 
dd, J2,3 = 10.6 Hz, H-3 B), 5.05 (1H, d, J1,2 = 3.4 Hz, H-1 A), 5.00-4.60 (6H, 
3x benzyl CH2), 4.29 (1H, bd, J5,6 = 6.6 Hz, H-5 B), 4.20-3.95 (4H, m, H-2 
A, H-2 B and H2-6 B), 3.83 (1H, bq, J5,6 = 6.6 Hz, H-5 A), 3.77 (1H, dd, J2,3 
= 10.2 Hz, J3,4 = 2.8 Hz, H-3 A), 3.63 (1H, bd, H-4 A), 2.16, 2.10, 2.03, 1.73 
(12H, 4xs, 4x acetyl CH3), 1.11 (3H, d, J5,6 = 6.6 Hz, H3-6 A). 13C NMR 
(50MHz, CDCl3) δ 170.4, 170.0, 170.0, 169.6 (4x -COCH3), 138.6, 138.6, and 138.5 (aromatic 
C), 128.3 - 127.2 (aromatic CH), 99.6 and 91.3 (C-1 A and B), 20.9, 20.6, 20.6, 20.4 (4x -
COCH3), 16.5 (6-CH3 A); other signals at δ 78.5, 77.2, 75.7, 74.7, 72.7, 72.6, 71.4, 69.3, 68.3, 
67.6, 67.2, 61.2.  
 
118. 1H NMR (200 MHz, CDCl3) δ 7.50-7.20 (aromatic 
protons), 5.50 (1H, s, benzylidene acetal CH), 5.17 (1H, 
d, J1,2 = 3.4 Hz, H-1 A), 4.98 (1H, d, J1,2 = 7.8 Hz, H-1 B), 
4.96-4.50 (8H, m, Troc CH2 and 3x benzyl CH2), 4.30 
(1H, dd, J5,6eq = 4.5 Hz, J6ax,6eq = 10.2 Hz, H-6eq B), 4.25 
(1H, t, J2,3 = J3,4 = 10.0 Hz, H-3 B), 4.14-4.04 (2H, m, H-2 
and H-5 A), 3.96 (1H, dd, J2,3 = 10.2 Hz, J3,4 = 2.6 Hz, H-3 A), 3.77 (1H, t, H-6ax B), 3.62 (1H, 
t, H-4 B), 3.57 (1H, bd, H-4 A), 3.47 (1H, m, H-5 B), 3.25 (1H, m, H-2 B), 0.87 (9H, s, -
SiC(CH3)3), 0.82 (3H, d, J5,6 = 6.6 Hz, H3-6 A), 0.09 and 0.06 (6H, 2xs, -Si (CH3)2).13C NMR 
(50MHz, CDCl3) δ 153.8 (-NH-CO-OCH2CCl3), 138.5, 138.4, 138.2, and 137.1 (aromatic C), 
129.0-126.2 (aromatic CH), 101.6, 97.8, and 95.6 (benzylidene acetal CH, C-1 A and B), 25.5 
(-SiC(CH3)3), 17.8 (-SiC(CH3)3), 16.2 (6-CH3 A), -4.3 and -5.4 (-Si (CH3)2); other signals at δ 
80.5, 79.4, 74.9, 74.8, 74.6, 74.3, 73.6, 72.9, 71.6, 69.7, 66.7, 66.1, 61.1.  
 
119. 1H NMR (300 MHz, CDCl3) δ 7.45-7.20 
(aromatic protons), 5.92-5.78 (1H, m, CH2=CH-CH2-
), 5.28 (1H, bd, Jtrans = 17.1 Hz, CHtrans=CH-CH2-), 
5.20 (1H, bd, Jcis = 9.3 Hz, CHcis=CH-CH2-), 5.08 
(1H, d, J1,2 = 8.7 Hz, H-1 B), 5.04 (1H, d, J1,2 = 3.6 Hz, 
H-1 A), 4.94 (1H, t, J2,3 = J3,4 = 10.2 Hz, H-3 B), 4.96-
4.38 (12H, Troc CH2, 4x benzyl CH2, and CH2=CH-CH2-), 4.20 (1H, bq, J5,6 = 6.4 Hz, H-5 
A), 4.01 (1H, dd, J2,3 = 10.5 Hz, H-2 A), 3.88-3.50 (7H, H-3 A, H-4 A, H-2 B, H-4 B, H-5 B, 
H2-6 B), 1.08 (3H, d, H3-6 A), 0.87 (9H, s, -SiC(CH3)3), 0.12 and 0.08 (6H, 2xs, -Si(CH3)2). 
13C NMR (50MHz, CDCl3) δ 155.2 and 154.0 (-NH-CO-OCH2CCl3 and -O-CO-All), 138.7, 
138.6, 138.5, 138.4 (aromatic C), 131.3 (CH2=CH-CH2-),128.4-127.4 (aromatic CH), 119.2 
(CH2=CH-CH2-), 99.4 and 95.9 (C-1 A and B), 25.6 (-SiC(CH3)3), 17.9 (-SiC(CH3)3), 16.5 
(6-CH3 A), -4.1 and -5.3 (-Si(CH3)2); other signals at δ 79.4, 79.2, 77.6, 76.3, 75.2, 74.8, 74.2, 
73.2, 72.8, 68.8, 67.4, 66.8, 58.7.  
 
126. 1H NMR (200 MHz, CDCl3) δ 7.50-7.20 (aromatic 
protons), 5.50 (1H, s, benzylidene acetal CH), 5.34-5.26 
(2H, m, H-3 and H-4 A), 5.24 (1H, JNH,2 = 7.2 Hz, NH-2 
B), 5.10 (1H, d, J1,2 = 3.8 Hz, H-1 A), 5.08 (1H, d, J1,2 = 7.6 
Hz, H-1 B), 4.90-4.44 (4H, m, Troc CH2 and benzyl 
CH2), 4.38-4.20 (3H, H-5 A, H-6eq and H-3 B), 3.82 (1H, 
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dd, J2,3 = 10.2 Hz, H-2 A), 3.78 (1H, t, J3,4 = J4,5 = 10.2 Hz, H-4 B), 3.59 (1H, t, J5,6ax = J6ax,6eq = 
9.2 Hz, H-6ax B), 3.48 (1H, m, H-5 B), 3.07 (1H, m, H-2 B) 2.07, 1.95 (6H, 2xs, 2x acetyl 
CH3), 0.85 (9H, s, -SiC(CH3)3), 0.57 (3H, d, J5,6 = 6.6 Hz, H3-6 A), 0.06 and 0.04 (6H, 2xs, -
Si(CH3)2). 13C NMR (50MHz, CDCl3) δ 170.6, 170.1, (2x -COCH3), 153.7 (-NH-CO-
OCH2CCl3), 138.7, 137.1 (aromatic C), 129.2 - 126.4 (aromatic CH), 102.0, 97.9, and 95.0 
(non aromatic CH benzylidene, C-1 A and B), 25.5 (-SiC(CH3)3), 20.9, 20.6 (2x -COCH3), 
17.8 (-SiC(CH3)3), 15.1 (6-CH3 A), -4.3 and -5.4 (-Si(CH3)2); other signals at δ 80.4, 77.1, 
74.9, 74.5, 74.2, 73.1, 71.6, 70.1, 68.8, 66.1, 64.4, 61.4.  
 
127. 1H NMR (200 MHz, CDCl3) δ 7.40-7.20 (aromatic protons), 6.34 
(1H, d, J1,2 = 4.0 Hz, H-1 B), 5.47 (1H, bd, J3,4 = 2.8 Hz, H-4 B), 5.34 (1H, 
dd, J2,3 = 10.4 Hz, H-3 B), 5.26-5.14 (2H, m, H-3 and H-4 A), 5.07 (1H, d, 
J1,2 = 3.6 Hz, H-1 A), 4.59 (2H, s, benzyl CH2), 4.29 (1H, bt, J5,6 = 7.0 Hz, 
H-5 B), 4.18-4.04 (4H, H-5 A, H-2 B, and H2-6 B), 3.82 (1H, dd, J2,3 = 9.6 
Hz, H-2 A), 2.21, 2.15, 2.11, 2.03, 1.93, and 1.74 (18H, 6xs, 6x acetyl 
CH3), 1.09 (3H, d, J5,6 = 6.6 Hz, H3-6 A). 13C NMR (50MHz, CDCl3) δ 
171.3, 170.9, 170.9, 170.7, 170.7, 170.3 (6x -COCH3), 138.6 (aromatic C), 
128.9, 128.6, and 128.3 (aromatic CH), 100.0 and 91.1 (C-1 A and B), 20.1-19.8 (6x -COCH3), 
15.1 (6-CH3 A); other signals at δ 73.2, 72.6, 71.3, 69.4, 69.1, 68.2, 65.3, and 61.0.  
 
128. 1H NMR (200 MHz, CDCl3) δ 7.40-7.20 
(aromatic protons), 6.00-5.80 (1H, m, CH2=CH-
CH2-), 5.40-5.14 (5H, CH2=CH-CH2-, H-3 A, H-4 A, 
and H-1 B), 5.11 (1H, d, J1,2 = 3.6 Hz, H-1 A), 4.93 
(1H, t, J2,3 = J3,4 = 9.6 Hz, H-3 B), 4.88-4.36 (8H, Troc 
CH2, 2x benzyl CH2, and CH2=CH-CH2-), 4.11 (1H, 
bq, J5,6 = 6.4 Hz, H-5 A), 3.96-3.45 (6H, H-2 A, H-2 B, H-4 B, H-5 B, and 6-CH2 B), 2.11 and 
1.96 (6H, 2xs, 2x acetyl CH3), 1.04 (3H, d, H3-6 A), 0.87 (9H, s, -SiC(CH3)3), 0.12 and 0.08 
(6H, 2xs, -Si(CH3)2). 13C NMR (50MHz, CDCl3) δ 170.5, 170.0 (2x -COCH3), 155.2 and 154.0 
(-NH-CO-OCH2CCl3 and -O-CO-All), 138.7, 137.1 (aromatic C), 131.1 (CH2=CH-CH2-), 
128.4-127.4 (aromatic CH), 119.4 (CH2=CH-CH2-), 99.2 and 96.1 (C-1 A and B), 25.5 (-
SiC(CH3)3), 20.8 and  20.7 (2x -COCH3), 17.9 (-SiC(CH3)3), 15.7 (6-CH3 A), -4.2 and -5.4 (-
Si(CH3)2); other signals at δ 76.0, 75.0, 74.6, 73.9, 73.7, 73.3, 71.6, 70.2, 69.0, 68.2, 65.4, 58.7.  
 
Lewisx assembly 
 
130. Acetyl chloride (530 µL, 6.75 mmol) was added to a solution of 
compound 122 (1.312 g, 2.5 mmol) in allyl alcohol  (11 mL). The 
mixture was heated at 70°C for two hours and then concentrated 
under vacuum. The residue was purified on a short silica gel 
column (eluent petroleum ether/ethyl acetate 9:1) to afford  130 (1.09 g, 88% yield) as a 
white solid. (α:β ca 3.5) 1H NMR of the major anomer (300 MHz, CDCl3): δ 7.40-7.20 
(aromatic protons), 6.00-5.84 (1H, m, CH2-CH=CH2), 5.26 (1H, bd, CH2-CH=CHtrans, Jtrans 
= 17.1 Hz), 5.17 (1H, bd, CH2-CH=CHcis, Jcis = 12.0 Hz), 4.98 (1H, d, J1,2 = 3.9 Hz, H-1), 
4.90-4.39 (6H, 3xAB, 3x benzyl CH2), 4.24-4.20 (3H, overlapped signals, H-2 and CH2-
CH=CH2), 3.98 (1H, bd, J3,4 = 2.4 Hz, H-4), 3.94 (1H, bt, J5,6a = J5,6b = 6.6 Hz, H-5), 3.71 (1H, 
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dd, J2,3 = 9.6 Hz, H-3), 3.65-3.50 (2H, m, 6-CH2). Significative signals of the δ anomer at δ 
4.27 (1H, d, J1,2 = 7.8 Hz, H-1), 3.42 (1H, bd, J2,3 = 9.6 Hz, J3,4 = 2.4 Hz, H-3). 13C NMR major 
anomer (50 MHz, CDCl3) δ 138.3, 138.1, 137.7 (aromatic C), 133.6 (-CH2-CH=CH2), 128.2-
127.4 (aromatic CH), 117.6 (-CH2-CH=CH2), 97.6 (C-1). Other signals at δ 79.5, 74.5, 73.9, 
73.3, 72.3, 69.5, 68.8, 68.7, 68.3. Significative signals of the β anomer at δ 133.8 (-CH2-
CH=CH2), 101.9 (C-1). C30H34O6: calcd C 73.45, H 6.99; found C 73.21, H 6.81. 
131. TMEDA (290 µL, 1.9 mmol) and methylchloroformate (200 µL, 
2.6 mmol) were sequentially added at 0°C to a solution of 130 (672 
mg, 1.4 mmol) in anhydrous dichloromethane (8 mL). After 30’ the 
mixture was diluted with dichloromethane and washed with water 
and the aqueous phase extracted with dichloromethane. The 
collected organic phases were concentrated to yield pure 131 (765 mg, quantitative yield) 
as an oil. (α:β ca 3.5:1) 1H NMR of the major anomer (200 MHz, CDCl3): δ 7.45-7.20 
(aromatic protons), 6.05-5.80 (1H, m, -CH2-CH=CH2), 5.40-5.16 (4H, overlapped signals, 
H-1, H-2, and -CH2-CH=CH2), 5.04-4.40 (6H, 3xAB, 3x benzyl CH2), 4.28-3.96 (5H, 
overlapped signals, H-3, H-4, H-5,  and  -CH2-CH=CH2), 3.81 (3H, -OCH3), 3.70-3.55 (2H, 
m, 6-CH2). Significative signals of the β anomer at δ 4.45 (1H, d, J1,2 = 7.8 Hz, H-1), 3.82 
(3H, -OCH3). 13C NMR major anomer (50 MHz, CDCl3) δ 155.2 (-CO2CH3), 138.4, 138.2, 
137.9 (aromatic C), 133.7 (-CH2-CH=CH2), 128.3-127.3 (aromatic CH), 117.4 (-CH2-
CH=CH2), 95.4 (C-1), 54.7 (OCH3). Other signals at 74.6, 74.5, 73.3, 72.9, 69.4, 68.7, 68.3. 
Significative signals of the β anomer at δ 155.0 (-CO2CH3), 116.9 (-CH2-CH=CH2), 100.0 
(C-1). C32H36O8: calcd C 70.06, H 6.61; found C 70.19, H 6.52. 
 
132. PdCl2  (51 mg, 0.28 mmol) was added to a solution of 131 (759 
mg, 1.4 mmol) in non anhydrous methanol (10 mL). After stirring for 
5 hours at room temperature  the mixture was concentrated and the 
residue filtrated on a short silica gel plug (eluent 
dichloromethane/methanol 95/5) to remove the palladium by products. The filtrated was 
concentrated to yield crude 132 (715 mg) in a satisfying purity to be directly used in the 
following step. (α:β ca 1.5:1) 1H NMR of the major anomer (200 MHz, CDCl3): δ  7.45-7.20 
(aromatic protons), 5.51 (1H, t, J1,2 = J1,OH = 3.4 Hz, H-1), 5.21 (1H, t, J2,3 = 9.6 Hz, H-2), 
4.96-4.38 (6H, 3xAB, 3x benzyl CH2), 4.17 (1H, bt, J5,6a = J5,6b = 6.0 Hz, H-5), 3.99 (1H, dd, 
J3,4 = 2.8 Hz, H-3), 3.93 (1H, bd, H-4), 3.78 (3H, s, -OCH3), 3.65-3.40 (2H, m, 6-CH2), 2.55 
(1H, bd, 1-OH). Significative signals of the β anomer at δ  5.01 (1H, dd, J1,2 = 7.8 Hz, J2,3 = 
9.8 Hz, H-2), 4.68 (1H, d, J1,2 = 7.8 Hz, H-1), 3.81 (3H, -OCH3). 13C NMR major anomer (50 
MHz, CDCl3) δ 155.1 (-CO2CH3), 138.1, 138.1, 137.3 (aromatic C), 128.2-127.3 (aromatic 
CH), 90.4 (C-1), 54.5 (OCH3). Other signals at 76.3, 74.6, 74.4, 73.2, 72.8, 69.0. Significative 
signals of the β anomer at δ 155.7 (-CO2CH3), 95.4 (C-1), 54.9 (-OCH3). 
 
129. Crude compound 132 (715 mg, 1.4 mmol) was dissolved in 
anhydrous dichloromethane (7 mL). DIPEA (890 µL, 5.0 mmol) 
and N- (phenyl)trifluoroacetimidoyl chloride (560 µL, 4.2 mmol) 
were added at 0°C. The mixture was stirred for 36 hours at 
room temperature and then concentrated. The residue was chromatographed on a silica 
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gel column eluted with petroleum ether/ethyl acetate 95:5 (with a few drops of TEA) to 
yield 129 (658 mg, 73% yield from 150) as an oil. [α]D + 53.6 (c 0.9 in CH2Cl2). 1H NMR 
(300 MHz, CDCl3) δ 7.50−6.80 (aromatic protons), 5.77 (1H, bs, H-1), 5.48 (1H, bt, J1,2 = J2,3 
= 9.6 Hz, H-2), 5.04-4.46 (6H, 3x AB, 3x benzyl CH2), 4.05 (1H, bd, J3,4 = 2.4 Hz, H-4), 3.88 
(3H, s, OCH3), 3.60-3.85 (4H, overlapped signals, H-3, H-5 and 6-CH2). 13C NMR (50 MHz, 
CDCl3) δ 154.7 (OCO2CH3), 143.2, 138.0, 137.6, and 137.4 (aromatic C), 128.6-127.4, 124.2, 
and 119.2 (aromatic CH), 95.1 (C-1), 55.1 (OCH3). Other signals at 79.8, 74.6, 74.5, 73.4, 
72.4, 67.8. ESI-MS for C37H36F3NO8 (m/z): Mr (calcd) 679.24, Mr (found) 701.94 (M+Na)+. 
C37H36F3NO8: calcd C 65.38, H 5.34; found C 65.43, H 5.39. 
 
 
133. 1H NMR (300 MHz, CDCl3) δ 7.50-7.20 
(aromatic protons), 5.82-5.66 (1H, m, 
CH2=CH-CH2-), 5.18 (1H, bd, Jtrans = 17.2 
Hz, CHtrans=CH-CH2-), 5.09 (1H, bd, Jcis = 
9.2 Hz, CHcis=CH-CH2-), 5.05 (1H, dd, J1,2 = 
7.5 Hz, J2,3 = 10.2 Hz, H-2 A), 4.95 (1H, t, J2,3 = J3,4 = 9.6 Hz, H-3 B), 4.95-4.24 (12H, Troc 
CH2, 4x benzyl CH2, and CH2=CH-CH2-), 4.69 (1H, d, J1,2 = 7.8 Hz, H-1 B), 4.52 (1H, d, H-1 
A), 3.96 (1H, bd, J3,4 = 2.4 Hz, H-4 A), 3.87 (1H, t, H-4 B), 3.75 (3H, s, -OCH3), 3.90-3.45 
(6H, H-5 A, H2-6A, H-2 B, H-5 B, H2-6 B), 3.42 (1H, dd, H-3 A), 0.88 (9H, s, -SiC(CH3)3), 
0.13 and 0.08 (6H, 2xs, Si(CH3)2). 13C NMR (50MHz, CDCl3) δ 154.9, 154.6, and 154.0 (-
NH-CO-OCH2CCl3, -O-CO-OMe, -O-CO-OAll), 138.5, 138.3, 137.8, and 137.8 (aromatic C), 
131.4 (CH2=CH-CH2-), 128.4-127.2 (aromatic CH), 118.3 (CH2=CH-CH2-), 101.1 and 96.1 
(C-1 A and B), 95.3 (-NH-CO-OCH2CCl3), 54.9 (-OCH3), 25.5 (-SiC(CH3)3), 17.8 (-
SiC(CH3)3), -4.2 and -5.4 (-Si(CH3)2); other signals at δ 80.4, 76.1, 75.8, 74.6, 74.5, 74.4, 73.4, 
73.1, 72.5, 71.9, 68.5, 68.0, 67.6, and 58.1.  
 
134. 1H NMR (300 MHz, CDCl3) δ 7.45-7.20 
(aromatic protons), 5.15 (1H, dd, J1,2 = 7.8 Hz, 
J2,3 = 10.2 Hz, H-2 A), 4.98 (1H, bd, NH), 4.94-
4.36 (10 H, Troc CH2, 4x benzyl CH2), 4.74 
(1H, d, J1,2 = 7.8 Hz, H-1 B), 4.41 (1H, d, H-1 
A), 3.88 (1H, bd, J3,4 = 3.0 Hz, H-4 A), 3.78 (3H, s, -OCH3), 3.82-3.44 (9H, H-3 A, H-5 A, H2-
6 A, H-3 B, H-4 B, H-5 B, H2-6 B), 3.36 (1H, m, H-2 B), 0.89 (9H, s, -SiC(CH3)3), 0.13 and 
0.09 (6H, 2xs, Si(CH3)2). 13C NMR (50MHz, CDCl3) δ 155.0 and 154.0 (-NH-CO-OCH2CCl3, 
-O-CO-OMe), 138.4, 137.9, 137.5, and 137.3 (aromatic C), 128.4-127.2 (aromatic CH), 101.7 
and 95.8 (C-1 A and B), 95.3 (-NH-CO-OCH2CCl3), 55.1 (-OCH3), 25.6 (-SiC(CH3)3), 17.9 (-
SiC(CH3)3), -4.2 and -5.3 (-Si(CH3)2); other signals at δ 81.8, 80.2, 75.5, 74.6, 74.5, 73.9, 73.7, 
73.6, 73.1, 72.5, 72.3, 71.9, 68.5, 68.1, 59.5.  
 
135. 1H NMR (300 MHz, CDCl3) δ 7.50-7.20 
(aromatic protons), 5.10 (1H, d, J1,2 = 3.9 Hz, 
H-1 Fuc), 5.07 (1H, d, J1,2 = 8.2 Hz, H-1 
GlcN), 5.03 (1H, dd, J1,2 = 7.4 Hz, J2,3 = 10.2 
Hz, H-2 Gal), 4.62 (1H, d, H-1 Gal), 4.90-4.34 
(17 H, Troc CH2, 7x benzyl CH2, and H-5 
Fuc), 4.18 (1H, t, J2,3 = J3,4 = 9.6 Hz, H-3 
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GlcN), 4.04-3.26 (12H, H-3 Gal, H-4 Gal, H-5 Gal, H2-6 Gal, H-4 GlcN, H-5 GlcN, H2-6 
GlcN, H-2 Fuc, H-3 Fuc, and H-4 Fuc), 3.81 (3H, s, -OCH3), 3.03 (1H, m, H-2 GlcN), 1.13 
(3H, d, J5,6 = 6.2 Hz, H3-6 Fuc), 0.86 (9H, s, -SiC(CH3)3), 0.08 and 0.03 (6H, 2xs, -Si(CH3)2). 
13C NMR (50MHz, CDCl3) δ 155.0 and 153.4 (-NH-CO-OCH2CCl3, -O-CO-OMe), 139.3, 
139.2, 138.8, 138.6, 138.4, 137.9, and 137.8 (aromatic C), 128.8-127.0 (aromatic CH), 99.5, 
97.3, and 94.4 (C-1 Gal, GlcN, Fuc), 95.1 (-NH-CO-OCH2CCl3)  55.0 (-OCH3), 25.6 
(-SiC(CH3)3), 17.9 (-SiC(CH3)3), 16.2 (C-6 Fuc), -4.2 and -5.3 (-Si(CH3)2); other signals at δ 
80.9, 79.6, 78.8, 76.6, 76.0, 75.4, 75.0, 74.7, 73.8, 73.4, 73.2, 72.8, 72.4, 72.3, 68.2, 67.6, 66.4, 
61.8.  
 
136. 1H NMR (400 MHz, CDCl3) δ 7.40-7.15 
(aromatic protons), 5.27 (1H, dd, J2,3 = 10.4 
Hz, J3,4 = 3.2 Hz, H-3 Fuc), 5.21 (1H, bd, H-4 
Fuc), 5.15 (1H, d, J1,2 = 3.6 Hz, H-1 Fuc), 5.11 
(1H, d, J1,2 = 7.8 Hz, H-1 GlcN), 5.00-4.96 
(2H, m, H-2 Gal and H-5 Fuc), 4.59 (1H, d, 
J1,2 = 8.0 Hz, H-1 Gal), 4.72-4.40 (12 H, Troc 
CH2, 5 x benzyl CH2), 4.20 (1H, t, J2,3 = J3,4 = 
9.4 Hz, H-3 GlcN), 3.98-3.28 (10H, H-3 Gal, H-4 Gal, H-5 Gal, H2-6 Gal, H-4 GlcN, H-5 
GlcN, H2-6 GlcN, and H-2 Fuc), 3.78 (3H, s, -OCH3), 2.91 (1H, m, H-2 GlcN), 2.09 and 1.98 
(6H, 2xs, 2x acetyl CH3), 0.93 (3H, d, J5,6 = 6.2 Hz, H3-6 Fuc), 0.84 (9H, s, -SiC(CH3)3), 0.06 
and 0.01 (6H, 2xs, -Si(CH3)2). 13C NMR (50 MHz, CDCl3) δ 170.4 and 169.4 (2x -COCH3), 
155.1 and 154.0 (-NH-CO-CH2CCl3, -O-CO-OMe), 138.6, 138.3, 138.3, 138.1, and 138.1 
(aromatic C), 129.0-127.2 (aromatic CH), 99.4, 97.5, 93.9 (C-1 Gal, GlcN, and Fuc), 55.0 (-
OCH3), 25.6 (-SiC(CH3)3), 20.9 and 20.7 (2x -COCH3), 17.9 (-SiC(CH3)3), 15.2 (C-6 Fuc), -4.2 
and -5.3 (-Si(CH3)2); other signals at δ 80.5, 74.8, 74.6, 74.4, 73.6, 73.2, 73.1, 72.3, 72.0, 7 
 
Globo-H Assembly 
 
Preparation of 5Å acid washed molecular sieves 
Commercial 5Å molecular sieves (UOP Type 5A, 1/8” rods, purchased from Fluka) were 
treated three times with a saturated aqueous solution of ammonium chloride for 20 
minutes. The sieves were then repeatedly washed with distilled water until neutralization 
of the washing liquid. The sieves were left to dry at room temperature and then were 
heated at 200°C under vacuum for 5 hours. The latter procedure was repeated until no 
further generation of moisture was observed from the sieves upon this treatment. 
 
 
144. 1.617 g (5.94 mmol) of commercially available 3,4,6-tri-O-acetyl-
D-galactal 143, 1.147 mg (3.6 mmol, 97%) of PhSeSePh and 927.0 mg 
(14.3 mmol) of NaN3 were fluxed under argon athmosphere and 
dissolved in 20.0 mL of dry CH2Cl2. 2.679 g (8.3 mmol) of (AcO)2PhI 
were added to the solution and the resulting mixture was stirred at 
room temperature for 48 h. The completion of the reaction was 
monitored via TLC analysis. The reaction mixture was then extracted in CH2Cl2/NaHCO3 
(aq.). The organic phases were collected and concentrated under reduced pressure. The 
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crude was purified by silica gel column chromatography (petroleum ether/ethyl acetate 
7:3) and 2.040 g of 14444 were obtained in 73% yield. 
 
145. 2.021 g of 144 (4.30 mmol) were dissolved in 12 mL of MeCN. 
1.637 g (6.45 mmol) of I2 and 60 µL of distilled H2O were admixed and 
the solution was stirred at room temperature. After completion (5 h) 
the mixture was concentrated and the crude was purified by silica gel 
column chromatography (Petroleum ether/ethyl acetate 8:2) and 145 
was obtained in 42% yield. (α:β ratio = 2:1) 1H NMR (200 MHz, CDCl3) α anomer: δ 5.46 
(1H, bd, J3,4 = 3.2 Hz, H-4), 5.45 (1H, d, J1,2 = 3.4 Hz, H-1), 5.40 (1H, bd, J2,3 = 9.8 Hz, H-2), 
4.46 (1H, bt, J5,6a = J5,6b = 6.8 Hz, H-5), 4.18-4.06 (2H, m, 6-CH2), 3.75 (1H, dd, H-2), 3.10 (1H, 
bs, 1-OH), 2.15, 2.07, 2.05 (3x3H, 3xs, 3x COCH3).  
 
139. 417 mg (1.33 mmol) of 145 were fluxed under argon 
atmosphere  and then dissolved into 3 mL of dry CH2Cl2. To the 
solution 250 µL (2.00 mmol) of N-phenyl trifluoroacetimidoyl 
chloride and 69 mg (1.73 mmol) of NaH were admixed at 0°C. 
After 1.5 h stirring, the reaction was warmed up to room 
temperature, concentrated under reducer pressure and purified by Et3N-neutralized silica 
gel column chromatography (petroleum ether/ ethyl acetate 8:2). 496 mg of 139 were 
obtained in 74% yield. (β:α mixture = 2.5:1) 1H NMR (200 MHz, CDCl3) 
δ 7.40−6.80 (aromatic), 6.46 (1H, bs, H-1α), 5.60 (1H, bs, H-1β), 5.53 (1H, bd, H-4 α), 5.42-
5.32 (overlapped signals, H-4 β and H-3 α), 4.88 (1H, dd, J2,3 = 9.8 Hz, J3,4 = 3.2 Hz, H-3 β), 
4.63 (1H, bt, J5,6a = J5,6b = 6.8 Hz, H-5α), 4.30-4.18 (6-CH2 α and β), 4.05-3.60 (overlapped 
signals, H-5 β, Η−2 α and β), 2.17, 2.07, 2.00 (3x3H, 3xs, 3x COCH3 β), 2.16, 2.08, 2.06 (3x3H, 
3xs, 3x COCH3 α).  
 
146. Donor 139 (246 mg, 0.49 mmol) and acceptor 138 
(194 mg, 0.35 mmol) were coevaporated three times 
with anhydrous toluene and kept for an our hour 
under vacuum. After the addition of freshly activated 
4Å AW 300 MS (ca 400 mg in pellets), the mixture was 
dissolved under argon in anhydrous acetonitrile (1.8 mL) at 0°C. After 15 minutes a 
solution of Yb(OTf)3 (21.7 mg, 0.035 mmol) in acetonitrile (1.1 mL) was added. The 
mixture was allowed to warm to room temperature and left overnight under stirring to 
ensure complete glycosidation. The reaction was quenched with a few drops of pyridine 
and the mixture filtered on a short plug of silica gel eluted with 9:1 
dichloromethane/methanol (with a few drops of pyridine). The residue was then 
chromatographed on a silica gel column eluted with petroleum ether/ethyl acetate (from 
8:2 to 7:3) to yield pure disaccharide 146 (211 mg, 70%). [α]D -32.6 (c 0.5 in CH2Cl2). 1H 
NMR (400 MHz, CDCl3) : δ  7.40−6.80 (aromatic protons), 5.33 (1Η, bd, J = 3.4 Hz), 5.11-
4.36 (6H, 3x AB, 3x benzyl CH2), 4.86 (2H, 2xd, J = 7.6 and 8.0 Hz), 4.76 (1H, dd, J = 7.6 and 
11.0 Hz), 4.22-4.06 (3H), 3.98-3.90 (2H), 3.78 (3H, s, -OCH3), 3.74-3.56 (5H), 2.16, 2.07, 2.00 
(3x3H, 3xs, 3x -COCH3). 13C NMR (50 MHz, CDCl3): δ 171.2, 170.2, 169.4, 155.3, 151.5, 
138.5, 138.5, 137.8, 128.5-127.8, 118.5, 114.5, 103.1, 102.7, 80.4, 79.2, 75.7, 75.3, 74.8, 73.7, 
O
OAc
AcO
N3
OAc
O
OBn
O
OBn
OBn
OMP
O
AcO
AcO
OHN3
OAc
O
AcO
AcO
ON3
OAc
CF3
NPh
Synthesis of Oligosaccharide Antigen Fragments
  92
73.6, 70.9, 70.6, 68.8, 66.4, 61.4, 61.1, 55.6, 20.6. C46H51N3O14: calcd C 63.51, H 5.91; found C 
63.23, H 5.68. 
 
 
147. Disaccharide 146 (199 mg, 0.23 mmol) was 
dissolved in MeOH (9.8 mL). Ammonium hydroxide 
(32% aqueous solution, 1.1 mL) was then added and the 
mixture was left under stirring at room temperature. 
After 3 hours the mixture was concentrated under 
vacuum and the residue coevaporated with anhydrous 
toluene. The crude triol was then dissolved in 
anhydrous acetonitrile (4 mL), and dimethoxytoluene (60 µL, 0.40 mmol) and 
camphorsulfonic acid (6 mg, 0.026 mmol) were added. The mixture was kept for 3 hours 
at 70°C and then diluted with ethyl acetate. The organic phase was washed with 
saturated aq bicarbonate. The residue from the organic phase was chromatographed on a 
silica gel column (eluent dichloromethane and 98:2 dichloromethane/methanol) to give 
pure compund 147 (152 mg, 80%) as an oil. 
[α]D -24.9 (c 1 in CH2Cl2). 1H NMR and COSY (500 MHz, CDCl3): δ 7.50−6.80 (aromatic 
protons), 5.58 (1Η, s, CH benzylidene), 4.87 (1H, d, J1,2 = 8.0 Hz, H-1 B), 4.74 (1H, d, J1,2 = 
8.0 Hz, H-1 A), 5.11-4.37 (6H, 3 x AB, 3x benzyl CH2), 4.32 (1H, d, J6a,6b = 12.0 Hz, H-6a A), 
4.19-4.15 (2H, overlapped signals, H-2 B and H-4 B), 4.10 (1H, d, J3,4 = 2.5 Hz, H-4 A), 4.06 
(1H, d, H-6b A), 3.90 (1H, dd, J2,3 = 10.0 Hz, J3,4 = 3.0 Hz, H-3 B), 3.77 (3H, s, -OCH3), 3.70-
3.52 (overlapped signals, H-2 A, H-3 A, H-5 B, and 6-CH2 B), 3.38 (1H, s, H-5 A). 13C NMR 
(50 MHz, CDCl3): δ 155.3 and 151.5 (oxygenated aromatic C), 138.4, 138.3, 138.3, and 137.3 
(non oxygenated aromatic C), 129.3-126.3 (aromatic CH of benzyl and benzylidene), 118.4 
and 114.4 (aromatic CH methoxyphenol), 103.0, 102.8, and 101.4 (C-1 and benzylidene 
non aromatic C), 55.6 (OCH3). Other signals at 81.0, 79.1, 75.5, 75.4, 74.7, 74.5, 73.9, 73.5, 
71.2, 69.0, 68.9, 66.3, 64.6. C47H49N3O11: calcd C 67.86, H 5.94; found C 67.68, H 5.99. 
 
148. A solution of donor 129 (86 mg, 0.12 
mmol) in 5:1 dichloroethane/cyclo-
hexane (720 µL) was added in 6 hours at 
room temperature by a syringe pump to 
a solution of acceptor 147 (53 mg, 0.063 
mmol) in 5:1 dichloroethane/cyclo-
hexane (1.2 mL) containing freshly activated 5Å AW molecular sieves in pellets (1.1 g). 
After completion of the addition the mixture was left under overnight stirring to ensure 
complete consumption of the donor. The mixture was then filtered on a cotton plug 
washed repeatedly with 9:1 dichloromethane/methanol (with drops of pyridine). Silica 
gel chromatography of the residue from the organic phase (eluent: petroleum ether/ethyl 
acetate from 8:2 to 65:35) afforded pure trisaccharide 148 (63 mg, 75%) as an oil. [α]D -12.3 
(c 1.2 in CH2Cl2). 1H NMR (300 MHz, CDCl3): δ 7.50−6.80 (aromatic protons), 5.51 (1Η, s), 
5.23 (1H, dd, J = 7.8 and 9.6 Hz), 5.10-4.30 (12H, 6x AB, 6x benzyl CH2), 4.84 (1H, d, J = 7.5 
Hz), 4.71 (1H, d, J = 7.8 Hz), 4.68 (1H, d), 4.26-4.20 (2H), 4.12-4.04 (2H), 3.94-3.78 (4H), 3.77 
and 3.74 (2x 3H, 2x s, 2x -OCH3), 3.70-3.40 (7H), 3.24 (1H, s). 13C NMR (75 MHz, CDCl3): 
δ 155.1, 155.0, 151.6, 138.6, 138.5, 138.3, 138.0, 137.8, 137.8, 137.4, 128.6-126.3, 118.4, 114.4, 
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103.1, 103.0, 102.4, 100.6, 81.0, 80.5, 79.1, 78.1, 75.8, 75.6, 75.2, 74.7, 74.5, 73.9, 73.4, 73.0, 
72.6, 69.2, 69.0, 66.5, 62.9, 55.6, 55.0. MALDI-TOF MS for C76H79N3O18 (m/z): Mr (calcd) 
1321.54, Mr (found) 1344.80 (M+Na)+.C76H79N3O18: calcd C 69.02, H 6.02; found C 68.88, H 
6.21. 
 
149. Trisaccharide 148 (119 mg, 0.090 
mmol) was dissolved with a saturated 
solution of K2CO3 in MeOH (12 mL, 
prepared suspending 5 mg of K2CO3 per 
mL of MeOH). The solution was stirred at 
40 °C for 8 hours and then diluted with 
dichloromethane. The organic phase was 
washed with water and the residue purified through a short silica gel chromatography 
(eluent dichlormetane: methanol 9.1) to afford acceptor 149 (107 mg, 89%).  
[α]D -14.1 (c 0.5 in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ 7.50−6.80 (aromatic 
protons), 5.49 (1Η, s, benzylidene non aromatic CH), 5.10-4.54 (12H, 6 x AB, 6x benzyl 
CH2), 4.93 (1H, d, J1,2 = 7.6 Hz, H-1 C), 4.84 (2x 1H, 2x d, J1,2 = 7.6 Hz, H-1 A and C), 4.30-
4.20 (2H, H-6a and H-4 B), 4.15-4.05 (3H, H-2 A and C, H-4 C), 3.94-3.80 (4H, H-3 A and 
C, H-4 A, H-6b B), 3.76 (3H, s, -OCH3), 3.70-3.45 (H-3 B, H-5 A and C, 6-CH2 A and C), 
3.24 (1H, s, H-5 A). 13C NMR (50 MHz, CDCl3): δ 155.0 and 151.6 (oxygenated aromatic 
C), 138.6, 138.5, 138.5, 137.8, 137.7, 137.7, and 135.9 (non oxygenated aromatic C), 128.9-
126.3 (aromatic CH of benzyl and benzylidene), 118.4 and 114.4 (aromatic CH of 
methoxyphenol), 105.1, 103.0, 103.0 and 101.0 (C-1 and non aromatic benzylidene CH), 
55.5 (OCH3). Other signals at 81.8, 81.1, 79.0, 77.9, 75.7, 75.2, 75.1, 74.7, 74.6, 74.0, 73.9, 
73.4, 73.0, 71.4, 69.1, 68.0. C74H77N3O16: calcd C 70.29, H 6.14; found C 70.39, H 6.01. 
 
137. Trisaccharide 149 (69 mg, 0.055 
mmol) and the fucosyl donor 113 (99 
mg, 0.16 mmol) were coevaporated 
three times in anhydrous toluene. 
After adding 4Å AW 300 MS, the 
mixture was dissolved under argon in 
4:1 dichloromethane/diethyl ether 
(1.5 mL) and immediately cooled to -
30 °C. After stirring for 15 minutes, a 
solution of ytterbium triflate (3.4 mg, 
5.5 µmol) in dioxane (300 µL) was added dropwise. After three hours at -30 °C the 
mixture was allowed to warm to room temperature to ensure the consumption of 
residual amounts of the donor and the reaction was then quenched with pyridine. The 
mixture was filtered on a short plug of silica gel washed with 9:1 
dichloromethane/methanol (with drops of pyridine). The residue was then purified on a 
silica gel column eluted with toluene/ethyl acetate (from 5:1 to 3:1) to yield 
tetrasaccharide 137 (61 mg, 66%) as the only detectable anomer. [α]D -38.6 (c 0.5 in 
CH2Cl2). 1H NMR (400 MHz, CDCl3): δ 7.50−6.80 (aromatic protons), 5.61 (1H, d, J = 3.2 
Hz), 5.18-4.40 (18 H, 9x AB, 9x benzyl CH2), 5.54 (1Η, s), 4.89 (1H, d, J = 7.6 Hz,), 4.78 (1H, 
d, J = 8.0 Hz), 4.75 (1H, d, J = 7.6 Hz), 4.34 (1H, bq, J = 6.8 Hz), 4.28-4.15 (5H), 4.10-3.90 
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(4H), 3.79 (3H, s, -OCH3), 3.80-3.50 (9H), 3.26 (1H, s), 0.69 (3H, d, J = 6.8 Hz). 13C NMR (50 
MHz, CDCl3): δ 155.2, 151.6, 139.0, 139.0, 138.9, 138.6, 138.4, 138.3, 138.2, 138.0, 137.9, 
137.9, 128.5-126.3, 118.5, 114.4, 103.6, 103.3, 102.9, 101.2, 97.8, 84.0, 81.2, 79.9, 79.1, 78.4, 
76.2, 75.5, 75.4, 75.3, 74.9, 74.5, 74.0, 73.5, 73.0, 72.8, 72.6, 72.4, 71.4, 69.1, 68.9, 66.7, 66.4, 
55.6, 16.1. MALDI-TOF MS for C101H105N3O20 (m/z): Mr (calcd) 1679.72, Mr (found) 
1702.40 (M+Na)+. C101H105N3O20: calcd C 72.17, H 6.30; found C 71.90, H 6.45. 
 
150. Pd(OH)2/C (68 mg) was added to 
a solution of tetrasaccharide 137 (44 
mg, 0.026 mmol) in 3:3:1 
DCM/MeOH/H2O (15 mL) and the 
mixture was hydrogenolized for 72 h 
at room temperature. The mixture was 
then filtered on a Celite pad that was 
washed with 18:13.5:3 
MeOH/H2O/DCM. The residue from the evaporation of the filtrate was treated with 
water and the soln was lyophilized to give 150 (18 mg, 90%). [α]D - 27.9 (c 0.5 in MeOH).  
1H NMR (500 MHz, D2O): δ 6.98-6.83 (aromatic protons), 5.14 (1H, d, J1,2 = 3.5 Hz), 4.90 
(1H, d, J1,2 = 8.0 Hz), 4.88 (1H, d, J1,2 = 8.0 Hz), 4.69 (1H, d, J1,2 = 7.5 Hz), 4.24 (1H, bd, J3,4 = 
3.0 Hz), 4.19 (1H, bq, J5,6 = 6.5 Hz), 4.14 (1H, bd, J3,4 = 3.0 Hz), 3.90-3.50 (overlapped 
signals), 3.70 (1H, s, -OCH3), 3.43 (1H, t, J1,2 = J2,3 = 8.0 Hz), 1.16 (3H, d, J5,6 = 6.5 Hz). 
13C NMR (125 MHz, D2O): δ 154.9 e 151.1 (oxygenated aromatic C), 118.4 and 115.2 
(aromatic CH of methoxyphenol), 103.2, 101.7, 100.6, 100.2 (4x C-1), 56.0 (OCH3), 52.8 (C-2 
C), 15.9 (6-CH3 A). Other signals at 81.7, 80.0, 78.2, 75.2, 75.0, 72.0, 71.8, 70.0, 69.6, 69.2, 
68.7, 68.6, 68.5, 67.7, 61.0, 60.9. MALDI-TOF MS for C30H47NO21 (m/z): Mr (calcd) 757.26, 
Mr (found) 780.21 (M+Na)+. 
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Chapter 4 
 
1,2-Dimethoxyethane: Novel α-Stereodirecting Solvent for 
Glycosylation Reactions 
 
 
 
 
 
 
 
 
 
Introduction 
One of the most relevant problems associated with oligosaccharide synthesis is the 
stereochemical control of the glycosidation reaction, especially in the synthesis of 1,2-cis 
glycosides. As described in the previous chapter, a very efficient approach for the 
stereocontrolled synthesis of 1,2-trans glycosides can be achieved by using 2-O-acylated 
glycosyl donors, taking advantage of a neighbouring participation mechanism.1 In 
contrast, complete stereocontrol in the synthesis of 1,2-cis glycosides is considerably a 
more difficult task. Several tactics have been proposed for solving this problem.2 The use 
of ether-type solvents in glycosylations conducted with perbenzylated donors represent 
one of the most reliable method for obtaining the predominance of α-linked glycosides.  
Very recently, our interest was attracted by the development of glycosylation promoters 
featuring convenient advantages such as chemical mildness and moisture stability in 
contrast to the acidic agents employed in the standard procedures. Among others, 
ytterbium(III) triflate proved3 to be an interesting promoter for glycosylations performed 
with glycosyl trichloro-4 and N-phenyl trifluoroacetimidates.5 In the course of this 
research, use of solvent mixtures containing diethyl ether and dioxane was found to give 
good α-selectivity in the glucosylation of secondary acceptors with a perbenzylated 
glucosyl imidate (with α/β ratios ranging from 3 to 4).3 Unfortunately, poor selectivity 
was achieved by coupling a more reactive primary  acceptor with a perbenzylated 
glucosyl trifluoroacetimidate (α/β 1.7:1, Table 4.1, entry 1), while no selectivity was 
registered when using the corresponding glucosyl trichloroacetimidate as donor (Table 4.1, 
entry 3). 
                                                 
1 For recent reviews on oligosaccharide synthesis: a) Boons. G. J. Tetrahedron 1996, 52, 1095; b) Seeberger, P. 
H.; Haase, W. Chem. Rev. 2000, 100, 4349. 
2 For a discussion on 1,2-cis-glycosides synthesis see pp. 23-31. 
3 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Tetrahedron Lett. 2002, 43, 5573. 
4 Schmidt; R. R.; Kinzy, W. Adv. Carohydr. Chem. Biochem. 1994, 50, 21. 
5 Yu, B.; Tao, H. Tetrahedron Lett. 2001, 42, 2405-2407; J. Org. Chem. 2002, 67, 9099. 
 
  96
Results and Discussion 
In an attempt to improve these disappointing results further investigations were dedicated 
to the stereo-directing capability of coordinating solvents. The α-stereo-directing 
behaviour of ether-type solvents is commonly explained assuming the conversion of the 
activated donor into glycosyl cation 32, the initial attack of an ether solvent molecule 
occurring at the α-side, and the fast conversion of this kinetic α-adduct 33 into the 
thermodynamically more stable (due to the inverse anomeric effect) β-adduct 34.6 Finally, 
nucleophilic attack of the alcoholic acceptor on this latter intermediate can account for the 
α-selectivity, especially in the case of less reactive secondary acceptors (Scheme 4.1).7  
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SCHEME 4.1 α-Stereodirecting Effect of Ether-Type Solvents. 
 
Reasoning on the conjectured mechanism, we hypothesized that an improved α-selectivity 
would be achieved by speeding the conversion of the kinetic α-linked solvent-glycosyl 
cation adduct (affording the undesired β-glycoside 38) into the corresponding β-adduct 
(providing the desired α-glycoside 35). 
On this regard, use of a bidentate ether as the solvent could appear beneficial, as the 
desired anomerization would be kinetically favoured by entropic factors as depicted in 
Scheme 4.2. 1,2-Dimethoxyethane (DME) appeared as an especially interesting option, 
because it is sufficiently cheap and volatile (b. p. 85 °C) to be practically used as a solvent.  
In a first experiment the coupling between donor 151 and primary acceptor 21 was 
attempted under the activation of ytterbium(III) triflate in DME (Table 4.1, entry 2). The 
choice of extremely reactive 21 as model acceptor in the preliminary reaction is due to the 
poor selectivities registered for this acceptor in glycosylations with standard solvents.3
                                                 
6 a) Wulff, G.; Rohle, G. Angew. Chem., Int. Ed. Eng. 1974,  13, 157; b) Schmidt; R. R.; Behrendt, M.; Toepfer, A. 
Synlett 1990, 694; c) Demchenko, A.; Stauch, T.; Boons. G. J. Synlett  1997, 818. 
7 For further details see pp. 26-27. 
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SCHEME 4.2 Hypothesized Intramolecular Mechanism of Anomerization of the Glycosyl Cation-Solvent 
Adduct with DME. 
In DME the coupling proceeded in high yield with a sensible improvement of α-selectivity 
(3.5:1). Higher temperature conditions (starting from 0 °C to reach spontaneously room 
value) were needed to achieve reaction rates comparable with those registered when using 
dioxane/diethyl ether solvent mixture (reaction conducted at -10 °C) (Table 4.1, entry 1). 
At -10 °C the glycosylation in DME proved to be very sluggish. This slowing down effect 
could be ascribed to the ability of DME to depress the activity of the promoter by chelation 
at the metal site. Several commercially available lanthanide triflates were also tested, in 
order to verify their ability to promote α-glycosylations using DME as stereodirecting 
solvent, possibly improving the results registered with Yb(OTf)3. Good to excellent 
coupling yields were registered (entries 5-10). The α/β ratios were comparable ranging 
from 2.0 (with Sc(OTf)3) to 3.0 (with Sm(OTf)3, Y(OTf)3 and Eu(OTf)3). In all cases reaction 
rates were very sluggish, up to 36 hours (entry 5) were required to reaction completion. In 
the light of these experiments, Yb(OTf)3 proved to be the best compromise in terms of 
experimental results and also considering the non secondary economic aspect (Yb(OTf)3 is 
the cheapest among the others).  
 
In an attempt to improve both selectivity and rate of Yb(OTf)3-promoted reactions, the use 
of co-solvents was tested (entries 11-15). For this issue toluene and dioxane were chosen, 
because of the good results previously obtained by their use in binary and ternary solvent 
mixtures in Yb(OTf)3-promoted α-glycosylations.3 Even improved stereoselectivities were 
registered by using dioxane/DME mixtures (entries 12-13). The best result in terms of 
stereocontrol was registered by adopting the ternary mixture dioxane /DME/toluene 4:1:1 
which produced a very good stereoselectivity (α/β 4.3:1) (entry 15). Interestingly, use of 
diethy ether as a cosolvent, commonly used in TMSOTf activation of 
trichloroacetimidates,8 here resulted in very sluggish reactions. 
 
                                                 
8 Schmidt, R. R:; Kinzy, W. Adv. Carbohydr. Chem. Biochem. 1994, 50, 5573. 
1,2-Dimethoxyethane: Novel alpha-Streodirecting Solvent for Glycosylation Reactions
  98
OBnO
BnO
OBn X
BnO
OBnO
BnO
BnO
BnO
O
O
O
O
O
OH
O
O
O
O
O
O
151 X = OC(NPh)CF3
152 X = OC(NH)CCl3
21 153
 
 
TABLE 4.1 α-Selective Glycosidation of Acceptor 21 with Glucosyl Imidate Donors 151 and 152 Promoted by 
Lanthanide Triflates. 
An interesting experimental evidence is the strong dependence of the reaction rate on the 
solvent used for dissolving the promoter. In Yb(OTf)3-promoted glycosylations, the 
promoter is generally added as solution to the mixture of glycosyl donor and acceptor. In 
the case of binary and ternary mixtures containing dioxane and DME, when the promoter 
is first dissolved in DME and then added to the reaction mixture (containing the other 
solvents) the reaction rate values are those reported in Table 4.1. If Yb(OTf)3 is first 
dissolved in dioxane and then added to the reaction medium, glycosylations result to be 
very sluggish. This difference in reactivity is a sign of the formation of solvent-promoter 
complexes of different stability. An excessive stability of the complex Yb(OTf)3-dioxane 
would make the promoter less prone to coordinate the glycosyl donor, explaining thus the 
decreased reactivity exhibited  by the lanthanide salt when dissolved first in dioxane.9 
 
The preliminary  results obtained with acceptor 21, led us to reconsider the α-selective 
glycosylation of a range of secondary glycosyl acceptors. In these cases, use of DME as the 
sole solvent often resulted in lengthy reactions. In contrast, use of binary and ternary 
solvent mixtures with dioxane and toluene provided appreciable glycosidation yields 
within a few hours. Good to excellent stereoselectivities were registered, in all cases the 
                                                 
9 Further studies are required to validate this hypothesis, the results will be reported in due course. 
Entry Donor Promoter (0.1 eq.) Solvent 
Temp 
(°C) 
Time 
(h) 
Yielda of 
153(%) 
(α/β)b 
1 151 Yb(OTf)3 Et2O/Dioxane 4:1 -10 4 86 (1.7) 
2 151 Yb(OTf)3 DME RT 4 80 (3.5) 
3 152 Yb(OTf)3 Et2O/Dioxane 4:1 -10 2 81 (1.0) 
4 152 Yb(OTf)3 DME -15 2 90 (1.7) 
5 151 Sm(OTf)3 DME 0 to RT 36 70d (3.0) 
6 151 Y(OTf)3 DME 0 to RT 24 90d (3.0) 
7 151 Gd(OTf)3 DME 0 to RT 48 95d (2.7) 
8 151 Eu(OTf)3 DME 0 to RT 48 90d (3.0) 
9 151 La(OTf)3 DME 0 to RT 48 60d (2.7) 
10 151 Sc(OTf)3 DME 0 to RT 5 95d (2.0) 
11 151 Yb(OTf)3 Dioxane/DME 1:4 RT 6 76 (3.1) 
12 151 Yb(OTf)3 Dioxane/DME 1:1 0 to RT 6 79 (4.0) 
13 151 Yb(OTf)3 Dioxane/DME 4:1 0 to RT 4 84 (3.9) 
14 151 Yb(OTf)3 Toluene/DME 4:1 0 to RT 6 73 (3.0) 
15 151 Yb(OTf)3 Dioxane/DME/Toluene 4:1:1 0 to RT 8 79 (4.3) 
a Isolated yield. b Measured by 1HNMR. c With 0.03 eq of Yb(OTf)3.d 1HNMR yield. 
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beneficial effect of DME was confirmed by comparison with the previously3 reported 
results (Table 4.2). Glycosylations with secondary glycosyl acceptors 154, 156, 158 and 160 
are intrinsically more difficult than those with the primary 21. The alcoholic functions of 
154 and 156 are made less nucleophile by the presence of neighbour electron-withdrawing 
acyl groups. Whereas acceptor 158 exhibits a low reactivity because of the sterical 
hindrance of the C4 hydroxyl group. 
 
Entry Donor Acceptor Product Solvent Yield
a 
(α/β)b 
1 151 
OO
HO
AcO
O
OMe
Ph
 
154 
OBnO
BnO
OBn
BnO OO
O
AcO
O
OMe
Ph
 
155 
Dioxane/DME 4:1 75% (7.4) 
2 151 154 155 Dioxane/DME 1:1 77% (7.2) 
3 151 154 155 Dioxane/DME/Toluene 4:1:1 
70% 
(8.2) 
4 151 
OO
AcO
HO
O
OMe
Ph
 
156 
OBnO
BnO
OBn
BnO
OO
AcO
O
O
OMe
Ph
 
157 
Dioxane/DME 4:1 82% (8.0) 
5 151 156 157 Dioxane/DME 1:1 51% (7.5) 
6 151 156 157 Dioxane/DME/Toluene 4:1:1 
80% 
(7.6) 
7 152 
OHO
BnO
BnO
BnO
OMe  
158 
OO
BnO
BnO
BnO
OMe
OBnO
BnO
OBn
BnO
158 
Dioxane/DME 4:1 63% (6.3) 
8 151 158 158 Dioxane/DME 4:1 55% (6.0) 
9 151 158 158 Dioxane/DME/Toluene 4:1:1 
51% 
(5.8) 
10 151 
O
BnO
HO
BnO
OPM
OBn
 
160 
OBnO
BnO
OBn
BnO
O
BnO
O
BnO
OPM
OBn
161 
Dioxane/DME/Toluene 
4:1:1 
65% 
(only 
α) 
11 
O
BnO
BnO
OBn O
OBn
CF3
NPh
 
162 
160 O
BnO
O
BnO
OPM
OBnO
BnO
BnO
BnO
OBn
 
163 
Dioxane/DME/Toluene 
4:1:1 
81% 
(only
α) 
a Isolated yield. b Measured by 1HNMR. 
 
TABLE 4.2 α-Selective Glycosidation of Secondary Acceptors Promoted by Yb(OTf)3 (0.1 eq).  
Acceptors 154 and 156 were glycosylated in high yields and improved α-selectivities  were 
registered, if compared with the results previously obtained with Yb(OTf)3 in other ether-
type solvent mixtures.3 Because of the low reactivity of acceptor 158, the coupling with 
glycosyl donor 151 yielded the desired disaccharide 159 in good stereoselectivity (α/β = 
6.0) but poor yield (55%). In this case better results were achieved using the more reactive 
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trichloroacetimidate donor 152 achieving disaccharide 159 improving both yield (63%) and 
α/β ratio (6.3) (entry 7). 
In some cases, exclusive formation of α-linked disaccharides was observed as in the 
preparation of the protected disaccharide fragment 163 representing the extensively 
studied epitope involved in the antibody-mediated hyperacute rejection in 
xenotransplantation.10 
 
Having established the conditions for achieving good α-selectivities in glycosylations with 
a variety of glycosyl acceptors, α-glycosylation of a non-saccharidic nucleophile was 
studied. In many O-linked glycoproteins the conjugation between the glycan and the 
peptide moieties is characterized by α-linkages involving serine or threonine residues. A 
relevant paradigm is given by mucins, a family of cell-surface glycoproteins often 
associated, in aberrant glycoforms, with tumors of epithelial tissues. Isolation and 
characterization of the oligosaccharide structures over-expressed on the malignant cells 
led to interesting application in medicinal chemistry.  
Clustered motifs of Tn and TF glycoepitopes (Figure 2.1), suitably conjugated with 
immunogenic carriers, proved to provoke robust production of antibodies, with promising 
cell-surface reactivity for those tumors expressing the respective antigen.  
These preliminary studies constitute the base for the development of a glycopeptide-based 
vaccine against prostate cancer, now under clinical trials.11 
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FIGURE 2.1 Tn and TF Antigens. 
 
The crux of the difficulty is the problematic character of synthesizing carbohydrate 
domains O-linked to the key amino acids, serine and threonine, with strong 
stereochemical control in the formation of the α-glycosidic linkage. 
Since improved α-selectivities were registered in glycosylations of primary hydroxyl 
functions using DME-based solvent mixtures, we decided to verify the versatility of our 
protocol in the difficult task of serine α-glycosylation. 
                                                 
10 a) Galili, U. Sci. Med. 1998, 5, 28; b) Cooper, D. K. C.; Good, A. H.; Koren, E.; Oriol, R.; Malcolm, A. J.; 
Ippolito, R. M.; Neethling, F. A.; Ye, Y.; Romano, E.; Zhudi, N. Transplant Immunol. 1993, 198;  c) Boons, G.-J.; 
Zhu, T. J. Chem. Soc., Perkin Trans.1, 1998, 857; d) Janczuk, A. J.; Zhang, W.; Andreana, P. R.; Warrick, J.; 
Wang, P. G. Carbohydr. Res. 2002, 337, 1247; e) Zhang, Y.; Telyatnikov, V.; Sathe, M.; Zeng, X.; Wang, P. G. J. 
Am. Chem. Soc.  2003, 125, 9292. 
11 a) Kuduk, S. D.; Schwarz, J. B.; Chen, X. –T.; Glunz, P. W.; Sames, D.; Ragupathi, G.; Livingston, P. O.; 
Danishewsky, S. J. J. Am. Chem. Soc. 1998, 120, 12474;  b) Schwarz, J. B.; Kuduk, S. D.; Chen, X. –T.; Sames, D.; 
Glunz, P. W.; Danishewsky, S. J. J. Am. Chem. Soc. 1999, 121, 2662. 
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Our synthetic target was the protected precursor of Tn antigen, chacacterized by the 
challenging α-linkage between a galactosamine and the hydroxyl group of serine.  
Glucosamine 139 was chosen as model donor, devoid of participating group at C-2 
position. Amino acid nucleophile 164 was prepared treating the amino group of 
commercially available methyl ester 165 with allyloxycarbonyl chloride in order to protect 
the amino function otherwise competing with the alcoholic group of serine side-chain in 
the glycosidation reaction (Scheme 4.4). 
 
CO2Me
ClH3N
H
OH
CO2Me
AllocHN H
OHAllocCl, NaHCO3
DCM, H2O, RT, 30 mins
74%
165 164  
 
SCHEME 4.4 Alloc Protection of Serine 165. 
 
Galactosyl donor 139 and the thus obtained serine 164 were coupled in Yb(OTf)3-
promoted glycosylation in sole DME. The reaction proceeded at room temperature in 5 
hours furnishing the desired galactoside 166 in 84% yield and 4.5 α/β ratio (Scheme 4.5). 
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SCHEME 4.5 Synthesis of Tn Antigen Precursor 166. 
 
Having established the ability of DME to improve the α-selectivity of Yb(OTf)3 promoted 
glycosidations, some efforts were dedicated to establish the feasible use of DME as α-
directing solvent in glycosidations performed with the more usual TMSOTf promoting 
system. As a matter of fact, the stereocontrolled synthesis of α-glucosides and α-
galactosides with the recently introduced N-phenyl trifluoroacetimidate donors has not 
yet been explored as extensively as with standard trichloroacetimidate donors. Therefore, 
the model coupling between donor 151 (1.4 eq) and acceptor 154 was examined under the 
activation of TMSOTf (0.05 eq) at 0°C with four different solvents (Table 4.3). 
Under Yu’s conditions (dichloromethane as the solvent)5 the reaction proceeded in high 
yield but poor selectivity (entry 1). In diethyl ether, commonly used to induce α-selectivity 
with glucosyl and galactosyl trichloroacetimidate donors,4 the coupling proceeded with 
high stereocontrol but moderate yield (entry 2). In DME (entry 3) the disaccharide was 
obtained with both high yield and selectivity, although a slightly lower α/β ratio than in 
the case of the coupling in diethyl ether was obtained. A comparable yield and an 
improved α-selectivity was registered with the ternary  mixture dioxane/toluene/DME 
4:1:1 (entry 4) consistently with the trend observed also with Yb(OTf)3. 
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Entry Solvent Yielda of 155 (α/β)b 
1 DCM 76% (1.8) 
2 Et2O 53% (8.8) 
3 DME 83% (6.5) 
4 Dioxane/DME/Toluene 4:1:1 84% (7.2) 
aIsolated yield. bMeasured by 1H NMR. 
 
TABLE 4.3 TMSOTf (0.05 eq) Promoted Glycosylation of Acceptor 154 with Donor 151 (1.4 eq) at 0 °C .  
Conclusion 
In conclusion, DME has been shown to be a suitable cosolvent for achieving high α-
selectivity in glycosidations catalytically promoted by Ytterbium(III) triflate. Under these 
conditions good results can be obtained even with reactive primary acceptors and amino 
acid residues. These results expand the potential of this moisture stable promoter in 
oligosaccharide synthesis. In addition, DME proved to be an interesting alternative to 
conventional ether solvents even in glycosidations performed with the standard TMSOTf 
activation of trifluoroacetimidates. 
Experimental Section 
 
General Methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were 
recorded on Varian spectrometers at 200 or 300 MHz and 50 or 75 MHz, respectively; or on 
a Bruker Avance 500 spectrometer at 500 MHz. The chemical shifts are given in parts per 
million (ppm) on the delta (δ) scale. Analytical thin layer chromatography (TLC) was 
performed on E. Merck pre-coated (25 nm) silica gel 60F-254 plates. Column 
chromatography was preformed using Carlo Erba 0.06-0.20 silica gel. Anhydrous solvents 
stored over molecular sieves (purchased from Aldrich) were used for performing the 
reactions. All reactions were conducted under argon atmosphere. 
 
General procedure of glycosidation with Yb(OTf)3 
A mixture of acceptor (0.10 mmol) and donor (0.13-0.15 mmol) are coevaporated three 
times in anhydrous toluene. After adding freshly activated 4 Å acid washed molecular 
sieves (AW 300 MS) in pellets, the mixture is dissolved at 0 °C under argon in 1:4 toluene-
dioxane (1.5  mL). After stirring for 20 minutes, a DME solution of Yb(OTf)3 (0.05 M, 200 
µL, 0.01 mmol) is added dropwise. The temperature is then allowed to raise to rt. After 
completion of the reaction (TLC analysis), a few drops of pyridine are added, the  mixture 
is filtered through a short pad of silica gel and then evaporated. The residue is purified by 
silica gel chromatography (petroleum ether-ethyl acetate mixtures).  
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General procedure of glycosidation with TMSOTf 
A mixture of acceptor 154 (11 mg, 35 µmol) and donor 151 (32 mg, 45 µmol) are 
coevaporated three times in anhydrous toluene. After adding freshly activated 4 Å 
molecular sieves in pellets, the mixture is dissolved in dichloromethane, or diethyl ether, 
or dimethoxyethane, or 4:1 dioxane/toluene (0.8 mL). After stirring for 20 minutes, a 
solution of TMSOTf in the reaction solvent (for entries 1-3 of Table 4.3) or dimethoxyethane 
(for entry 4)  (30 µL, 1.7  µmol) is added dropwise to the mixture at 0°C.  After completion 
of the reaction (1-3 hours, TLC analysis), a few drops of pyridine are added and the 
mixture is concentrated. The disaccharide 155 is purified by PLC (petroleum ether-ethyl 
acetate, 7:3).  
 
153.  1H NMR (200 MHz, CDCl3): δ 7.50-7.10 (aromatic protons), 
5.52 (1H, d, J1,2 = 5.2 Hz, H-1 B), 5.05-4.10 (8H, 4xAB, CH2 
benzyl), 5.00 (1H, d, J1,2 = 3.8 Hz, H-1 A), 4.58 (1H, m, H-3 B), 4.34 
(1H, dd, J4,3 = 8.4 Hz, J4,5 = 2.2 Hz, H-4 B), 4.30 (1H, dd, J2,3 = 2.8 
Hz, H-2 B), 4.10 (1H, t, H-5 B), 3.98 (1H, t, J3,2 = J3,4 = 9.0 Hz, H-3 
A), 3.88-3.64 (6H), 3.58 (1H, dd, H-2 A), 1.53, 1.45, 1.32 and 1.31 
(12H, 4xs, CH3). 13C NMR (50 MHz, CDCl3): δ 138.9, 138.3, 138.3 
and 138.0 (aromatic C), 128.6 - 127.5 (aromatic CH), 109.2 and 
108.5 (-C(CH3)2), 97.0 and 96.3 (C-1 A and B), 26.1, 26.0, 24.9, and 
24.6 (-C(CH3)2). Other signals at δ 81.9, 79.8, 75.6, 74.9, 73.4, 72.3, 70.8, 70.6, 70.6, 70.2, 68.3, 
66.2 and 65.7. 
 
155. 1H NMR (CDCl3, 300 MHz): δ 7.45-6.95 (aromatic 
protons), 5.58 (1H, d, J1,2 = 3.9 Hz, H-1 A), 5.46 (1H, s, non 
aromatic CH benzylidene), 4.99 (1H, d, J1,2 = 3.9 Hz, H-1 B), 
4.92 (1H, dd, J2,3 = 9.9 Hz, H-2 B), 5.00-4.33 (8 H, 4xAB, 4x-
CH2Ph), 4.27 (1H, dd, J6eq, 6ax = 9.9 Hz, J6eq, 5 = 3.9 Hz, H-6eq 
B), 4.03 (1H, m, H-5 A), 3.95-3.70 (7H), 3.62 (1H, t, J3,4 = J4,5 = 
9.6 Hz, H-4 A),  3.46 (1H, dd, J2,3 = 9.9 Hz, H-2 A), 3.40 (3H, 
s, -OCH3), 2.03 (3H, s, -COCH3). 13C NMR (CDCl3, 50 
MHz): δ 170.2 (acetyl CO), 138.8, 138.6, 137.9, 137.8, 136.9 (aromatic C), 128.4-126.3 
(aromatic CH), 102.1 (benzylidene benzyl CH), 97.4 and 96.0 (C-1 A and B), 55.3 (OCH3), 
20.9 (acetyl CH3). Other signals at δ 82.6, 81.4, 78.6, 77.2, 75.6, 74.7, 73.5, 72.2, 71.2, 70.5, 
70.3, 69.0, 68.3, 61.9. 
 
157. H NMR (CDCl3, 300 MHz): δ 7.50-7.05 (aromatic protons), 
5.61 (1H, t, J2,3 = J3,4 = 9.6 Hz, H-3 B), 5.46 (1H, s, non aromatic CH 
benzylidene), 4.97-4.43 (8 H, 4xAB, 4x-CH2Ph), 4.90 (1H, d, J1,2 = 
3.9 Hz, H-1 B), 4.80 (1H, d, J1,2 = 3.6 Hz, H-1 A), 4.29 (1H, dd, J6eq, 
6ax = 10.2 Hz, J6eq, 5 = 4.8 Hz, H-6eq B), 3.98-3.82 (3H, overlapped 
signals, H-3 A, H-5 A, and H-5 B), 3.79 (1H, dd, H-2 B), 3.76-3.57 
(4H), 3.53 (1H, t, J4,5 = 9.6 Hz, H-4 B),  3.52 (1H, dd, J2,3 = 9.9 Hz, 
H-2 A), 3.44 (3H, s, -OCH3), 2.00 (3H, s, -COCH3). 13C NMR 
(CDCl3, 50 MHz): δ 169.6 (acetyl CO), 138.7, 138.5, 138.4, 137.9, 
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137.0 (aromatic C), 129.0-126.2 (aromatic CH), 101.5 benzylidene benzyl CH), 97.7 and 96.0 
(C-1 A and B), 55.3 (OCH3), 21.0 (acetyl CH3). Other signals at δ 81.6, 79.5, 79.3, 77.2, 75.6, 
74.7, 73.4, 73.1, 70.7, 69.9, 69.0, 68.2, 62.3. 
 
158. 1H NMR (500 MHz, CDCl3) δ 7.40-7.05 (aromatic 
protons), 5.70 (1H, d, J1,2 = 4.0 Hz, H-1 A), 5.06-4.28 (14H, 
7xAB, 7x -CH2Ph AB), 4.60 (1H, d, J1,2 = 4.0 Hz, H-1 B), 
4.10 (1H, dd, t, J2,3 = J3,4 = 9.0 Hz, H-3 B), 4.05 (1H, t, J4,5 = 
9.0 Hz, H-4 B), 3.95-3.83 (3H, overlapped signals, H-3 A, 
H-4 A, and H-5 B), 3.75-3.62 (3H, overlapped signals, H-5 
A, H2-6 B), 3.60 (1H, dd, H-2 B), 3.54-3.49 (2H, overlapped signals, H-2 A,  H-6a A), 3.40 
(1H, bd, J6a,6b = 10.5 Hz, H-6b A), 3.39 (3H, s, -OCH3). 13C NMR (50 MHz, CDCl3): δ 138.9, 
138.7, 138.5, 138.1, 137.9, 138.0 and 138.0 (aromatic C), 128.2-126.7 (aromatic CH), 97.7 and 
96.6 (C-1 A and C-1 B), 55.1 (1-OCH3). Other signals at δ 82.0, 80.2, 79.4, 75.5, 74.9, 74.4, 
73.3, 73.1, 72.3, 71.0, 69.5, 69.0, 68.1.  
 
161. 1H NMR (CDCl3, 200 MHz) δ 7.40-6.75 (aromatic 
protons), 5.14  (1H, d, J1,2 = 3.6 Hz, H-1 A), 5.15-4.29 
(14H, 7xAB, 7x-CH2Ph), 4.79 (1H, d, J1,2 = 7.4 Hz, H-1 B), 
4.17 (1H, m, H-5 A), 4.09 (1H, t, J2,3 = J3,4 = 9.4 Hz, H-3 
A), 4.05 (1H, dd, J2,3 = 10.0 Hz, H-2 B), 3.93 (1H, bd, J3,4 = 
2.2 Hz, H-4 B), 3.81 (1H, dd, H-3 B), 3.76 (3H, s, -OCH3), 
3.70-3.20 (7H). 13C NMR (CDCl3, 75 MHz) δ  155.0 and 
151.6 (oxygenated aromatic C), 138.8, 138.7, 138.6, 138.0, 138.0, 138.0, and 138.0 (other 
aromatic C), 128.8-127.2, 118.2, and 114.4 (aromatic CH), 103.2 (C-1 B), 95.8 (C-1 A), 55.6 
(OCH3). Other signals at δ 82.2, 79.8, 78.7, 78.0, 75.5, 75.3, 74.9, 74.7, 74.2, 73.6, 73.5, 73.2, 
72.9, 70.2, 68.8, 68.0. 
 
163. 1H NMR (CDCl3, 300 MHz): δ 7.40-6.75 (aromatic 
protons), 5.22 (1H, d, J1,2 = 3.3 Hz, H-1 A), 5.08-4.35 (12H, 
6xAB, 6x-CH2Ph), 4.74 (1H, d, J1,2 = 7.5 Hz, H-1 B), 4.32 
(1H, bt, J5,6a = J5,6b = 6.0 Hz, H-5 B), 4.25 (2H, s, -CH2Ph), 
4.14 (1H, dd, J2,3 = 9.6 Hz, H-2 A), 4.06 (1H, dd, J2,3 = 9.9 Hz, 
H-2 B), 3.97 (1H, dd, J3,4 = 1.8 Hz, H-3 A), 3.92 (1H, bd, J3,4 = 
1.6 Hz, H-4 B), 3.84 (1H, dd, H-3 B), 3.77 (3H, s, -OCH3), 3.70 (1H, bs, H-5 B), 3.60-3.25 
(5H). 13C NMR (CDCl3, 75 MHz) δ  155.0 and 151.7 (oxygenated aromatic C), 138.7, 138.6, 
138.6, 138.6, 138.3, 138.3, and 138.0 (other C), 129.0-126.5, 118.3, and 114.4 (aromatic CH), 
103.2 (C-1 B), 95.7 (C-1 A), 55.6 (OCH3). Other signals at δ 79.1, 78.1, 77.5, 75.2, 75.0, 74.7, 
74.3, 73.7, 73.4, 72.7, 72.5, 69.1, 68.9. 
 
164. To a solution of serine methyl ester 165 (373 mg, 2.4 mmol) in CH2Cl2 
(3 mL) 1 mL of aqueous solution of NaHCO3 (210 mg, 2.5 mmol) and 300 
µL  of allylchloroformiate were added. After 30 minutes stirring at room 
temperature, the organic phase was diluted with CH2Cl2, washed with 
water and concentrated to furnish pure 164 (370 mg) in 74% yield. 
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1HNMR (CDCl3, 200 MHz) δ 5.95 (1H, m, CH=CH2), 5.73 (1H, bs, N-H), 5.53 e 5.50 (2H, 
dd, CH=CH2, Jcis = 10.0 Hz ,Jtrans = 14.2 Hz ), 4.64 (2H, d, -CH2CH=CH2), 4.44 (1H, bt, 
HOCH2-C-H), 4.02 (2H, m, CH2OH), 3.85 (3H, s, COOCH3), 2.32 (1H, t, CH2OH). 
 
166. 1HNMR (CDCl3, 200 MHz) δ 5.86 (1H, m, CH=CH2), 5.72 
(1H, bs N-H), 5.53 (2H, dd, Jcis = 10 Hz, Jtrans = 14 Hz, 
CH=CH2,), 5.35-5.19 (2H, m, H-3, H-4, A), 4.95 (1H,dd, H-1, J1,2 
=3.8 Hz) 4.61 (1H, bt, B), 4.09-3.87 (5 H, H-5, 2xH-6, CH2, allyl), 
3.60 (1H, dd, J1,2 = 3.6 Hz, J2,3 = 11 Hz, H-2), 2.11, 1.99, 1.97 (9H, 
3xs, 3xCH3 acetyl). 13C NMR (CDCl3,  50 MHz) significative 
signals at δ 170.2, 170.0, 170.0, 169.9 (C=O acetyl and methyl 
ester), 153.6 (C=O allyloxycarbonyl), 132.3 (-CH2CH=CH2), 117.9 (CH2CH=CH2), 99.0 
(anomeric carbon), 20.5 (3xCH3). Other signals at 69.5, 67.7, 67.3, 66.0, 63.2, 61.5, 57.2, 54.2, 
52.8. 
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Chapter 5 
 
Regioselective Glycoconjugation of 17β-Estradiol and Derivatives 
Thereof 
 
 
 
 
 
 
 
 
Introduction 
 
Mono- and oligo-saccharide structures are often found as decoration of many natural 
compounds such as proteins, lipids or other cellular secondary metabolites.  As described 
in previous chapters, recent studies have been proving the crucial role played by the 
carbohydrate portions in the several processes involving these bioactive glycoconjugates. 
Specific action of saccharidic moieties is often exerted in trafficking and signalling 
processes, where structural diversity of oligosaccharide chains is the key element of 
recognition events. However, carbohydrates accomplish also less specific but, at the same 
time, extremely important tasks. Saccharidic portions, when don’t take directly part in the 
process, often improve the bioactivity of the molecules they decorate affecting, for 
example, the stability. Glycosides can be, in fact, considered nature’s protecting groups, 
they often prevent hydrolysis of the biomolecules which are conjugated to by shielding 
labile sites with their encumbrance. An example of glycans-dependent proteolysis 
modulation is represented by tissue plasmogenin activation.1 Furthermore, conjugation 
with deoxygenated and/or functionalized sugars represents a powerful tool used by 
nature to influence biomolecules absorption, distribution and excretion by a fine tuning of 
their hydrophobic/hydrophilic features. Moreover, saccharide-decorations proved to have 
a strong effect in protein folding processes, driving the formation of peculiar 
threedimensional structures macromolecule activity is strictly related to. All these findings 
stressed the interest of the scientific community towards the application of 
oligosaccharides and oligosaccharides-decorated molecules in medicinal chemistry. 
Conjugation of active principles with saccharide moieties proved to influence their 
pharmacodynamic and pharmacokinetic features and has become an usual strategy for 
improving drug properties. Obviously, this adds a further challenge to the often not easy 
task of synthesizing the sole active principle. For the efficient total or partial synthesis of 
mono- and oligo-saccharide-containing complex products there are several issues to 
overcome. The first one is the moment of glycosylation within the planned sequence so as 
                                                 
1 Wittwer, A.; Howard, S. C. Biochemistry 1990, 29, 4175. 
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to optimize efficiency. The second issue relates to the choice of the glycosylation method 
to be used with regard to the yield and stereoselectivity and, first of all, the withstanding 
of the non-saccharidic portion. The third issue is associated with the choice of appropriate 
protecting groups, whose cleavage must not compromise the stability of the rest of the 
molecule. 
On the basis of our experience in carbohydrates elaboration, with a particular attention in 
mild glycosylation procedures, we set up a collaboration with dr. Pezzella, Univeristy of 
Napoli, for the feasible glycoconjugation of 17β-estradiol (Figure 5.1) and derivatives 
thereof. 
 
HO
H
H
H3C OH
H
167  
 
FIGURE 5.1 17β-Estradiol. 
 
17β-Estradiol functionalization has attracted considerable attention over the past years 
because of the wide pharmacological use of this hormone in substitutive therapies.2 As 
previously anticipated, in medicinal chemistry drugs implementation is often achieved 
introducing chemical modification on lead compounds with the overall effect of altering 
both pharmacodynamic and pharmacokinetic features. This strategy was also applied to 
17β-estradiol as well as to some related derivatives i.e. diethylstilbestrol, 17α-
ethynylestradiol, 2-methoxyestradiol, fulvestrant. As witnessed by the case of 2-
methoxyestradiol,3 modifications at the aromatic moiety of the hormone affect the 
biological activity by modulating its affinity of for estrogen receptors,4 whereas the 
pharmacokinetic properties of these hydrophobic compounds are tightly connected with 
water solubility. A paradigm of what has been just described is offered by the case of 
fulvestrant (Figure 5.2), a 7α substituted estradiol derivative approved for the treatment of 
advanced postmenopausal breast cancer,5 whose glycosylation either at the phenol or the 
carbinol site proved to improve its water solubility and bioavailability.6 These 
transformations were accomplished adopting fulvestrant derivatives protected at either of 
the OH groups to guarantee complete regioselectivity in the glycoconjugation.  
                                                 
2 Nilsson, S.; Koehler K.F. Basic Clin. Pharmacol. Toxicol. 2005, 1, 15. 
3 Leese, M. P.; Newman, S.P.; Purohit, A.; Reed, M. J.; Potter, B. V. Bioorg. Med. Chem. Lett. 2004, 12, 3135. 
4 a) Pribluda, V. S.; Gubish, E. R. Jr.; La Vallee, T. M.; Treston, A.; Swartz, G. M.; Green, S. J. Cancer Metastasis 
Rev. 2000, 19, 173; b) Edsall, A. B.; Mohanakrishnan, A. K.; Yang, D.; Fanwick, P. E.; Hamel, E.; Hanson, A. 
D.; Agoston, G. E.; Cushman, M. J. Med. Chem. 2004, 47, 5126 and references therein. 
5 Osborne, C. K.; Pippen, J.; Jones, S. E.; Parker, L.M.; Ellis, M.; Come, S.; Gertler, S. Z.; May, J.; Burton, G.; 
Dimery, I.; Webster, A.; Morris, C.; Elledge, R.; Buzdar, A. J. Clin. Oncol. 2002, 20, 3386. 
6 a) Thompson, M. J.; Hutchinson, E. J.; Stratford, T. H.; Bowler, W. B.; Blackburn, G. M. Tetrahedron Lett. 
2004, 45, 1207; b) Ferguson, J. R.; Harding, J. R.; Lumbard, K. W.; Schneimann, F.; Stachulski, A. V. 
Tetrahedron Lett. 2000, 41, 389. 
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FIGURE 5.2 Fulvestrant. 
 
The glucuronidation of estradiol was also reported starting from a precursor protected at 
the carbinol site, while regioselectivity was achieved only by resorting to enzymatic 
approaches.7 The carbinol glucuronidation of estradiol has also been very recently 
reported still adopting an acceptor protected at the other potentially nucleophilic site.8 
Programs aimed at the preparation and biological evaluation of glycosylated derivatives 
of steroids are in progress.9 On this regard, the search for the regioselective glycosidation 
of 17β-estradiol was pursued to accelerate the whole synthetic procedure by avoiding 
preventive protection steps. In our approach we wanted to develop feasible protocols for 
regioselective glycosidation of estradiol and derivatives thereof either at the phenol or the 
carbinol site (Scheme 5.1). 
 
HO
H
H
H3C OH
Hglycosyl halides
glycosyl imidates
R1
R2 R1, R2: H, H; NO2, H; NO2, NO2  
 
SCHEME 5.1 17β-Estradiol Regioselective Glycosylation Strategy. 
 
Results and Discussion 
 
It’s well known that phenols can be functionalized by reactions conducted under double 
phase conditions in the presence of a base and a suitable phase-transfer catalyst, generally 
a tetraalkylammonium salt. This strategy enabled the glycosidation of simple phenols with 
glycosyl halides (especially bromides or chlorides) under non anhydrous conditions,10 in 
contrast to other conventional glycosidation procedures. The regioselective application of 
this approach to unprotected estradiol derivatives appeared viable by virtue of the 
relevantly lower acidity of the 17-OH functionality. In addition, we decided to test the 
                                                 
7 For chemical approaches: a) Werschkun, B.; Gorziza, K.; Thiem, J. J. Carbohydr. Chem. 1999, 18, 629; b) 
Conrow, R. B.; Bernstein, S. J. Org. Chem. 1971, 36, 863; c) Elce, J. J.; Carpenter, J. G. D.; Kellie, A. E. J. Chem. 
Soc. (C) 1967, 542. For one example of enzymatic glucuronidation at the 3-OH: Werschkun, B.; Wendt, A.; 
Thiem, J. J. Chem. Soc., Perkin Trans. I 1998, 3021. 
8 Harding, J. R.; King, C. D.; Perrie, J. A.; Sinnott, D.; Stachulski, A. V. Org. Biomol. Chem. 2005, 3, 1501. 
9 For a review on the glycosidation of steroids: Pellissier, H. Tetrahedron  2004, 60, 5123. 
10 Jensen, K. J. J. Chem. Soc., Perkin Trans. I 2002, 2219 and references therein. 
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reactivity of glycosyl iodides for these transformations, as we recently11 disclosed a very 
efficient approach for their preparation. Such a procedure entails the short exposure (less 
than one hour) of a peracetylated sugar to iodine and triethylsilane in refluxing 
dichloromethane.12 The produced anomeric iodides are rapidly isolated by a simple 
extractive work-up. They are contaminated by a side product from triethylsilane 
(presumably the corresponding bis(silyl)ether) that is however expected to be unreactive 
under the conditions of the ensuing transformation. On the other hand, we had previously 
found that these crude iodides can be transformed into the corresponding glycals, 
ethylidenes and orthoesters in high yields without any apparent interference of the 
triethylsilyl impurity.11 
 
The first experiments for the present work were conducted by coupling 17β-estradiol with 
tetra-O-acetylated galactosyl iodide 88 (Table 5.1). The reaction was tested under a wide 
range of conditions by varying the amounts and the nature of the base (NaOH, KOH, 
sodium or potassium carbonate) and the phase-transfer catalyst (TBAB, TBAC, TBAI, 
cetyltrimethylammonium bromide). The best result in terms of yield and reaction rate 
(75% yield of glycoside 168) was obtained by using NaOH as the base and 
tetrabutylammonium bromide as the phase-transfer catalyst (Table 5.1, entry 1). In all cases 
2-O-acetyl 1,2-galactal represented the main by-product. For comparison purposes, the 
coupling was also tried under analogous conditions with the corresponding galactosyl 
bromide 169 to obtain 168 in a slightly improved yield (entry 2). However, it should be 
noted that the use of the crude galactosyl iodide could be advantageous in terms of 
rapidity of preparation. Coupling of 17β-estradiol with tetra-O-acetylated glucosyl iodide 
86 or bromide 171 gave poor to modest yields, the elimination process being favoured 
(entries 3 and 4). The higher trend of glucosyl halides to afford elimination products than 
the galactosyl counterparts has also been observed in other investigations.13 However, 
slightly improved yields were obtained when the more expensive cesium hydroxide was 
used as the base (entry 5 and 6). 
The protocol was also extended to the use of  glucosamine iodide donors. A recent work of 
Lay and coworkers14 evidenced the difficulty in performing glucosamine iodination with 
the effective Gervay’s protocol by the use of TMSI with anomeric acetates.15 In these 
conditions, the preparation of anomeric iodides proved to require N-phtalimido or N-
dimethylmaleimido protection of the glucosamine precursors. In the course of the present 
investigation the application of the iodine/triethylsilane system in refluxing DCM proved 
equally efficient for the synthesis of the N-phtalimido and N-Troc protected donors 172 
and 97 from the corresponding 1-O-acetylated β-anomers. However, glycosylation of 17β-
estradiol with 172 did not provide any detectable amount of the corresponding glycoside 
173 (entry 7), while a very satisfying yield was registered when using glucosamine donor 
97 (entry 8). 
 
 
 
                                                 
11 Adinolfi, M.; Iadonisi, A.; Ravidà, A.; Schiattarella, M. Tetrahedron Lett. 2003, 44, 7863. 
12 For further approaches towards the synthesis of glycosyl iodides see Chapter 2. 
13 Dess, D.; Kleine, H. P.; Weinberg, D. V.; Kaufman, R. J.; Sidhu, R. Synthesis 1981, 883. 
14 Miquel, N.; Vignando, S.; Russo, G.; Lay, L. Synlett 2004, 341. 
15 Gervay, J.; Nguyen, T. N.; Hadd, M. J. Carbohydr. Res. 1997, 300, 119. 
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5 86 CsOH 170 31 
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NaOH 
O
AcO
AcO
PhthN
OAc
O
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H
H3C OH
H
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N.d. 
8 
O
AcO
AcO
ITrocHN
OAc
 
97 
NaOH 
O
AcO
AcO
TrocHN
OAc
O
H
H
H3C OH
H
 
174 
81 
aConditions: donor (1.5 eq.), 17β-estradiol 167 (1 eq.), TBAB (1 eq.), base (5 eq.), H2O, CH2Cl2, RT, 2 h. 
 
TABLE 5.1 Regioselective Phenolic Glycosylation of 17β-Estradiol 167. 
 
Due to the biological interest of some estradiol derivatives containing further substituents 
at the aromatic A ring (for example, 2-methoxyestradiol),2 we have examined the 
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glycosylation of the easily accessible 2-nitro- and 2,4-dinitroestradiol derivatives.16 As a 
matter of fact, these acceptors were both β-galactosylated in excellent yields (Table 5.2). 
The observed yields of coupling reflected the increased acidity of the phenolic hydroxyl of 
these derivatives due to the presence of the electron-withdrawing nitro groups. These 
latter not only allowed better coupling yields but their versatile reactivity should also 
enable the synthesis of a small library of glycoconjugate-estradiol derivatives variously 
substituted on the aromatic cycle. 
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HO
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OAc
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HO
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H
H3C OH
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R1,R2: NO2, H; NO2, NO2
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Entry 17β-Estradiol Derivatives Base Product Yield (%) 
1a 
HO
H
H
H3C OH
H
O2N
 
175 
NaOH 
O
H
H
H3C OH
HO
AcO
AcO
AcO
OAc
O2N
 
176 
75 
2b 
HO
H
H
H3C OH
H
O2N
NO2  
177 
NaOH 
O
H
H
H3C OH
HO
AcO
AcO
AcO
OAc
O2N
NO2  
178 
84 
aConditions: donor 88 (1 eq.), 175 (2 eq.), TBAB (2 eq.), base (10 eq.), H2O, CH2Cl2, RT, 2 h; bConditions: 
donor 108 (1 eq.), 177 (2 eq.), TBAB (2 eq.), base (5 eq.), H2O, CH2Cl2, RT, 20 h. 
 
TABLE 5.2 Regioselective Phenolic Glycosylation of 17β-Estradiol Derivatives with Galactosyl Iodide 88. 
 
After exploring the glycosidation at the phenol site, we attempted to attain the 
complementary selectivity adopting non basic glycosylation conditions. In absence of the 
base the carbinol function was expected to be more nucleophilic because of the higher 
electronic delocalization occurring at the phenol oxygen. The carbinol glycosidation of 
both 3-O-protected fulvestrant and estradiol was reported to be rather difficult under the 
acid promoted activation of glycosyl trichloroacetimidates owing to the generation of 
undesired orthoester coupling products and the occurrence of an acyl transfer process 
yielding the 17-O-acylated product.5,7 These problems could be partly circumvented by 
                                                 
16 Pezzella, A.; Manini, P.; Di Donato, P.; Boni, R.; Napolitano, A.; Palumbo, A.; D’Ischia, M. Biorg. Med. 
Chem. 2004, 12, 2927. 
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adopting trichloroacetimidate donors equipped with sterically bulky acyl groups (pivaloyl 
or isobutyryl) and following an “inverse addition” protocol (slow addition of the donor to 
a mixture of the steroidal alcohol and the acid promoter).5,7 Recently our group reported 
the convenient use of 4Å acid washed molecular sieves (4Å AW 300 MS) in the dual role of 
promoters and drying agents in glycosidations with trihaloacetimidate donors.17 The 
mildness of such procedure prompted us to test its applicability to the difficult 
regioselective carbinol glycosidation of 17β-estradiol. On the bases of our previous 
experience, a 2-O-methoxycarbonylated donor was expected to be more efficient than a 2-
O-acetylated congener because of the lower propensity to yield undesired orthoester-like 
coupling products.18 As a matter of fact, when trichloroacetimidate 17918 and a slight 
stoichiometric excess of 17β-estradiol were stirred in the presence of commercially 
available 4Å AW 300 MS in dichloroethane, the desired carbinol glycoside 180 (Scheme 5.2) 
was obtained in the appreciable yield of 47% along with the di-glycosylated derivative 181 
(32% yield). Interestingly, the product of mono glycosylation at the phenol site was not 
detected from the reaction mixture, thus suggesting a sequential order of glycosylation 
with the carbinol site occourring first. It is worth of note that acetyl and methoxycarbonyl 
groups can be readily removed from 180 and 181 under standard Zemplen conditions 
whereas time-consuming procedures may be needed for the removal of pivaloyl groups 
from the above mentioned glycosylated steroids.5,7 
 
O
H
H
H3C O
HOAcO
MeO2CO
MeO2CO
OAc
HO
H
H
H3C OH
H
OAcO
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H
H
H3C O
H
AcO
O
AcO
OCO2Me
OCO2Me
180 181
(48%) (32%)
AW 300 MS
DCE, RT, overnight
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SCHEME 5.2 Regioselective Carbinol Glycosylation of 17β-Estradiol with Glycosyl Donor 179. 
 
                                                 
17 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Org. Lett. 2003, 5, 987. 
18 Adinolfi, M.; Barone, G.; Iadonisi, A.; Mangoni, L.; Schiattarella, M. Tetrahedron Lett. 2001, 42, 5967. 
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Under analogous conditions the corresponding tetra-O-acetylated donor 182 afforded 17-
O-glucosylated estradiol 183 in lower yield (30%) along with the di-O-glucosylated 
product 184 (estimated yield 10-15%, the product being recovered contaminated). NMR 
analysis of the crude reaction mixture revealed the formation of 2,3,4,6-tetra-O-acetyl 
glucose as the main by-product from the donor, and lower amounts (5-10%) of the 1,2-
orthoester coupling product and of 17-O-acetyl estradiol (Scheme 5.3).  
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SCHEME 5.2 Regioselective Carbinol Glycosylation of 17β-Estradiol with Glycosyl Donor 182. 
 
When 2-nitro-17β-estradiol was coupled with donor 179, the mono glycosidation of the 
carbinol site was achieved in very good yield (77%) without appreciable detection of any 
other glycosylation product (Scheme 5.3).  
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SCHEME 5.3 Regioselective Carbinol Glycosylation of 17β-Estradiol Derivative 175 with Glycosyl Donor 179. 
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Conclusion 
 
In conclusion, we have demonstrated that selective glycosidation of estradiol derivatives 
can be achieved either at the phenol or at the carbinol centre without extra steps for 
preventive protection of the estrogen derivative. The regioselective glycosidation at the 
phenolic site can be achieved adopting experimentally simple reactions conducted under 
two-phase conditions and good results were obtained with a variety of glycosyl bromides 
and iodides as the donors. The alternative regioselective glycosidation at the carbinol site 
can instead be obtained by the mild activation of trichloroacetimidates by acid washed 
molecular sieves. In both cases especially high yields were obtained in the glycosidation of 
estradiols bearing aromatic nitro groups. Work is in progress for the exploitation of the 
proposed methodologies for the synthesis of novel glycosylated derivatives of estradiol 
and for the chemical elaboration of the obtained glycosyl nitroestradiols. The complete 
library of deprotected compounds will be then submitted to microbiological tests for 
evaluation of the biological activity. 
 
Experimental Section 
 
General Methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were 
recorded on Varian spectrometers at 200 or 300 MHz and 50 or 75 MHz, respectively; or on 
a Bruker Avance 500 spectrometer at 500 MHz. The chemical shifts are given in parts per 
million (ppm) on the delta (δ) scale. Analytical thin layer chromatography (TLC) was 
performed on E. Merck pre-coated (25 nm) silica gel 60F-254 plates. Column 
chromatography was preformed using Carlo Erba 0.06-0.20 silica gel. Mass spectra were 
recorded in a reflection positive mode on a MALDI-TOF spectrometer. Acid washed 
molecular sieves were dried by overnight heating at 200 °C under vacuum before their use 
in glycosidations. Anhydrous solvents stored over molecular sieves (purchased from 
Aldrich) were used for performing the reactions.  
 
Typical procedure of phenol glycosidation of estradiol: An aqueous solution of NaOH 
(5%, 4 mL) was added at room temperature to a suspension of 17β-estradiol (27 mg, 0.1 
mmol) and TBAB (32 mg, 0.1 mmol) in dichloromethane (2 mL) and the system kept under 
stirring for ten minutes. A solution of crude iodide11 88 (0.15 mmol) in dichloromethane (2 
mL) was then added. After the consumption of the donor (ca 4 hours, TLC analysis), the 
mixture was repeatedly extracted with dichloromethane and the collected organic phases 
dried and concentrated. The residue was purified by silica gel chromatography (eluent 
petroleum ether/ethyl acetate from 7:3 to 6:4) to yield pure glycoside 168 (45 mg, 75% 
yield).   
 
168. [α]D +51.9 (c 0.7, CH2Cl2); 1H NMR (200 MHz, 
CDCl3) significative signals at δ 7.21 (1H, d, J1,2 = 8.2 
Hz, H-1 estradiol), 6.77 (1H, dd, J2,4 = 2.4 Hz, H-2 
estradiol), 6.72 (1H, d, H-4 estradiol), 5.47 (1H, dd, 
J1,2 = 7.8 Hz, J2,3  = 10.4 Hz, H-2 Gal), 5.44 (1H, bd, J3,4 
= 3.6 Hz, H-4 Gal), 5.08 (1H, dd, H-3 Gal), 4.99 (1H, O
H
H
H3C OH
HO
AcO
AcO
AcO
OAc
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d, H-1 Gal), 4.30-4.08 (2H, m, H2-6 Gal), 4.04 (1H, bt, J5,6a = J5,6b = 6.4 Hz, H-5 Gal), 3.73 (1H, 
t, J = 8.0 Hz, H-17 estradiol), 2.18, 2.06, 2.06, 2.01 (12H, 3xs, 4x -COCH3), 0.77 (3H, s, CH3 
estradiol). 13C NMR (50 MHz, CDCl3) δ 170.3, 170.1, and 169.4 (-COCH3), 154.9, 138.3, 135.5 
(aromatic C), 126.4, 116.9, and 114.3 (aromatic CH), 99.9 (C-1 Gal), 81.8 (C-17 estradiol), 
70.9, 70.9, 68.7, 67.0 (C-2, C-3, C-4, and C-5 Gal), 61.4 (C-6 Gal), 20.6 (4x -COCH3), 11.0 
(CH3 estradiol). Other signals of estradiol at δ 50.0, 44.0, 43.2, 38.7, 36.7, 30.6, 29.7, 27.1, 
26.2, 23.1. MALDI-TOF MS for C32H42O11 (M 602.3), m/z 625. 5 [M+Na]+. 
 
170. 1H NMR (200 MHz, CDCl3) significative 
signals at δ 7.21 (1H, d, Jab = 8.4 Hz, H-1 estradiol), 
6.78 (1H, dd, Jbd = 3.4 Hz, H-2 estradiol), 6.73 (1H, 
d, H-4 estrdiol), 5.36-5.15 (3H, overlapped signals, 
H-2, H-3, and H-4 Glc), 5.04 (1H, d, J1,2 = 8.0 Hz, H-
1 Glc), 4.26 (1H, dd, J6a,6b = 12.0 Hz, J5,6a = 5.6 Hz, H-
6 Glc), 4.16 (1H, dd, J5,6b = 2.4 Hz, H-6 Glc), 3.84 
(1H, m, H-5 Glc), 3.73 (1H, t, J = 8.0 Hz, H-17 estradiol), 2.08, 2.05, 2.04, 2.03 (12H, 4xs, 
4xCH3 acetyls), 0.77 (3H, s, CH3 estradiol). 
 
174. 1H NMR (300 MHz, CDCl3) significative 
signals at δ  7.17 (1H, d, Jorto = 8.7 Hz, H-1 
estradiol), 6.77 (1H, dd, Jmeta = 2.7 Hz, H-2 
estradiol), 6.71 (1H, d, H-4 estrdiol), 5.40 (1H, d, 
J2,NH = 9.3, NHTroc), 5.39 (1H, J3,4 = J4,5 = 9.3 Hz, 
H-4 GlcNHTroc), 5.17 (1H, d, J1,2 = 8.4 Hz, H-1 
GlcNHTroc), 5.12 (1H, t, J2,3 = 9.3 Hz, H-3 GlcNHTroc), 4.72 (2H, bs, -OCH2CCl3), 4.28 (1H, 
dd, Jgem = 12.6 Hz, J5,6a = 5.4 Hz, H-6 GlcNHTroc), 4.17 (1H, dd, J5,6b = 2.4 Hz, H-6 
GlcNHTroc), 3.95-3.70 (2H, m, H-2 and H-5 GlcNHTroc), 3.73 (1H, t, J = 8.1 Hz, H-17 
estradiol), 2.08, 2.05, 2.04 (9H, 3xs, 3xCH3 acetyls), 0.74 (3H, s, CH3 estradiol). 
 
176. 1H NMR (200 MHz, CDCl3) significative signals 
at δ  7.78 (1H, s, H-1 estradiol), 7.04 (1H, s, H-4 
estradiol), 5.53 (1H, dd, Hz, J1,2 = 8.0 Hz, H-2 Gal), 
5.46 (1H, d, J3,4 = 3.0 Hz, H-4 Gal), 5.08 (1H, dd, J2,3  
=10.2 Hz, H-3 Gal), 5.01 (1H, d, H-1 Gal), 4.23 (1H, 
dd, J5,6a = 6.8 Hz, J6a,6b = 10.8 Hz, H-6 Gal), 4.17 (1H, 
dd, J5,6b =7.6 Hz, H-6 Gal), 4.05 (1H, t, H-5 Gal), 3.74 
(1H, t, Js,r= 8.2  Hz, H-17 estradiol), 2.98 (2H, m, H-9 and H-6 estradiol), 2.18, 2.12, 2.08 and 
2.01 (4 x s, CH3CO), 0.78 (3H,s, CH3 estradiol).  
 
 
178. 1H NMR (200 MHz, CDCl3) significative signals 
at δ  7.83 (1H, s, H-1 estradiol),  5.39 (1H, dd, J1,2 =8.0 Hz, 
J2,3 =10.6 Hz, H-2 Gal), 5.35 (1H, d, J3,4 =3.4 Hz, H-4 
Gal), 5.01 (1H, dd, H-3 Gal), 4.91 (1H, d, H-1 Gal), 
4.09 (1H, dd, J5,6a =6.4 Hz, J6a,6b =11.2 Hz, H-6 A Gal), 
4.00 (1H, dd, J5,6=8.4 Hz, H-6 B Gal), 3.81 (1H, t, H-5 
Gal), 3.74 (1H, t, J =8.0 Hz, H-17 estradiol), 2.98-2.62 
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(2H, m, H-9 e 2xH-6 estradiol), 2.19, 2.14, 2.01 e 1.98 (4 x CH3CO), 0.79 (3H, s, CH3 
estradiol). 
 
 
Typical procedure of carbinol glycosidation of estradiol: Freshly activated 4Å  AW 300 
MS (ca 500 mg in pellets) were added to a mixture of donor 179 (28 mg, 0.053 mmol) and 
17β-estradiol (16 mg, 0.059 mmol). The mixture was suspended under argon with 
anhydrous dichloroethane (1 mL) at 0 °C and then the temperature was allowed to raise 
spontaneously. The mixture was left overnight under stirring at room temperature  and 
then filtered on a short plug of silica gel. The residue was purified by silica gel 
chromatography (eluent toluene/ethyl acetate 8:2) to afford monoglycoside  180 (16 mg, 
47% yield), unreacted estradiol, and then  diglycoside 181 (9 mg, 32% ).  
 
180. [α]D +16.4 (c 0.6, CH2Cl2); 1H NMR (400 MHz, 
CDCl3) significative signals at δ 7.14 (1H, d, J1,2  = 8.4 Hz, 
H-1 estradiol), 6.63 (1H, dd, J2,4 = 2.4 Hz, H-2 estradiol), 
6.56 (1H, d, H-4 estradiol), 5.13 (1H, t, J2,3  = J3,4 = 9.6 Hz, 
H-4 Glc), 5.06 (1H, t, J2,3  = 9.6 Hz, H-3 Glc), 4.85 (1H, dd, 
J1,2  = 8.0 Hz, H-2 Glc), 4.58 (1H, d, H-1 Glc), 4.26 (1H, dd, 
J6a,5  = 5.2 Hz, J6a,6b  = 12.3 Hz, H-6a Glc), 4.15 (1H, dd, J6b,5  
= 2.8 Hz, H-6b Glc), 3.81 and 3.78 (6H, 2xs, 2x -OCH3), 
3.70 (1H, m, H-5 Glc), 3.63 (1H, t, J = 8.4 Hz, H-17 estradiol), 2.10 and 2.05 (6H, 2xs, 2 -
COCH3), 0.75 (3H, s, CH3 estradiol). 13C NMR (50 MHz, CDCl3) δ 170.6 and 169.4 (2x -
COCH3), 155.1 and 154.5 (2x –OCO2CH3), 153.3, 138.2, 126.5 (aromatic C), 126.4, 115.2 and 
112.6 (aromatic CH), 101.6 (C-1 Glc), 90.7 (C-17 estradiol), 76.6, 75.2, 71.6, 68.7 (C-2, C-3, C-
4, and C-5), 62.1 (C-6), 55.3 and 55.2 (–OCO2CH3), 20.8 and 20.6 (2x -COCH3), 11.5 (CH3 
estradiol). Other signals of estradiol at δ 49.6, 43.9, 43.3, 38.5, 37.2, 29.5, 28.8, 27.1, 26.3, 23.1. 
MALDI-TOF MS for C32H42O13 (M 634.3), m/z 657.4 [M+Na]+.  
 
181. [α]D +26.6 (c 0.5, CH2Cl2); 1H NMR 
(400 MHz, CDCl3) significative signals 
at δ 7.18 (1H, d, J1,2  = 8.4 Hz, H-1 
estradiol), 6.75 (1H, dd, J2,4 = 2.4 Hz, H-
2 estradiol), 6.71 (1H, d, H-4 estradiol), 
5.20-5.00 (6H, overlapped signals, H-3 
and H-4 phenol and carbinol Glc, H-1 
and H-2 phenol Glc), 4.84 (1H, dd, J1,2  = 
8.0 Hz, H-2 Glc), 4.57 (1H, d, H-1 Glc), 
4.28-4-10 (4H, overlapped signals, H2-6 carbinol and phenol Glc), 3.84 (1H, m, H-5 phenol 
Glc), 3.82, 3.80, 3.78, and 3.77 (12H, 4xs, 4x -OCH3), 3.70 (1H, m,  H-5 carbinol Glc), 3.64 
(1H, t, J = 8.4 Hz, H-17 estradiol), 2.09, 2.07, 2.05 and 2.04 (12H, 4xs, 4x-COCH3), 0.73 (3H, 
s, CH3 estradiol). 13C NMR (50 MHz, CDCl3) δ 170.6 and 169.3 (-COCH3), 155.1 and 154.5 (–
OCO2CH3 and C-3 estradiol), 138.2, 135.4 (aromatic C), 126.4, 117.2, and 114.5 (aromatic 
CH), 101.6 (C-1 carbinol Glc), 99.1 (C-1 phenol Glc), 90.6 (C-17 estradiol), 76.6, 75.2, 74.8, 
71.6, 71.5, 68.7, 68.3 (C-2, C-3, C-4, and C-5, phenyl and carbinol Glc), 61.9 (C-6, phenyl and 
carbinol Glc), 55.3 (–OCO2CH3), 20.6 and 20.5  -COCH3), 11.4 (CH3 estradiol). Other signals 
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of estradiol at δ 49.6, 43.9, 43.2, 38.3, 37.1, 29.6, 28.8, 27.0, 26.1, 23.1. MALDI-TOF MS for 
C46H60O24 (M 996.4), m/z 1019.3 [M+Na]+. 
 
183. 1H NMR (300 MHz, CDCl3) significative signals at δ 7.17 
(1H, d, H-1 estradiol), 6.68-6.52 (2H, m,  H-2 and H-4 
estradiol), 5.30-4.96 (3H, m, H-2, H-3 and H-4 Glc), 4.56 (1H, 
d, J1,2= 7.8 Hz, H-1 Glc), 4.26 (1H, dd, J5,6a = 4.8 Hz, J6a,6b = 
12.2 Hz, H-6A Glc), 4.13 (1H, dd, J5,6b =2.8 Hz, H-6 B Glc), 
3.72-3.59 (2H, m, H-5 Glc and H-17 estradiol), 2.79 (3H, m,  
H-9 and 2 x H-6 estradiol),  2.09, 2.06, 2.02 and 2.01 (12H, 
4xs, 4xCH3 acetyls), 0.74 (3H, s, CH3  estradiol).  
 
188. 1H NMR (400 MHz, CDCl3) significative signals at 
δ 10.40 (1H, s, OH phenolic estradiol), 7.97 (1H, s, H-1 
estradiol), 6.84 (1H, s, H-4 estradiol), 5.11-5.06 (2H, m, 
overlapped signals H-4 and H-3 Glc), 4.85 (1H, t, J1,2  = 
8.4 Hz, H-2 Glc), 4.56 (1H, d, H-1 Glc), 4.25 (1H, dd, J6a,5  
= 5.1 Hz, J6a,6b  = 12.0 Hz, H-6a Glc), 4.13 (1H, dd, J6b,5  = 
2.4 Hz, H-6b Glc), 3.82 and 3.78 (6H, 2xs, 2x -OCH3), 
3.70 (1H, m, H-5 Glc), 3.61 (1H, t, J = 7.8 Hz, H-17 
estradiol), 2.09 and 2.04 (6H, 2xs, 2 -COCH3), 0.75 (3H, s, CH3 estradiol). 13C NMR (50 
MHz, CDCl3) δ 170.6 and 169.4 (2x -COCH3), 155.1 and 154.6 (2x –OCO2CH3), 152.8 (C-2 
estradiol), 149.1 (C-3 estradiol), 133.6 and 131.7 (C-5 and C-6 estradiol), 121.5 and 118.9 (C-
4 and C-1 estradiol), 101.8 (C-1 Glc), 90.7 (C-17 estradiol), 76.6, 75.2, 71.6, 68.7 (C-2, C-3, C-
4, and C-5 Glc), 62.1 (C-6 Glc), 55.3 and 54.9 (2x –OCO2CH3), 20.7 and 20.6 (2x -COCH3), 
11.4 (CH3 estradiol). Other signals of estradiol at δ 49.5, 43.4, 43.2, 39.7, 37.8, 29.7, 28.8, 26.5, 
26.0, 23.1. 
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Chapter 6 
 
Toward Novel Antibiotics: Glycosyl 4-Alkilidene-β-Lactams 
 
 
 
 
 
 
 
 
 
Introduction 
Antibiotics are natural or synthetic compounds that inhibit the growth of bacteria. Natural 
sources of antibiotic substances are micro-organisms and moulds. Among these, Penicillum 
and Cephalosporium are very well known because produce, as secondary metabolites, 
penicillins and cephalosporins, β-lactam-containing antibacterial molecules. Since 
penicillins, the first major class of antibiotics, were introduced in the 1940s and 1950s, the 
number of antibiotic agents available had been rising steeply. Nevertheless as result of 
saturation of the market, many pharmaceutical companies lost interest in the development 
of antibiotic drugs and instead focused on chronic diseases.1 Nowadays a new emergency 
has to be faced: sixty years of use and misuse of such drugs resulted in an impressive rise 
in bacterial resistance not only to single but also to multiple antibiotics exposure.2 Many 
factors have contributed to the development and spread of antibiotic resistance, including 
the expanding population of immuno-compromised patients, the increased use of invasive 
medical procedures, and the inappropriate use of antibiotics in both medicine and 
agriculture. One of the main causes is represented by the non-compliance to the course of 
treatment by patients. Both the long-term exposure to low doses and the failure to finish a 
prescription encourage more resistant bacterial strains to flourish. Furthermore, despite 
the wealth of treatment options, a limited variety of antibiotic mechanisms are 
implemented. The various antibiotics target few vital processes, whose tampering results 
in micro-organism death. Five types of cellular processes inhibition are generally 
performed: 
 
 Protein synthesis  
 Bacterial cell wall synthesis 
 DNA synthesis 
 RNA synthesis 
 Folic acid metabolism.  
                                                 
1 Shales, D. M. Curr. Opinion in Pharmacology 2003, 3, 470. 
2 Gold, H. S.; Moellering, R. C. N. Engl. J. Med. 1996, 335, 1445. 
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The bacterial adaptation to these ways of action has been so successful that some 
infections resulted untreatable with any antibiotic.  
Obviously, the widespread occurrence of resistance mechanisms has renewed the 
industrial interest in this field. World Health Organisation (WHO) encourages the research 
community to have a better insight into the mechanism of bacterial resistance with the aim 
of developing new effective drugs.3  
Bacterial resistance to antibiotic drugs is mediated by one or more of the following 
processes:4 
 Prevention of the drug from reaching its target either by active efflux from or by 
reduced uptake into the cell, as well as by sequestration of the antibiotic by protein 
binding. 
 Deactivation of the antibiotic by enzymatic modification. 
 Modification of the drug’s target, thereby eliminating or reducing the binding of the 
antibiotic. 
 Metabolic bypass of the inhibited reaction. 
 Overproduction of the antibiotic target. 
Of these mechanisms, the first three represent the most common processes that enhance 
bacterial resistance to antibiotics (Figure 6.1).5 
 
 
 
FIGURE 6.1 Mechanisms of Bacterial Drug Resistance: A) Active Reflux; B) Enzymatic Modification of the 
Drug; C) Modification of Target Receptor or Enzymes. 
 
To efficiently overcome resistance problems, the identification of new targets as well as the 
improvement of the existing drugs will be necessary. 
For several years our group has been part of a multidisciplinary team whose expertise in 
various field was addressed to the development of novel glycoconjugates with antibiotic 
activity against resistant bacteria. The aim of the project, supported by Ministero 
dell’Istruzione, dell’Università e della Ricerca  as a “Research Programme of Prominent 
National Interest”, is the design, synthesis and screening of β-lactam-glycoconjugates. 
Three research groups are responsible for the synthesis and conjugation of novel β-lactam-
containing molecules, whose activity is then microbiologically tested on clinical isolates 
belonging to both Gram-positive and Gram-negative bacteria, including antibiotic 
                                                 
3 World Organization Report of Infection Diseases 2000 Overcoming Antimicrobial Resistance, 
www.who.int/infectious-disease-report/2000/index.html. 
4 Davies, J. Science 1994, 262, 375.  
5 Walsh, C. Nature 2000, 406, 775. 
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resistant strains. The study and design phase as well as the microbiological tests analysis 
are assisted by chemoinformatic means. Molecular modelling is applied to correlate the 
changes in chemical structures with antibiotic activities in order to better understand the 
drug-receptor molecular interactions and therefore predict feasible modifications on the 
structures to be synthesized. The mechanism of action of β-lactam antibiotics, such as 
penicillins and cephalosporins, targets the peptidoglycan biosynthesis. In the cell envelope 
of both Gram-positive and Gram-negative bacteria the peptidoglycan layer provides the 
strength and rigidity, which allows them to live in a hypotonic environment and gives 
them their characteristic shape (Figure 6.2). 
 
 
 
FIGURE 6.2 The Cell Envelope of Gram-Positive and Gram-Negative Bacteria. 
 
Antibiotic-induced defects lead to cell lysis as a result of the inability of the bacteria to 
cope with the internal osmotic pressure. 
Peptidoglycan is a polymer composed by polysaccharide chains of two sugars, N-acetyl 
glucosamine (NAG) and N-acetyl muramic acid (NAM) linked through β(1→4) glycosidic 
bond, that in turn are crosslinked by pentapeptide-pentaglycine bridges (Figure 6.3). 
 
 
 
FIGURE 6.3 Structure of Peptidoglycan. 
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Peptidoglycan biosynthesis6 commences with the transformation of one unit of UDP-N-
acetylglucosamine (UDP-GlcNAc) into UDP-N-acetylmuramic acid (UDP-MurNAc) via 
phosphoenolpyruvate (PEP) transfer followed by reduction of the resulting unsaturated 
acid (Figure 6.4). Three amino acid residues are then attached sequentially in ATP-
dependent reactions to the lactic acid residue of UDP-MurNAc. This is followed by the 
coupling of a preformed dipeptide, usually D-Ala-D-Ala, to the peptide terminus. The 
presence of unusual D-amino acid residues confers to peptidoglycan a better stability 
against proteolysis. In the next step, MurNAc-pentapeptide phosphate is transferred from 
its UDP derivative to undecaprenyl phosphate, a carrier molecule embedded in the 
cytoplasmic membrane. A second GlcNAc residue is then coupled at the C-4 position of 
MurNAc-pentapeptide. At this point, the GlcNAc-MurNAc peptide is translocated across 
the cytoplasmic membrane to the cell surface by an unknown mechanism. Here, the 
disaccharide units are polymerized by the action of several transglycosylases. Finally, 
transpeptidases catalyze the attack of the terminal side-chain  of meso-diaminopimelic acid 
(mDAP, Gram-negative bacteria) or the amino terminus of the oligo-Gly linker (Gram-
positive bacteria) at the peptide bond between the two D-Ala residues of a neighbouring 
peptide chain, resulting in crosslinking with a concomitant loss of a D-Ala.  
 
 
 
FIGURE 6.4 Biosynthesis of Peptidoglycan (UDP = uridine diphosphate, Mur = muraminic acid, P = 
phosphate substituent, MraY = translocase). 
                                                 
6 van Heijenoort, J. New. Compr. Biochem. 1994, 27, 39. 
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Each of these enzymes represents a target for antibiotic development.  
Penicillins and cephalosporins (Figure 6.5) target the enzyme transpeptidase that catalyze 
the crosslinking step.7 The pharmacological activity of these molecules is mainly due to the 
presence of the four membered lactam ring (azetidinone) that mimics the D-Ala-D-Ala 
extremity of peptide chains to be crosslinked. 
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FIGURE 6.5 Penicillin G and Cephalosporin C Structures. 
 
During the crosslinking step a serine-carboxypeptidase, named Penicillin Binding Protein 
(PBP), hydrolyzes the peptide bond between the two D-Ala residues generating a 
temporary ester linkage with the peptide chain to be crosslinked. After the departure of 
the terminal D-Ala residue from the active site of the enzyme, the amino group of a 
neighbouring peptide chain (mDAP or oligo-Gly) interacts with the PBP-D-Ala adduct 
completing the crosslinking (Scheme 6.1).  
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 SCHEME 6.1 Penicillin Binding Protein Mechanism of Action. 
 
Penicillins, and, more generally, β-lactam-based antibiotics effectively interact with PBPs 
because of their structural resemblance with D-alanyl-D-alanine (Figure 6.6).  
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FIGURE 6.6 Structural Resemblance between D-Alanyl-D-Alanine and Penicillins. 
                                                 
7 Beadle, B. M.; Nicholas, R. A.; Shoichet, B. K. Science 2001, 10, 1254.  
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Penicillin inhibits the PBP’s crosslinking capabilities by acylating the enzyme and binding 
irreversibly to its catalytic site (Scheme 6.2).8 The great stability of the PBP-Penicillin adduct 
is due to the steric hindrance that occurs at the enzyme active site. Despite the D-Ala-D-Ala 
case, because of the cyclic nature of penicillin no release of encumbrance is registered after 
acylation of the enzyme. The PBP-penicillin adduct is thus inaccessible to oligo-Gly chains 
for the crosslinking step or even to water for hydrolysis reaction.  
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SCHEME 6.2 Penicillin Binding Protein Acylation. 
 
The overall effect is the peptidoglycan reticulation inhibition that means cell wall 
weakening and results in bacteria death by lysis. The effectiveness of β-lactam antibiotics 
made them a widely used class of antibacterial drugs. However, some bacteria developed 
specific resistance mechanisms against β-lactam-based drugs such as (Figure 6.7): 
 producing enzymes (zinc- or serine-dependent β-lactamases) that inactivate the drug 
 synthesizing modified PBPs with a low affinity for the drug 
 altering their permeability for the drug or providing efficient extrusion of it by efflux 
pumps. 
 
 
FIGURE 6.7 Major Bacterial β-Lactam Resistance Mechanisms. 
                                                 
8 Blumberg, P. M.; Strominger, J. L. Bacteriological Rev. 1974, 38, 291. 
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The most important mechanism of bacterial resistance to β-lactams is represented by 
expression of β-lactamases, enzymes able to hydrolyze the β-lactam ring causing loss of 
activity of these drugs (Figure 6.8). These enzymes, which make up a large heterogeneous 
group, are found widely among Gram-positive and Gram-negative bacteria. 
 
 
 
FIGURE 6.8 β-Lactamase Action. 
 
Of particular interest for our studies is the resistance mechanism relevant to the synthesis 
of modified PBPs. A recent study on methicillin resistant Staphylococcus aureus (MRSA) 
revealed that in the presence of classical β-lactam antibiotics the biosynthesis of bacterial 
cell wall can be regularly fulfilled, because  resistant strains codify a new modified protein 
(PBP2A) with low-affinity for these types of drugs.9 This investigation, developed on a 
molecular level, demonstrated that PBP2A couples with PBPs, whose active site have been 
locked by β-lactams, and restores the trans-peptidic domain, thus bypassing the antibiotic 
effect of the drugs (Figure 6.9).  
More recently, the combined administration of a β-lactam drug (niotrocephin) together 
with short synthetic fragments of peptidoglycan increased the affinity of PBP2A for these 
kind of antibiotics, suggesting a feasible inhibition of this protein as well.10 The short 
saccharidic structures, interacting with the transglycosylase domain of PBPs/PBP2A, 
likely promote conformational changes in the protein hence enabling the β-lactam to 
access the inhibition site.  
These latter results together with the consideration that none of the other classes of 
antibiotics is featured by as high efficiency and low toxicity as β-lactams are, suggested the 
idea of synthesizing novel β-lactam-based glycoconjugates. A few number of reports 
describe the synthesis of β-lactams conjugated to carbohydrates, and in many cases the 
                                                 
9 Pinho, M. G.; de Lencastre, H.; Tomasz, A. Proc. Natl : Acad. Sci. USA 2001, 98, 10886. 
10 Fuda, C.; Hesek, D.; Lee, M.; Morio, K. –I.; Nowak, T.; Mobashery, S. J. Am. Chem. Soc. 2005, 127, 2056.  
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saccharidic moiety plays the role of chiral auxiliary for the stereocontrolled construction of 
the lactam ring.11 
 
 
FIGURE 6.9 PBP2A Mechanism of Action. 
 
Isolated examples are instead focused on the biological properties of such conjugates11 
even though this strategy offers several theoretical advantages, among the others an 
improved resemblance of the drug with the natural substrates of PBPs. Furthermore, the 
saccharidic portion of these molecules is supposed not only to improve the farmacokinetic 
properties of the drugs, as already proved by other studies,12 but also might play an 
important role in the inhibition process as well as the β-lactam moiety. Recently, several 
carbohydrate-based antibiotics, exploiting various mechanisms of action, have been 
developed.13 A significant paradigm is offered by vancomycin (Figure 6.10), whose 
                                                 
11 a) I. Izquierdo, M. T. Plaza, R. Robles, A. J. Mota, Tetrahedron: Asymmetry 2000, 11, 4509; b) T. B. Durham, 
M. J. Miller, Org. Lett. 2002, 4, 135; c) G. I. Georg, E. Akgün, P. M. Mashava, M. Milstead, H. Ping, Z.-J. Wu, 
D. V. Velde, Tetrahedron Lett. 1992, 33, 2111; d) B. C. Borer, D. W. Balogh, Tetrahedron Lett. 1991, 32, 1039; e) A. 
K. Bose, B. K. Banik, C. Mathur, D. R. Wagle, M. S. Manhas, Tetrahedron 2000, 56, 5603; f) A.  Dondoni, A. 
Massi, S. Sabbatini, V.  Bertolasi, Adv. Synth. Catal. 2004, 346, 1355.  
12 a) Toth, I. R. A.; Hughes, G.; Dekany, R. S.; Hillery, A. M.; Ward. P. Liebigs Ann. Chem. 1994, 685; b) Molina, 
L.; Gerardin-Charbonnier, C.; Selve, C.; Stebe, M. –J.; Maugras, M.; Infante, M. –R.; Torres, J. –L.; Manresa, M. 
–A.; Vinardell, P. New J. Chem. 1997, 21, 1027; c) Shibata, H.; Nagaoka, M.; Takagi, I.; Hashimoto, S. European 
Patent n° WO 2000020009. 
13 Ritter, T. K.; Wong, C. –H. Angew. Chem. Int. Ed. 2001, 40, 3508. 
Chapter 6
  127
disaccharide and cyclopeptide moieties proved to separately exert an antibiotic effect by 
interfering with different processes of the peptidoglycan biosynthesis.14 
In the light of these data, a favourable synergy is expected by the coupling between 
carbohydrates and β-lactams, because these novel glycoconjugates might potentially be 
able to simultaneously lock both transpeptidase (with the β-lactam core) and trans-
glycosylase domains (with the saccaridic portion) of resistant bacteria PBPs. 
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FIGURE 6.10 Vancomycin. 
Results and Discussion 
In the first phase of our multidisciplinary project, the effective synthesis of the β-lactam 
portion has been pursued by Cainelli’s group, University of Bologna. 4-Alkylidene-β-
lactams were chosen as synthetic target because of encouraging preliminary results 
registered with some derivatives belonging to this class in the inhibition of serine 
proteases such as leuckocyte elastase and gelatinase.15 The promising reactivity of these 
molecules is strictly related to the conjugation of the exocyclic double bond with the 
lactam carbonyl group, that therefore exhibits an increased electrophilic character (Scheme 
6.3).  
NH
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SCHEME 6.3 Effective Delocalization of the Charge after Nucleophilic Attack on 4-Alkylidene-β-Lactams. 
                                                 
14 Ge, M.; Chen, Z.; Onishi, H. R.; Kohler, J.; Silver, L. L.; Kerns, R.; Fukuzawa, S.; Thompson, C.; Kahne, D. 
Science 1999, 284, 507.  
15 G. Cainelli, P. Galletti, S. Garbisa, D. Giacomini, L. Sartor, A. Quintavalla, Bioorg. Med. Chem. 2003, 11, 5391. 
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4-Alkylidene-azetidinone precursors were effectively synthesized by exploiting as the key 
step the Lewis acid-mediated reaction of 4-acetoxy-azetidinones with α-diazo carbonyls.16 
4-Alkyliden-azetidin-2-one 192 was obtained in excellent yield by reaction of the N-
trimethylsilyl derivative of commercially available (3R,4R)-4-acetoxy-3-[(1R)-1-(tert-
butyldimethylsilyloxy)-ethyl]-azetidin-2-one 189 and ethyldiazoacetate in presence of 
TiCl4 (Scheme 6.4).  
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SCHEME 6.4 Synthesis of 4-Alkylidene-β-Lactam 192. 
 
The reaction proceeded smoothly, to yield an 85:15 mixture of the Z and E isomers 190 and 
191. Critical to the success of the reaction were the stoichiometric amount of TiCl4 and the 
excess of the diazo-compound associated with the requirement for trimethylsilyl 
protection of the β-lactam nitrogen atom. The diastereomeric products E and Z were easily 
separated by column chromatography, allowing access to stereochemically pure 190. 
Treatment of 190 with HCl in acetonitrile produced the deprotected derivative 192. 
The presence of a free hydroxyl in compound 192 and the positive inhibitory effects 
associated to its functionalization15,,17 prompted us to explore an initial glycoconjugation 
strategy based on a direct connection mediated by a glicosidic bond.  
The sensitivity of 192 toward both acidic and basic conditions posed some concerns in the 
choice of a suitable glycosidation approach and of the protection pattern for the 
saccharidic moiety, since both glycosylation and final deprotection steps had to be 
compatible with the whole structure of the glycosylated β-lactam. As the extreme lability 
of 192 in mild basic conditions was revealed in preliminary tests,18 acyl protection for the 
saccharidic moiety was ruled out. On the other hand, the observed survival of the 
alkylidene-β-lactams under mild hydrogenation conditions drove our choice towards 
benzyl groups.19 
                                                 
16 a) G. Cainelli, P. Galletti, M. Gazzano, D. Giacomini, A. Quintavalla, Tetrahedron Lett. 2002, 43, 233; b) G. 
Cainelli, D. Giacomini, P. Galletti, A. Quintavalla, Eur. J. Org. Chem. 2003, 1765. 
17 G. Cainelli, P. Galletti, S. Garbisa, D. Giacomini, L. Sartor, A. Quintavalla, Bioorg. Med. Chem. 2005, 13, 6120. 
18 After 1 minute treatment with K2CO3 in MeOH at 0 °C complete degradation of 192 was observed. 
19 4-Alkylidene-β-lactams are stable towards under pression (7 bar) hydrogenation with Pd on charcoal as 
the catalyst. 
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As for the glycosylation approach, the choice was addressed to the catalytic activation of 
glycosyl N-phenyl trifluoroacetimidates20 with Yb(OTf)3 which had proved compatible 
with a wide range of functional groups,21 including extremely acid labile ones.22 The 
unviability of using acyl groups also led to the necessity of controlling the stereochemical 
outcome with a mechanism other than the neighbouring participation that typically 
operates when 2-O-acylated donors are used. In previous reports, the suitable choice of the 
solvent was shown to tune the anomeric selectivity of ytterbium(III) triflate-promoted 
glycosylations with (N-phenyl)trifluoroacetimidates (nitrile-type solvents favour β-
selectivity, whereas ether mixtures display α-selectivity).21,23  
For this investigation N-phenyl trifluoroacetimidate donors 151, 162 and 113 (Table 6.1) of 
perbenzylated D-glucose, D-galactose, and L-fucose were prepared as previously reported 
(treatment of the commercially available hemiacetals in anhydrous dichloromethane with 
N-phenyl trifluoroacetimidoyl chloride and sodium hydride as the base).21,22 Under these 
conditions all the donors were obtained with a large predominance of the β-anomer and 
were used in the ensuing glycosidation steps as anomeric mixtures.  
 
Entrya Donor 
Solvent  
and  
Temperature [°C] 
Product 
Yield 
[%] 
(α:β) 
1 
OBnO
BnO O
OBn
BnO
CF3
NPh
 
151 
DME/dioxane  
1:1 
0 to RT 
NHO
O
COOEt
O
BnO
BnO
OBn
BnO
193 
70 
(3.9:1) 
2 151 CH3CN -15 to RT 193 
73 
(1:2.4) 
3 
O
BnO
BnO O
OBn
OBn
CF3
NPh
 
162 
DME/dioxane  
1:1 
0 to RT 
NHO
O
COOEt
O
BnO
BnO
OBn
OBn
194 
90 
(4.3:1) 
4 162 CH3CN -15 to RT 194 
55 
(1:1.4) 
5b O
O
OBn
OBn
OBn
PhN CF3
 
113 
CH2Cl2/Et2O/dioxane 
4:1:1 
-30 to RT 
O OBnH3C
BnO
NHO
O
COOEt
OBn
195 
88 
(7.4:1) 
aConditions: donor (1.3-1.5 eq.), 192 (1 eq.), Yb(OTf)3 (0.1 eq.), AW MS; bdonor (2.5 eq.), Yb(OTf)3 (0.05 eq.). 
 
TABLE 6.1 Yb(OTf)3-Promoted Glycosylations of 4-Alkylidene-β-Lactam 192. 
                                                 
20 B. Yu, H. Tao, Tetrahedron Lett. 2001, 42, 2405. 
21 M. Adinolfi, G. Barone, A. Iadonisi, M. Schiattarella, Tetrahedron Lett. 2002, 43, 5573. 
22 M. Adinolfi, A. Iadonisi, M. Schiattarella, Tetrahedron Lett. 2003, 44, 6479. 
23 a) M. Adinolfi, A. Iadonisi, A. Ravidà, M. Schiattarella, Tetrahedron Lett. 2004, 45, 4485; b) M. Adinolfi, A. 
Iadonisi, A. Ravidà, M. Schiattarella, Synlett 2004, 1645; c) M. Adinolfi, A. Iadonisi, A. Ravidà, M. 
Schiattarella, J. Org. Chem. 2005, 70, 5316. 
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In the first attempts the syntheses of α-linked glycosides of glucose and galactose were 
investigated taking advantage of the α-directing ability of dimethoxyethane/dioxane 
solvent mixtures.23a In both cases, the glycosylations produced the desired glycosides in 
high yields (70 and 90%, respectively) and satisfying stereocontrol (α/β ≈ 4:1 in both 
cases). The anomers could be separated by silica-gel chromatography and characterized by 
NMR spectroscopy, which also clearly indicated the integrity of the alkylidene-β-lactam 
skeleton. Glycoconjugation of compound 192 was also attempted through a α-L-
fucosidation reaction which represents an important task in oligosaccharide synthesis 
because of the frequent occurrence of α-L-fucosyl residues in important antigen 
sequences.24 In the present study the reaction might have allowed the access to glycosyl-
conjugated products of reduced polarity. Owing to the high reactivity of fucosyl donors, 
the glycosylation with 113 could be performed at low temperature. Consistently with 
previous findings23b,c a solvent mixture containing dioxane and diethyl ether led to desired 
product in very good yield and α-selectivity (88%, α/β ≈ 7.5:1). 
β-Selective glycosylations of 192 with donors 151 and 162 were then attempted by catalytic 
activation with ytterbium(III) triflate in nitrile-type solvents. In both cases, lower yields 
and selectivities  were registered if compared with the results previously obtained with 
ether solvents (Table 6.1, entries 2 and 4). Neverthless, the obtained β-glycosides 193β and 
194β were easily separated from the corresponding α-anomers by chromatography. It 
should be noted that acceptors bearing hydroxyl groups in the proximity of rigid cyclic 
structures appear to be glycosylated in lower yield and β-selectivity when using nitrile 
solvents.20,25 The origin of such behaviour will be further explored. 
α-Glycosides 193α, 194α, and 195α were deprotected by transfer-hydrogenolysis in 
methanol/formic acid (9:1) mixture under sonication.26 Careful control of temperature was 
found to play a decisive role in obtaining the desired products 196α–198α in high yields (> 
90%) (Figure 6.12). Noteworthy the exocyclic double bond on the β-lactam backbone 
appeared to be completely unaffected by this reaction. 
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FIGURE 6.11 Deprotected Derivatives 196α-198α. 
 
A second approach was also followed for the conjugation of alkylidene-β-lactam 192 with 
the saccharide portion. A different class of glycoconjugated was generated interposing a 
succinyl spacer between the β-lactam and the carbohydrate moieties. Despite the previous 
strategy, in this case the conjugation calls for the formation of an ester linkage. Derivatives 
199 and 200 represented our synthetic targets (Figure 6.12). The choice of C-3 position for 
                                                 
24 See Chapter 3. 
25 R. R. Schmidt, M. Behrendt, M. Toepfer, Synlett 1990, 694. 
26 V. S. Rao, A. S. Perlin, Carbohydr. Res. 1980, 83, 175. 
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the linker installation and therefore β-lactam conjugation is intended to mimic the natural 
PBPs substrates. In fact, the pentapeptide chain terminating with the D-Ala-D-Ala residue 
naturally occurs on C-3 position of MurNAc units. Moreover, in order to further improve 
the biomimetic feature of these glycoconjugates, the use of a glucosamine residue was also 
investigated. 
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FIGURE 6.12 Synthetic Targets. 
 
Therefore, suitably protected succinyl derivatives 201 and 202 were synthesized and 
effectively conjugated with 4-alkyliden-β-lactam 192 (Schemes 6.5 and 6.6). 
Derivative 201 was prepared using as starting material the commercially available 4,6-
benzylidene-protected methyl glucoside 203 (Scheme 6.5). Derivative 203 was 
regioselectively benzylated at C-2 position by a one-pot procedure taking advantage of the 
formation of a temporary stannilidene acetal as intermediate. The benzylation proceeded 
with a good overall yield (92%), but the regiomeric mixture of products furnished the 
desired regioisomer in 55% yield.   
Monobenzylated derivative 204 was then treated with succinic anhydride and base to 
yield 201 in excellent yield. Several approaches have been followed for effectively 
achieving the conjugation with the β-lactam moiety. Activation of carboxylic function of 
derivative 201 proved to be not trivial. Low yields and/or reaction rates were registered 
exploiting classical procedures for example using carbodimides (DCC and DPC) or 
generating the acyl chloride intermediate by the use of Ph3P/CH3CN system.27 Excellent 
results were instead obtained using the Yamaguchi protocol, widely used to perform 
macrolactonization reactions.28 The mixed anhydride intermediate, formed by treating the 
succinyl group with 2,4,6-trichlorobenzoyl chloride, effectively reacted with nucleophile 
192 in the presence of dimethylaminopyridine (DMAP) furnishing glycoconjugate 205 in 
excellent 95% yield. As previously described, block deprotection was perfomed by Perlin 
hydrogenolisis26 and desired derivative 199 was isolated in good yield. Noteworthy, also 
in this case the chioice of protecting groups was driven by the stability of the β-lactam ring 
and the mild deprotection step allowed the effective cleavage of both benzyl group and 
benzylidene acetal without affecting the labile azetidinone moiety. 
 
 
                                                 
27 Jang, D. O.; Park, D. J.; Kim, J. Tetrahedron Lett. 1999, 40, 5323. 
28 Inanaga, J. ; Hirata, K. ; Saeki, H. ; Katsuki, T. ; Yamaguchi, M. Bull. Chem. Soc. Jap. 1979, 52, 1989. 
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SCHEME 6.5 Synthesis of Derivative 199. 
 
The synthetic strategy used for the obtainment of glucosamine derivative 200 is very 
similar to that just described for glucose derivative 199. As evident from Scheme 6.6, a 
further manipulation was required to convert N-acetyl glucosamine 206 into derivative 
209 that was then subjected to the succinylation-conjugation-hydrogenation sequence 
already performed on glucose.   
Treatment of commercially available N-acetyl glucosamine 206 with an excess of acetyl 
chloride allowed the straightforward installation of a chlorine atom at the anomeric 
position and the simultaneous acetylation of the other hydroxyl groups. Glucosamine 
derivative 207 was then glycosidated by methanol exerting the silver-promoted activation 
of the anomeric chloride. Conversion of 208 into benzilidene protected 209 was 
accomplished by cleavage of ester acetyls by ammonia treatment and ensuing installation 
of the acetal protection catalytic acidic conditions. Noteworthy, here Yamaguchi 
esterification protocol furnished the desired glycoconjugate 211 in lower yield than that 
registered in the case of glucose derivative. However, derived 211 was subjected to Perlin 
hydrolysis yielding the final target 200. 
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SCHEME 6.6 Synthesis of Derivative 200. 
 
The small library of β-lactam-glycoconjugates thus synthesized (Figure 6.13) was tested by 
Milanese group of prof. Cocuzza for evaluating the activity against more than 100 Gram-
positive and Gram-negative bacteria, including antibiotic resistant strains.  
Unfortunately, the β-lactam 192 itself, despite the positive preliminary tests on leukocyte 
elastase and gelatinase, proved to be ineffective as antibiotic, exhibiting in all cases 
Minumum Inhibition Concentration (MIC) values never lower than 128 mg/L. Results as 
bad as in the case of the sole 192 were registered for glycosides 196α-198α directly linked 
to the β-lactam moiety. On the contrary, promising results were obtained using the second 
class of glycoconjugates, especially in the case of glucosamine derivative 200. This latter 
showed antibiotic activity against several antibiotic resistant bacteria strains. The MIC 
values observed are still higher than those exhibited by the commercially available 
antibiotics used as control (such as Imipenem, Meropenem), but validate the principle that 
drove our investigation. Conjugation with glucosamine and interposition of the succinyl 
spacer drastically modified the antibiotic activity of 4-alkylidene-β-lactam 192. 
Furthermore, the conjugation through the linker seems to positively influence the 
antimicrobial activity in a more specific fashion than the generic improvement of  drug 
solubility and/or stability. This observation is prompted by the different behaviour 
exhibited by the two classes of glycoconjugates. Both classes of molecules are supposed to 
have similar properties in terms of stability and solubility, but the second, especially in the 
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case of glucosamine derivative, is characterized by a far higher similarity to the natural 
substrates of the target protein, thus suggesting a specific involvement of the saccharidic 
portion in the overall antibiotic action. Further studies are required to verify these 
hypotheses, that, for the moment, lie over on a speculative level. 
From an applicative point of view, novel β-lactam structures have been designed and 
synthesized by Cainelli and coworkers with the support of the chemoinformatic means of 
prof. Musumarra group of University of Catania. The molecules exhibiting the best 
antibiotic activities will be subjected to conjugation. A second generation of 
glycoconjugates will be prepared, exploiting the already performed interposition of a 
spacer between the β-lactam and the saccharide portions. Furthermore more bio-mimetic 
structures will be synthesized using glucosamine di- and oligo-saccharides and also 
varying the nature and the length of the spacer. 
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FIGURE 6.13 Glycoconjugates Tested for Antibiotic Activity. 
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Conclusion 
In conclusion, two class of novel β-lactam-glycoconjugates were synthesized. The extreme 
sensitivity of the 4-alkylidene-β-lactam 192 called for the exploitation of very mild 
protocols for performing glycosylation and deprotection reactions. In the first class of 
glycoconjugates the generation of a direct linkage between the β-lactam and the 
saccharidic moieties was performed. The glycosylation of the sensitive β-lactam acceptor 
192 exploited the mild activation of N-phenyl trifluoroacetimidate donors with 
ytterbium(III) triflate. Satisfying yields were obtained in the synthesis of both α- and β-
linked glycosides, the best results being registered in the former case. In the second 
approach a succinyl spacer was interposed between the two cyclic molecules. The 
conjugation in this case was performed by an esterification reaction, effectively 
accomplished exerting the Yamaguki protocol. The thus obtained glycoconjugates 
underwent hydrogenolytic deprotection of the saccharidic portions without the β-lactam 
moiety being affected. Evaluation of these unprecedented derivatives for antibiotic activity 
against resistant bacteria furnished promising results for the second type of 
glycoconjugates. Further studies are in progress. New β-lactam structures have been 
screened and will be conjugated to suitable saccharidic structures generating a second 
generation of antibiotic β-lactam-glycoconjugates.  
 
Experimental Section 
 
General Methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were 
recorded on Varian spectrometers at 200 or 300 MHz and 50 or 75 MHz, respectively; or on 
a Bruker Avance 500 spectrometer at 500 MHz. The chemical shifts are given in parts per 
million (ppm) on the delta (δ) scale. Analytical thin layer chromatography (TLC) was 
performed on E. Merck pre-coated (25 nm) silica gel 60F-254 plates. Column 
chromatography was preformed using Carlo Erba 0.06-0.20 silica gel. Mass spectra were 
recorded in a reflection positive mode on a MALDI-TOF spectrometer. Acid washed 
molecular sieves and Ytterbium(III) triflate were dried by overnight heating at 200 °C 
under vacuum before their use in glycosidations. Anhydrous solvents stored over 
molecular sieves (purchased from Aldrich) were used for performing the reactions.  
 
 
Starting materials: Compounds 190, 191, and 192 were prepared accordingly to reference 
16. N-Phenyl trifluoroacetimidates 151, 162, and 113 were prepared from the 
corresponding commercially available hemiacetals as reported in references 20 and 22. 
 
 
192. 1H NMR (CDCl3 300 MHz) δ 8.37 (1H, bs, N-H, Hf), 5.27 
(1H, s, He), 4.20 (3H, m, Hb e 2xHg), 3.74 (1H, d, Jbd = 5.7 Hz, 
Hd), 2.13 (1H, bs, Hc), 1.39 (3H, d, Jab = 6.6 Hz, Ha), 1.29 (3H, t, 
Jgh = 7.2 Hz, Hh).13C NMR (CDCl3, 50 MHz) significative 
signals at δ 166.9 and 166.2 (NHC=O, C=C-C=O), 152.2 (C=C-
C=O), 90.8 (C=C-C=O), 64.8, 64.0, 60.2 (Cb, Cd, Cg), 21.4 and 14.3 (Ca,  Ch). 
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General procedure for glycosylations: A mixture of 192 (0.10 mmol) and the glycosyl 
donor (0.14 mmol) was dissolved under argon in anhydrous 1,2-dimethoxyethane (0.75 
mL) and dioxane (1 mL) in the presence of freshly activated 4Å acid washed molecular 
sieves (AW 300 MS). A solution of Yb(OTf)3 (6.2 mg, 0.01 mmol ) in DME (0.25 mL) was 
then added at 0 °C. The mixture was allowed to gradually warm to room temperature. 
After consumption of the donor (TLC analysis, generally ca 5 hours) a few drops of 
pyridine were added and the mixture was filtered on a short plug of silica gel eluted with 
dichloromethane/methanol 9:1. The residue was then purified on a short silica gel column 
eluted with toluene/ethyl acetate mixtures.  
 
193α. (40 mg, yield 56%) [α]D +40.3 (c 1, CH2Cl2). 1H 
NMR (200 MHz, CDCl3): δ = 8.39 (bs, 1H, NH), 7.40–
7.05 (aromatic protons), 5.55 (bs, 1H, –C=CH–CO2Et), 
4.96 (d, J1,2 = 3.6 Hz, 1H, 1-H Glc), 5.00–4.42 (4 × AB, 
8H, 4 ×  CH2 benzyl protons), 4.13 (q, J = 7.0 Hz, 2H, –
OCH2CH3), 4.00 (m, 1H, CH3–CH(OGlc)CH–), 3.96 (t, 
J2,3 = J3,4 = 9.8 Hz, 1H, 3-H Glc), 3.88 (m, 1H, 5-H Glc), 
3.75 (bd, J = 7.0 Hz, 1H, CH3CH(OGlc)CH–), 3.75–3.55 (overlapped signals, 3H, 4-H and 
CH2-6 Glc), 3.51 (dd, 1H,  2-H Glc), 1.42 (d, J = 6.4 Hz, 3H, CH3CH(OGlc)CH–), 1.21 (t, J = 
7.2 Hz, 3H, –OCH2CH3).  13C NMR (50 MHz, CDCl3): δ = 167.3, 165.6, 152.3, 138.8, 138.3, 
138.2, 138.0, 128.4–127.7, 98.7 (C-1 Glc), 91.4, 81.7, 79.5, 75.5, 75.1, 73.8, 73.5, 73.1, 70.9, 68.4, 
62.6, 60.0, 17.0, 14.3. MALDI-TOF MS: for C43H47NO9 (721.3) m/z = 744.4 [M+Na]+. 
 
 
193β. (37 mg, yield 51%) 1H NMR (200 MHz, 
CDCl3): δ = 8.45 (bs, 1H, NH), 7.40–7.05 (aromatic 
protons), 5.31 (bs, 1H, –C=CH–CO2Et), 4.95–4.52 
(4 × AB, 8H, 4× CH2 benzyl protons), 4.47 (d, J1,2  = 
7.6 Hz, 1H, 1-H Glc), 4.31 (quintuplet, J = 6.2 Hz, 
1H, CH3CH(OGlc)CH–), 4.20–4.05 (m, 2H, –
OCH2CH3), 3.87 (bd, J = 5.8 Hz, 1H, CH3CH(OGlc)CH–), 3.80–3.53 (overlapped signals, 4H, 
3-H, 4-H and CH2-6 Glc), 3.50–3.38 (overlapped signals, 2H, 2-H and 5-H Glc), 1.37 (d, J = 
6.4 Hz, 3H, CH3CH(OGlc)CH–), 1.22 (t, J = 7.2 Hz, 3H, –OCH2CH3). 13C NMR (50 MHz, 
CDCl3): δ = 167.2, 165.5, 152.5, 138.6, 138.4, 138.3, 138.1, 128.4–127.7, 100.6 (C-1 Glc), 90.7, 
84.7, 81.9, 75.3, 75.1, 75.0, 73.5, 70.1, 69.0, 62.8, 60.1, 17.5, 14.2. MALDI-TOF MS: for 
C43H47NO9 (721.3) m/z = 744.3 [M+Na]+. 
 
194α. (58 mg, yield 81%) [α]D +54.9 (c 1, CH2Cl2). 1H 
NMR (200 MHz, CDCl3): δ = 8.37 (bs, 1H, NH), 7.40–7.20 
(aromatic protons), 5.57 (bs, 1H, –C=CH–CO2Et), 4.98 (d, 
J1,2 = 3.6 Hz, 1H, 1-H Glc), 4.95–4.36 (4 × AB, 8H, 4 ×  CH2 
benzyl protons), 4.14 (q, J = 7.2 Hz, 2H, –OCH2CH3), 
4.04–3.95 (overlapped signals, 4H, 2-H, 4-H, 5-H Gal, and 
CH3CH(OGal)CH–), 3.75 (bd, J = 8.0 Hz, 1H, 
CH3CH(OGal)CH–), 3.56–3.42 (m, 2H, CH2-6 Gal), 1.41 
(d, J = 6.2 Hz, 3H, CH3CH(OGal)CH–), 1.23 (t, J = 7.2 Hz, 3H, –OCH2CH3). 13C NMR (50 
MHz, CDCl3): δ = 167.3, 165.6, 152.5, 138.6, 138.5, 137.9, 128.4–127.4, 99.2 (C-1 Gal), 91.3, 
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79.0, 75.6, 74.9, 74.7, 73.5, 73.4, 72.7, 69.9, 69.0, 62.7, 60.0, 20.2, 14.3. MALDI-TOF MS: for 
C43H47NO9 (721.3) m/z = 744.4 [M+Na]+. 
 
194β. (23 mg, yield 32%) 1H NMR (CDCl3, 400 MHz): 
δ = 8.41 (bs, 1H, NH), 7.40–7.20 (aromatic protons), 
5.31 (bs, 1H, –C=CH–CO2Et), 4.97–4.36 (4 × AB, 8H, 
4 ×  CH2 benzyl protons), 4.42 (d, J1,2  = 7.8 Hz, 1H, 1-
H Gal), 4.25 (quintuplet, J  = 6.4 Hz, 1H, 
CH3CH(OGal)CH–), 4.15–4.10 (m, 2H, –OCH2CH3), 
3.87–3.84 (overlapped signals, 2H, 4-H Gal and CH3CH(OGal)CH–), 3.78 (dd, J2,3  = 9.6 Hz, 
1H, 2-H Gal), 3.60–3.48 (overlapped signals, 4H, 3-H, 5-H, and CH2-6 Gal), 1.34 (d, J = 7.2 
Hz, 3H, CH3CH(OGal)CH–), 1.23 (t, J  = 7.2 Hz, 3H, –OCH2CH3). 13C NMR (50 MHz, 
CDCl3): δ = 167.2, 165.5, 152.4, 138.7, 138.6, 138.5, 138.0, 128.4–127.5, 101.2 (C-1 Gal), 90.8, 
82.2, 79.3, 77.1, 75.2, 74.5, 73.7, 73.5, 73.1, 70.5, 68.9, 62.8, 60.0, 17.4, 14.3. MALDI-TOF MS: 
for C43H47NO9 (721.3) m/z = 744.3 [M+Na]+. 
 
195α. (48 mg, yield 78%) [α]D –94.6 (c 1, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ = 8.43 (bs, 1H, NH), 7.40–
7.20 (aromatic protons), 5.21 (bs, 1H, –C=CH–CO2Et), 
4.95 (d, J1,2 = 3.8 Hz, 1H, 1-H Fuc), 5.00–4.59 (3 × AB, 
6H, 3 ×  CH2 benzyl protons), 4.18 (q, J = 7.2 Hz, 2H, –
OCH2CH3), 4.15–4.05 (overlapped signals, 2H, 2-H 
Fuc and CH3CH(OFuc)CH–), 3.93 (bq, J5,6 = 6.6 Hz, 
1H, 5-H Fuc), 3.90–3.85 (overlapped signals, 2H, 3-H Fuc and CH3CH(OFuc)CH–), 3.66 
(bd, J3,4 = 2.4 Hz, 1H, 4-H Fuc), 1.32 (d, J  = 6.2 Hz, 3H, CH3CH(OFuc)CH–), 1.29 (t, 3H, –
OCH2CH3), 1.10 (d, 3H, CH3-6 Fuc). 13C NMR (50 MHz, CDCl3): δ = 167.0, 165.8, 152.6, 
138.8, 138.6, 128.5–127.5, 94.8 (C-1 Fuc), 90.7, 78.9, 76.1, 74.8, 73.1, 72.9, 68.5, 67.0, 62.7, 60.1, 
16.8, 16.6, 14.3. MALDI-TOF MS: for C36H41NO8 (615.3) m/z = 638.3 [M+Na]+. 
 
General debenzylation procedure 
35 mg of Pd/C 10% were suspended in  methanol/formic acid 9:1 (500 µL) under argon 
atmosphere, the glycoconjugated was then admixed as solution in the same solvent 
mixture (1 mL) under argon atmosphere. The reaction mixture was sonicated keeping the 
temperature  ≤ 15°C. After reaction completion (TLC analysis), the mixture was filtered on 
Celite and the resulting mixture was eluted on mixed-bed ionic exchange resin DOWEX 
MR-3 or purified by preparative thin layer chromatography. 
 
196α. (13 mg, yield 92%) [α]D +49.6 (c 1, CH3OH).1H 
NMR (200 MHz, D2O): δ = 5.40 (bs, 1H, –C=CH–
CO2Et), 5.04 (d, J1,2 = 3.8 Hz, 1H, 1-H Glc), 4.26 (m, 1H, 
CH3CH(OGlc)CH–), 4.21 (q, J = 7.2 Hz, 2H, –
OCH2CH3), 4.07 (d, J = 5.4 Hz, 1H, CH3CH(OGlc)CH–), 
3.87–3.62 (overlapped signals, 4H, 3-H, 5-H and CH2-6 
Glc), 3.49 (dd, J2,3 = 10.0 Hz, 1H, 2-H Glc), 3.37 (t, J3,4 = 
J4,5 = 9.2 Hz, 1H, 4-H Glc), 1.38 (d, J = 6.4 Hz, 3H, 
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CH3CH(OGlc)CH–), 1.27 (t, 3H, –OCH2CH3). 13C NMR (50 MHz, D2O): δ = 167.7, 167.7, 
150.4, 96.5 (C-1 Glc), 89.1, 70.6, 69.9, 69.6, 69.2, 67.4, 59.2, 59.0, 58.3, 16.2, 11.3. MALDI-TOF 
MS: for C15H23NO9 (361.2) m/z = 384.3 [M+Na]+. 
 
197α. (15 mg, yield 94%) [α]D +60.7 (c 1, CH3OH). 1H 
NMR (200 MHz, D2O): δ = 5.38 (bs, 1H, –C=CH–CO2Et), 
5.03 (d, J1,2 = 3.2 Hz, 1H, 1-H Glc), 4.23 (m, 1H, 
CH3CH(OGal)CH–), 4.17 (q, J = 7.0 Hz, 2H, –OCH2CH3), 
4.12–3.90 (overlapped signals, 4H, 3-H, 4-H, 5-H Gal and 
CH3CH(OGal)CH–), 3.80–3.65 (overlapped signals, 3H, 2-
H, and CH2-6 Gal), 1.36 (d, J = 6.4 Hz, 3H, 
CH3CH(OGlc)CH–), 1.24 (t, J = 7.2 Hz, 3H, –OCH2CH3). 
13C NMR (50 MHz, D2O) δ 168.0, 166.3, 150.5, 96.9 (C-1 Gal), 89.2, 69.5, 69.0, 67.1, 66.2, 59.4, 
59.1, 16.2, 13.4. MALDI-TOF MS: for C15H23NO9 (361.2) m/z = 384.2 [M+Na]+. 
 
198α. (15 mg, yield 91%) 1H NMR (500 MHz, D2O): δ 
= 5.38 (s, 1H, –C=CH–CO2Et), 5.02 (d, J1,2 = 3.5 Hz, 
1H, 1-H Fuc), 4.25 (q, J = 7.0 Hz, 2H, –OCH2CH3), 
4.12 (d, J  = 7.0 Hz, 1H, CH3CH(OFuc)CH–), 4.05 (bd, 
J5,6 = 6.5 Hz, 1H, 5-H Fuc), 3.85–3.75 (overlapped 
signals, 3H, 2-H, 3-H and 4-H Fuc), 1.35 (d, J = 6.0 Hz, 
3H, CH3CH(OFuc)CH–), 1.31 (t, 3H, –OCH2CH3), 
1.21 (3H, CH3-6 Fuc). 13C NMR (50 MHz, D2O): δ = 
168.4, 166.2, 150.4, 94.1 (C-1 Fuc), 90.7, 89.2, 69.7, 68.7, 67.4, 66.8, 65.6, 65.0, 59.7, 59.1, 14.0, 
13.1, 11.4. MALDI-TOF MS: for C15H23NO8 (345.1) m/z = 368.2 [M+Na]+. 
 
204. Diol 203 (846 mg, 3 mmol) and dibutyltinoxide (846 mg, 3 
mmol) were suspended in a benzene/methanol 10:1 mixture 
(22 mL). The system was refluxed and after three hours the 
resulting mixture was concentrated and coevaporated three 
times with dry toluene. To the crude were added sequentially dry toluene (15 mL), benzyl 
bromide (2 mL) and tetrabutylammonium iodide (1.1g, 3 mmol). The reaction mixture was 
stirred at 90 °C overnight and then purified on silica gel by column chromatography 
(petrol ether/ethyl acetate 85:15). The purification yielded 204 (614 mg, 55%) together with 
a smaller amount of the other monobenzylated regioisomer (412 mg, 37%).1H NMR 
(CDCl3 200 MHz) significative signals at δ 5.10 (1H, s, CH benzylidene), 4.75 (2H, AB, Jgem 
=12.4 Hz, CH2 benzyl), 4.62 (1H, d, J1,2 =3.8 Hz, H-1), 4.26 (1H, dd, J5,6eq =3.2 Hz, J6ax,6eq 
=10.2 Hz, H-6 eq.), 4.16 (1H, t, J2,3 = J3,4=10.2 Hz, H-3), 3.81 (1H, td, J4,5= J5,6ax =10.2 Hz, H-5), 
3.70 (1H, t, H-4), 3.48 (2H, m, H-2 e H-6 ax.), 3.38 (3H, s, OCH3). 
 
209. Derivative 207 (774 mg, 2.1 mmol) was dissolved into a 
dichloromethane/methanol 2:1 mixture (7.7 mL). To this 
solution freshly activate 4Å molecular sieves and Ag2CO3 
(583 mg, 2.1 mmol) were admixed at room temperature 
under argon atmosphere. The reaction mixture was stirred overnight at room temperature 
and then filtered on a pad of Celite. The crude was then treated with a 
methanol/ammonia 9:1 mixture (8mL). After 6 hours stirring at room temperature the 
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mixture was concentrated under reduced pressure and the residue was coevaporated 
three times with dry toluene. 4Å Molecular sieves, camphorsulfonic acid (43 mg, 0.19 
mmol) and dry acetonitrile were added under argon atmosphere. After 5 minutes stirring, 
dimethoxytoluene (411 µL, 2.7 mmoli) was admixed and the mixture was stirred at room 
temperature for 12 hours. The resulting mixture was diluted with dichloromethane and 
washed with NaHCO3 aq. The organic phase was purified by column chromatography 
(dichloromethane/methanol from 98:2 to 95:5) that yielded the desired 209 (170 mg, 25% 
yield over three steps). 1H NMR (200 MHz, CDCl3) significative signals at  δ  5.95 (1H, bd, 
J2,NH =8.2 Hz, NH), 5.56 (1H, s, H benzylidene), 4.64 (1H d, J1,2 =8.0 Hz, H-1), 4.36 (1H, dd, 
J6ax,6eq =10.4 Hz,  J5,6eq =4.8 Hz, H-6 eq.), 4.16 (1H, t, J3,4 =9.6 Hz, H-3), 3.79 (1H, t, H-6 ax.), 
3.60-3.47 (2H, m, H-2 e H-5), 3.53 (3H, s, -OCH3), 2.06 (3H, s, CH3CONH).   
  
General succinylation procedure 
The saccaridi derivative (0.34 mmol) and succinic anhydride (52 mg, 0.52 mmol) were 
dissolved in a dichloromethane/pyridine 1:1 mixture (2mL). To the mixture DMAP (67 
mg, 0.55 mmol) was added under argon atmosphere. After stirring overnight at room 
temperature the mixture was condentrated under reduced pressure and purified on siliga 
gel by column chromatography (dichloromethane/methanol mixtures). 
 
201. 1H NMR (200 MHz, CDCl3) significative signals at  δ  7.23-
7.10 (H aromatics), 5.57 (1H, t, J3,4 =9.8 Hz, H-3), 5.45 (1H, s, H 
benzylidene), 4.64 (2H, AB, Jgem= 12.4 Hz, CH2 benzyl), 4.65 
(1H, d, J1,2 = 3.2 Hz, H-1), 4.26 (1H, dd, J6ax,6eq = 9.6 Hz, J5,6eq 
=4.4 Hz, H-6 eq.), 3.88 (1H, td, J4,5=J5,6ax =9.6 Hz, H-5), 3.69 (1H, 
t, H-6 ax.), 3.59 (1H, dd, H-2), 3.54 (1H, t, H-4), 3.45 (3H, s, 
OCH3), 2.62 (4H, s, 2xCH2 succinate). 13C NMR (CDCl3, 50 
MHz) significative signals at δ 175.9, 171.1 (CO succinate), 138.4, 137.8 (C aromatics),  
128.9, 128.5, 128.2, 128.0, 127.9, 126.1 (CH aromatics), 101.3 (CH del benzylidene), 98.8 (C 
anomeric), 55.4 (CH3O), 29.0, 28.9 (CH2 succinate). Other signals at δ 79.4, 77.2,  73.1, 70.9, 
68.9, 62.3. 
 
210. 1H NMR (200 MHz, CDCl3) significative signals at δ  
7.30-7.50 (5H, m, H aromatics), 5.57 (1H, s, H 
benzylidene), 5.27 (1H, t, J2,3= 9.8 Hz, H-3), 4.54 (1H, d, 
J1,2= 8.4 Hz, H-1), 4.31 (1H, dd, J5,6eq =5.2 Hz,  J6ax,6eq =10.4 
Hz, H-6 eq.), 3.93 (1H, dd, H-2), 3.83 (1H, t, J5,6ax = 10.4 Hz, 
H-6 ax.), 3.75 (1H, t, J4,5 =9.4 Hz, H-4), 3.52 (1H, td, H-5), 
3.46 (3H, s, OCH3), 2.58 (4H, s, 2 x CH2 succinate), 1.92 
(3H, s, CH3CONH). 
 
General Yamaguki esterification  
Derivative 201 (14 mg, 0.03 mmol) was coevaporated three times with dry toluene and 
then dissolved in 600 µL of dry THF under argon atmosphere. To this solution 4Å 
molecular sives were added followed by triethylamine (10 µL,    0.08 mmol) and 2,4,6-
trichlorobenzoyl chloride (5 µL, 0.03 mmol). After two hours stirring, derivative 192 was 
added as THF solution (500 µL) and followed by DMAP (9 mg, 0.075 mmol). After reaction 
completion (overnight at room temperature) the mixture was purified on silica gel by 
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preparative thin layer chromatography (toluene/ethyl acetate 7:3) furnishing 16 mg of 205 
(95% yield). 
 
201. 1H NMR (CDCl3 200 MHz) ) δ 8.47 (1H, bs, N-H), 7.34-
7.26 (aromatics), 5.56 (1H, t, J2,3= J3,4= 9.8 Hz, H-3), 5.45 (1H, s, 
H benzylidene), 5.23-5.10 (2H, m, Hb e Hf ), 4.65 (2H, AB, Jgem 
= 12.4 Hz, CH2 benzyl), 4.67 (1H, d, J1,2 = 3.8  Hz,  H-1), 4.26 
(1H, dd, J5,6eq =4.4 Hz, J6ax,6eq =10.0 Hz, H-6 eq.), 4.17 (2H, q, Jhi 
=7.2 Hz, Hh), 3.94-3.81 (1H, m, H-5), 3.80 (1H, d, Jbc= 6.8 Hz, 
Hc), 3.70 (1H, t, J5,6ax =10.0 Hz,  H-6 ax.), 3.55 (1H, t, J4,5=9.8 
Hz, H-4), 3.48 (3H, s, -OCH3), 2.60 (4H, s, 2 x CH2 succinate), 
1.33 (3H, d, Jab =6.2 Hz, Ha), 1.29 (3H, t, Hi). 13C NMR (CDCl3, 
50 MHz) significative signals at δ 171 e 170.8 (CO succinate), 
166.9 and 164.5 (NHC=O, C=C-C=O), 151.2 (C=C-C=O), 137.9 
and 137.0 (C aromatics), 129.0-126.2 (CH aromatics), 101.5 (C acetal benzylidene), 98.8 (C1 
anomeric), 91.0 (C=C-C=O), 79.4 (C2), 73.1, 71, 69 67.1 (carbinolic carbons), 62.3, 61.2, 60.3 
(CH2-6, -OCH2CH3, CH2 benzyl), 55.4  (OCH3), 29.1 and 14.3 ( 2 x CH2 succinate), 17.8 and 
14.3 (CH3 a,  -OCH2CH3). 
 
211. 1H NMR (CDCl3 200 MHz) δ 8.55 (1H, s, NH), 7.50-7.12 (aromatics), 5.91 (1H, d, J2,NH 
=8.8 Hz, NH-Ac), 5.50 (1H, s, H benzylidene), 5.36 (1H, t, 
J2,3= J3,4 = 9.4 Hz, H-3), 5.23-5.13 (2H, m, Hb and Hf ), 4.63 (1H, 
d, J1,2 = 8.4  Hz,  H-1), 4.36 (1H, dd, J5,6eq =4.6 Hz, J6ax,6eq = 10.2 
Hz,  H-6 eq.), 4.19 (2H, q, Jhi = 7.0 Hz,  Hi), 3.98-3.81 (3H, m, 
H-2, Hc, H-6 ax.), 3.70 (1H, t, J4,5 =9.4 Hz, H-4), 3.52 (1H, td, 
H-5), 3.50 (3H, s, -OCH3), 2.61 (4H, bs, 2 x CH2 succinate), 
1.97 (3H, s, NHCOCH3), 1.35 (3H, d, Jab =6.4 Hz, Ha), 1.30 
(3H, t, Hi). 
 
 
 
 
199. 1H NMR (CDCl3, 200 MHz) δ 5.32-5.19 (2H, m, Hb e Hf), 5.13 (1H, bt,  J3,4 =10.2 Hz, H-
3), 4.79 (1H, d, J1,2 = 3.8 Hz, H-1), 4.19 (2H, q, Jh,i = 7.2 Hz, Hh), 
3.89-3.86 (3H, m, Hc and 2xH-6), 3.67-3.57 (2H, m, H-2 and H-4), 
3.49 (3H, s, -OCH3), 2.69 (4H, s, 2xCH2 succinate), 1.40 (3H, d, Jab 
= 6.4 Hz, Ha), 1.30 (3H, t, Hi). 13C NMR (CDCl3, 50 MHz) 
significative signals at δ 176.5 e 173.3 (CO succinate), 171.5 and 
167.5 (NHC=O, C=C-C=O), 154.5 (C=C-C=O), 99.4 (C1 
anomeric), 91.2 (C=C-C=O), 71.3, 70.7, 69.3, 67.3 (carbinolic 
carbons), 55.5 (OCH3), 29.7 e 29.4 (CH2 succinate). 
 
 
 
 
 
 
O
O
OCH3
BnO
O
OPh
O
O
O
NH O
O
O
a b
c
d
e
f
g h
i
O
O
OCH3
HO
HO
HO
O
O
O
NH O
O
O
a b
c
d
e
f
g h
i
O
O OCH3
AcHN
O
OPh
O
O
O
NH O
O
O
a b
c
d
e
f
g h
i
Chapter 6
  141
200. 1H NMR (CDCl3 200 MHz) δ 5.93 (1H, d, JNH,2 = 8.6 Hz, NHAc), 5.33-5.19 (2H, m, Hb 
and Hf ), 5.10 (1H, t, J2,3 = J3,4 = 9.8 Hz, H-3), 4.51 (1H, d, J1,2= 8.2 
Hz, H1), 4.19 (2H, q,  Jh,i =7.0  Hz, Hh), 3.95-3.87 (3H, m, 2xH-6, 
H-2), 3.77 (1H, t, J4,5 =9.6 Hz, H-4), 3.49-3.42 (4H, m, -OCH3 and 
H-5), 2.64 (4H, bs, 2xCH2  succinate), 1.95 (3H, bs, NHAc), 1.39 
(3H, d, Ja,b= 6.4  Hz, Ha), 1.30 (3H, t, Hi). 13C NMR (CDCl3, 50 
MHz) significative signals at δ 172.9 and 171.6 (2C, succinate), 
170.7 and 166.8 (NHC=O, C=C-C=O), 150.9 (C=C-C=O), 102.1 
(C1 anomeric), 91.4 (C=C-C=O), 75.4, 69.2, 67.1 (carbinolic 
carbons C-3, C-4 and C-5), 56.9 (carbinolic C-2), 54.0 (OCH3), 
29.4 and 29.4 (CH2 succinate), 23.4 (CH3 NHAc), 17.6 and 14.3 
(CH3 a,  CH3 i). Other signals at δ 62.1, 61.2, 60.4.  
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Chapter 7 
 
One-Pot Trisaccharides Synthesis 
 
 
 
 
 
 
 
 
Introduction 
 
One of the most important recent advances in oligosaccharide synthesis is represented by the 
development of synthetic procedures enabling the construction of multiple glycosidic bonds 
in a one-pot fashion. These advances were strongly elicited by the recognition of the dramatic 
influence exerted by protecting groups on the reactivity of the glycosyl donors, an 
observation that has been elaborated  in the “armed” and “disarmed” concept.1 This tunable 
reactivity may be exploited in the sequential connection of several building-blocks all bearing 
an identical leaving group.2,3 Recently this approach culminated in the development of a 
computer-assisted planning of oligosaccharide synthesis based on the preliminary 
assessment of the relative reactivity for a great number of protected or partially protected 
thioglycoside donors.2  
In an alternative conceptual approach, the one-pot sequential multiglycosidation process can 
also take advantage of an available set of glycosyl donors activated under orthogonal 
conditions.4  
                                                 
1 Mootoo, D. R.; Konradsson, P.; Udodong, U.; Fraser-Reid, B. J. Am. Chem. Soc. 1988, 110, 5583. 
2 a) Zhang, Z.; Ollman, I. R.; Ye, X.-S.; Wischnat, R.; Baasov, T.; Wong, C.-H. J. Am. Chem. Soc. 1999, 121, 734; b) 
Ye,  X.-S.; Wong, C.-H. J. Org. Chem. 2000, 65, 2410; c) G. H Burkhart, F.; Zhang, Z.; Wacowich-Sgarbi, S.; Wong, 
C.-H. Angew. Chem. Int. Ed. 2001, 40, 1274; d) Mong, T. K.- K.; Wong, C.-H. Angew. Chem. Int. Ed. 2002, 41, 4087; 
e) Mong, T. K.- K.; Lee, H.-K.; Durón, S. G.; Wong, C.-H. Procl. Natl. Acad. Sci. U. S. A. 2003, 100, 797; f)  Mong, T. 
K.- K.; Lee, H.-K.; Durón, S. G.; Wong, C.-H. J. Org. Chem. 2003, 68, 2135; g) Durón, S. G.; Polat, T.; Wong, C.-H. 
Org. Lett. 2004, 6, 839; h) Lee, H.-K.; Scanlan, C. N.; Huang, C.-Y.; Chang, A. Y.; Calarese, D. A.; Dwek, R. A.; 
Rudd, P. M.; Burton, D. R.; Wilson, I. A.; Wong, C.-H. Angew. Chem. Int. Ed. 2004, 43, 1000. 
3 a)  Ley, S. V.; Priepke, H. W. M. Angew. Chem. Int. Ed. 1994, 33, 2292; b) Douglas, N. L.; Ley, S. V.; Lücking, U.; 
Warriner, S. L.  J. Chem. Soc., Perkin Trans. 1 1998, 51; c) Fridman, M.; Solomon, D.; Yogev, S.; Baasov, T. Org. 
Lett. 2002, 4, 281; d) Wang, Y.; Huang, X.; Zhang, L.-H., Ye, X.-S. Org. Lett. 2004, 6, 4415. 
4 a) Grice, P.; Ley, S. V.; Pietuszka, J.; Priepke, H. W. M.; Walther, E. P. E. Synlett 1995, 781; b) Cheung, M.-K.; 
Douglas, N.; Hinzen, B.; Ley, S. V.; Pannecouncke,  X. Synlett 1997, 257; c) Grice, P.; Ley, S. V.; Pietuszka, J.; 
Osborn, H. M. I.; Priepke, H. W. M.; Warriner, S. L. Chem. Eur. J. 1997, 3, 431; d) Green, L.; Hinzen, B.; Ince, S. J.; 
Langer, P.;  Ley, S. V.; Warriner, S. L. Synlett 1998, 440; e) Langer, P.; Ince, S. J.; Ley, S. V. J. Chem. Soc., Perkin 
Trans. 1 1998, 3913; f) Tanaka, H.; Adachi, M.; Tsukamoto, H.; Ikeda, T.; Yamada, H.; Takahashi, T. Org. Lett. 
2002, 4, 4213; g) Hashihayata, H.; Ikegai, K.; Takeuchi, K.; Jona, H.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 2003, 76, 
1829; h) Mukaiyama, T.; Kobashi, Y. Chem. Lett. 2004, 33, 10; i) Tanaka, H.; Adachi, M.; Takahashi, T. Tetrahedron 
Lett. 2004, 45, 1433. 
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A further option is represented by preactivating a thioglycoside building block (donor) with 
a stoichiometric promoter and subsequently adding a partially protected thioglycoside which 
is intended to act at this stage as the acceptor. The sequence is thus iterated until the desired 
elongation is achieved (Scheme 7.1).5  
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SCHEME 7.1 Oligosaccharide One-pot Synthesis via Thioglycoside Donors Preactivation. 
 
This approach allows to circumvent the normal reactivity of the building blocks, in fact 
following this strategy a disarmed thioglycoside can be selectively activated in the coupling 
with an armed thioglycoside.5 A less common approach contemplates the use of residues 
equipped with analogous but differentiated leaving groups (for example thioaryl and 
thioethyl glycosides) whose selective activation can be tuned by the proper choice of  
experimental conditions.3c,6 
The one-pot multiglycosidation procedures are more commonly accomplished with thio-
glycosides.7 This is not surprising since partially non protected thioglycosides, the necessary 
building blocks for this purpose, can be routinely prepared. Glycosyl fluorides, bromides,8 
selenides, sulfoxides9 and underivatized hemiacetals10 have also been used, especially in 
synthetic schemes relying on orthogonal activation.11 These mentioned methodologies are all 
based on activation systems entailing the use of stoichiometric amounts of promoter or 
coreagent (NIS, triflic anhydride, phenyl sulfoxide, silver triflate, Cp2HfCl2, BF3.OEt2, etc). In 
contrast, use of glycosyl trichloroacetimidates12 in multiglycosidations approaches is 
seriously restricted by the difficult preparation of partially unprotected saccharidic 
derivatives equipped with the trichloroacetimidate leaving group at the anomeric position. 
Indeed, the installation of the trichloroacetimidate leaving group is commonly carried out by 
                                                 
5 Huang, X.; Huang, H.; Wang, H.; Ye, X.-S. Angew. Chem. Int. Ed. 2004, 43, 5221. 
6 Lahmann, M.; Oscarson, S. Org. Lett. 2001, 3, 4201. 
7 For an excellent recent review: Codée, J. D. C.; Litjens, R. E. J. N.; van den Bos, L. J.; Overkleeft, H. S.; van der 
Marel, G. A. Chem. Soc. Rev.  2005, 34, 769. 
8 Yamada, H.; Kato, T.; Takahashi, T. Tetrahedron Lett. 1999, 40, 4581. 
9 Raghavan, S.; Kahne, D. J. Am. Chem. Soc. 1993, 115, 1580. 
10 Codée, J. D. C.; van den Bos, L. J.; Litjens, R. E. J. N.; Overkleeft, H. S.; van Boom, J. H.; van der Marel, G. A. 
Org. Lett. 2003, 5, 1947. 
11 See also Chapter 1. 
12 Schmidt, R. R.; Kinzy, W. Adv. Carbohydr. Chem. Biochem. 1994, 50, 21. 
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reacting the sugar hemiacetal with trichloroacetonitrile in the presence of catalytic amounts 
of base. Under similar conditions non anomeric hydroxyl groups of sugars are also known to 
react, so that the trichloroacetimidate functionality has also beeen exploited for protection of 
non anomeric alcohols (Scheme 7.2).13  
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SCHEME 7.2 Trichloroacetimidate as non-Anomeric Hydroxyl Protecting Group. 
 
As a matter of fact, use of glycosyl trichloroacetimidates in multiglycosidation approaches 
has been limited to the attachment of fragments at the non reducing terminus of the targets 
and in combination with donors orthogonally activated under stoichiometric conditions, 
such as thio- and pentenyl-glycosides.14 
Recently, Yu and coworkers have introduced glycosyl (N-phenyl)trifluoracetimidates as a 
class of analogues of trichloroacetimidate donors.15 On the other hand, in the course of our 
investigation aimed at establishing the development of glycosidation procedures relying on 
moisture stable promoters such as Ytterbium(III) triflate,16 we have realized that the 
activation of these novel donors is entailing relatively more forced conditions than their 
trichloroacetimidate congeners. For example, the coupling in nitrile solvents between the 
trichloroacetimidate donor 152 (1.4 eq) and acceptor 21 (1 eq) proceeds at -30 °C and requires 
a very low amount of catalyst (3%) whereas higher temperatures and amounts of promoter 
(10%) are needed with the fluorinated donor 151 (Scheme 7.3).  
                                                 
13 a) Qiu, D.; Koganty, R. R. Tetrahedron Lett. 1997, 38, 961; b) Yu, B.; Yu, H.; Hui, Y. ; Han, X. Synlett 1999, 753; c) 
Dowlut, M.; Hall, D. G.; Hindsgaul, O. J. Org. Chem. 2005, 70, 9809. 
14 a) Yamada, H.; Harada, T.; Takahashi, T. J. Am. Chem. Soc. 1994, 116, 7919; b) Jayaprakash, K. N.; Fraser-Reid, 
B. Org. Lett. 2004, 6, 4211. 
15 Yu, B.; Tao, H. Tetrahedron Lett. 2001, 42, 2405. 
16 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Tetrahedron Lett. 2002, 43, 5573. 
One-Pot Trisaccharides Synthesis
  
 146
BnO O
BnO
BnO
OBn
O CF3
NPh
O
O
O
O
OHO
O
O
O
O
OO
BnO O
BnO
BnO
OBn
Yb(OTf)3(0.03 eq)
CH3CN/t-BuCN
-30°C,1h
BnO O
BnO
BnO
OBn
O
CCl3
NH
86% β/α 9.8
O
O
O
O
OHO
Yb(OTf)3(0.1 eq)
CH3CN/t-BuCN
from -25°C to rt, 5h
95% β/α >10
152 21
151 21
153
 
 
SCHEME 7.3 Comparative Glycosylation of Acceptor 21 with Glycosyl Trichloro- and N-Phenyl Trifluoro-
acetimidate Donors 152 and 151. 
 
In both these experiments the lanthanide salt was added as a solution in pivalonitrile, the 
beneficial effect of such a cosolvent on both rate and β-selectivity having been recently 
disclosed.17 This different behaviour suggested the feasible development of a one-pot multi-
glycosidation procedure based on: i) selective activation of a trichloroacetimidate donor in 
the presence of a (N-phenyl)trifluoroacetimidate derivative bearing a free hydroxyl 
functionality (acting as the acceptor in the first glycosidation step) and ii) the subsequent 
addition of a further new acceptor and the adjustment of the conditions to achieve the 
activation of the less reactive trifluoroacetimidate leaving group. 
Results and Discussion 
For the accomplishment of the planned one-pot glycosylation strategy, the synthetic access to 
a partially protected glycosyl (N-phenyl)trifluoroacetimidate is necessary. In contrast to 
trichloroacetimidates, these derivatives appear less difficult to be prepared. Indeed, the 
installation of (N-phenyl)trifluoroacetimidate group entails a substitution reaction with (N-
phenyl)trifluoroacetimidoyl chloride in the presence of a stoichiometric amount of a mild 
base (for instance K2CO3). Use of one equivalent of the base should allow the selective 
functionalization of the anomeric hydroxyl group in the presence of a second alcoholic 
function owing to the higher acidity of the former. Actually, in a recent report Yu and 
coworkers attained this kind of selective functionalization on a disaccharide substrate.18 
However in that example the non anomeric hydroxyl was barely accessible so that the high 
regioselectivity observed may be ascribed to steric crowding.  To demonstrate the generality 
of this selectivity  the readily accessible 2,3,4-tri-O-benzyl glucopyranose19 was reacted with 
(N-phenyl)trifluoroacetimidoyl chloride in the presence of a slight excess of K2CO3 in acetone 
to yield the desired derivative 213 in a satisfying isolated yield (Scheme 7.4).  
                                                 
17 Communication at 13th European Carbohydrate Symposium, Bratislava, Slovakia, August 22-26, 2005, 
abstract OP 48. 
18 Sun, J.; Han, X. ; Yu, B. Synlett 2005, 437. 
19 This compound was readily accessed by Zemplen deacetylation of the corresponding 1,6-di-O-acetylated 
precursor obtained as described in: Lam, S. N.; Gevay-Hague, J. Carbohydr. Res. 2002, 337, 1953. 
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SCHEME 7.4 Synthesis of 6-OH Glucosyl Donor 213. 
 
The successful access to this building block prompted us to test the “one-pot” synthesis of the 
model trisaccharide 214 (Scheme 7.5). Initial mixing of 152 (1.4 eq) and 213 (1 eq) in 
acetonitrile at -30 °C in the presence of a low amount of Yb(OTf)3 (0.03 eq) led to the 
consumption of the more reactive compound 152 in less than one hour (TLC). Then acceptor 
21 (1.4 eq) was added together with a further amount of lanthanide triflate (0.07 eq) and the 
mixture was allowed to slowly warm up to room temperature.  The desired trisaccharide was 
thus obtained in 55% yield slightly contaminated by anomeric by-products containing α-
glycosidic bonds. 
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SCHEME 7.5 One-Pot Synthesis of Trisaccharide 214 via Sequential Activation of Donors 152 and 213. 
 
To demonstrate the applicability of the approach also in ether solvents, generally adopted for 
obtaining the preferential generation of α-glycosides in the absence of a participating effect 
on the donor, the protocol was examined for the synthesis of trisaccharide 215 (Scheme 7.7) 
representing the protected form of an important epitope of mannans from Saccharomyces 
cerevisiae.20 To this aim, trifluoroacetimidate derivative 216, with the free 3-OH, was readily 
prepared according to the sequence illustrated in Scheme 7.6. Known allyl 3-O-allyl-2,3,6-tri-
                                                 
20 a) Young, M.; Haavik, S.; Paulsen, B. S.; Broker, M.; Barnes, R. M. R. Carbohydr. Polym. 1996, 30, 243; b) Young, 
M.; Davies, M. J.; Bailey, D.; Gradwell, M. J.; Paulsen, B. S.; Wold, J. K.; Broker, M.; Barnes, R. M. R.; Hounsell, E. 
F. Glycoconjugate J. 1998, 15, 815. 
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O-benzyl-α-mannopyranoside21 was submitted to a sequence of double deallylation and 
regioselective anomeric installation of the trifluoroacetimidate group that afforded the 
desired building-block 216. 
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SCHEME 7.6 Synthesis of 3-OH Mannosyl Donor 216. 
 
In this case the one-pot synthesis was performed in a solvent mixture containing dioxane and 
diethyl ether to maximize the α-selectivity of the Yb(OTf)3 promoted glycosidation steps as 
suggested by our previous observations.16 The initial coupling between 216 (1 eq) and 219 
(1.4 eq) was performed at -10 °C under the agency of catalytic Yb(OTf)3  (0.03 eq) (Scheme 7.7). 
After one hour acceptor 220 (1.4 eq) was added to the mixture together with an additional 
amount of promoter (0.07 eq) and the temperature was allowed to raise. Chromatographic 
purification of the mixture afforded 215 as the only detectable trisaccharide in a good 40% 
overall yield. 
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SCHEME 7.5 One-Pot Synthesis of Trisaccharide 215 via Sequential Activation of Donors 219 and 216. 
 
It should be noted that this result is comparable with the overall glycosidation yields 
reported in a recent synthesis of the analogous sequence by a conventional stepwise 
                                                 
21 Ogawa, T.; Yamamoto, H. Carbohydr. Res. 1985, 137, 79. 
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approach,22 and with the results obtained in the one-pot synthesis of similar mannan 
sequences.5d On the other hand, to the best of our knowledge the here reported syntheses are 
representing the first examples of one-pot preparation of trisaccharides under catalytic 
activation (an overall 10% amount of promoter is sufficient for both glycosidation steps). 
Conclusion 
In conclusion, we have reported that the different reactivity of glycosyl trichloro- and (N-
phenyl)trifluoroacetimidates can be suitably exploited for the one-pot assembly of 
trisaccharides without using the stoichiometric activation of the donors. In addition, a good 
stereo control was achieved without resorting to donors equipped with “disarming” 
participating groups. In perspective, the inclusion of electronically disarmed building blocks 
in the proposed approach would offer  a further element of flexibility which may useful for 
the one-pot assemblage of even longer sequences.    
Experimental Section 
 
General Methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were recorded 
on Varian spectrometers at 200 or 300 MHz and 50 or 75 MHz, respectively; or on a Bruker 
Avance 500 spectrometer at 500 MHz. The chemical shifts are given in parts per million 
(ppm) on the delta (δ) scale. Analytical thin layer chromatography (TLC) was performed on 
E. Merck pre-coated (25 nm) silica gel 60F-254 plates. Column chromatography was 
preformed using Carlo Erba 0.06-0.20 silica gel. Acid washed molecular sieves and Yb(OTf)3 
were dried by overnight heating at 200 °C under vacuum before their use in glycosidations. 
Anhydrous solvents stored over molecular sieves (purchased from Aldrich) were used for 
performing the reactions.  
 
Procedure for the synthesis of glycosyl (N-phenyl) trifluoroacetimidates from diols: (N-
Phenyl) trifluoroacetimidoyl chloride (55 µL, 0.45 mmol) was added at room temperature to a 
mixture of  2,3,4-tri-O-benzyl glucopyranose (100 mg, 0.22 mmol) and K2CO3 (37 mg, 0.26 
mmol) in acetone (2 mL). After ca. two hours a few drops of pyridine were added and the 
mixture was filtered on a short pad of neutral alumine (eluent dichloromethane). The residue 
was chromatographed on neutral aluminum oxide I (eluent: petroleum ether/ ethyl acetate 
from 85:15 to 7:3) to yield 213 (91 mg, yield 66 %) as an oil. Analogous procedure was 
adopted for the synthesis of 216 (38 % over two steps).  
 
213. (β-anomer): 1H NMR (300 MHz, CDCl3) δ 7.60-6.80 (aromatic 
protons), 5.75 (1H, bs, H-1), 5.00-4.40 (benzyl CH2), 4.00-3.20 (6H). 
13C NMR (50 MHz, CDCl3) δ 143.3, 138.3, 137.8, 137.6, 129.3-127.8, 
126.2, 124.4, 120.6, 119.3, 97.0 (C-1), 84.3, 81.0, 76.7, 76.0, 75.6, 75.2, 
75.1, 61.4.  
 
 
 
                                                 
22 Carpenter, C.; Nepogodiev, S. A. Eur. J. Org. Chem. 2005, 3286. 
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216. (α-anomer): 1H NMR (300 MHz, CDCl3) δ 7.50-6.80 (aromatic 
protons), 6.42 (1H, bs, H-1), 4.95-4.55 (benzyl CH2), 4.08 (1H, td, J2,3 = 
3.3 Hz, J3,OH = J3,4 = 9.3 Hz, H-3), 4.00-3.70 (5H), 2.45 (d, 3-OH). 13C 
NMR (50 MHz, CDCl3) δ 143.4, 138.1, 138.0, 137.1, 128.7-127.5, 124.4, 
120.6, 119.4, 94.7 (C-1), 76.0, 75.6, 75.1, 73.8, 73.4, 72.8, 71.3, 68.6.  
 
 
214. Trichloroacetimidate 152 (38 mg, 56 µmol) 
and trifluoroacetimidate 213 (25 mg, 40 µmol) 
were coevaporated three times in anhydrous 
toluene and then, after the addition of freshly 
activated acid washed molecular sieves, 
dissolved in acetonitrile (0.5 mL). The mixture 
was cooled at -30°C and then a solution of 
Yb(OTf)3 (0.7 mg, 1.2 µmol) in  pivalonitrile (30 
µL) was added. After consumption of the 
trichloroacetimidate donor (1 h), a solution of 
acceptor 21 (13 mg, 56 µmol) in acetonitrile (0.9 mL) and a further aliquot of Yb(OTf)3 (1.6 
mg, 2.8 µmol) in  pivalonitrile (70 µL) were added and the mixture was allowed to warm 
spontaneously to room temperature. A few drops of pyridine were added and the mixture 
was filtered on a short pad of silica gel. The residue was chromatographed on a silica gel 
column eluted with ether petroleum: ethyl acetate mixtures to yield trisaccharide 214 (27 mg, 
55 % yield) slightly contaminated by minor amounts of anomers. 1H NMR (400 MHz, CDCl3) 
δ 7.40-7.22 (aromatic protons), 5.75 (1H, d, J1,2 = 4.8 Hz, H-1 Gal), 5.10-4.40 (16 H), 4.43 and 
4.41 (2H, 2xd, J1,2 = 7.2 Hz, 2x H-1 Glc), 4.28 (1H, dd, J2,3 = 2.4 Hz, H-2 Gal), 4.25-3.40 (15 H), 
1.50, 1.38, 1.30, 1.22 (12H, 4xs, acetonides CH3). 13C NMR (50 MHz, CDCl3) δ 138.7, 138.6, 
138.5, 138.2, 128.3-127-7, 109.3, 108.5, 104.4, 104.0, 96.3, 84.8, 84.5, 81.8, 81.5, 78.0, 77.8, 77.3, 
77.1, 76.5, 75.7, 75.6, 75.0, 74.8, 74.7, 74.6, 74.2, 73.5, 71.3, 70.7, 70.5, 70.0, 68.9, 68.6, 67.4, 26.1, 
25.9, 25.0, and 24.4. 
 
215. Trichloroacetimidate 219 (58 mg, 85 µmol) and 
trifluoroacetimidate 216 (37 mg, 60 µmol) were 
coevaporated three times in anhydrous toluene and then, 
after the addition of freshly activated acid washed 
molecular sieves, dissolved in 4:1 toluene/diethyl ether (0.5 
mL). The mixture was cooled at -10°C and then a solution of 
Yb(OTf)3 (1.2 mg, 1.7 µmol) in dioxane (100 µL) was added. 
After consumption of the trichloroacetimidate donor (ca 30 
min), a solution of acceptor 220 (41 mg, 84 µmol) in 4:1 
toluene/diethyl ether (1.2 mL) and a further aliquot of Yb(OTf)3 (2.8 mg, 4.0 µmol) in  
dioxane (230 µL) were added and the mixture was allowed to warm spontaneously to room 
temperature. After ca 3 hours a few drops of pyridine were added and the mixture was 
filtered on a short pad of silica gel. The residue was chromatographed on a silica gel column 
eluted with ether petroleum: ethyl acetate mixtures to yield trisaccharide 215 (34 mg, 40 % 
yield) as an oil. 1H NMR (400 MHz, CDCl3) δ 7.40-6.90 (aromatic protons), 5.83 (1H, m, -
CH2CH=CH2), 5.25-5.22 (2H, H-1 and -CH2CH=CHtrans), 5.20 (1H, d, J1,2 = 1.2 Hz, H-1), 5.13 
(1H, bd, J1,2 = 10.4 Hz, -CH2CH=CHcis), 4.97 (1H, d, J1,2 = 1.2 Hz, H-1), 4.90-4.30 (20 H), 4.21 
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(1H, dd, J2,3 = 3.2 Hz, J3,4 = 8.4 Hz, H-3), 4.15-3.55 (19 H). 13C NMR (50 MHz, CDCl3) δ 138.9, 
138.6, 138.5, 138.4, 138.3, 13.9, 128.3-127.0, 117.1, 99.5, 99.4, 98.2, 80.1, 79.9, 75.5, 75.3, 75.2, 75.0, 
74.8, 73.3, 72.6, 72.3, 72.1, 71.8, 69.4, 68.9, 67.8. 
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Chapter 8 
 
New Routes to Glycosyl Phosphates and Their Application to in 
Situ Glycosylation Reactions 
 
 
 
 
 
 
 
 
Introduction 
The chemical synthesis of oligosaccharides is of utmost importance to procure tools for 
glycobiology in sufficient amounts.1 A plethora of glycosylating agents carrying a variety 
of anomeric leaving groups have been developed to construct glycosidic linkages.2 
Glycosyl chlorides, bromides, iodides, trichloroacetimidates, fluorides, n-pentenyl 
glycosides, anhydro sugars, as well as anomeric aryl sulfoxides, and thioglycosides have 
been applied to the construction of complex oligosaccharides and glycosylated natural 
products.3 Despite the ever increasing number of glycosylating agents available, one of the 
most limiting factors for the advancement of glycochemistry is surely the lack of a 
generally applicable glycosylation method.  
Glycosyl phosphate triesters, the nature’s glycosyl donors, proved to be effective 
glycosylating agents for the chemical synthesis of carbohydrates.4,5 However, difficulties 
associated with the synthesis of anomeric phosphates diminished the synthetic utility of 
this class of glycosylating agents. Glycosyl phosphates can be synthesized from anomeric 
lactols either by treatment with a suitable chlorophosphonate in the presence of a base,6 or 
via a dehydrative mechanism that takes advantage of the formation of an anomeric 
oxosulfonium species (Scheme 8.1).7 
 
                                                 
1 a) Garegg, P. J. Med. Res. Rev. 1996, 16, 345; b) Seeberger, P. H. Chem. Commun. 2003, 1115. 
2 Toshima, K.; Tatsuta, K. Chem. Rev. 1993, 93, 1503.  
3 a) Koenigs, W.; Knorr, E. Chem. Ber. 1901, 34, 957; b) Lemieux, R. U.; Hayami, J. Can. J. Chem. 1965, 43, 2162; 
c) Paulsen, H.; Lockhoff, O. Chem. Ber. 1981, 114, 3102; d) Schmidt, R. R.; Kinzy, W. Adv. Carbohydr. Chem. 
Biochem. 1994, 50, 21; e) Mukaiama, T.; Murai, Y.; Shoda, S. Chem. Lett. 1981, 431; f) Fraser-Reid, B.; 
Konradsson, P.; Mootoo, D. R.; Udodong, U. J. Chem. Soc., Chem. Commun. 1988, 823; g) Seeberger, P. H.; 
Bilodeau, M. T.; Danishefsky, S. J. Aldrichim. Acta 1997, 30, 75; h) Kahne, D.; Walker, S.; Cheng, Y.; Van 
Engen, D. J. Am. Chem. Soc. 1989, 111, 6881; i) Garegg, P. J. Adv. Carbohydr. Chem. Biochem. 1997, 52, 179.  
4 See Chapter 1, pp. ff-gg. 
5 Hashimoto, S.; Honda, T.; Ikegami, S. J. Chem. Soc. Chem. Comm. 1989, 685. 
6 Sabesan, S.; Neira, S. Carbohydr. Res. 1992, 223, 169. 
7 Garcia, B. A.; Gin, D. Y.  Org. Lett. 2000, 2, 2135. 
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SCHEME 8.1 Glycosyl Phosphate Syntheses from Anomeric Lactols. 
 
Alternative approaches involve the conversion of parent glycosylating agents such as 
glycosyl trichloroacetimidates, halides, or n-pentenyl- and thioglycosides into the 
corresponding phosphates.8 Introduction of a one-pot protocol9 gave ready access to 
glycosyl phosphate building blocks that now serve as key monomers for the synthesis of 
complex oligosaccharides in solution and by automated solid-phase synthesis (Scheme 
8.2).10  
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1) DMDO, CH2Cl2, -78°C
2) HOPO(OR'')2, -78°C
3) R'-Cl, DMAP, 0°C
 
 
SCHEME 8.2 Glycosyl Phosphate Synthesis via One-Pot Conversion of 1,2-Glycals. 
 
Although extremely efficient, the main drawback of this protocol entails the use of 
dimethyldioxirane (DMDO). DMDO has to be freshly prepared, can be dangerous to 
handle and makes reaction scale-up difficult.11 Furthermore, this procedure doesn’t allow 
the generation of C-2 epimers of glucose, such as mannosyl phosphates. That’s due to the 
peculiar reaction mechanism that proceeds through the formation of an 1,2-anhydro sugar 
intermediate that, right after, undergoes the phosphate diester nucloephilic attack. As a 
matter of fact, the epoxidation step turned to be very stereo-selective, leading to the 
exclusive equatorial orientation of the epoxide oxygen at C-2 position, thus enabling only 
the synthesis of gluco-type anhydro sugars.  
The need to access a host of glycosyl phosphate monomers for use in automated 
oligosaccharide synthesis prompted the pursuit of efficient synthetic means to generate 
glycosyl phosphates.  
                                                 
8 a) Schmidt, R. R.; Stumpp, M. Liebigs Ann. Chem. 1984, 680; b) Adelhorst, K.; Whitesides, G. M. Carbohydr. 
Res. 1993, 242, 69; c) Boons, G-J; Burton, A.; Wyatt, P. Synlett 1996, 310; d) Pale, P.; Whitesides, G. M. J. Org. 
Chem. 1991, 56, 4547; e) Timmers, C. M.; van Straten, N. C. R.; van der Marel, G. A.; van Boom, J. H. J. 
Carbohydr. Chem. 1998, 17, 471. 
9 a) Plante, O. J.; Andrade, R. B.; Seeberger, P. H. Org. Lett. 1999, 2, 211; b) Plante, O. J.; Palmacci, E. R.; 
Andrade, R. B.; Seeberger, P. H. J. Am. Chem. Soc. 2001, 123, 9545. 
10 Plante, O. J.; Palmacci. E. R.; Seeberger, P. H. Science 2001, 291, 1523. 
11 Love, K. R; Seeberger, P. H. Org. Synth. 2005, 81, 225.   
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General applicability and ready scale-up of such a transformation are essential. 1,2-
Glycosyl orthoesters are valuable synthetic intermediates in the preparation of 
carbohydrate building blocks.12 Like 1,2-glycals, 1,2-glycosyl orthoesters possess only 
three hydroxyl groups to be differentiated. Treatment of 1,2-glycosyl orthoesters with 
excess alcohol nucleophiles under Lewis acid activation generates 2-O-acyl glycosides 
with 1,2-trans configuration.13 In the 1970s, per-acetylated 1,2-orthoesters served as 
precursors to glycosyl phosphate monoesters and nucleotide 5’-diphospho sugars albeit in 
highly variable yields.14  
Here, we describe the stereoselective conversion of 1,2-orthoesters to glycosyl 1-phosphate 
triesters by employing phosphate diesters both as nucleophile and acidic activator.  
Results and Discussion 
Tribenzylmannosyl 1,2-orthoacetate 222 served as test substrate en route to finding the 
optimal reaction conditions. Slow addition of a solution of 222 in dichloromethane to a 
solution of dibutyl phosphate in the presence of molecular sieves (MS) yielded the desired 
glycosyl phosphate 223. In order to minimize the excess of dibutyl phosphate and to 
simplify the work-up procedures, different bases to quench the acidic dibutyl phosphate 
were tested. Just three equivalents of dibutyl phosphate are sufficient to convert 222 into 
mannosyl phosphate 223 in 30 min at room temperature (Scheme 8.3). Activated 4Å MS 
function as drying agent15 while excess dibutyl phosphate was quenched by the addition 
of triethylamine. Filtration through a pad of Et3N-deactivated silica gel, followed by 
column chromatography afforded 223 in 96% yield.  
 
BnO O
BnO
AcO
O
BnO
P
O
OBu
OBu
BnO O
BnO
OBnO
O
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223222  
 
SCHEME 8.3 Conversion of 1,2-Orthoester 222 to Mannosyl Phosphate 223. 
 
The protocol can be further simplified by adding dibutyl phosphate dropwise to a solution 
of 1,2-orthobenzoate 225 in CH2Cl2. The corresponding mannosyl phosphate 235 was 
isolated in 97% yield. This addition sequence can also be employed when handling 
orthoacetates such as 222, although longer reaction times are required to achieve full 
conversion. With a suitable protocol in hand, the synthetic scope of this transformation 
was explored using a range of mannose 224-227, glucose 228,229, galactose 230, 
arabinofuranose 231, rhamnose 232 and xylose 233 1,2-orthoesters (Table 8.1). 
 
 
                                                 
12 Lemieux, R. U.; Morgan, A. R. Can. J. Chem. 1965, 43, 2199.  
13 a) Ogawa, T.; Beppu, K.; Nakabayashi, S. Carbohydr. Res. 1981, 93, C6; b) Leroux, J.; Perlin, A. S. Carbohydr. 
Res. 1981, 94, 108. 
14 a) Volkova, L. V.; Danilov, L. L.; Evstigneeva, R. P. Carbohydr. Res. 1974, 32, 165; b) Tsai, J.-H; Behrman E. J. 
Carbohydr. Res. 1978, 64, 297; c) Salam, M. A.; Behrman E. J. Carbohydr. Res. 1981, 90, 83; Carbohydr. Res. 1982, 
101, 339; Behrman E. J. Carbohydr. Res. 1982, 102, 139. 
15 AW 300 molecular sieves were also examinated, but their acidity resulted in significant formation (5-20%) 
of the corresponding O-methyl-glycoside due to the rearrangement of the 1,2-orthoester. 
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Entrya 1,2-Orthoester Product Yield (%) 
1 AcO O
AcO
OAcO
O
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224  
AcO O
AcO
AcO
O
AcO
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O
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OBu
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86c 
2 BnO O
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BnO O
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O
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P
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97 
86b 
3 BnO O
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OTIPSO
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226  
BnO O
BnO
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OBu
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95c 
4 BnO O
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quant 
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90c 
8 
O
BnO
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TIPSO
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TIPSO
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OBu
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O
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O
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OBu
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92 
10 
BnO O
BnO
O O
OMe
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BnO O
BnO
AcO
O P
O
OBu
OBu
243  
90 
aConditions: 3 equiv of dibutyl phosphate were added by syringe to a CH2Cl2  solution of sugar at rt; 
bMultigram scale; cAddition of the sugar as solution to dibutyl phosphate (3 equiv) in CH2Cl2 at rt. 
 
TABLE 8.1 Preparation of Various Glycosyl Phosphates from 1,2-Orthoesters. 
 
The corresponding glycosyl phosphates were obtained in high yield. 1,2-Orthobenzoates 
(225, 227, 229, 231) reacted faster with dibutyl phosphate (30 min) than 1,2-orthoacetates 
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(222, 224, 226, 228, 230, 232, 233) that required reaction times of 2-3 h. These differences in 
reactivity can be rationalized when considering that the phenyl moiety at the orthoester 
helps to stabilize the carboxonium intermediate during orthoester ring opening.  
Since the procurement of large amounts of monosaccharide building blocks is required to 
supply the starting materials for automated oligosaccharide synthesis, process scalability 
is important. The proof-of-principle reactions were carried out on 0.2–0.5 mmol scale, but 
the process can be readily scaled up, as demonstrated for the preparation of several grams 
of 235. 
The work-up and purification procedure called for filtration through a plug of silica 
followed by column chromatography. NMR spectra of the crude glycosyl phosphates 
obtained after simple silica gel filtration indicated very high purity of the desired 
products. Therefore, we began to examine the efficiency of crude glycosyl phosphates as 
glycosylating agents.  
The crude mannosyl and glucosyl phosphates 223, 238, 239 derived from the 
corresponding orthoesters (1.2 eq.) were coupled to methyl glucoside 244 (1.0 eq.) at -30 °C 
by TMSOTf activation (Table 8.2). The desired 1,2-trans-linked disaccharides 245–247 were 
obtained in excellent yield and complete stereoselectivity.5 The formation of disaccharide 
orthoester by-products was not observed. 
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aGlycosidations were carried out with 1.2 equiv of donor, 1.0 equiv of acceptor and 1.2 equiv of TMSOTf 
at -30 °C in CH2Cl2 , within 1 h. 
 
TABLE 8.2 Glycosidations with Crude Glycosyl Phosphates. 
 
The carbohydrate impurities generated during glycosyl phosphate synthesis did not 
interfere with the glycosylations. Thus, a one-pot coupling following the in situ generation 
of glycosyl phosphates should be possible since excess acidic dibutyl phosphate was not 
expected to negatively affect the glycosylation.  
To evaluate the in situ route, mannosyl phosphate 235 was generated from orthoester 225 
(1.2 eq.) as described above. Then, a solution of glucoside 244 (1.0 eq.) in CH2Cl2 was 
added. After cooling the reaction mixture to -30 °C three equivalents of TMSOTf were 
New Routes to Glycosyl Phosphates and Their Application to in Situ Glycosylation Reactions
  158
required to activate the glycosyl phosphate. Partial quenching of TMSOTf by some 
remaining phosphoric acid necessitated this increased amount of activator. Disaccharide 
248 was isolated in 98% yield (Scheme 8.4). The formation of O-methyl glycoside was not 
observed, probably because the molecular sieves that are present in the reaction mixture 
act as methanol scavenger. A further simplification of the reaction protocol was achieved 
when orthoester 225 was treated with dibutyl phosphate in the presence of the coupling 
partner, nucleophile 244. The in-situ generated glycosyl phosphate was activated by 
simple addition of TMSOTf to furnish disaccharide 248 in excellent yield. 
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SCHEME 8.4 Glycosidations Using in situ Generated Glycosyl Phosphates 
 
1,2-Glycosyl orthoesters had been used previously as glycosylating agents.16 Direct 
coupling generally resulted in poor yield and excess orthoester was required to improve 
coupling yields. Only a limited range of substrates such as 1,2-pentenol and –thio 
orthoesters were effective in the assembly of complex carbohydrates.17 Based on the new 
procedure reported here, 1,2-orthoesters may be viewed as latent glycosylating agents 
similar to 1,2-glycals whereby the in-situ conversion to glycosyl phosphates is employed 
for efficient couplings. 
The synthetic utility of the new approach was further demonstrated by the rapid assembly 
of a group B Streptococcus trirhamnoside epitope.18 Rhamnose orthoester 232 served as the 
only building block for both glycosylating agent 242 and nucleophile 249 via chain 
elongation with in-situ generation of glycosyl phosphates. Allyl rhamnoside 249 was 
obtained in 91% yield by selective opening of 232 under acidic conditions with an excess of 
allyl alcohol and subsequent cleavage of the acetate. Treatment of orthoester 232 with 
dibutyl phosphate in the presence of 249, followed by the activation with TMSOTf, gave 
dirhamnoside in 88% yield. Removal of the acetate furnished 250 that served as 
                                                 
16 a) Kochetkov, N. K.; Khorlin, A. J.; Bochkov, A. F. Tetrahedron 1967, 23, 693; b) Kochetkov, N. K.; Bochkov, 
A. F.; Sokolovskaya, T. A.; Snyatkova, V. J. Carbohydr. Res. 1971, 16, 17; c) Wang, W.; Kong, F. J Org. Chem.. 
1998, 63, 5744. 
17 a) Allen, J. G.; Fraser-Reid, B. J. Am. Chem. Soc. 1999, 121, 468; b) Jayapraskash, K. N.; Radhakrishnan, K. V.; 
Fraser-Reid. B. Tetrahedron Lett. 2002, 43, 6953; c) Kochetkov, N. K.; Backinowsky, L. V.; Tsvetkov, Y. E. 
Tetrahedron Lett. 1977, 18, 3681; d) Backinowsky, L. V.; Tsvetkov, Y. E.; Balan, N. F.; Byramova, N. E.; 
Kochetkov, N. K. Carbohydr. Res. 1980, 85, 209; e) Wang, W.; Kong, F. Angew. Chem. Int. Ed. 1999, 38, 1247. 
18 a) Michon, F.; Katzenellenbogen, E.; Kasper, D. L.; Jennings, H. J. Biochemistry 1987, 26, 476; b) Michon, F.; 
Brisson, J.-R.; Dell, A.; Kasper, D. L.; Jennings, H. J. Biochemistry 1988, 27, 5341; c) Michon, F.;  Chalifur, R.; 
Feldman, R.; Wessels, M.; Kasper, D. L.; Gamian, A.; Pozsgay, V.; Jennings, H. J. Infect. Immun. 1991, 59, 1690. 
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nucleophile in the coupling with the in-situ generated rhamnosyl phosphate to yield 87% 
of trirhamnoside 251. Removal of all protective groups furnished trirhamnoside 252 in 
98% yield (Scheme 8.5).  
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SCHEME 8.5 Synthesis of Rhamnose Trisaccharide 252. 
 
 
On the basis of the excellent results obtained with glycosyl 1,2-orthoesters, we extended 
our protocol for the synthesis of glycosyl phosphates to less usual building blocks such as 
1,2-oxazolines and 1,2,6-mannosyl orthoester.19 
1,2-Oxazolines can be considered as C-2 nitrogenated analogues of 1,2-orthoesters, in fact, 
as these latter, they are easily prepared from the corresponding anomeric bromides by 
basic treatment and undergo nucleophilic attack in acidic conditions. Although 
glycosamine phosphates proved to be very effective glycosylating agents,20 their use has 
been limited by their difficult synthesis, often achieved by converting parent glycosyl 
donors or using labile chlorophosphates. Despite the presence in literature of some 
glucosamine phosphates preparations via oxazoline opening, their application was limited 
to the obtainment of unprotected derivatives to be used as probes for biological tests.21 We 
intended to develop a feasible protocol to easily access synthetically useful glucosamine 
donors. 
                                                 
19 Ravidà, A; Liu, X; Seeberger, P. H. unpublished results. 
20 Plante, O. J.; Palmacci, E. R.; Seeberger, P. H. Org. Lett. 2000, 24, 3841. 
21 a) Khorlin, A. Y.; Zurabyan, S. E.; Antonenko, T. S. Tetrahedron Lett. 1970, 55, 4803; b) Busca, P.; Martin, O. 
R. Tetrahedron Lett. 1998, 39, 8101. 
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Glucosamine phosphates 256 and 258 were synthesized from the corresponding trichloro-
oxazoline 25522 and 257 in excellent to good yield, using the above described protocol 
(Scheme 8.6). The use of trichloroacetamide protection at the C-2 position is due to the 
better coupling yields registered when such functionalized glucosamine are used as 
donors, if compared with acetamide protection. 
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SCHEME 8.6 Synthesis of Glucosamine Phosphates 256 and 258. 
 
Noteworthy, the armed glucosamine phosphate 258 was isolated as an α/β mixture. The 
major reactivity of this derivative, if compared with the disarmed 256, allowed the more 
reactive β-anomer to isomerize into the more stable α-phosphate. This behaviour had 
reported to occur in the one-pot procedure from glycals as well, and can be taken as 
starting point for further studies, as the different reactivities exhibited by α- and β-
phosphates as donors found interesting application in sequential one-pot glycosidations.9 
As previously anticipated, the protocol was also applied to the unusual 1,2,6-mannosyl 
orthoester 259,23 whose synthesis was achieved developing a new mild procedure (Scheme 
8.7). Triol 260 has been treated with acid washed molecular sieves (AW 300 MS) in 
                                                 
22 a) Wolfrom, M. L.; Bhat, H. B. J. Org. Chem. 1967, 32, 1821 ; b) Blatter, G.; Beau, J.-M.; Jacquinet, J.-C. 
Carbohydr. Res. 1994, 260, 189. 
23 Hiranuma, S.; Kanie, O.; Wong, C.-H. Tetrahedron Lett. 1999, 40, 6423. 
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dichloroethane in order to promote the conversion into the tricyclic orthoester, whose in 
situ benzylation afforded 259 in 90% yield over two steps. Derivative 259 slugghishly 
reacted with 5 equiv. of dibutyl phosphate  furnishing the partially protected mannosyl 
phosphate 262 in 68% yield.  
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SCHEME 8.7 Synthesis of 6-OH Mannosyl Phosphate 262. 
 
The thus obtained phosphate 262 is a very interesting building block, since the free 
hydroxy group at the C-6 can be further orthogonally protected or directly involved in 
one-pot synthetic strategies (Scheme 8.8). 
 
 
 
 
SCHEME 8.8 Feasible Applications of Mannosyl Phosphate 262. 
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Conclusion 
In summary, we developed a highly effective protocol to convert 1,2-glycosyl orthoesters 
to C2-acyl glycosyl phosphates. The synthetic scope was established by preparing a series 
of mannosyl, glucosyl, galactosyl, rhamnosyl, xylosyl and arabinofuranosyl phosphates in 
high yield. Pure glycosyl phosphates are obtained following column chromatography. In 
situ generation of glycosyl phosphates from 1,2-orthoesters allows for simple and efficient 
glycoside formation as shown for a trirhamnoside antigen. Straightforward access to 
glycosyl phosphate building blocks will facilitate the synthesis of complex carbohydrates 
in solution and by automated solid phase synthesis. Furthermore, the effective protocol 
thus developed was extended to the syntheses of useful glucosamine phosphates from 1,2-
oxazolines. A novel mild procedure has been developed for the synthesis of the unusual  
1,2,6 mannosyl orthoester that has been then subjected to dibutyl phosphate treatment to 
yield the very versatile of 6-OH mannosyl phosphate, whose applications will be reported 
in due course. 
 
Experimental Section 
 
General Methods and Material 
 
All chemicals used were reagent grade and used as supplied except where noted. All 
reactions were performed in oven-dried glassware under an inert atmosphere (nitrogen or 
argon) unless noted otherwise. Reagent grade dichloromethane (CH2Cl2), tetrahydrofuran 
(THF), diethyl ether (Et2O) and toluene (PhMe) were passed through activated neutral 
alumina column prior to use. Reagent grade N,N-dimethylformamide (DMF) and 
methanol (MeOH) were dried over activated molecular sieves prior to use. Pyridine, 
triethylamine and acetonitrile were distilled over CaH2 prior to use. Analytical thin layer 
chromatography (TLC) was performed on Merck silica gel 60 F254 plates (0.25mm). 
Compounds were visualized by UV irradiation or dipping the plate in a cerium sulfate-
ammonium molybdate (CAM) solution or phosphomolybdic acid (PMA) or sulforic acid 
ethanol solution, or spraying with Bial’s reagent (orcinol in acidic ethanol). Flash column 
chromatography was carried out using forced flow of the indicated solvent on Fluka 
Kieselgel 60 (230-400 mesh). 
1H, 13C and 31P NMR spectra were recorded on a Varian Mercury 300 (300 MHz), Varian 
Gemini 300 (300 MHz), Bruker DRX400 (400 MHz), Bruker DRX500 (500 MHz), in CDCl3 
with chemical shifts referenced to internal standards CDCl3 (7.26 ppm 1H, 77.0 ppm 13C) 
unless otherwise stated. 31P spectra are reported in δ value relative to H3PO4 (0.0 ppm) as 
an external reference. Splitting patterns are indicated as s, singlet; d, doublet; t, triplet; q, 
quartet; brs, broad singlet for 1H NMR data.  Signals were assigned by means of DEPT, 1H-
1H COSY and 1H-13C HSQC spectra. High-resolution mass spectral (HRMS) analyses were 
performed by the MS-service at the Laboratorium für Organische Chemie (LOC) at ETH 
Zürich. High-resolution MALDI and ESI mass spectra were run on an IonSpec Ultra and a 
Bruker BioAPEXII instruments respectively. In case of MALDI-MS, 2,5-dihydroxybenzoic 
acid (DHB) or 3-hydroxypyridine 2-carboxylic acid (3-HPA) or 2-(4-hydroxyphenylazo) 
benzoic acid (HABA) served as the matrix. IR spectra were recorded on a Perkin-Elmer 
1600 FTIR spectrometer. Optical rotations were measured using a Perkin-Elmer 241 
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polarimeter. Elemental analyses were performed by the Microanalytical Laboratory of the 
LOC, ETH Zürich. 
 
 
Synthesis of Glycosyl Phosphates: General Procedure A. 
Suitably protected 1,2-orthoester (1.0 equiv) was azeotropically dryed with toluene (3 x 2 
mL) followed by 1 h under vacuum. Activated Molecular sieves under flux of argon were 
added and the sugar was dissolved in CH2Cl2 (1 mL/0.10 mmol 1,2-orthoester). After 15 
min stirring at room temperature, the mixture was added dropwise (within 30 min) to a 3 
M solution of dibutyl phosphate in CH2Cl2 (3 equiv) in the presence of molecular sieves. 
After completion of the reaction (TLC analysis), the reaction was cooled to 0°C and 
triethylamine (4 equiv) was added. The solution was warmed to room temperature and 
filtered off through a pad of Et3N-deactivated silica gel. The resulting mixture was 
purified by flash silica column chromatography. 
 
223. General procedure A with orthoester 22224 (253 mg, 0.50 
mmol), dibutyl phosphate (300 µL, 1.5 mmol), 4Å MS (250 mg), 
CH2Cl2 (5 mL), room temperature, 30 min gave 223 (328 mg, 96%).  
The spectral data were in agreement with those in the literature.25 
 
234. General procedure A with orthoester 22425 (72 mg, 0.20 mmol), 
dibutyl phosphate (120 µL, 0.6 mmol), 4Å MS (80 mg), CH2Cl2 (2 
mL), room temperature, 3 h gave 234 (93 mg, 86%).  The spectral 
data were in agreement with those in the literature.26 
 
236. General procedure A with orthoester 22626 (115 mg, 0.20 mmol), 
dibutyl phosphate (120 µL, 0.60 mmol), 4Å MS (100 mg), CH2Cl2 (2 
mL), room temperature, 40 min gave 236 (143 mg, 95%).   Rf 0.62 
(Hexanes/EtOAc = 6 : 4); [α]Dr.t. = +21.2 (c = 1.0, CHCl3); 1H-NMR 
(300 MHz, CDCl3): δ (ppm) 7.37-7.27 (m, 10 H, arom.), 5.62 (dd, J = 6.3, 2.1 Hz, 1 H, H-
C(1)), 5.40 (t, J = 2.4 Hz, 1 H, H-C(2)), 4.92 (AB, J = 10.5 Hz, 1 H, OCHHPh), 4.73 (AB, J = 
9.0 Hz, 1 H, OCHHPh), 4.70 (AB, J = 9.0 Hz, 1 H, OCHHPh), 4.57 (AB, J = 11.4 Hz, 1 H, 
OCHHPh), 4.19-3.81 (m, 9 H, H-C(3), H-C(4), H-C(5), Ha-C(6), HbC(6), 2 x 
OCH2CH2CH2CH3), 2.12 (s, 3 H, COCH3), 1.70-1.60 (m, 4 H, 2 x OCH2CH2CH2CH3), 1.47-
1.33 (m, 4 H, 2 x OCH2CH2CH2CH3), 1.11-1.07 (m, 21 H, 3 x CH(CH3)3), 0.94 (t, J = 7.5 Hz, 3 
H, OCH2CH2CH2CH3), 0.94 (t, J = 7.5 Hz, 3 H, OCH2CH2CH2CH3); 31P-NMR (121 MHz, 
CDCl3): δ (ppm) -2.36; IR (film): 3005, 2962, 2867, 1744, 1492, 1464, 1374, 1262, 1172, 1105, 
1029, 960, 882, 652, 626 cm-1. Anal. Calcd for C39H63O10SiP; C, 62.38; H, 8.46; P, 4.12.  Found: 
C, 62.63; H, 8.59; P, 4.07; HRMS-ESI Calcd for C39H63O10SiPNa 773.3820 (M+Na): Found: 
773.3835. 
 
 
 
                                                 
24 Ziegler, T.; Lemanski, G. Eur. J. Org. Chem. 1998, 163. 
25 Soldaini, G.; Cardona, F.; Goti, A. Org. Lett. 2005, 7, 725. 
26 Seeberger, P. H.; Hewitt, M. C.; Snyder, D.  PCT Int. Appl. 2004005532, 2004, 69. 
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241. General procedure A with orthoester 23127 (77 mg, 0.15 mmol), 
dibutyl phosphate (150 µL, 0.45 mmol), 4Å MS (100 mg), CH2Cl2 
(1.5 mL), room temperature, 1 h gave 241 (104 mg, quant.).   Rf 0.30 
(Hexanes/EtOAc = 6 : 4); 1H-NMR (300 MHz, CDCl3): δ (ppm) 8.00 
(dd, J = 8.7, 0.9 Hz, 2 H, Ho Bz), 7.59 ( tt, J = 7.2, 1.8 Hz, 1 H, Hp Bz), 7.44 ( tt, J = 7.5, 1.5 Hz, 
2 H, Hm Bz), 7.36-7.22 (m,  5 H, arom.), 5.97 (d, J = 4.8 Hz, 1 H, H-C(1)), 5.52 (d, J = 1.2 Hz, 1 
H, H-C(2)), 4.82 (AB, J = 11.7 Hz, 1 H, OCHHPh), 4.65 (AB, J = 12.0 Hz, 1 H, OCHHPh), 
4.41 (q, J = 4.5 Hz, 1 H), 4.20 (d, J = 5.1 Hz, 1 H), 4.08 (dq, J = 6.6, 0.9 Hz, 4 H, 
OCH2CH2CH2CH3), 3.89 (dd, J = 11.1, 4.5 Hz, 1 H, Ha-C(5)), 3.82 (dd, J = 11.1, 5.1 Hz, 1 H, 
Hb-C(5)), 1.70-1.61 (m, 4 H, 2 x OCH2CH2CH2CH3), 1.46-1.33 (m, 4 H, 2 x 
OCH2CH2CH2CH3), 1.00 (s, 18 H, 3 x CH(CH3)3), 0.99 (q, J = 4.0 Hz, 3 H, 3 x CH (CH3)3), 
0.91 (t, J = 7.2 Hz, 6 H, 2 x OCH2CH2CH2CH3); 13C-NMR (75 MHz, CDCl3): δ (ppm) 165.0, 
137.5, 133.4, 129.7-127.7 (10 C arom.), 103.4 (d, 2JC,P = 5.5 Hz, 1 C, C(1)), 85.9, 82.4, 82.2, 82.1, 
72.3, 67.7, 62.5, 32.3 (d, 3JC,P = 7.2 Hz), 18.8, 18.0, 13.7, 12.0; 31P-NMR (121 MHz, CDCl3): δ 
(ppm) -2.75. 
 
Synthesis of Glycosyl Phosphates: General Procedure B. 
Suitably protected 1,2-orthoester (1.0 equiv) and activated molecular sieves were mixed 
under argon. CH2Cl2 (1 mL/0.10 mmol 1,2-orthoester) was added, and the mixture was 
stirred at room temperature for 15 min. Dibutyl phosphate (3 equiv) was added dropwise 
within 30 min. After completion of the reaction (TLC analysis), the reaction was cooled to 
0°C and triethylamine (4 equiv) was added. The solution was warmed to room 
temperature and filtered off through a pad of Et3N-deactivated silica gel. The resulting 
mixture was purified by flash silica column chromatography. 
 
235. General procedure B with orthoester 22528 (200 mg, 0.35 mmol), 
dibutyl phosphate (210 µL, 1.05 mmol), 4Å MS (200 mg), CH2Cl2 (3.5 
mL), room temperature, 30 min gave 235 (253 mg, 97%). 
General procedure B with orthoester 225 (2.60 g, 4.57 mmol), dibutyl 
phosphate (2.72 mL, 13.72 mmol), 4Å MS (1.5 g), CH2Cl2 (10 mL), room temperature, 50 
min gave 235 (2.93 g, 86%). Rf 0.61 (Hexanes/EtOAc = 1 : 1); [α]Dr.t. = -3.8 (c = 1.0, CHCl3); 
1H-NMR (300 MHz, CDCl3): δ (ppm) 8.09 (d, J = 7.2 Hz, 2 H arom.), 7.57 (t, J = 7.2 Hz, 1 H 
arom.), 7.41-7.22 (m, 17 H arom.), 5.83 (dd, J = 6.3, 2.1 Hz, 1 H, H-C(1)), 5.71 (d, J = 2.4 Hz, 
1 H, H-C(2)), 4.91 (AB, J = 10.8 Hz, 1 H, CHHPh), 4.83 (AB, J = 11.1 Hz, 1 H, CHHPh), 4.76 
(AB, J = 12.0 Hz, 1 H, CHHPh), 4.62 (AB, J = 11.4 Hz, 1 H, CHHPh), 4.60 (AB, J = 11.4 Hz, 1 
H, CHHPh), 4.56 (AB, J = 12.0 Hz, 1 H, CHHPh), 4.23-4.03 (m, 7 H, H-C(3), H-C(4), H-C(5), 
2x CH2CH2CH2CH3), 3.95 (dd, J = 10.8, 3.3 Hz, 1 H, Ha-C(6)), 3.79 (dd, J = 11.1, 1.5 Hz, 1 H, 
Hb-C(6)), 1.68 (m, 4 H, CH2CH2CH2CH3), 1.42 (m, 4H, CH2CH2CH2CH3), 0.96 (t, J = 7.5 Hz, 
3 H, CH2CH2CH2CH3), 0.95 (t, J = 7.5 Hz, 3 H, CH2CH2CH2CH3); 13C-NMR (75 MHz, 
CDCl3): δ (ppm) 165.5, 138.5, 138.4, 137.9, 133.6, 130.2-127.8 ( 20 C ar.), 95.9 (d, 2JC,P = 5.5 
Hz, 1 C, C(1)), 77.5, 75.6, 74.0, 73.8, 73.7, 72.0, 68.9, 68.7, 68.2 (d, 2JC,P = 4.3 Hz, 2 C, 
CH2CH2CH2CH3), 32.4 (d, 3JC,P = 6.1 Hz, 2 C, CH2CH2CH2CH3), 18.9, 13.8; 31P-NMR (121 
MHz, CDCl3): δ (ppm) -2.25; IR (film): 3007, 2963, 2874, 1724, 1603, 1496, 1453, 1362, 1268, 
1167, 1095, 1028, 961, 913 cm-1. Anal. Calcd for C42H51O10P; C, 67.55; H, 6.88; P, 4.15.  
                                                 
27 Hölemann, A.; Seeberger P. H. unpublished results. 
28 Prepared in a similar fashion as the n-pentenyl-analogue in Fraser-Reid, B.; Udodung, U. E.; Wu, Z.; 
Ottosson, H.; Merritt, J. R.; Rao, C. S:; Roberts, C.; Madsen, R. Synlett 1992, 927. 
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Found: C, 67.50; H, 6.94; P, 4.21; HRMS-ESI Calcd for C42H51O10PNa 769.3112 (M+Na): 
Found: 769.3098. 
 
237. General procedure B with orthoester 22729 (150 mg, 0.20 
mmol), dibutyl phosphate (120 µL, 0.60 mmol), 4Å MS (200 mg), 
CH2Cl2 (2 mL), room temperature, 40 min gave 237 (159 mg, 
89%).  Rf 0.59 (Hexanes/EtOAc = 6 : 4); [α]Dr.t. = -15.4 (c = 1.0, 
CHCl3); 1H-NMR (300 MHz, CDCl3): δ (ppm) 8.19 (dd, J = 7.2, 1.2 Hz, 2 H, Ho Bz), 7.78 (dd, 
J = 6.0, 1.8 Hz, 2 H, Hoa TBDPS), 7.75 (dd, J = 6.9, 1.2 Hz, 2 H, Hob TBDPS), 7.59 ( tt, J = 7.5, 
1.2 Hz, 1 H, Hp Bz), 7.45-7.22 (m,  18 H), 5.89 (d, J = 6.0, 2.1 Hz, 1 H, H-C(1)), 5.78 (t, J = 2.1 
Hz, 1 H, H-C(2)), 5.03 (AB, J = 10.8 Hz, 1 H, CHHPh), 4.87 (AB, J = 11.1 Hz, 1 H, CHHPh), 
4.76 (AB, J = 10.5 Hz, 1 H, CHHPh), 4.66 (AB, J = 11.4 Hz, 1 H, CHHPh), 4.43 (t, J = 9.6 Hz, 
1 H, H-C(4)), 4.21-3.90 (m, 8 H, H-C(3), H-C(5), Ha-C(6), Hb-C(6), 2 x OCH2CH2CH2CH3), 
1.75-1.56 (m, 4 H, OCH2CH2CH2CH3), 1.50-1.28 (m, 4 H, OCH2CH2CH2CH3), 1.16 (s, 9 H, t-
Bu), 0.95 (t, J = 7.2 Hz, 3 H, OCH2CH2CH2CH3), 0.88 (t, J = 7.2 Hz, 3 H, OCH2CH2CH2CH3); 
13C-NMR (75 MHz, CDCl3): δ (ppm) 165.3, 138.3, 137.7, 135.8, 135.5, 133.4, 133.3, 132.7, 
130.0, 129.7, 129.6, 129.5, 128.4, 128.3, 128.1, 127.8, 127.6, 96.7 (d, 2JC,P = 5.3 Hz, 1 C, C(1)), 
75.6, 74.2, 73.4, 72.0, 68.9, 68.8, 67.9 (d, 2JC,P = 5.5 Hz, 2 C, CH2CH2CH2CH3), 62.1, 32.3 (d, 
3JC,P = 6.7 Hz, 2 C, CH2CH2CH2CH3), 27.0, 19.6, 18.9, 13.7; 31P-NMR (121MHz, CDCl3): δ 
(ppm) -2.38; IR (film): 3008, 2962, 2872, 1724, 1492, 1453, 1428, 1362, 1268, 1169, 1113, 1027, 
959, 910, 823, 614 cm-1; HRMS-ESI Calcd for C51H63O10PSiNa 917.3820 (M+Na): Found: 
917.3803. 
 
238. General procedure B with orthoester 22830 (150 mg, 0.3 mmol), 
dibutyl phosphate (180 µL, 0.9 mmol), 4Å MS (150 mg), CH2Cl2 (3 
mL), room temperature, 1.5 h gave 238 (170 mg, 83%).  
General procedure A with orthoester 228 (75 mg, 0.15 mmol), dibutyl phosphate (90 µL, 
0.45 mmol), 4Å MS (80 mg), CH2Cl2 (1.5 mL), room temperature, 30 min gave 238 (91 mg, 
89%).  Rf 0.54 (Hexanes/EtOAc = 1 : 1); [α]Dr.t. = 16.7 (c = 1.0, CHCl3); 1H-NMR (300 MHz, 
CDCl3): δ (ppm) 7.34-7.18 (m, 15 H arom.), 5.20 (t, J = 7.5 Hz, 1 H), 5.10 (t, J = 8.1 Hz, 1 H), 
4.82 (AB, J = 11.7 Hz, 1 H, CHHPh), 4.80 (AB, J = 10.8 Hz, 1 H, CHHPh), 4.68 (AB, J = 11.7 
Hz, 1 H, CHHPh), 4.61 (AB, J = 11.7 Hz, 1 H, CHHPh), 4.59 (AB, J = 10.8 Hz, 1 H, CHHPh), 
4.51 (AB, J = 12.0 Hz, 1 H, CHHPh), 4.11-3.95 (m, 4 H), 3.85-3.67 (m, 4 H), 3.62-3.57 (m, 1 
H), 1.97 (s, 3 H), 1.68-1.58 (m, 4 H, CH2CH2CH2CH3), 1.42-1.33 (m, 4H, CH2CH2CH2CH3), 
0.93 (t, J = 7.5 Hz, 3 H, CH2CH2CH2CH3), 0.90 (t, J = 7.5 Hz, 3 H, CH2CH2CH2CH3); 13C-
NMR (75 MHz, CDCl3): δ (ppm) 169.6, 138.2, 138.1, 137.9, 128.7-127.9 ( 15 C ar.), 96.7 (d, 
2JC,P = 4.8 Hz, 1 C, C(1)), 82.6, 77.5, 75.8, 75.4, 75.3, 73.7, 73.3, 68.4, 68.1 (d, 2JC,P = 6.0 Hz, 2 C, 
CH2CH2CH2CH3), 32.2 (d, 3JC,P = 6.1 Hz, 2 C, CH2CH2CH2CH3), 21.0, 18.8 13.8; 31P-NMR 
(121 MHz, CDCl3): δ (ppm) -2.13; IR (film): 3005, 2964, 2872, 1749, 1492, 1451, 1364, 1267, 
1082, 1046, 903, 631 cm-1.  
 
239. General procedure B with orthoester 22931 (114 mg, 0.2 mmol), 
dibutyl phosphate (120 µL, 0.6 mmol), 4Å MS (100 mg), CH2Cl2 (2 
                                                 
29 Prepared in a similar fashion as the n-pentenyl-analogue in Udodung, U. E.; Madsen, R.; Roberts, C.; 
Fraser-Reid, B. J. Am. Chem. Soc. 1993, 115, 7886. 
30 Boren, H. B.; Ekborg, G.; Eklind, K.; Garegg, P. J.; Pilotti, A.; Swahn, C. –J. Acta Chem. Scand. 1973, 27, 2639. 
31 Ekborg, G.; Glaudemans, C. P.J. Carbohydr. Res. 1984, 129, 287. 
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mL), room temperature, 30 min gave 239 (149 mg, quant). Rf 0.64 (Hexanes/EtOAc = 1 : 1); 
[α]Dr.t. = 26.9 (c = 2.0, CHCl3); 1H-NMR (300 MHz, CDCl3): δ (ppm) 8.05 (d, J = 8.0 Hz, 2 H 
arom.), 7.58 (t, J = 7.8 Hz, 1 H arom.), 7.44 (t, J = 7.8 Hz, 2 H arom.), 7.36-7.20 (m, 15 H 
arom.), 5.44-5.37 (m, 2 H), 4.85 (AB, J = 11.1 Hz, 1 H, CHHPh), 4.78 (AB, J = 11.1 Hz, 1 H, 
CHHPh), 4.68 (AB, J = 11.1 Hz, 1 H, CHHPh), 4.64 (AB, J = 11.1 Hz, 1 H, CHHPh), 4.63 (AB, 
J = 10.5 Hz, 1 H, CHHPh), 4.54 (AB, J = 12.0 Hz, 1 H, CHHPh), 4.12-4.01 (m, 4 H), 3.96-3.64 
(m, 5 H), 1.73-1.57 (m, 2 H), 1.48-1.24 (m, 4H), 1.09-0.94 (m, 2 H), 0.90 (t, J = 7.5 Hz, 3 H, 
CH2CH2CH2CH3), 0.69 (t, J = 7.5 Hz, 3 H, CH2CH2CH2CH3); 13C-NMR (75 MHz, CDCl3): δ 
(ppm) 165.0, 137.8, 137.7, 137.5, 133.3, 129.8-127.7 (20 C ar.), 96.7, 82.1, 77.5, 75.8, 75.2, 73.6, 
73.4, 68.3, 68.0, 67.8, 32.2, 31.9, 18.7, 18.4, 13.8, 13.5; 31P-NMR (121 MHz, CDCl3): δ (ppm) -
2.25; IR (film): 3007, 2963, 2875, 1230, 1602, 1496, 1453, 1361, 1266, 1094, 1070, 1029, 908, 647 
cm-1.  
 
240. General procedure B with orthoester 23032 (100 mg, 0.2 mmol), 
dibutyl phosphate (120 µL, 0.6 mmol), 4Å MS (250 mg), CH2Cl2 (2 
mL), room temperature, 1 h gave 240 (126 mg, 92%). 
General procedure A with orthoester 230 (76 mg, 0.15 mmol), 
dibutyl phosphate (90 µL, 0.45 mmol), 4Å MS (80 mg), CH2Cl2 (1.5 mL), room 
temperature, 30 min gave 240 (92 mg, 90%). Rf 0.47 (Hexanes/EtOAc = 1 : 1); [α]Dr.t. = 10.0 
(c = 1.0, CHCl3); 1H-NMR (300 MHz, CDCl3): δ (ppm) 7.37-7.24 (m, 15 H arom.), 567 (AB, J 
= 12.0 Hz, 1 H, CHHPh), 4.59 (AB, J = 11.4 Hz, 1 H, CHHPh), 4.51 (AB, J = 12.0 Hz, 1 H, 
CHHPh), 4.43 (AB, J = 12.0 Hz, 2 H, CHHPh), 4.06-3.92 (m, 5 H), 3.72-3.52 (m, 4 H), 2.03 (s, 
3 H), 1.65-1.54 (m, 4 H, CH2CH2CH2CH3), 1.43-1.26 (m, 4H, CH2CH2CH2CH3), 0.91 (t, J = 
7.5 Hz, 3 H, CH2CH2CH2CH3), 0.87 (t, J = 7.5 Hz, 3 H, CH2CH2CH2CH3); 13C-NMR (75 
MHz, CDCl3): δ (ppm) 169.3, 138.2, 137.6, 128.4-127.5 ( 15 C ar.), 97.0, 79.7, 77.3, 74.7, 74.2, 
73.6, 72.3, 72.2, 71.3, 68.0, 32.2,  21.1, 18.7 13.7; 31P-NMR (121 MHz, CDCl3): δ (ppm) -2.42. 
IR (film): 3008, 2961, 2874, 1750, 1496, 1454, 1368, 1265, 1103, 1059, 1028, 909, 866, 600 cm-1. 
 
242. General procedure B with orthoester 23233 (100 mg, 0.25 
mmol), dibutyl phosphate (150 µL, 0.75 mmol), 4Å MS (100 mg), 
CH2Cl2 (3 mL), room temperature, 3 h, gave 242 (132 mg, 92%). Rf 
0.22 (Hexanes/EtOAc = 3 : 1); [α]Dr.t. = -18.1 (c = 3.2, CHCl3); 1H 
NMR (300 MHz, CDCl3) δ 0.93 (t, J = 7.5 Hz, 3H), 0.94 (t, J = 7.5 Hz, 3H), 1.33 (d, J = 6.3 Hz, 
3H), 1.33-1.47 (m,4H), 1.66 (tt, J = 6.6, 6.6 Hz, 4H), 3.47 (t, J = 9.6 Hz, 1H), 3.93-4.09 (m, 7H), 
4.53 (d, J = 11.1 Hz, 1H), 4.62 (d, J = 11.5 Hz, 1H), 4.71 (d, J = 11.1 Hz, 1H), 4.92 (d, J = 11.5 
Hz, 1H), 5.43 (dd, J = 3.0, 2.1 Hz, 1H), 5.56 (dd, J = 6.0, 1.8 Hz, 1H), 7.25-7.38 (m, 10H); 13C 
NMR (75 MHz, CDCl3) δ 13.7, 18.0, 18.8, 21.1, 32.5, 67.8, 68.5, 69.7, 71.9, 75.5, 77.1, 79.3, 
95.5, 127.7-128.3, 137.5, 138.1, 169.7; 31P NMR (121 MHz, CDCl3) δ −2.22; IR (film): 2961, 
1749, 1456, 1372, 1279, 1231, 1167, 1110, 1063, 1025, 958, 736 cm-1. Anal. Calcd for 
C30H43O9P; C, 62.27; H, 7.49; P, 5.35. Found: C, 62.25; H, 7.47; P, 5.39. 
 
243. General procedure B with orthoester 23334 (103 mg, 0.27 
mmol), dibutyl phosphate (150 µL, 0.75 mmol), 4Å MS (100 mg), 
CH2Cl2 (3 mL), room temperature, 1 h, gave 243 (131 mg, 90%) . Rf 
                                                 
32 Asai, N.; Fusetani, N.; Matsunaga, S. J. Nat. Prod. 2001, 64, 1210. 
33 Demetzos, C.; Skaltsounis, A. L.; Razanamahefa, B.; Tillequin, F. J. Nat. Prod. 1994, 57, 1234. 
34 Lichtenthaler, F. W.; Metz, T. Eur. J. Org. Chem. 2003, 3081-3093. 
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0.26 (Hexanes/EtOAc = 1 : 1); [α]Dr.t. = +2.4 (c = 1.7, CHCl3); 1H NMR (300 MHz, CDCl3) δ 
0.91 (t, J = 7.2 Hz, 6H), 1.31-1.42 (m, 4H), 1.56-1.68 (m, 4H), 1.97 (s, 3H), 3.41 (dd, J = 12.0, 
8.4 Hz, 1H), 3.62 (t, J = 7.8 Hz, 1H), 3.60-3.70 (m, 1H), 3.92-4.07 (m, 1H+4H), 4.60 (d, J = 12.0 
Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.68 (d, J = 12.0 Hz, 1H), 4.80 (d, J = 12.0 Hz, 1H), 4.99 
(dd, J = 7.8, 7.8 Hz, 1H), 5.20 (dd, J = 6.6 Hz, 1H), 7.25-7.39 (m, 10H); 13C NMR (75 MHz, 
CDCl3) δ 13.7, 18.8, 21.0, 32.3, 93.9, 68.1, 72.0, 73.3, 74.7, 76.8, 79.8, 97.1, 127.9-128.7, 137.9, 
138.2, 169.6; 31P NMR (121 MHz, CDCl3) δ −2.15; IR (film): 2961, 1749, 1496, 1454, 1372, 
1281, 1231, 1028, 911 cm-1 Anal. Calcd for C29H41O9P; C, 61.69; H, 7.32; P, 5.49.  Found: C, 
61.43; H, 7.29; P, 5.67. 
 
 
Crude Glycosyl Phosphate Couplings: General Procedure C. 
Crude glycosyl phosphate (1.2 equiv) and acceptor (1.0 equiv) were combined and 
azeotropically dried with toluene (3 x 5 mL) followed by 1 h under vacuum. The mixture 
was dissolved in CH2Cl2 (2 mL/0.10 mmol acceptor) and cooled to -30°C for 15 min before 
trimetylsilyltriflate (1.2 equiv) was added dropwise. After completion of the reaction (TLC 
analysis) triethylamine (2 equiv) was added. The solution was warmed to room 
temperature, the solvent was removed and the resulting mixture was purified by flash 
silica gel chromatography. 
 
245. General procedure C with donor  223 (205 mg, 0.30 mmol), 
acceptor 244 (116 mg, 0.25 mmol), and TMSOTf (58 µL, 0.30 
mmol), 30 min afforded  24535 (230 mg, 98%) as a colorless oil 
after flash silica gel column chromatography (25% 
EtOAc/Hexane) Rf 0.64.; [α]Dr.t. = 38.5 (c = 1.0, CHCl3); 1H-NMR 
(300 MHz, CDCl3): δ (ppm) 7.40-7.13 (m, 30 H arom.), 5.40 (s, 1 H), 5.01 (AB, J = 10.8 Hz, 1 
H, CHHPh), 4.91-4.40 (m, 5 H), 4.60 (d, J = 3.3 Hz, 1 H), 4.00 (t, J = 9.6 Hz, 1 H), 3.96-3.53 
(m, 10 H), 3.45 (t, J = 9.3 Hz, 1 H), 3.33 (s, 3 H), 2.15 (s, 3 H); 13C-NMR (75 MHz, CDCl3): δ 
(ppm) 170.2, 138.6, 138.4, 138.1, 138.0, 137.7, 128.4-127.5 (30 C ar.), 98.0, 97.8, 82.1, 80.1, 77.6, 
75.8, 75.1, 75.0, 74.2, 73.4, 71.6, 71.5, 69.7, 68.7, 68.5, 66.1, 55.2, 21.3. IR (film): 3067, 3008, 
2927, 2862, 1743, 1600, 1496, 1454, 1363, 1248, 1139, 1089, 1046, 1028, 911, 600 cm-1. 
 
246. General procedure C with building block 238 (205 mg, 
0.30 mmol), acceptor 244 (116 mg, 0.25 mmol), and TMSOTf 
(58 µL, 0.30 mmol), 30 min afforded of 24636 (228 mg, 97%) as 
a colorless oil after flash silica gel column chromatography 
(45% EtOAc/Hexane) Rf 0.76. [α]Dr.t. = 9.7 (c = 1.0, CHCl3); 1H-NMR (300 MHz, CDCl3): δ 
(ppm) 7.38-7.18 (m, 30 H arom.), 5.08 (t, J = 8.1 Hz, 1 H), 4.99 (AB, J = 10.8 Hz, 1 H, 
CHHPh), 4.87-4.78 (m, 4 H), 4.83  (d, J = 3.6 Hz, 1 H), 4.67 (AB, J = 11.4 Hz, 1 H, CHHPh), 
4.66 (AB, J = 11.5 Hz, 1 H, CHHPh), 4.62-4.52 (m, 5 H), 4.42 (d, J = 7.8 Hz, 1 H), 4.14-4.10 
(m, 1 H), 3.99 (t, J = 9.3 Hz, 1 H), 3.80-3.65 (m, 6 H), 3.57-3.44 (m, 3 H), 3.37 (s, 3 H), 1.90 (s, 
3 H); 13C-NMR (75 MHz, CDCl3): δ (ppm) 169.1, 138.8, 138.2, 138.1, 137.7, 128.4-127.5 (30 C 
ar.), 100.9, 98.0, 83.1, 82.1, 79.8, 78.1, 77.8, 75.7, 75.4, 75.1, 74.9, 73.5, 73.0, 69.7, 68.8, 68.0, 
55.2, 21.1. IR (film): 3067, 3008, 2932, 2862, 1748, 1496, 1454, 1362, 1154, 1066, 1028, 913, 600 
cm-1.  
                                                 
35 Barresi, F.; Hindsgaul, O. Can. J. Chem. 1994, 72, 1447. 
36 Shi, L.; Kim, Y.-L.; Gin, D. Y. J. Am. Chem. Soc. 2001, 123, 6940. 
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247. General procedure C with donor  239 (150 mg, 0.20 
mmol), acceptor 244 (77 mg, 0.17 mmol), and TMSOTf (39 
µL, 0.20 mmol), 40 min afforded 247 (155 mg, 91%) as a 
colorless oil after flash silica gel column chromatography 
(45% EtOAc/Hexane) Rf 0.77; [α]Dr.t. = 22.6 (c = 1.0, CHCl3); 1H-NMR (300 MHz, CDCl3): δ 
(ppm) 7.95 (d, J = 7.8 Hz, 2 H), 7.46 (t, J = 6.9 Hz, 1 H), 7.34-7.02 (m, 32 H arom.), 5.37 (t, J = 
8.4 Hz, 1 H), 4.89 (AB, J = 10.8 Hz, 1 H, CHHPh), 4.83 (AB, J = 10.8 Hz, 1 H, CHHPh), 4.77-
4.54 (m, 8 H), 4.60 (d, J = 3.6 Hz, 1 H), 4.49 (d, J = 3.3 Hz, 1 H), 4.45 (AB, J = 11.1 Hz, 1 H, 
CHHPh), 4.29 (AB, J = 11.1 Hz, 1 H, CHHPh), 4.17-4.13 (m, 1 H), 3.92-3.65 (m, 7 H), 3.60-
3.56 (m, 1 H), 3.50-3.36 (m, 2 H), 3.21 (s, 3 H); 13C-NMR (75 MHz, CDCl3): δ (ppm) 164.9, 
138.8, 138.2, 138.1, 137.8, 137.7, 132.9, 129.8, 129.7, 128.3-127.3 ( 34 C ar.), 101.2, 97.9, 82.7, 
81.8, 79.6, 78.0, 75.0, 74.6, 73.6, 73.4, 73.3, 69.4, 68.8, 68.0, 54.9. IR (film): 3067, 3008, 2932, 
2928, 2872, 1729, 1600, 1496, 1453, 1360, 1267, 1154, 1092, 1070, 1028, 913 cm-1. 
 
 
One-pot Glycosylation: General Procedure D. 
Suitably protected 1,2-orthoester (1.2 equiv) and activated molecular sieves were mixed 
under argon. CH2Cl2 (1 mL/0.10 mmol 1,2-orthoester) was added, and the mixture was 
stirred at room temperature for 15 min. Dibutyl phosphate (3.6 equiv) was added 
dropwise within 30 min. After completion of the reaction (TLC analysis), a solution of the 
acceptor (1.0 equiv) in CH2Cl2 (1 mL/0.01 mmol acceptor) was added dropwise and the 
mixture was cooled to -30°C. After the mixture was stirred  for 15 min, TMSOTf (3.6 equiv) 
was added. After completion of the reaction (TLC analysis), triethylamine (4 equiv) was 
added. The solution was warmed to room temperature and filtered off through a pad of 
Et3N-deactivated silica gel. The resulting mixture was purified by flash silica column 
chromatography. 
 
One-pot Glycosylation: General Procedure E. 
1,2-Orthoester (1.2 equiv) and acceptor (1.0 equiv) were combined and azeotropically 
dried with toluene (3 x 5 mL) followed by 1 h under vacuum. Activated molecular sieves 
were mixed under argon, the mixture was dissolved in CH2Cl2 (2 mL/0.10 mmol acceptor) 
at room temperature. After the mixture was stirred for 15 min, dibutyl phosphate (3.6 
equiv) was added dropwise within 30 min. After the formation of the desired glycosyl 
phosphate (TLC analysis), the reaction mixture was cooled to -30°C and TMSOTf (3.6 
equiv) was added dropwise. After completion of the reaction (TLC analysis), triethylamine 
(4 equiv) was added. The solution was warmed to room temperature and filtered off 
through a pad of Et3N-deactivated silica gel. The resulting mixture was purified by flash 
silica column chromatography. 
 
248. General Procedure D with 1,2-orthoester 225 (170 mg, 0.30 
mmol), dibutyl phosphate (178 µL, 0.90 mmol), acceptor 244 
(116 mg, 0.25 mmol), and TMSOTf (174 µL, 0.90 mmol) afforded 
245 mg (98%) of 24837 as colorless oil after flash silica gel 
chromatography (30% EtOAc/Hexane) Rf 0.71.  
General Procedure E with 1,2-orthoester 225 (142 mg, 0.25 
                                                 
37 Mathew, F.; Mach, M.; Hazen, K.C; Fraser-Reid, B. Tetrahedron Lett. 2003, 44, 9051. 
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mmol), acceptor 244 (97 mg, 0.21 mmol), dibutylphosphate (149 µL, 0.75 mmol), and 
TMSOTf (145 µL, 0.75 mmol) afforded 208 mg (99%) of 248 as colorless oil after flash silica 
gel chromatography.  
 
249. To a solution of rhamnose orthoester 232 (0.91 g, 2.27 mmol), allyl 
alcohol (2.3 mL, 33.9 mmol) in dry CH2Cl2 (9 mL) was added BF3·Et2O 
(114 µL, 0.90 mmol) at room temperature in the presence of activated 
powdered 4Å molecular sieves (1 g). After stirring for 3 h, the mixture 
was diluted with CH2Cl2 and filtered through a pad of Celite. The filtrate was then washed 
with saturated aqueous NaHCO3 solution, water and dried over Na2SO4. The solvents 
were removed in vacuo and the residue was dissolved in a solution of NaOMe (11.8 mg, 0.2 
mmol) in MeOH (6 mL).  The mixture was stirred then at room temperature for ca. 12 h. 
The solvents were then removed in vacuo and the residue was purified by silica gel column 
chromatography to give 24538 as a syrup (793 mg, 91% 2 steps). Rf 0.22 (Hexanes/EtOAc = 
4 : 1).[α] Drt = -32.1 (c = 1.7, CHCl3); 1H NMR (300 MHz, CDCl3) δ 1.33 (d, J = 6.3 Hz, 3H), 
2.55 (d, J = 2.1 Hz, 1H), 3.48 (t, J = 9.3 Hz, 1H), 3.72-3.82 (m, 1H), 3.89 (dd, J = 9.3, 6.3 Hz, 
1H), 3.94-4.01 (m, 1H), 4.06-4.09 (m, 1H), 4.14-4.20 (m, 1H), 4.65 (d, J = 10.8 Hz, 1H), 4.71 (s, 
2H), 4.87 (d, J = 1.5 Hz, 1H), 4.90 (d, J = 10.8 Hz, 1H), 5.18-5.32 (m, 2H), 5.83-5.96 (m, 1H), 
7.26-7.39 (m, 10H); 13C NMR (75 MHz, CDCl3) δ 18.1, 67.6, 68.0, 68.7, 72.2, 75.6, 80.2, 80.3, 
98.3, 117.6, 127.9-128.7 (CH-Aryl), 134.0, 138.1, 138.6;  IR (film): 3459, 3063, 2910, 1497, 1364, 
1211, 1061, 922, 737 cm-1. Anal. Calcd for C23H28O5; C, 71.85; H, 7.34.  Found: C, 71.81; H, 
7.53. 
 
250. A solution of rhamnoside 249 (226 mg, 0.59 mmol) and 
rhamnose orthoester 232 (260 mg, 0.65 mmol) in CH2Cl2 (5 mL) was 
stirred at room temperature for 30 min in the presence of activated 
4Å MS (300 mg) and was then added dibutyl phosphate (385 µL, 1.94 
mmol) dropwise. After stirring for 3 h, the mixture was cooled to -40 
°C and TMSOTf (354 µL, 1.94 mmol) added. The glycosylation went 
to completion in 30 min and Et3N (1 mL) was added to quench the 
excess acid. The mixture was filtered through a pad of Celite and the filtrate was 
concentrated in vacuo. The residue was then purified by silica gel column chromatography 
to give allyl (2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl)-(1→2)-3,4-di-O-benzyl-α-
L-rhamnopyranoside (384 mg, 88%). The dirhamnoside (384 mg, 0.51 mmol) was then 
dissolved in a solution of NaOMe in MeOH (0.01 M, 3 mL) at room temperature. After 
stirring for 12 h, the solvent was removed in vacuo and the residue was purified by silica 
gel column chromatography to give 25039 (340 mg, 96%) as a white solid. Rf 0.30 
(Hexanes/EtOAc = 3 : 1). [α]Drt = -35.9 (c = 0.7, CHCl3); 1H NMR (300 MHz, CDCl3) δ 1.29 
(d, J = 6.3 Hz, 6H), 2.43 (d, J = 1.8 Hz, 1H), 3.39 (t, J = 9.3 Hz, 1H), 3.47 (t, J = 9.3 Hz, 1H), 
3.64-3.96 (m, 5H), 4.03-4.15 (m, 3H), 4.58-4.72 (m, 6H), 4.76 (d, J = 1.8 Hz, 1H), 4.88 (d, J = 
10.8 Hz, 1H), 4.90 (d, J = 10.8 Hz, 1H), 5.08 (d, J = 1.5 Hz, 1H), 5.14-5.25 (m, 2H), 5.79-5.92 
(m, 1H), 7.25-7.39 (m, 20H); 13C NMR (75 MHz, CDCl3) δ 18.1, 18.3, 67.9, 68.2, 68.9, 72.4, 
72.5, 74.8, 75.6, 75.7, 79.8, 80.1, 80.3, 80.6, 98.2, 101.0, 117.5, 127.9-128.9 (CH-Aryl), 134.1, 
138.2, 138.5, 138.6, 138.8;  IR (film): 3477, 3005, 2930, 1497, 1389, 1078, 985, 912 cm-1. HRMS-
MALDI (m/z): [M + Na]+ Calcd for C43H50O9, 710.3455; Found: 710.3453. 
                                                 
38 Bousqueta, E.;  Khitri, M.;  Lay, L.; Nicotra, L.; Panza, L.; Russo, R. Carbohydr. Res. 1998, 311, 171-181. 
39 Bélot, F.; Wright, K.; Costachel, C.; Phalipon, A.; Mulard, L. A. J. Org. Chem. 2004, 69, 1060-1074. 
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251. A solution of dirhamnoside 250 (192 mg, 0.27 mmol) and 
rhamnose orthoester 232 (120 mg, 0.30 mmol) in CH2Cl2 (3 mL) 
was stirred at room temperature for 30 min in the presence of 
activated 4Å MS (200 mg) and was then added dibutyl 
phosphate (178 µL, 0.90 mmol) dropwise. After stirring for 3 h, 
the mixture was cooled to -40 °C and TMSOTf (164 µL, 0.90 
mmol) was added. The glycosylation was completed in 30 min 
and Et3N (0.5 mL) was added to quench the excess acid. The 
mixture was filtered through a pad of Celite and the filtrate was 
concentrated in vacuo. The residue was then purified by silica gel column chromatography 
to give 251 (261mg, 87%) as a syrup. Rf 0.55 (Hexanes/EtOAc = 3 : 1); [α]Dr.t. = -26.1 (c = 2.3, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.21 (d, J = 6.3 Hz, 3H), 1.26 (d, J = 6.3 Hz, 6H), 2.13 
(s, 3H), 3.35 (t, J = 9.2 Hz, 1H), 3.40 (t, J = 9.3 Hz, 1H), 3.44 (t, J = 9.3 Hz, 1H), 3.61-3.98 (m, 
8H), 4.06-4.11 (m, 2H), 4.52-4.75 (m, 10H), 4.84-4.91 (m, 2H), 4.99 (d, J = 1.7 Hz, 1H), 5.07 (d, 
J = 1.8 Hz, 1H), 5.16 (ddt, J = 10.4, 2.9, 1.3 Hz, 1H), 5.22 (ddt, J = 17.0, 2.9, 1.3 Hz, 1H), 5.54 
(dd, J = 3.3, 1.8 Hz, 1H), 5.78-5.88 (m, 1H), 6.98-7.37 (m, 30H); 13C NMR (75 MHz, CDCl3) δ 
17.9, 18.0, 21.1, 67.6, 68.0, 68.3, 68.5, 69.0, 71.8, 72.1, 72.2, 74.5, 74.7, 75.2, 75.3, 75.4, 77.2, 
77.8, 79.1, 79.6, 80.1, 80.2, 80.3, 97.9, 99.1, 100.4, 117.2, 127.4-128.4, 133.8, 138.1, 138.3, 138.5, 
138.5, 138.5, 138.6, 170.0;  IR (film): 3025, 2913, 1744, 1492, 1451, 1364, 1077, 918 cm-1. 
HRMS-MALDI Calcd for C65H74O14Na 1101.4971 (M+Na): Found: 1101.495. 
 
252. Tri-rhamnoside 251 (23 mg, 21.3 µmol) was dissolved in a 
solution of NaOMe in MeOH (0.01 M, 1 mL) and stirred at room 
temperature for 10 h. Afterwards, the solvent was removed in 
vacuo and the residue was passed through a pad of silica gel to 
give allyl (3,4-di-O-benzyl-α-L-rhamnopyranosyl)-(1→2)-(3,4-
di-O-benzyl-α-L-rhamnopyranosyl)-(1→2)-3,4-di-O-benzyl-α-L-
rhamnopyranoside (21 mg). The tri-rhamnoside was then 
dissolved in a mixture of THF/MeOH/H2O (5:5:1, 5 mL) and 
stirred in presence of Pd/C (30 mg) under H2 atmosphere for 15 
h. The mixture was then filtered through a pad of Celite and the 
solvents were evaporated in vacuo. Subsequent lyophilization gave 252 (11 mg, 98% 2 
steps) as a white solid, 1H NMR (500 MHz, CD3OD) δ 0.88 (t, J = 7.5 Hz, 3H), 1.17 (d, J = 6.5 
Hz, 3H), 1.18 (d, J = 6.5 Hz, 3H+3H), 1.50-1.58 (m, 2H), 3.24-3.33 (m, 3H), 3.47-3.73 (m, 9H), 
3.91 (dd, J = 3.5, 2.0 Hz, 1H), 3.94 (dd, J = 3.5, 2.0 Hz, 1H), 4.71 (d, J < 1Hz, 1H), 4.86 (d, J = 
1.5 Hz, 1H), 5.01 (d, J = 1.5 Hz, 1H); 13C NMR (125 MHz, CD3OD) δ 9.83, 16.7, 16.9, 16.9, 
22.6, 68.7, 69.1, 69.1, 70.7, 70.8, 70.9, 71.1, 72.8, 73.0, 73.1, 78.7, 79.2, 99.1, 101.5, 102.7; 
HRMS-ESI Calcd for C21H38O13Na 521.22046 (M+Na): Found: 521.22043. 
 
255. 1.872 g (3.80 mmol) of glucosamine derivative 25340 were dissolved 
into 2.5 mL of CH2Cl2 and to this solution 1.7 mL of HBr (33% solution 
in AcOH) were admixed at room temperature. After three hours 
stirring, the solvent was removed, the residual syrup was dissolved in 
ethyl ether and the solution was evaporated again. Glucosamine 
                                                 
40 a) Silva, D. J.; Wang, H.; Allanson, N. M.; Jain, R. K.; Sofia, M. J. J. Org. Chem. 1999, 64, 5926; b) Dempsey, 
A. M.; Hough, L. Carbohydr. Res. 1975, 41, 63. 
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bromide 254 was directly used in the following step. Crude 254 together with 1,220 g ( 3.80 
mmol) of TBAB were coevaporated in dry toluene. The mixture was dissolved in 1.5 mL of 
dry CH2Cl2 and then 663 µL (5.70 mmol) of lutidine were added at room temperature. 
After reaction completion (TLC analysis), the reaction mixture was diluted with CH2Cl2 
and washed with water. The organic phase was concentrated and purified on silica gel by 
column chromatography furnishing oxazoline 255 (1.430 g, 3.31 mmol) in 87% yield over 
two steps. [α]Dr.t. = 21.4 (c = 2.0, CHCl3); 1H-NMR (300 MHz, CDCl3): δ (ppm) 6.29 (t, J = 
7.5, 1 H, H-C(1)), 5.34 (t, J = 2.4 Hz, 1 H, H-C(3)), 4.89 (dt, J = 8.1, 1.8 Hz, 1 H, H-C(4)), 4.43 
(dq, J = 7.5, 1.2 Hz, 1 H, H-C(2)), 4.23 (dd, J = 12.0, 3.0 Hz, 1 H, Ha-C(6)), 4.13 (dd, J = 12.0, 
5.7 Hz, 1 H, Hb-C(6)), 3.75-3.69 (m, 1 H, H-C(5)), 2.09 (s, 3 H, CH3 Ac), 2.04 (s, 3 H, CH3 
Ac), 2.03 (s, 3 H, CH3 Ac); 13C-NMR (125 MHz, CDCl3): δ (ppm) 170.6, 169.6, 169.1, 162.9, 
103.3, 77.5, 69.1, 68.9, 67.8, 64.8, 63.6, 21.7, 21.1, 20.9; IR (film): 3032, 1747, 1660, 1370, 1248, 
1139, 1040, 970, 909, 830, 600 cm-1. HRMS-ESI Calcd for C14H16NO8Cl3Na 455.6336 (M+Na): 
Found: 455.9801. 
 
 
 256. General procedure B with oxazoline 255 (189 mg, 0.44 
mmol), dibutyl phosphate (240 µL, 1.3 mmol), 4Å MS (150 
mg), CH2Cl2 (3 mL), room temperature, 1 h gave 256 (258 mg, 
92%). [α]Dr.t. = 5.48 (c = 1.0, CHCl3); 1H-NMR (300 MHz, 
CDCl3): δ (ppm) 8.26 (d, J = 9.6 Hz 1 H, NHTCA.), 5.51 (t, J = 8.1, 1 H, H-C(1)), 5.41 (t, J = 
9.6 Hz, 1 H, H-C(3)), 5.04 (t, J = 9.6 Hz, 1 H, H-C(4)), 4.28-3.90 (m, 7 H, H-C(2), Ha-C(6), 
Hb-C(6) and 2 x OCH2CH2CH2CH3), 3.79-3.74 (m, 1 H, H-C(5)), 2.04 (s, 3 H, CH3 Ac), 1.99 
(s, 3 H, CH3 Ac), 1.97 (s, 3 H, CH3 Ac), 1.62-1.52 (m, 4 H, 2 x OCH2CH2CH2CH3), 1.38-1.28 
(m, 4 H, 2 x OCH2CH2CH2CH3), 0.86 (t, J = 7.5 Hz, 3 H, OCH2CH2CH2CH3), 0.85 (t, J = 7.5 
Hz, 3 H, OCH2CH2CH2CH3); 31P-NMR (121 MHz, CDCl3): δ (ppm) -2.95; IR (film): 3401, 
2964, 1749, 1713, 1523, 1368, 1248, 1181, 1033, 908, 842, 600 cm-1. Anal. Calcd for 
C22H35NO12PCl3; C, 41.10; H, 5.49; N, 2.18; P, 4.82.  Found: C, 41.20; H, 5.78; N, 2.19; P, 4.67; 
HRMS-ESI Calcd for C22H35NO12PCl3Na 664.08547 (M+Na): Found: 664.0854. 
 
257. Oxazoline 255 (248 mg, 0.57 mmol) was dissolved into  3 mL of 
CH2Cl2/MeOH 3:1 mixture, then 12 µL of MeONa (0.5 M solution in 
MeOH, 5.70 µmol) were added at room temperature. After stirring 
overnight, the solvent was removed under reduced pressure and the 
resulting white solid was directly used in the following step. The triol 
and 200 mg of freshly activated molecular sieves were fluxed under argon atmosphere 
then 2 mL of dry CH2Cl2 were added. After q0 minutes stirring at room temperature, 68 
µL (5.13 mmol) of BnBr and 1.46 g (6.84 mmol) of freshly prepared Ag2O were added at 
room temperature. After reaction completion (TLC analysis), the reaction mixture was 
filtered through a pad of celite and the solvent was evaporated under reduced pressure. 
The crude was purified on silica gel by column chromatography furnishing 257 (187 mg, 
0.32 mmol) in 57% yield over two steps. [α]Dr.t. = 45.3 (c = 1.0, CHCl3); 1H-NMR (300 MHz, 
CDCl3): δ (ppm) 7.38-7.26 (m, 13 H, aromatic), 7.21-7.18 (m, 2 H, aromatic), 6.38 (t, J = 7.5, 1 
H, H-C(1)), 4.72 (AB, J = 12.0 Hz, 1 H, CHHPh), 4.64 (AB, J = 12.3 Hz, 1 H, CHHPh), 4.58 
(AB, J = 12.0 Hz, 1 H, CHHPh), 4.56 (AB, J = 11.7 Hz, 1 H, CHHPh), 4.50 (AB, J = 12.0 Hz, 1 
H, CHHPh), 4.49 (ddd, J = 0.9, 3.0, 8.0 Hz, 1 H, H-C(2)), 4.32 (AB, J = 12.0 Hz, 1 H, 
CHHPh), 4.12 (t, J = 3.0 Hz, 1 H, H-C(4)), 3.75 (ddd, J = 1.2, 2.7, 8.7 Hz, 1 H, Ha-C(3)), 3.69 
AcO O
AcO
NHTCA
OPO(OBu)2
AcO
BnO O
BnO
N O
BnO
Cl3C
New Routes to Glycosyl Phosphates and Their Application to in Situ Glycosylation Reactions
  172
(m, 1 H, H-C(5)), 3.67 (m, 2 H, H-C(6a) and H-C(6b)); 13C-NMR (125 MHz, CDCl3): δ (ppm) 
162.5 (C oxazoline), 137.8, 137.6, 137.4 (C aromatic), 128.5, 128.3, 128.2, 128.0, 127.9, 127.7, 
127.7, 127.6 (CH aromatic), 77.1 (CCl3), 75.7, 74.2, 73.2, 71.8, 71.6 (C carbinolic), 71.3, 69.2, 
65.9 (benzyl); IR (film): 3008, 2923, 2867, 1657, 1496, 1454, 1363, 1318, 1138, 1096, 1072, 1028, 
882, 820, 600 cm-1. Anal. Calcd for C29H28NO5Cl3; C, 60.38; H, 4.89; N, 2.43.  Found: C, 
60.94; H, 5.21; N, 2.27; HRMS-ESI Calcd for C29H28NO5Cl3Na 598.0925 (M+Na): Found: 
598.0923. 
 
258. General procedure B with oxazoline 257 (104 mg, 0.18 
mmol), dibutyl phosphate (110 µL, 0.54 mmol), 4Å MS (150 
mg), CH2Cl2 (3 mL), room temperature, 3 h gave 257 as α/β 
mixture 1.4:1.(122 mg, 86%). 1H-NMR (300 MHz, CDCl3) 
significative signals: δ (ppm) 8.34 (d, J = 9.6 Hz 1 H, NHTCA.), 7.37-7.01 (m, 15 H 
aromatic), 5.75 (dd, J = 5.8, 3.3, 1 H, H-C(1)-α anomer), 5.51 (t, J = 7.7, 1 H, H-C(1)-β 
anomer), 4.85 (AB, J = 11.1 Hz, 1 H, CHHPh β-anomer), 4.80 (t, J = 10.8 Hz, 2 H, CH2Ph α-
anomer), 4.75 (AB, J = 11.0 Hz, 1 H, CHHPh β-anomer), 4.64-4.44 (overlapped AB systems, 
4 H α-anomer and 4 H β-anomer), 4.32 (tt, J = 10.0, 3.3 Hz, 1 H, H-C(2) α-anomer), 4.21 (t, J 
= 7.8 Hz, 1 H, H-C(2) β-anomer), 4.10-4.01 (m, 12 H, overlapped signals 2 x  
OCH2CH2CH2CH3, H-C(3) and H-C(4) α- and β- anomers), 4.00-4.39 (m, 2 H, Ha-C(6) and 
Hb-C(6) α anomer), 3.83-3.75 (m, 2 H, Ha-C(6) and Hb-C(6) β anomer), 3.69-3.64 (m, 2 H , 
H-C(5) α and β anomers), 1.71-1.55 (m, 8 H, 2 x OCH2CH2CH2CH3 α- and β anomers), 1.45-
1.28 (m, 8 H, 2 x OCH2CH2CH2CH3 α- and β anomers), 0.98-0.90 (m, 12 H, 2 x 
OCH2CH2CH2CH3 α- and β-anomers); 13C-NMR major anomer (125 MHz, CDCl3): δ (ppm) 
162.2, 138.1, 137.9 137.8, (C aromatic), 128.8, 128.6, 128.6, 128.5, 128.1, 128.1, 127.9, 127.8 
(CH aromatic), 96.9 (C-1 β-anomer), 96.3(C-1 α-anomer), 77.9 (CCl3), 75.7, 75.4, 74.1, 73.2, 
68.4, 68.1, 67.7, 32.4, 32.3, 18.8, 13.8; 31P-NMR (121 MHz, CDCl3): δ (ppm) -2.05 (α-anomer) 
and -3.02 (β-anomer); IR (film): 3415, 3008, 2962, 2875, 1719, 1600, 1515, 1454, 1361, 1265, 
1149, 1028, 949, 822, 600 cm-1. Anal. Calcd for C37H47NO9PCl3; C, 56.46; H, 6.02; N, 1.78; P, 
3.94.  Found: C, 56.74; H, 6.12; N, 1.83; P, 3.84; HRMS-ESI Calcd for C37H47NO9PCl3Na 
808.1946 (M+Na): Found: 808.1952. 
 
 259. 137 mg (0.46 mmol) of derivative 260 together with 120 mg of 
AW 300 MS were fluxed under argon atmosphere and then 2 mL of 
dry dichloroethane were added. After completion (8 hours at 50 °C), 
the solvent was evaporated and the resulting crude was dissolved in 2 mL of DMF. To this 
solution 64 mg of NaH and 190 µL of BnBr were admixedand the mixture was kept 
reacting at room temperature overnight. The reaction mixture was diluted with water and 
extracted with ethyl ether, the organic phase was evaporated and the residue was purified 
by column chromatography furnishing 259 (185 mg, 0.41 mmol) in 90% yield over two 
steps. [α]Dr.t. = 2.39 (c = 2.0, CHCl3); 1H-NMR (300 MHz, CDCl3): δ (ppm) 7.71-7.68 (m, 2 H, 
aromatic), 7.49-7.35 (m, 13 H, aromatic), 5.89 (d, J = 5.7, 1 H, H-C(1)), 4.89 (AB, J = 12.0 Hz, 
1 H, CHHPh), 4.85 (AB, J = 12.3 Hz, 1 H, CHHPh), 4.84 (AB, J = 11.7 Hz, 1 H, CHHPh), 4.69 
(AB, J = 11.3 Hz, 1 H, CHHPh), 4.68 (dd, J = 2.4, 6.0 Hz, 1 H, H-C(2)), 4.29-4.22 (m, 3 H), 
3.83-3.78 (m, 2 H); 13C-NMR (125 MHz, CDCl3): δ (ppm) 138.3, 137.4, 129.6 (C aromatic), 
128.8-128.1 (14 CH aromatic), 126.2, 122.1, 99.9, 79.5, 77.6, 74.6, 73.4, 72.6, 70.8; IR (film): 
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3067, 3008, 2932, 2868, 1496, 1453, 1368, 1324, 1291, 1162, 1133, 1102, 1077, 1049, 1025, 1006, 
960, 917, 841, 600 cm-1. Anal. Calcd for C27H26O6; C, 72.63; H, 5.87.  Found: C, 72.50; H, 5.91. 
 
258. General procedure B with 259 (100 mg, 0.22 mmol), dibutyl 
phosphate (133 µL, 0.67 mmol), 4Å MS (150 mg), CH2Cl2 (3 mL), 
room temperature, 48 h gave 258 (100 mg, 68%). 1H-NMR (300 
MHz, CDCl3): δ (ppm) 8.09-8.05 (m, 2 H), 7.64-7.58 (m, 1 H), 7.50-
7.45 (m, 2 H), 7.37-7.24 (m,  10 H), 5.76 (dd, J = 6.0, 2.1 Hz, 1 H, 
H-C(1)), 5.65 (t, J = 2.7 Hz, 1 H, H-C(2)), 4.92 (AB, J = 10.8 Hz, 1 H, CHHPh), 4.79 (AB, J = 
11.4 Hz, 1 H, CHHPh), 4.65 (AB, J = 10.8 Hz, 1 H, CHHPh), 4.59 (AB, J = 11.4 Hz, 1 H, 
CHHPh), 4.14-3.83 (m, 5 H), 1.17-1.62 (m, 4 H, 2 x OCH2CH2CH2CH3), 1.47-1.35 (m, 4 H, 2 x 
OCH2CH2CH2CH3), 0.98-0.91 (m, 6 H, 2 x OCH2CH2CH2CH3) 13C-NMR (75 MHz, CDCl3): 
δ (ppm) 165.1, 137.9, 137.5, 133.4, 129.8-127.7 (15 C aromatic), 95.6, 77.3, 75.4, 73.8, 73.3, 
71.8, 68.6, 68.1, 67.4, 61.7, 32.4, 32.3, 18.8, 13.7; 31P-NMR (121MHz, CDCl3): δ (ppm) -2.45.  
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Conclusion 
 
 
 
 
 
 
 
 
 
 
 
In this work several synthetic aspects of carbohydrate chemistry have been explored. 
The main focus has been addressed to the development and implementation of mild 
glycosidation procedures. Despite the ever increasing number of glycosylating agents 
available, to date one of the most limiting factors for the advancement of glycochemistry is 
surely the lack of a generally applicable method. Furthermore, the most versatile 
glycosylation methods, thioglicosydes, glycosyl trihaloacetimidates and phosphate 
triesters, although very efficient, suffer from the use of strong Lewis and Brønsted acids as 
promoters (such as BF3·Et2O, TMSOTf, NIS and TfOH). These reagents not only 
complicate the experimental procedures because of their corrosiveness, moisture 
sensitivity and difficulty to be handled, but, because of their strong acidity, they also limit 
the pattern of protecting groups to be used. Therefore, the search of new mild 
glycosylation promoters, able to overcome these experimental problems, is continuously 
pursued by several research groups. Recently, in our laboratory some novel protocols for 
the mild activation of trihaloacetimidate donors have been developed. Particularly, 
Yb(OTf)3, commercially available acid washed molecular sieves (AW 300 and 500 MS) and 
Bi(OTf)3 proved to effectively promote the activation of variously protected glycosyl 
trihaloacetimidates, becoming a valid alternative to the harsh promoters classically 
employed. In this thesis a particular emphasis is put on the use of Yb(OTf)3 and AW MS. 
The experimental advantages connected with the use of these cheap and easy to handle 
reagents had been evidenced by previous work. Yb(OTf)3 was reported to be compatible 
with a wide range of very acid-labile protecting groups, as demonstrated by the 
unprecedented withstanding of the dimethoxytrityl moiety in the glycosylation medium. 
Whereas the insolubility of AW MS  guarantees an extreme simplification of the 
experimental procedure, the promoters being easily removed from the reaction mixture by 
simple filtration.  
Interestingly, the two systems exhibited different behaviours towards glycosylation 
stereoselectivity. Yb(OTf)3 proved to be extremely versatile, being compatible with the 
mostly used methodologies to direct the stereochemical outcome of glycosylations, while 
the control of the stereochemistry in AW MS-promoted reaction could be effectively 
performed only exerting the anchimeric assistance of acyl protecting groups, thus limiting 
the application of this latter promoting system to the generation of peculiar types of 
glycosidic bonds. 
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In order to test the effectiveness of Yb(OTf)3 and AW 300 MS promoting systems and 
contextually expand the scope of these approaches, we investigate their application to the 
synthesis of biologically relevant oligosaccharide antigens such as Lewisx trisaccharide 
and Globo-H tetrasaccharide reducing end (Chapter 3). The synthesis of these 
oligosaccharides posed several synthetic challenges due to their structural complexity, 
among the others, the construction of non trivial α-L-fucosidic linkages. A preliminary 
investigation on the feasible use Yb(OTf)3 and AW 300 MS in α-fucosylations promotion 
preceded the assembly of the target molecules. Once settled the suitable conditions for 
performing α-fucosylations, Lewisx and Globo-H tetrasaccharide were synthesized 
exploiting in all glycosidation steps exclusively the mild activating systems developed in 
our laboratory. Moreover, the planned synthetic strategies relied on the use of building 
blocks conveniently prepared from cheap precursors often following unprecedented 
synthetic pathways. The isolation in good overall yield of both oligosaccharide targets 
witnessed the versatility of the proposed glycosylation protocols, evidencing , at the same 
time, the feasibility of the proposed strategy as a valid synthetic alternative for the 
obtainment of these compounds of undoubted pharmacological interest. Noteworthy, in 
the course of Lewisx and Globo-H assembly we faced the need of effectively accessing to a 
galactosyl 1,2-orthoester as key precursor for the obtainment of a crucial building block. 
This experimental necessity prompted us to investigate a feasible protocol for the 
convenient one-pot synthesis of such a derivative. In the course of our survey a novel 
procedure for glycosyl iodides synthesis has been developed. Peracetylated sugars were 
effectively converted into the corresponding anomeric iodides by treatment with the 
I2/Et3SiH combined system, effectively used as source of HI. The iodination protocol was 
then applied to the one-pot synthesis of the glycosyl orthoester of our interest, that could 
effectively be isolated in good overall yield and with a clear simplification of the 
experimental procedure. The protocol was also extended to the syntheses of synthetically 
useful 1,2-ethylidene and 1,2-glycal derivatives (Chapter 2).  
 
A further study was conducted in order to improve the control of the stereochemical 
outcome of Yb(OTf)3-promoted α-glycosylation reactions (Chapter 4). Particularly, the use 
of dimethoxyethane (DME) as a novel α-stereodirecting solvent was proposed. 
Considerable improvements of α-selectivities were registered using DME as cosolvent, 
achieving good results even with primary acceptors as well as with amino acidic residues. 
Furthermore, the beneficial effect of DME as α-stereodirecting solvent was effectively 
proved also in TMSOTf-promoted glycosylations, thus evidencing its general applicability. 
 
Our experience in carbohydrate elaboration exploiting mild procedures prompted the 
implementation of two different projects with the aim of synthesizing novel classes of 
glycoconjugated with pharmacological activity. 
In the first project, in collaboration with dr. Pezzella of University “Federico II” of Napoli, 
the regioselective glycosylation of 17β-estradiol and derivatives thereof was performed 
(Chapter 5). The scope of the work was the improvement of pharmacokinetic and 
pharmacodinamic properties of the drugs, exerting a minimal number of chemical 
operation on the active molecules. Glycosylations either at the phenol or carbinol site of 
the unprotected hormone were carried out taking advantage of the different nature, and 
therefore reactivity, of the two hydroxyl groups. Phenol hydroxyl was glycosylated by 
glycosyl iodides (synthesized with the  I2/Et3SiH-based protocol) in a double phase 
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reaction, while the carbinol hydroxyl was chemoselectively glycosylated in acidic 
conditions exploiting the AW 300 MS activation of glycosyl trichloroacetimidate donors. 
The glycoconjugated derivatives thus generated will be subjected to biological tests to 
evaluate the effect of the glycoconjugation on their pharmacological activity. 
The aim of the second project, supported by Ministero dell’Istruzione, dell’Università e 
della Ricerca  as a “Research Programme of Prominent National Interest”, was the design, 
synthesis and screening of β-lactam-glycoconjugates (Chapter 6). Two class of novel β-
lactam-glycoconjugates were synthesized. The extreme sensitivity of the chosen β-lactam 
structure called for the exploitation of very mild protocols for performing glycosylation 
and deprotection reactions. In the first class of glycoconjugates, the generation of a direct 
linkage between the β-lactam and the saccharidic moieties was performed. The 
glycosylation of the sensitive β-lactam acceptor exploited the mild activation of N-phenyl 
trifluoroacetimidate donors with ytterbium(III) triflate. In the second approach a succinyl 
spacer was interposed between the two cyclic molecules. The glycoconjugates thus 
obtained underwent hydrogenolytic deprotection of the saccharidic portions without the 
β-lactam moiety being affected. Evaluation of these unprecedented derivatives for 
antibiotic activity against resistant bacteria furnished promising results for the second type 
of glycoconjugates. Further studies are in progress. New β-lactam structures have been 
screened and will be conjugated to suitable saccharidic structures generating a second 
generation of antibiotic β-lactam-glycoconjugates. 
 
From the experience matured in activating glycosyl trihalo-acetimidates donors with 
Yb(OTf)3, a novel one-pot approach for the synthesis of oligosaccharides was developed 
exerting the different reactivity exhibited by glycosyl trichloro- and N-phenyl trifluoro-
acetimidates.(Chapter 7). Trisaccharide structures were effectively synthesized by 
sequentially activating glycosyl trichloroacetimidates and the fluorinated analogues by 
adjusting the glycosylation conditions in due course. To the best of our knowledge, this 
represents the first case of trisaccharides one-pot synthesis carried out using exclusively 
trihaloacetimidates as donors and, furthermore, using just catalytic amounts of promoter 
in every glycosylation step.  
 
In the last project a highly effective protocol to convert 1,2-glycosyl orthoesters to C2-acyl 
glycosyl phosphates was developed (Chapter 8). The synthetic scope was established by 
preparing a series of mannosyl, glucosyl, galactosyl, rhamnosyl, xylosyl and 
arabinofuranosyl phosphates in high yield. In situ generation of glycosyl phosphates from 
1,2-orthoesters allowed simple and efficient trirhamnoside antigen assembly. Furthermore, 
the effective protocol thus developed was extended to the syntheses of useful glucosamine 
phosphates from 1,2-oxazolines and mannosyl 1,2,6 orthoester. A novel mild procedure 
has been developed for the synthesis of the unusual  1,2,6 mannosyl orthoester that has 
been then subjected to dibutyl phosphate treatment to yield the very versatile of 6-OH 
mannosyl phosphate, whose applications will be reported in due course. Straightforward 
access to glycosyl phosphate building blocks will facilitate the synthesis of complex 
carbohydrates in solution and by automated solid phase synthesis. 
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